{
  "meta": {
    "title": "Inicet_Nov_2022_Session_2_2022_11_13",
    "url": "https://brainandscalpel.vercel.app/inicet-nov-2022-session-2-2022-11-13-6bd53377.html",
    "scrapedAt": "2025-11-29T18:21:39.880Z"
  },
  "questions": [
    {
      "id": 50000,
      "choices": [
        {
          "id": 200000,
          "text": "<p><span style=\"font-size:12.0pt;\">Glycosaminoglycan</span></p>"
        },
        {
          "id": 200001,
          "text": "<p><span style=\"font-size:12.0pt;\">Urea</span></p>"
        },
        {
          "id": 200002,
          "text": "<p><span style=\"font-size:12.0pt;\">Fructose</span></p>"
        },
        {
          "id": 200003,
          "text": "<p><span style=\"font-size:12.0pt;\">Albumin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Fructosamine (which is used for assessing long term glycemic control in a person with hemolysis) is a glycated product of: (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2022)</span></p>",
      "unique_key": "Q6907227",
      "question_audio": null,
      "question_video": null,
      "map_id": 34562384,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Albumin</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Fructosamine is a compound formed when glucose binds to serum albumin, which is the most abundant protein in the blood. This glycated product provides an indicator of long-term glycemic control because it reflects the average blood glucose levels over the previous 2 to 3 weeks. Since it is primarily formed from the glycation of albumin, option d (Albumin) is the correct answer.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Glycosaminoglycan </strong>refers to a different type of compound, glycosaminoglycans, which are long, linear polysaccharides found in connective tissues.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Urea </strong>is a waste product removed by the kidneys and is not involved in fructosamine formation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fructose</strong> is a sugar but is not directly related to the formation of fructosamine.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Glucose can be attached to proteins, albumin, and also to RBCs forming HbA1c. Fructosamine is term used for all the glycated proteins including <strong>glycated albumin.</strong></span></p><p> </p><p><span style=\"color:#212529;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture11_IMtPhem.jpg\" alt=\"\" width=\"500\" height=\"239\"></span></p><p> </p><p><span style=\"color:#212529;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture12_Gkvqsnu.jpg\" alt=\"\" width=\"400\" height=\"324\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In hemolysis patient, HbA1c analysis cannot be done because it will be falsely decreased due to damage to RBCs and loss of hemoglobin. So, fructosamine determination is used for these patients.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-150418.jpg\" alt=\"\" width=\"1000\" height=\"550\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture11_IMtPhem.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200003,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50001,
      "choices": [
        {
          "id": 200004,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-family:\"Calibri\",sans-serif\">1-b, 2-c, 3-d, 4-a</span></span></span></p>"
        },
        {
          "id": 200005,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-family:\"Calibri\",sans-serif\">1-a, 2-b, 3-d, 4-c</span></span></span></p>"
        },
        {
          "id": 200006,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-family:\"Calibri\",sans-serif\">1-d, 2-c, 3-a, 4-b</span></span></span></p>"
        },
        {
          "id": 200007,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-family:\"Calibri\",sans-serif\">1-c, 2-b, 3-d, 4-a</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following scale types with their lesions?</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13558_1YHi2Nx.jpg\" style=\"height:200px; width:800px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13558_1YHi2Nx.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3267675",
      "question_audio": null,
      "question_video": null,
      "map_id": 34472811,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:\"Calibri\",sans-serif\">Ans. A) 1-b, 2-c, 3-d, 4-a</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Matched Pairs:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><strong><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">1-b: Collarette scales - Pityriasis Rosea:</span> </strong><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Collarette scales are characteristic of Pityriasis Rosea, where these scales are fine, peripherally attached but centrally detached, often found around the edge of the herald patch or subsequent lesions.</span></span></span></li>\r\n\t<li><strong><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">2-c: Silvery scales - Psoriasis</span>: </strong><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Silvery scales are hallmark features of Psoriasis. These scales are typically seen as thick, shiny, and silvery white, indicative of excessive proliferation of skin layers, particularly due to parakeratosis.</span></span></span></li>\r\n\t<li><strong><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">3-d: Mica-like scales - Pityriasis lichenoides chronica:</span> </strong><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Mica-like scales in Pityriasis lichenoides chronica refer to the fine, adherent scales that resemble mineral mica, found on polymorphic lesions that can also show hemorrhagic crusting.</span></span></span></li>\r\n\t<li><strong><span style=\"font-family:Calibri,sans-serif; font-size:12pt\">4-a: Branny scales - Pityriasis versicolor</span>: </strong><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Branny scales are a feature of Pityriasis versicolor, described as fine, powdery, and often easily detachable, much like bran. These scales highlight the superficial fungal infection's impact on the skin.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture8.jpg\" style=\"height:177px; width:500px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture9_6tWtHra.jpg\" style=\"height:229px; width:500px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture10.jpg\" style=\"height:271px; width:500px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture11.jpg\" style=\"height:249px; width:500px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture12_BOpEZzo.jpg\" style=\"height:205px; width:500px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture14.jpg\" style=\"height:253px; width:500px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture15.jpg\" style=\"height:232px; width:500px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:\"Calibri\",sans-serif\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:\"Calibri\",sans-serif\">Diseases & special scales:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-181649.png\" style=\"height:445px; width:1000px\" /></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-family:\"Calibri\",sans-serif\">Ref - Rook's Textbook of Dermatology -9th Edition Chapter 28 Page no 4.13, 26.2, 29.15, 40.1-40.5, 50.6, 65.2, 107.3, 109.8</span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture8.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200004,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50002,
      "choices": [
        {
          "id": 200008,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 200009,
          "text": "<p><span style=\"font-size:12.0pt;\">2</span></p>"
        },
        {
          "id": 200010,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        },
        {
          "id": 200011,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The viruses of the filoviridae family like Ebola and Marburg resemble which of the following morphologies?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-123335.png\" alt=\"\" width=\"600\" height=\"386\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-123335.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q3899457",
      "question_audio": null,
      "question_video": null,
      "map_id": 34355343,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) 3</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Viruses belonging to the filoviridae family, such as Ebola and Marburg, resemble the morphology shown in image 3.</span></li><li><span style=\"font-size:12.0pt;\">Image 3 - Ebola viruses are filamentous viruses with nonsegmented single-stranded RNA as genetic material.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-123451.png\" alt=\"\" width=\"400\" height=\"264\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Image 1- Influenza viruses have linear segmented, single-stranded RNA.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-123609.png\" alt=\"\" width=\"500\" height=\"355\"></p><p> </p><p><span style=\"font-size:12.0pt;\">Image 2- Adenovirus is an icosahedroal symmetry with fibres extruding from vertices and contains double-stranded DNA.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-99.jpg\" alt=\"\" width=\"740\" height=\"368\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Image 4 - Corona virus is non-segmented single-stranded RNA virus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Coronavirus Structure</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-101.jpg\" alt=\"\" width=\"743\" height=\"479\"></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Filoviruses, such as Ebola and Marburg, are filamentous and contain nonsegmented single-stranded RNA.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-123451.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200008,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50003,
      "choices": [
        {
          "id": 200012,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased uptake due to diffuse metastasis</span></p>"
        },
        {
          "id": 200013,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased uptake by carcinoma prostate</span></p>"
        },
        {
          "id": 200014,
          "text": "<p><span style=\"font-size:12.0pt;\">Increased uptake by the bone</span></p>"
        },
        {
          "id": 200015,
          "text": "<p><span style=\"font-size:12.0pt;\">Decreased uptake by adrenal glands and kidney</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A patient who was diagnosed with prostate cancer is being investigated. The bone scan is reported as a super scan with increased uptake in the bones and reduced activity in the kidney and soft tissue. What is the reason for this super scan appearance? (INICET NOV 2022)</span></p>",
      "unique_key": "Q4013040",
      "question_audio": null,
      "question_video": null,
      "map_id": 34532840,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Increased uptake due to diffuse metastasis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The super scan appearance is due to increased uptake due to diffuse metastasis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">On a bone scan, a generalized increase in skeletal uptake relative to soft tissue and absent or faint renal activity. This is referred to as a super scan.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/27/untitled-185.jpg\" alt=\"\" width=\"240\" height=\"443\"></p><p> </p><ul><li><span style=\"color:black;font-size:12.0pt;\">All the bones show diffusely increased uptake whereas<strong> kidneys </strong>are not visualized.</span></li><li><span style=\"color:black;font-size:12.0pt;\">Seen with-</span><ol style=\"list-style-type:lower-roman;\"><li><span style=\"color:black;font-size:12.0pt;\">Metabolic bone diseases</span></li><li><span style=\"color:black;font-size:12.0pt;\">Diffuse Sclerotic bone metastasis</span></li></ol></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Increased uptake by carcinoma prostate: </strong>While the primary prostate carcinoma may cause metastases, the increased uptake seen in a super scan specifically refers to bone metastases, not the primary tumor itself.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Increased uptake by the bone: </strong>This option is too general and does not specify the underlying cause, which in the context of a super scan is typically metastatic disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Decreased uptake by adrenal glands and kidney: </strong>This choice misrepresents the scenario, as the decreased visualization of kidneys is a result of the intense skeletal uptake overshadowing other areas, not due to decreased uptake by these organs themselves.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A bone scan super scan appearance in a patient with known malignancy such as prostate cancer usually indicates extensive bone metastasis, necessitating aggressive management and treatment planning to address widespread disease.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/27/untitled-185.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200012,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50004,
      "choices": [
        {
          "id": 200016,
          "text": "<p><span style=\"font-size:12.0pt;\">Peritoneal Biopsy</span></p>"
        },
        {
          "id": 200017,
          "text": "<p><span style=\"font-size:12.0pt;\">Start ATT</span></p>"
        },
        {
          "id": 200018,
          "text": "<p><span style=\"font-size:12.0pt;\">Observation</span></p>"
        },
        {
          "id": 200019,
          "text": "<p><span style=\"font-size:12.0pt;\">Laparotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with cough, cold, fever, and malaise associated with weight loss and ascites. The patient does not have any evidence of cirrhosis and her coagulation profile is normal. Ascitic fluid analysis showed elevated adenosine deaminase. What can be done next? (INICET NOV 2022)</span></p>",
      "unique_key": "Q9084572",
      "question_audio": null,
      "question_video": null,
      "map_id": 34600232,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Start ATT</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In countries with a high prevalence of tuberculosis, such as India, the presence of elevated adenosine deaminase (ADA) in ascitic fluid is highly suggestive of abdominal tuberculosis (TB). ADA is a useful diagnostic marker for TB, particularly when its levels are significantly elevated (e.g., above 39 IU/L). Given the clinical context of weight loss, fever, and ascites, along with a high ADA level, it is reasonable to initiate anti-tubercular therapy (ATT) without further invasive testing. Starting ATT and monitoring the patient's response is an effective and practical approach, especially in resource-limited settings. This strategy avoids unnecessary invasive procedures like peritoneal biopsy, which should be reserved for cases where there is doubt about the diagnosis or if the patient does not respond to initial therapy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Peritoneal Biopsy:</strong> While peritoneal biopsy is the gold standard for diagnosing peritoneal TB, it is invasive and resource-intensive. In high-prevalence areas, where elevated ADA levels strongly suggest TB, initiating ATT is preferred.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Observation:</strong> Given the significant clinical symptoms and elevated ADA levels, mere observation is not appropriate. Delay in treatment could lead to worsening of the patient’s condition.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Laparotomy:</strong> Laparotomy is an invasive surgical procedure and is not warranted for diagnosing TB when non-invasive methods like ADA testing and clinical presentation strongly suggest the disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In high-prevalence countries for tuberculosis, elevated adenosine deaminase (ADA) in ascitic fluid, along with clinical signs, is sufficient to start anti-tubercular therapy (ATT) without the need for invasive procedures.</span></p>",
      "correct_choice_id": 200017,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50005,
      "choices": [
        {
          "id": 200020,
          "text": "<p><span style=\"font-size:12pt;\">Gottron's papules - Juvenile dermatomyositis</span></p>"
        },
        {
          "id": 200021,
          "text": "<p><span style=\"font-size:12pt;\">Rheumatoid nodules - Juvenile rheumatic arthritis</span></p>"
        },
        {
          "id": 200022,
          "text": "<p><span style=\"font-size:12pt;\">Sclerodactyly - Systemic sclerosis</span></p>"
        },
        {
          "id": 200023,
          "text": "<p><span style=\"font-size:12pt;\">Mechanic's hand - Systemic lupus erythematosus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The clinical finding in the 10-year-old boy includes fever, joint pain, and a hand lesion as shown in the image below. What is the likely diagnosis based on these findings? (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/1_3RUwRSy.jpg\" alt=\"\" width=\"300\" height=\"224\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/1_3RUwRSy.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4888432",
      "question_audio": null,
      "question_video": null,
      "map_id": 34577745,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Gottron's papules - Juvenile dermatomyositis.</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Juvenile dermatomyositis </strong>is a rare <strong>inflammatory</strong> disease affecting the skin and <strong>muscles</strong>. It typically presents in children with a characteristic <strong>skin rash</strong> and <strong>muscle weakness</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Gottron's papules </strong>are distinctive <strong>red or violet</strong>, raised, scaly lesions seen over <strong>knuckles </strong>(dorsal interphalangeal or metacarpophalangeal joints)<strong>, elbows, knees</strong>, and other <strong>extensor</strong> surfaces, highly suggestive of dermatomyositis.</span></li><li><span style=\"font-size:12pt;\">The combination of <strong>fever, joint pain, and Gottron's papules strongly indicates juvenile dermatomyositis.</strong></span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other features associated with Dermatomyositis are:</strong></span></p><p><span style=\"font-size:12pt;\"><strong> </strong></span></p><ul><li><span style=\"font-size:12pt;\"><strong>The Gottron's sign </strong>is a distribution of symmetric, <strong>non-scaling</strong>, <strong>violaceous, erythematous macules or plaques</strong> that are frequently <strong>atrophic</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture1.jpg\" alt=\"\" width=\"300\" height=\"201\"></strong></i></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Gottron's sign: seen in the above image</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Shawl sign or V-sign: </strong>Fixed <strong>macular erythema</strong> spanning the <strong>shoulders</strong> and <strong>outer arms</strong> (Shawl distribution) as seen in the image below</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture2.jpg\" alt=\"\" width=\"300\" height=\"228\"></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Periungual telangiectasias: </strong>enlarged capillaries in the <strong>nail folds</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture3_TWy4qiE.jpg\" alt=\"\" width=\"300\" height=\"222\"></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Mechanic's hand:</strong> <strong>Roughening </strong>and cracking of the <strong>fingertip</strong> and <strong>side</strong> skin that results in <strong>scuffed, crooked lines</strong> that resemble those of a <strong>mechanic or manual laborer.</strong></span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><i><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture4.jpg\" alt=\"\" width=\"300\" height=\"224\"></strong></i></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Proximal myopathy: </strong>Patients have trouble performing everyday activities like <strong>climbing stairs, getting up</strong>, and <strong>lifting their arms</strong> above their heads.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Laboratory evaluation </strong>of patients with <strong>dermatomyositis</strong> will reveal <strong>elevated serum creatinine kinase</strong> and <strong>antinuclear antibodies.</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Rheumatoid nodules - Juvenile rheumatoid arthritis:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Juvenile rheumatoid arthritis </strong>is an <strong>autoimmune disorder </strong>causing chronic <strong>joint inflammation </strong>in <strong>children.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Rheumatoid nodules </strong>are <strong>firm, painless</strong>, <strong>subcutaneous nodules </strong>that usually occur in areas of <strong>pressure</strong> but are <strong>not typically </strong>seen in the <strong>hands</strong> in this form.</span></li><li><span style=\"font-size:12pt;\">The lesion in the image doesn't match the typical appearance of rheumatoid nodules.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C Sclerodactyly - Systemic sclerosis:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Systemic sclerosis </strong>is a <strong>connective tissue</strong> disease characterized by skin <strong>thickening</strong> and <strong>hardening</strong> <strong>(scleroderma).</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Sclerodactyly </strong>refers to <strong>thickening and tightening</strong> of the skin on the <strong>fingers</strong> and <strong>hands</strong>, leading to a <strong>claw-like appearance</strong>.</span></li><li><span style=\"font-size:12pt;\">The lesion shown doesn't indicate the skin thickening or tightness characteristic of sclerodactyly.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D Mechanic's hand - Systemic lupus erythematosus (SLE):</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>SLE </strong>is an <strong>autoimmune</strong> disease affecting <strong>multiple organ</strong> systems.</span></li><li><span style=\"font-size:12pt;\"><strong>Mechanic's hand </strong>is a sign associated more with <strong>dermatomyositis</strong> than SLE, characterized by <strong>rough, cracked skin</strong> on the sides of the <strong>fingers,</strong> mimicking the hands of a <strong>manual labourer</strong>.</span></li><li><span style=\"font-size:12pt;\">The presentation of mechanic's hand in SLE is less common and the symptoms described do not align well with SLE.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">In a case involving <strong>fever, joint pain, and hand lesions in a child</strong>, the presence of <strong>Gottron's papules</strong> is indicative of <strong>Juvenile dermatomyositis</strong>.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition Chapter 53 page no 53.1-53.12</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Harrison’s principles of internal medicine 21<sup>st</sup> edition Page 2820-2821</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture1.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200020,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50006,
      "choices": [
        {
          "id": 200024,
          "text": "<p><span style=\"font-size:12pt;\">3, 1, 2, 4</span></p>"
        },
        {
          "id": 200025,
          "text": "<p><span style=\"font-size:12pt;\">3, 2, 4, 1</span></p>"
        },
        {
          "id": 200026,
          "text": "<p><span style=\"font-size:12pt;\">2, 4, 3, 1</span></p>"
        },
        {
          "id": 200027,
          "text": "<p><span style=\"font-size:12pt;\">2, 4, 1, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Consider the following actions under AMTSL. Arrange them in the right order? </span>(INICET NOV 2022)</p><p> </p><ol><li><span style=\"font-size:12pt;\">Uterine tone assessment</span></li><li><span style=\"font-size:12pt;\">Give uterotonic (oxytocin 10 mg)</span></li><li><span style=\"font-size:12pt;\">Exclude the presence of another fetus</span></li><li><span style=\"font-size:12pt;\">Controlled cord traction</span></li></ol><p> </p><p><span style=\"font-size:12pt;\">AMTSL- Active management of the third stage of labor.</span></p>",
      "unique_key": "Q4134041",
      "question_audio": null,
      "question_video": null,
      "map_id": 34790965,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 3, 2, 4, 1</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Active Management of 3<sup>rd</sup> Stage of Labor</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Active Management of the Third Stage of Labor (AMTSL) is a set of interventions aimed at preventing postpartum hemorrhage (PPH). The correct order of actions is:</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>3. Exclude the presence of another fetus</strong>: Ensure there is no additional fetus before administering any uterotonic.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>2. Give uterotonic (oxytocin 10 mg)</strong>: Administer a uterotonic drug to help the uterus contract and reduce bleeding. It is given after the delivery of baby.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>4. Controlled cord traction</strong>: Perform controlled traction on the umbilical cord to deliver the placenta.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>1. Uterine tone assessment</strong>:<strong> </strong>assess the uterine tone every 15 minutes to detect uterine atony.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The steps of Active Management of the Third Stage of Labor (AMTSL) should be followed in a specific order: exclude the presence of another fetus, administer a uterotonic, perform controlled cord traction, and then assess the uterine tone.</span></p>",
      "correct_choice_id": 200025,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50007,
      "choices": [
        {
          "id": 200028,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3</span></p>"
        },
        {
          "id": 200029,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4</span></p>"
        },
        {
          "id": 200030,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 200031,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following types of headaches requires further evaluation? (INICET NOV 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Headache for > 4 hours</span></li><li><span style=\"font-size:12.0pt;\">Worst headache of life</span></li><li><span style=\"font-size:12.0pt;\">New-onset progressive headache</span></li><li><span style=\"font-size:12.0pt;\">Headache with blurring of vision</span></li></ol>",
      "unique_key": "Q8138182",
      "question_audio": null,
      "question_video": null,
      "map_id": 34815777,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.  C) 2, 3, 4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Certain types of headaches can be indicative of serious underlying conditions and thus require further evaluation to rule out life-threatening or severe pathologies:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2. Worst headache of life:</strong> This is a classic description of a subarachnoid hemorrhage, which is a medical emergency. Patients experiencing this type of headache require immediate medical attention and thorough investigation, typically involving neuroimaging.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>3. New-onset progressive headache:</strong> Progressive headaches, especially those that are new in onset and occur in adults, raise concern for potential serious conditions such as brain tumors or other intracranial pathologies. These headaches warrant detailed medical evaluation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>4. Headache with blurring of vision:</strong> This symptom combination suggests possible increased intracranial pressure, which can be associated with conditions like papilledema or optic neuritis. Such cases need prompt assessment to determine the cause and appropriate management.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Option:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. Headache for > 4 hours:</strong> While a headache lasting more than four hours can be distressing, it is not necessarily indicative of a severe underlying condition. Such headaches could be primary headaches like tension-type headaches or migraines, which often do not require immediate further evaluation unless they have other alarming features.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Headaches described as the \"worst headache of life,\" new-onset progressive headaches, and headaches accompanied by blurring of vision require further medical evaluation to rule out serious conditions.</span></p>",
      "correct_choice_id": 200030,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50008,
      "choices": [
        {
          "id": 200032,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1, 2, 3</span></span></p>"
        },
        {
          "id": 200033,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">4, 3, 2, 1</span></span></p>"
        },
        {
          "id": 200034,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1, 2 </span></span></p>"
        },
        {
          "id": 200035,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">3, 4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following drugs is a β2 agonist? </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dopexamine</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Dipivefrine</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Fenoldopam</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Mirabegron</span></span></li>\r\n</ol>",
      "unique_key": "Q1007488",
      "question_audio": null,
      "question_video": null,
      "map_id": 34993214,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) 1, 2</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Dipivefrine</strong> and <strong>dopexamine</strong> are β2-adrenergic receptor agonists.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Dipivefrine</strong> is a prodrug of epinephrine used to lower intraocular pressure in patients with open-angle glaucoma and ocular hypertension. It decreases aqueous humor production and enhances its outflow.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Dopexamine</strong> is a synthetic analogue of dopamine, which acts on <strong>D1</strong> and <strong>D2</strong> receptors and exhibits weak activity on <strong>β2 receptors</strong>. It is used in patients with severe heart failure, sepsis, and shock.</span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Fenoldopam</strong> (Option 3) is a selective <strong>D1 receptor agonist</strong> with moderate affinity for <strong>α2-adrenergic receptors</strong>. It is primarily used as a vasodilator in hypertensive emergencies and does not act as a β2 agonist.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Mirabegron</strong> (Option 4) is a <strong>β3-adrenergic receptor agonist</strong> used to treat overactive bladder by relaxing the detrusor muscle, increasing bladder capacity, and improving storage symptoms. It is not a β2 agonist.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Dipivefrine</strong> and <strong>dopexamine</strong> are β2-adrenergic receptor agonists used in clinical settings for conditions such as glaucoma and heart failure, respectively. Recognizing drug-receptor interactions is essential for understanding their therapeutic applications.</span></span></p>",
      "correct_choice_id": 200034,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50009,
      "choices": [
        {
          "id": 200036,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Equinus, eversion, forefoot adduction, cavus</span></span></p>"
        },
        {
          "id": 200037,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Equinus, inversion, forefoot adduction, cavus</span></span></p>"
        },
        {
          "id": 200038,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Equinus, eversion, forefoot abduction, cavus</span></span></p>"
        },
        {
          "id": 200039,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Equinus, inversion, forefoot adduction, planus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Combination of appearance in CTEV (Congenital Talipes Equinovarus) is: </span></span></p>",
      "unique_key": "Q6313925",
      "question_audio": null,
      "question_video": null,
      "map_id": 34359617,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) Equinus, inversion, forefoot adduction, cavus</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">In <strong><span style=\"font-family:\"Calibri\",sans-serif\">congenital talipes equinovarus</span></strong> (CTEV), or <strong><span style=\"font-family:\"Calibri\",sans-serif\">idiopathic clubfoot</span></strong>, the deformity involves <strong><span style=\"font-family:\"Calibri\",sans-serif\">equinus</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">inversion</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">forefoot adduction</span></strong>, and <strong><span style=\"font-family:\"Calibri\",sans-serif\">cavus</span></strong>. CTEV is a congenital malformation of the foot and is predominantly seen in <strong><span style=\"font-family:\"Calibri\",sans-serif\">male children</span></strong>. The calf and medial foot tissues are underdeveloped.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h4><strong><span style=\"font-size:12pt\"><span style=\"font-family:\"Calibri Light\",sans-serif\"><em><span style=\"font-family:\"Calibri\",sans-serif\">Components of the deformity:</span></em></span></span></strong></h4>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Cavus</span></strong>: This deformity occurs due to exaggerated arching of the foot at the <strong><span style=\"font-family:\"Calibri\",sans-serif\">mid-tarsal joint</span></strong>.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Adduction</span></strong>: This deformity occurs at the <strong><span style=\"font-family:\"Calibri\",sans-serif\">talonavicular joint</span></strong>.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Inversion</span></strong>: This deformity occurs at the <strong><span style=\"font-family:\"Calibri\",sans-serif\">subtalar joint</span></strong>, where the calcaneus is inverted, leading to a medially facing sole.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Equinus</span></strong>: This deformity occurs at the <strong><span style=\"font-family:\"Calibri\",sans-serif\">ankle joint and tarsal joints</span></strong>, causing plantar flexion.</span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The equinovarus deformity causes <strong><span style=\"font-family:\"Calibri\",sans-serif\">inward twisting of the foot</span></strong>, with the sole facing posteromedially in severe cases. Associated disorders like <strong><span style=\"font-family:\"Calibri\",sans-serif\">hip dislocation</span></strong> and <strong><span style=\"font-family:\"Calibri\",sans-serif\">spina bifida</span></strong> should be evaluated.</span></span></span></p>\r\n\r\n<h4> </h4>\r\n\r\n<h4><strong><span style=\"font-size:12pt\"><span style=\"font-family:\"Calibri Light\",sans-serif\"><em><span style=\"font-family:\"Calibri\",sans-serif\">Treatment:</span></em></span></span></strong></h4>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ponseti's method </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">is a successful manipulation technique for CTEV. It begins as early as the first 2 weeks after birth, involving weekly manipulation of the foot using plaster casts. Ponseti’s method follows the correction order: <strong><span style=\"font-family:\"Calibri\",sans-serif\">Cavus-adduction-varus-equinus (CAVE)</span></strong>.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Typically, <strong><span style=\"font-family:\"Calibri\",sans-serif\">five casts</span></strong> are required for correction, followed by bracing to maintain the corrected position. <strong><span style=\"font-family:\"Calibri\",sans-serif\">Foot abduction brace (FAB)</span></strong> is used initially full-time and then at night for up to <strong><span style=\"font-family:\"Calibri\",sans-serif\">4 years</span></strong> to prevent relapse.</span></span></span></li>\r\n</ul>\r\n\r\n<h3> </h3>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Equinus, eversion, forefoot adduction, cavus: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">This option is incorrect as the deformity involves <strong><span style=\"font-family:\"Calibri\",sans-serif\">inversion</span></strong>, not eversion.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Equinus, eversion, forefoot abduction, cavus: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">This option is incorrect because <strong><span style=\"font-family:\"Calibri\",sans-serif\">forefoot adduction</span></strong> is the correct deformity pattern, not abduction, and <strong><span style=\"font-family:\"Calibri\",sans-serif\">inversion</span></strong>, not eversion.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Equinus, inversion, forefoot adduction, planus: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">While this option correctly includes <strong><span style=\"font-family:\"Calibri\",sans-serif\">equinus</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">inversion</span></strong>, and <strong><span style=\"font-family:\"Calibri\",sans-serif\">adduction</span></strong>, it incorrectly describes the foot as <strong><span style=\"font-family:\"Calibri\",sans-serif\">planus</span></strong> (flat). In <strong><span style=\"font-family:\"Calibri\",sans-serif\">CTEV</span></strong>, there is <strong><span style=\"font-family:\"Calibri\",sans-serif\">cavus</span></strong>, or an exaggerated arch.</span></span></span></p>\r\n\r\n<h3> </h3>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The deformity in <strong><span style=\"font-family:\"Calibri\",sans-serif\">Congenital Talipes Equinovarus (CTEV)</span></strong> consists of <strong><span style=\"font-family:\"Calibri\",sans-serif\">equinus</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">inversion</span></strong>, <strong><span style=\"font-family:\"Calibri\",sans-serif\">forefoot adduction</span></strong>, and <strong><span style=\"font-family:\"Calibri\",sans-serif\">cavus</span></strong>. Early detection and treatment using <strong><span style=\"font-family:\"Calibri\",sans-serif\">Ponseti’s method</span></strong> can correct the deformity and prevent long-term complications.</span></span></span></p>",
      "correct_choice_id": 200037,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50010,
      "choices": [
        {
          "id": 200040,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">100 mL/hour</span></span></span></span></p>"
        },
        {
          "id": 200041,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">150 mL/hour</span></span></span></span></p>"
        },
        {
          "id": 200042,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">50 mL/hour</span></span></span></span></p>"
        },
        {
          "id": 200043,
          "text": "<p><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">200 mL/hour</span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What is the normal insensible water loss?</span></span><strong> </strong></p>",
      "unique_key": "Q9985355",
      "question_audio": null,
      "question_video": null,
      "map_id": 34019993,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) 50 mL/hour</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The normal insensible water loss is 50 mL/hour.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In human beings, there is a loss of water through vaporization from the respiratory tract (300–400 mL) and diffusion from the skin (300–400 mL). This is called insensible water loss. It is about 50 mL/hour. This insensible water loss via the skin is independent of sweating and occurs in people without sweat glands as well.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. 100 mL/hour</span></strong>: 100 mL/hour is incorrect. The normal insensible water loss is <strong><span style=\"font-family:\"Calibri\",sans-serif\">50 mL/hour</span></strong>, not 100 mL/hour.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. 150 mL/hour</span></strong>: 150 mL/hour is incorrect. Insensible water loss is less, typically around <strong><span style=\"font-family:\"Calibri\",sans-serif\">50 mL/hour</span></strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. 200 mL/hour</span></strong>: 200 mL/hour is incorrect. This value is too high for normal insensible water loss.</span></span></p>\r\n\r\n<h3> </h3>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Insensible water loss is the loss of water through vaporization from the respiratory tract and diffusion from the skin, which accounts for approximately <strong><span style=\"font-family:\"Calibri\",sans-serif\">50 mL/hour</span></strong> in humans.</span></span></span></p>",
      "correct_choice_id": 200042,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50011,
      "choices": [
        {
          "id": 200044,
          "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone</span></p>"
        },
        {
          "id": 200045,
          "text": "<p><span style=\"font-size:12.0pt;\">Amoxicillin+ clavulanate</span></p>"
        },
        {
          "id": 200046,
          "text": "<p><span style=\"font-size:12.0pt;\">Vancomycin</span></p>"
        },
        {
          "id": 200047,
          "text": "<p><span style=\"font-size:12.0pt;\">Meropenem</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with complaints of fever, rash, body ache, and throat ache. He has a history of thorn prick injury a week back. What antibiotics would you give empirically to this child?</span> <span style=\"font-size:12.0pt;\">(INICET NOV 2022)</span></p>",
      "unique_key": "Q3526796",
      "question_audio": null,
      "question_video": null,
      "map_id": 34149799,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Amoxicilin +clavulanate</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The symptoms described in this case—fever, rash, sore throat, and body aches—following a thorn prick injury suggest the possibility of <strong>scarlet fever</strong> caused by Group A Streptococcus (GAS). Scarlet fever typically presents with a diffuse erythematous rash, which may be papular, along with other symptoms such as a sore throat, body aches, and the characteristic \"strawberry tongue.\"</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Scarlet Fever and GAS: </strong>Scarlet fever is most commonly caused by GAS and is characterized by the production of pyrogenic (erythrogenic) exotoxin, leading to the rash and other systemic symptoms.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Empirical Antibiotic Treatment:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Amoxicillin + Clavulanate</strong>: This combination is a first-line treatment for infections caused by GAS, particularly when there is a concern for beta-lactamase-producing bacteria. Clavulanate inhibits beta-lactamase enzymes, allowing amoxicillin to remain effective against the bacteria.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Penicillin or Amoxicillin </strong>alone is generally the treatment of choice for scarlet fever, but adding clavulanate broadens the spectrum to cover potential mixed infections.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Diagnostic Confirmation: </strong>While empirical treatment is initiated, a rapid antigen detection test or throat culture for Streptococcus should be performed to confirm the diagnosis of GAS infection.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Ceftriaxone: </strong>Ceftriaxone is a broad-spectrum antibiotic that is typically reserved for more severe infections requiring hospitalization. It is not the first choice for uncomplicated scarlet fever.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vancomycin. and Option D. Meropenem: </strong>These are higher-tier antibiotics reserved for severe or resistant infections, often guided by culture and sensitivity results. They are not typically used as first-line treatment in cases of suspected scarlet fever or mild GAS infections.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">For a child presenting with symptoms suggestive of scarlet fever following a thorn prick injury, empirical antibiotic treatment with amoxicillin + clavulanate is appropriate while awaiting diagnostic confirmation of Group A Streptococcus infection.</span></p>",
      "correct_choice_id": 200045,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50012,
      "choices": [
        {
          "id": 200048,
          "text": "<p><span style=\"font-size:12pt;\">Yellow fluorescence</span></p>"
        },
        {
          "id": 200049,
          "text": "<p><span style=\"font-size:12pt;\">Coral red fluorescence</span></p>"
        },
        {
          "id": 200050,
          "text": "<p><span style=\"font-size:12pt;\">Blue fluorescence</span></p>"
        },
        {
          "id": 200051,
          "text": "<p><span style=\"font-size:12pt;\">Green fluorescence</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a diabetic patient, the following lesions are present in the armpit. What would be observed during a Wood's lamp examination? </span>(INICET NOVEMBER 2022)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13579.jpg\" alt=\"\" width=\"300\" height=\"224\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/19/untitled-13579.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6930420",
      "question_audio": null,
      "question_video": null,
      "map_id": 34695771,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Coral red fluorescence.</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">The clinical scenario of a <strong>diabetic patient</strong>, along with the observed <strong>hyperpigmented </strong>lesion in <strong>axilla</strong> strongly suggests e<strong>rythrasma</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Coral-red fluorescence under Wood's lamp examination </strong>is the characteristic finding in this disease.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture20.jpg\" alt=\"\" width=\"400\" height=\"224\"></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Erythrasma</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">It is a skin infection caused by <strong>Corynebacterium minutissimum</strong>. This condition is commonly seen in individuals with diabetes and weakened immune systems and is associated with factors such as <strong>obesity, excessive sweating, and poor hygiene.</strong></span></li><li><span style=\"font-size:12pt;\">The characteristic feature of erythrasma is the <strong>presence of hyperpigmented patches that are typically asymptomatic.</strong> These patches commonly appear in areas like the <strong>axilla, groin, intergluteal, and sub-mammary regions.</strong></span></li><li><span style=\"font-size:12pt;\">The <strong>coral pink fluorescence observed during Wood's lamp examination</strong> is a defining feature of erythrasma and is caused by <strong>coproporphyrin III</strong>, a pigment produced by the <strong>bacterium</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture21.jpg\" alt=\"\" width=\"300\" height=\"249\"></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Wood's lamp uses ultraviolet wavelength light at <strong>365nm (320-400nm)</strong> with a peak at 365nm. <strong>The filter of the Wood's lamp is composed of Barium silicate and 9% Nickel oxide.</strong></span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options: </strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Yellow fluorescence: </strong>Often seen with <strong>Pityriasis versicolor</strong>, which fluoresces yellow or apple green due to the presence of tryptophan metabolites produced by Malassezia species.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Blue fluorescence: </strong>Not commonly associated with bacterial or fungal infections of the skin but may appear in certain conditions unrelated to common skin infections.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Green fluorescence: </strong>Typically observed with <strong>Pseudomonas infections</strong> or some cases of <strong>Tinea capitis</strong> caused by fungi that produce substances that fluoresce green.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Additional Information</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Table: Various diseases & their colour on woods lamp examination</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-22-175903.jpg\" alt=\"\" width=\"1000\" height=\"422\"></strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture22.jpg\" alt=\"\" width=\"300\" height=\"211\"></strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture23.jpg\" alt=\"\" width=\"400\" height=\"166\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-182645.png\" alt=\"\" width=\"500\" height=\"228\"></p><p> </p><p><span style=\"color:black;font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"color:black;font-size:12pt;\">The <strong>Wood's</strong> lamp uses <strong>UVA</strong> light with a wavelength of <strong>365nm</strong> (<strong>320</strong>-<strong>400</strong> nm) for the diagnosis of various skin conditions based on the <strong>fluorescence</strong> characteristics of the skin under this specific range of ultraviolet light.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref - Rooks textbook of dermatology- 9<sup>th</sup> Edition volume I Chapter 4 page no 4.20</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Rook's Textbook of Dermatology -9th Edition, Chapter 26 Page no 26.40</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Image source: </strong></span><a href=\"https://dermnetnz.org/assets/Uploads/bacterial/erythrasma13__WatermarkedWyJXYXRlcm1hcmtlZCJd.jpg\"><span style=\"font-size:12pt;\"><strong><u>https://dermnetnz.org/assets/Uploads/bacterial/erythrasma13__WatermarkedWyJXYXRlcm1hcmtlZCJd.jpg</u></strong></span></a></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/picture20.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200049,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50013,
      "choices": [
        {
          "id": 200052,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Masson's trichrome</span></span></span></p>"
        },
        {
          "id": 200053,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Prussian blue</span></span></span></p>"
        },
        {
          "id": 200054,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">PAS</span></span></span></p>"
        },
        {
          "id": 200055,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Fite-Faraco</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What of the following stain can be used for staining Iron in tissues? </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">(INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q1277148",
      "question_audio": null,
      "question_video": null,
      "map_id": 34552281,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>B) Prussian blue </strong> </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Perl's iron stain </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">is the classic method for demonstrating iron in tissues. The section is treated with dilute hydrochloric acid to release ferric ions from binding proteins. These ions then react with potassium ferrocyanide to produce an insoluble blue compound (<strong>the Prussian blue reaction).</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/52_XMAcGmy.jpg\" style=\"height:379px; width:577px\" /></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Used in <strong>hereditary hemochromatosis</strong> to stain liver tissue, lead toxicity to visualize iron-laden mitochondria <strong>of ring sideroblasts and myelodysplastic syndrome</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Masson's trichrome</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This stain is used to differentiate between collagen and other tissue components. It stains collagen fibers blue or green, muscle fibers red, and cytoplasm light red or pink. It is not used for detecting iron.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. PAS (Periodic Acid-Schiff)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: PAS stain is primarily used to detect glycogen and other polysaccharides in tissues. It stains these components magenta. PAS is not useful for detecting iron in tissues.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Fite-Faraco</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a special stain used for detecting <strong>Mycobacterium leprae</strong>, the bacterium responsible for leprosy. It is not used for staining iron.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Prussian blue stain is specifically used for detecting iron deposits in tissues, particularly in cases of iron overload or iron-related disorders.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/52_XMAcGmy.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200053,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50014,
      "choices": [
        {
          "id": 200056,
          "text": "<p><span style=\"font-size:12.0pt;\">Durham's rule</span></p>"
        },
        {
          "id": 200057,
          "text": "<p><span style=\"font-size:12.0pt;\">Curren's rule</span></p>"
        },
        {
          "id": 200058,
          "text": "<p><span style=\"font-size:12.0pt;\">Both A and B</span></p>"
        },
        {
          "id": 200059,
          "text": "<p><span style=\"font-size:12.0pt;\">Neither A nor B</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following rules of law are associated with insanity? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2022)</span></p>",
      "unique_key": "Q7598022",
      "question_audio": null,
      "question_video": null,
      "map_id": 34358969,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Both A and B</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Durham's rule and Curren's rule are laws associated with insanity.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Curren's rule of 1964 states that an accused person is not criminally responsible, if at the time of committing the act, he did not have the capacity to regulate his conduct to the requirements of the law, as a result of mental disease or defect.</span></li><li><span style=\"font-size:12.0pt;\">Durham 's rule of 1954 States that an accused person is not criminally responsible if his unlawful act is the product of mental disease or mental defect.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Both Durham's rule and Curren's rule are significant tests used to determine criminal responsibility in cases where the defendant's mental state is in question.</span></p>",
      "correct_choice_id": 200058,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50015,
      "choices": [
        {
          "id": 200060,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Raltegravir</span></span></span></span></span></p>"
        },
        {
          "id": 200061,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Enfuvirtide</span></span></span></span></span></p>"
        },
        {
          "id": 200062,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Tenofovir</span></span></span></span></span></p>"
        },
        {
          "id": 200063,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Zidovudine</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The image below shows the life cycle of human immunodeficiency virus. Which of the following drugs acts at step 5? (INICET NOV 2022)</span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/752.jpg\" style=\"height:262px; width:300px\" /></span></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/752.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1650113",
      "question_audio": null,
      "question_video": null,
      "map_id": 34325022,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A. </span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Raltegravir</span></span></strong></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The step 5 in the given image shows the step of integration of the viral genome into the host DNA with the help of Integrase enzyme. Among the above given drugs, Raltegravir can be used to block this step as it is an integrase inhibitor.</span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/8.jpg\" style=\"height:491px; width:600px\" /></span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Enfuvirtide: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">It is fusion inhibitor, which acts by binding to gp41 protein on the surface of the virus. This inhibits the Step 1 of this diagram.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Tenofovir & Option D) Zidovudine</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">: These are NRTIs which are used in combination therapy against HIV virus. NRTI works by inhibiting the activity of reverse transcriptase (Step 6 of the diagram), thereby, preventing the viral replication.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/8.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200060,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50016,
      "choices": [
        {
          "id": 200064,
          "text": "<p><span style=\"font-size:12.0pt;\">30% malignant transformation</span></p>"
        },
        {
          "id": 200065,
          "text": "<p><span style=\"font-size:12.0pt;\">Epiphyseal</span></p>"
        },
        {
          "id": 200066,
          "text": "<p><span style=\"font-size:12.0pt;\">Ground glass opacity is diagnostic</span></p>"
        },
        {
          "id": 200067,
          "text": "<p><span style=\"font-size:12.0pt;\">Radiotherapy is the treatment</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following statements is correct regarding the tumor shown in the radiograph? </span>(INICET NOVEMBER 2022)</p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102700.jpg\" alt=\"\" width=\"250\" height=\"344\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102700.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3662301",
      "question_audio": null,
      "question_video": null,
      "map_id": 34501105,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Epiphyseal</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>GIANT-CELL TUMOR (Osteoclastoma):</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">It is bone lesion of uncertain origin, most commonly seen in distal femur, proximal tibia, proximal humerus and distal radius.</span></li><li><span style=\"font-size:12.0pt;\">Most commonly seen in 20-40 years of age, after epiphyseal fusion.</span></li><li><span style=\"font-size:12.0pt;\">There is a slight <strong>female predominance</strong>.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Histology</strong><i><strong>:</strong></i></span><ul><li><span style=\"font-size:12.0pt;\">Multinucleated giant cells are seen on a background of stromal cells with little or no visible intercellular tissue.</span></li><li><span style=\"font-size:12.0pt;\">The osteoclast giant cells are the malignant cells, which induce the proliferation of mononuclear macrophage-lineage cells, hence the dividing cell population is the mononuclear cells which form the matrix.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">GCT has egg shell crackling on palpation.</span></li><li><span style=\"font-size:12.0pt;\">Although these tumors typically are benign, pulmonary metastases occur in approximately 3% of patients.</span></li><li><span style=\"font-size:12.0pt;\">Malignant giant cell tumors represent less than 5% of total GCT.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong></span><ul><li><span style=\"font-size:12.0pt;\">Most commonly presents with pain, with or without swelling</span></li><li><span style=\"font-size:12.0pt;\">Pathological fracture occurs in 10-15% of cases</span></li><li><span style=\"font-size:12.0pt;\">Pulmonary metastasis occurs in 4% of cases, but they usually regress spontaneously.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Radiological features:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Eccentric lytic lesion at epiphyseal region</strong>, bounded by subchondral bone plate, with <strong>soap bubble appearance </strong>without any calcifications & reactive sclerosis.</span></li><li><span style=\"font-size:12.0pt;\">Biopsy is necessary for confirming the diagnosis.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Treatment:</strong></span><ul><li><span style=\"font-size:12.0pt;\"><strong>Curettage and ‘stripping’ of the cavity</strong>, followed by swabbing with hydrogen peroxide or by the application of liquid nitrogen.</span></li><li><span style=\"font-size:12.0pt;\">More aggressive tumors and recurrent lesions<i>: </i><strong>Excision followed by bone grafting</strong>.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 30% malignant transformation</strong>. This is incorrect. Pulmonary metastases occur in approximately 3% of patients. Malignant giant cell tumors represent less than 5% of total GCT.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Ground glass opacity is diagnostic</strong>. This is incorrect. Ground glass opacity of the bone is seen in fibrous dysplasia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Radiotherapy is the treatment</strong>. This is incorrect. The mainstay of treatment of GCT is curettage and stripping of the cavity. More aggressive tumors are treated by excision and bone grafting.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Giant cell tumors are epiphyseal tumors of the long bones.</span></li></ul>",
      "correct_choice_id": 200065,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50017,
      "choices": [
        {
          "id": 200068,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Café au lait spot</span></span></p>"
        },
        {
          "id": 200069,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Medullary thyroid carcinoma</span></span></p>"
        },
        {
          "id": 200070,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Parathyroid adenoma</span></span></p>"
        },
        {
          "id": 200071,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Optic nerve glioma</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is seen in MEN 2B syndrome? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q5917370",
      "question_audio": null,
      "question_video": null,
      "map_id": 34174943,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Medullary thyroid carcinoma</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Multiple Endocrine Neoplasia type 2B (MEN 2B) is a genetic syndrome characterized by the presence of specific tumors and physical features. This syndrome is often referred to as \"Triple M syndrome\" because it commonly presents with three key features: mucosal neuromas, a marfanoid body habitus, and medullary thyroid carcinoma. In addition, pheochromocytomas may also occur.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Medullary thyroid carcinoma (MTC) is a type of thyroid cancer originating from the parafollicular cells (C cells) that produce calcitonin. MTC is a hallmark of MEN 2B, making it one of the primary diagnostic criteria for the syndrome.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The condition is associated with mutations in the RET proto-oncogene, specifically the codon 918 mutation on chromosome 10, which leads to the development of these tumors.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Café au lait spot:</span></strong><span style=\"font-size:12.0pt\"> Café au lait spots are not characteristic of MEN 2B syndrome. These pigmented skin lesions are more commonly associated with neurofibromatosis type 1 (NF1) and, in some cases, tuberous sclerosis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Parathyroid adenoma:</span></strong><span style=\"font-size:12.0pt\"> Parathyroid adenomas are typically seen in patients with MEN 1 and MEN 2A syndromes, not in MEN 2B. These adenomas cause hyperparathyroidism, which is not a feature of MEN 2B.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Optic nerve glioma:</span></strong><span style=\"font-size:12.0pt\"> Optic nerve gliomas are primarily associated with neurofibromatosis type 1 (NF1). They are not a feature of MEN 2B syndrome.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most significant feature of MEN 2B syndrome is the presence of medullary thyroid carcinoma, alongside mucosal neuromas and a marfanoid body habitus, often linked to mutations in the RET proto-oncogene</span></span></span></p>",
      "correct_choice_id": 200069,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50018,
      "choices": [
        {
          "id": 200072,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">In the axillary pad of fat, at the apex of the axilla </span></span></p>"
        },
        {
          "id": 200073,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Along the margin of the pectoralis minor </span></span></p>"
        },
        {
          "id": 200074,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Along the subscapular veins</span></span></p>"
        },
        {
          "id": 200075,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Anterior in the center</span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 45-year-old woman presents with a breast lump and the physician suspects breast cancer. The physician orders imaging studies and a biopsy to confirm the diagnosis. During the diagnostic workup, the physician explains the lymphatic drainage of the breast and discusses the location of the apical lymph nodes. In which location are the apical lymph nodes located?</span></span></span></p>",
      "unique_key": "Q9929841",
      "question_audio": null,
      "question_video": null,
      "map_id": 34043528,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A. In the axillary pad of fat, at the apex of the axilla.</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">The lymphatic drainage from the breast is mostly drained into the axillary lymph nodes. The axillary lymph nodes are divided into five groups, and the apical group of axillary lymph nodes is located at the apex of the axilla. The apical lymph nodes are present partly above the superior margin of the pectoralis minor and partly posterior to the superior part of the muscle. They are present along the axillary vessels. The other four groups of axillary lymph nodes are lateral/humeral, anterior/pectoral, posterior/subscapular, and central. Understanding the location and distribution of axillary lymph nodes is important in the diagnosis and management of breast cancer.</span></span></p>",
      "correct_choice_id": 200072,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50019,
      "choices": [
        {
          "id": 200076,
          "text": "<p><span style=\"font-size:12.0pt;\">Amygdala</span></p>"
        },
        {
          "id": 200077,
          "text": "<p><span style=\"font-size:12.0pt;\">Mammillary body</span></p>"
        },
        {
          "id": 200078,
          "text": "<p><span style=\"font-size:12.0pt;\">Caudate nucleus</span></p>"
        },
        {
          "id": 200079,
          "text": "<p><span style=\"font-size:12.0pt;\">Hippocampus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Fibres of the given structure originate from? (</span>INICET Nov 2022)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/anatomy-nov-inicet-2022-05.jpg\" alt=\"\" width=\"300\" height=\"245\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/05/18/anatomy-nov-inicet-2022-05.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5710468",
      "question_audio": null,
      "question_video": null,
      "map_id": 34731494,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Hippocampus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given structure is the fornix and its fibres arise from the hippocampus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The fornix is a C-shaped bundle of white matter fibers that connects the hippocampus to other regions of the brain, including the mammillary bodies, thalamus, and septal nuclei. The fibers of the fornix arise from the hippocampus, which is involved in the formation and consolidation of memories, and then project through the fornix to other parts of the limbic system. Dysfunction of the fornix and hippocampus can result in memory impairments, as seen in conditions such as Alzheimer's disease.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Amygdala</strong>: The amygdala is a small almond-shaped structure located deep within the temporal lobes of the brain. It is involved in processing emotions, especially fear and emotional memory. While the amygdala does have connections to the limbic system, it is not a direct source of fibers for the fornix. However, it does interact with the hippocampus and other limbic structures.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Mammillary Body:</strong> The mammillary bodies are a pair of small, round structures located on the undersurface of the brain, specifically in the diencephalon. They are closely connected to the hippocampus and are considered part of the limbic system. The fornix sends fibers to and receives fibers from the mammillary bodies, facilitating the flow of information within the limbic circuit.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C</strong>. <strong>Caudate Nucleus</strong>: The caudate nucleus is a component of the basal ganglia and is involved in motor control and cognitive functions. While it interacts with some limbic structures, it is not a primary source of fornix fibers. Instead, it has connections with other regions involved in motor control and reward processing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The hippocampus is a critical structure within the limbic system that plays a central role in memory formation and spatial navigation. It is the primary source of fibers that make up the fornix. The fornix carries information from the hippocampus to other limbic structures, including the mammillary bodies and the anterior thalamic nuclei, as well as to the septal nuclei and the cingulate gyrus.</span></p>",
      "correct_choice_id": 200079,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50020,
      "choices": [
        {
          "id": 200080,
          "text": "<p style=\"margin-left:-1px;text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">Preoxygenation with 100% oxygen for 3 minutes is done.</span></p>"
        },
        {
          "id": 200081,
          "text": "<p style=\"margin-left:-1px;text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">High-volume low-pressure cuff Endotracheal tube is used.</span></p>"
        },
        {
          "id": 200082,
          "text": "<p style=\"margin-left:-1px;text-align:justify;\"><span style=\"color:black;font-size:12.0pt;\">It is the method of choice in cardiac arrest </span><span style=\"font-size:12.0pt;\">patients</span><span style=\"color:black;font-size:12.0pt;\">.</span></p>"
        },
        {
          "id": 200083,
          "text": "<p><span style=\"color:black;font-size:12.0pt;\">Induction agent and muscle relaxant are given simultaneously.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the incorrect statement in rapid sequence intubation?</span> (INICET NOVEMBER 2022)</p>",
      "unique_key": "Q6198209",
      "question_audio": null,
      "question_video": null,
      "map_id": 34473057,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. It is the method of choice in cardiac arrest patients</strong>.</span></p><p><br><span style=\"font-size:12.0pt;\">Incorrect statement. Rapid sequence intubation typically involves administering an induction agent and a neuromuscular blocking agent to facilitate endotracheal intubation without the risk of aspiration. However, in cardiac arrest patients, the priority is to secure the airway quickly without delay. Often, these patients do not require medications for intubation as they are unresponsive and without protective reflexes. Also, chest compressions and defibrillation (if indicated) are of higher priority.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Preoxygenation with 100% oxygen for 3 minutes is done:</strong></span><br><span style=\"font-size:12.0pt;\">Correct statement. Preoxygenation with 100% oxygen before RSI helps to denitrogenate the lungs, ensuring that the patient has an adequate oxygen reserve during the apneic period (the time between paralysis and successful intubation). The goal is to delay the onset of hypoxemia during the apnea.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. High-volume low-pressure cuff Endotracheal tube is used:</strong></span><br><span style=\"font-size:12.0pt;\">Correct statement. A high-volume low-pressure cuff on the endotracheal tube distributes the pressure over a larger area of the tracheal mucosa. This minimizes the risk of tracheal injury or necrosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Induction agent and muscle relaxant are given simultaneously:</strong></span><br><span style=\"font-size:12.0pt;\">Correct statement. In RSI, immediately after administering the induction agent (to render the patient unconscious), a neuromuscular blocking agent (muscle relaxant) is given to paralyze the patient, thus facilitating endotracheal intubation. This rapid administration of drugs is to minimize the time between loss of protective reflexes and securing the airway, hence reducing the risk of aspiration.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective :</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Rapid sequence intubation is not the method of choice in cardiac arrest patients due to the need for immediate airway management and ongoing chest compressions, making drug administration less critical.</span></p>",
      "correct_choice_id": 200082,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50021,
      "choices": [
        {
          "id": 200084,
          "text": "<p><span style=\"font-size:12.0pt;\">Megaloblastic anemia</span></p>"
        },
        {
          "id": 200085,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron-deficiency anemia</span></p>"
        },
        {
          "id": 200086,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia major</span></p>"
        },
        {
          "id": 200087,
          "text": "<p><span style=\"font-size:12.0pt;\">Essential thrombocytosis</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\">A 35-year-old woman presented in OPD with complaints of fatigue and weakness. Investigations revealed the following as shown below. The peripheral smear is shown below. What is the diagnosis? (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hb – 5 g%</span></p><p> </p><p><span style=\"font-size:12.0pt;\">MCH – 24</span></p><p> </p><p><span style=\"font-size:12.0pt;\">MCV – Low</span></p><p> </p><p><span style=\"font-size:12.0pt;\">TLC – 11000 /µL</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Platelets – 5,00,000 /cubic mm</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Normal values:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Mean cell volume (MCV): 90 +/- 8 fL</span></li><li><span style=\"font-size:12.0pt;\">Mean cell Hb (MCH): 30 +/- 3 pg</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture11.jpg\" alt=\"\" width=\"300\" height=\"216\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture11.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5120809",
      "question_audio": null,
      "question_video": null,
      "map_id": 34882636,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Iron-deficiency anemia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The given clinical scenario is suggestive of microcytic hypochromic anemia for which the most common cause is Iron Deficiency Anemia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Iron deficiency anemia is characterized by:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Low serum ferritin</strong>: Reflects low iron stores.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Low serum iron</strong>: Indicates a lack of available iron.</span></li><li><span style=\"font-size:12.0pt;\"><strong>High TIBC (Total Iron Binding Capacity)</strong>: Reflects the body’s increased capacity to bind iron, which happens when iron levels are low.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Low transferrin saturation</strong>: Reflects low iron availability relative to the binding capacity.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">These findings together with the low MCV, low MCH, low Hb and compensatory increase in the platelets strongly suggest iron deficiency anemia rather than other conditions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Megaloblastic anemia</strong>: Typically presents with macrocytic anemia (high MCV), which is not the case here. Also, MCH would generally be elevated in megaloblastic anemia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thalassemia major</strong>: This condition would also present with microcytic anemia, but it typically does not show such severe hypochromia or the thrombocytosis seen in this case. Additionally, the Mentzer index (MCV/RBC count) is typically less than 13 in thalassemia trait, not in severe iron deficiency anemia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Essential thrombocytosis</strong>: While this condition does present with an elevated platelet count, it does not typically present with the microcytic, hypochromic anemia seen in iron deficiency anemia. The primary abnormality in essential thrombocytosis is the elevated platelet count, without the severe anemia observed here.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-171012.png\" alt=\"\" width=\"500\" height=\"415\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-171054.png\" alt=\"\" width=\"1000\" height=\"328\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/06/screenshot-2024-09-06-171012.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200085,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50022,
      "choices": [
        {
          "id": 200088,
          "text": "<p><span style=\"font-size:12.0pt;\">Echocardiogram</span></p>"
        },
        {
          "id": 200089,
          "text": "<p><span style=\"font-size:12.0pt;\">Chest x-ray</span></p>"
        },
        {
          "id": 200090,
          "text": "<p><span style=\"font-size:12.0pt;\">Spirometry</span></p>"
        },
        {
          "id": 200091,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI to rule out enlarged heart</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The parents notice that their child is tired and that he has shortness of breath on climbing stairs and while lying down. What is the first investigation that you would do? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q3968934",
      "question_audio": null,
      "question_video": null,
      "map_id": 34614760,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Chest x-ray</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The first investigation to be done for a child who feels shortness of breath on climbing stairs and in the supine position is a chest x-ray.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The child having shortness of breath on dyspnea on exertion worsened in the supine position is orthopnea could be suggestive of congestive heart failure.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Causes -</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Respiratory causes include asthma, chronic obstructive pulmonary disorder (COPD), pneumonia, and pulmonary embolism.</span></li><li><span style=\"font-size:12.0pt;\">Cardiovascular causes include congestive heart failure (CH), pulmonary edema, valvular heart defect, and pulmonary hypertension.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Evaluation</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Oxygen saturation at rest and during physical activity</span></li><li><span style=\"font-size:12.0pt;\">Chest x-ray is the first diagnostic test as pulmonary pathology or pulmonary edema and signs of CHF may be seen</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A:</strong> An echocardiogram to evaluate cardiac cause if the chest X-ray is abnormal</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C:</strong> Spirometry to assess lung function when the chest x-ray is normal.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D:</strong> Cardiac MRI (Magnetic resonance imaging) is an emerging modality done to look for cardiomegaly.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">For a child presenting with shortness of breath on exertion and orthopnea, the first investigation should be a chest x-ray to evaluate potential pulmonary pathology and signs of congestive heart failure.</span></p>",
      "correct_choice_id": 200089,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50023,
      "choices": [
        {
          "id": 200092,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 200093,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 200094,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 200095,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman presented with total ophthalmoplegia, pulsatile proptosis of the right eye, retroorbital pain accompanied with fever and headache. On examination, fundus and BP were normal. Which of the following structures are involved?</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Abducens nerve</span></li><li><span style=\"font-size:12.0pt;\">Oculomotor nerve</span></li><li><span style=\"font-size:12.0pt;\">Internal carotid artery</span></li><li><span style=\"font-size:12.0pt;\">Cavernous sinus</span></li></ol>",
      "unique_key": "Q2750228",
      "question_audio": null,
      "question_video": null,
      "map_id": 34407517,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 2, 3, 4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The clinical presentation of pulsatile proptosis, retroorbital pain, fever, and headache in a pregnant woman suggests the involvement of multiple cranial structures, primarily those associated with the cavernous sinus, a critical venous sinus at the base of the brain that acts as a conduit for venous blood drainage from the brain and eye. This constellation of symptoms and signs is indicative of cavernous sinus thrombosis (CST), a severe and potentially life-threatening condition.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Cavernous sinus thrombosis (CST) is a septic thrombus formed in the cavernous sinus due to the spread of infection from sinuses, teeth, ears, nose, and skin of the face.</span></li><li><span style=\"font-size:12.0pt;\">Symptoms include fever, severe headache, supraorbital pain, seizures, and edema in the mastoid region.</span></li><li><span style=\"font-size:12.0pt;\">Eye signs include proptosis, chemosis, and diplopia due to ophthalmoplegia from the involvement of oculomotor (CN-III), trochlear (CN-IV), and abducens nerve (CN-VI).</span></li><li><span style=\"font-size:12.0pt;\">Absence of corneal sensation due to the involvement of the ophthalmic division of trigeminal nerve (CN-V1)</span></li><li><span style=\"font-size:12.0pt;\">Ipsilateral ptosis, dilated pupil, and absence of direct and consensual pupillary right reflex due to oculomotor nerve palsy.</span></li><li><span style=\"font-size:12.0pt;\">Pulsatile proptosis occurs with the involvement of the internal carotid artery.</span></li><li><span style=\"font-size:12.0pt;\">Brain magnetic resonance imaging or magnetic resonance venography should be done urgently for diagnosis.</span></li><li><span style=\"font-size:12.0pt;\">Management of CST includes intravenous broad-spectrum antibiotics, analgesics, anti-inflammatory drugs, and anticoagulants.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/inicet-ophtha-15.jpg\" alt=\"\" width=\"500\" height=\"439\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/24/picture89.jpg\" alt=\"\" width=\"1000\" height=\"289\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/25/inicet-ophtha-15.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200095,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50024,
      "choices": [
        {
          "id": 200096,
          "text": "<p><span style=\"font-size:12.0pt;\">Malaria</span></p>"
        },
        {
          "id": 200097,
          "text": "<p><span style=\"font-size:12.0pt;\">Dengue</span></p>"
        },
        {
          "id": 200098,
          "text": "<p><span style=\"font-size:12.0pt;\">Sexually transmitted infections</span></p>"
        },
        {
          "id": 200099,
          "text": "<p><span style=\"font-size:12.0pt;\">AIDS</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">For which medical condition is the provided drug typically recommended?</span> <span style=\"font-size:12.0pt;\">(INICET NOV 2022)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip53.jpg\" alt=\"\" width=\"400\" height=\"370\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip53.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8645429",
      "question_audio": null,
      "question_video": null,
      "map_id": 34262536,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Malaria</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The picture depicts artemisin-based combination therapy (ACT). This medicine is used to treat falciparum malaria.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>ARTEMISINS - </strong>Artesunate and Artemether</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Fastest acting anti-malarial</span></li><li><span style=\"font-size:12.0pt;\">Effective against MDR parasites</span></li><li><span style=\"font-size:12.0pt;\">Short acting</span></li><li><span style=\"font-size:12.0pt;\">C/I in 1st trimester</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Artemisin Combination Therapy [ACT]</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Artemisin + Long acting drug</span></li><li><span style=\"font-size:12.0pt;\">DOC for chloroquine resistant malaria Combinations</span></li><li><span style=\"font-size:12.0pt;\">Artemether + Lumefantrine: DOC in North Eastern States</span></li><li><span style=\"font-size:12.0pt;\">Artesunate + Sulfadoxine-Pyrimethamine: DOC for rest of India</span></li><li><span style=\"font-size:12.0pt;\">The dose of artesunate is 200 mg OD for 3 days whereas sulfadoxine (1500 mg) and pyrimethamine (75 mg) should be taken on day 1 only</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Artemisinin-based combination therapy (ACT), is typically recommended for the treatment of falciparum malaria.</span></p>",
      "correct_choice_id": 200096,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50025,
      "choices": [
        {
          "id": 200100,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Loss of taste sensation in anterior 2/3rd of tongue</span></span></p>"
        },
        {
          "id": 200101,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Loss of taste sensation in posterior 1/3rd of tongue</span></span></p>"
        },
        {
          "id": 200102,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Loss of general sensation in anterior 2/3rd of tongue</span></span></p>"
        },
        {
          "id": 200103,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Loss of motor sensation in anterior 2/3rd of tongue</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Fracture of the jugular canal can present as: </span></span></p>",
      "unique_key": "Q4997943",
      "question_audio": null,
      "question_video": null,
      "map_id": 34354721,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B) Loss of taste sensation in posterior 1/3rd of tongue</strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Fracture of the <strong>jugular canal</strong> affects the <strong>glossopharyngeal nerve</strong> (cranial nerve IX) and presents as a <strong>loss of taste sensation</strong> in the <strong>posterior 1/3rd</strong> of the tongue.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>lingual nerve</strong>, which is a branch of the <strong>mandibular division</strong> of the trigeminal nerve, gives <strong>general sensation</strong> to the <strong>anterior 2/3rd</strong> of the tongue. The <strong>chorda tympani branch</strong> of the <strong>facial nerve</strong> gives <strong>taste sensation</strong> to the anterior 2/3rd of the tongue.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Both taste and general sensation of the <strong>posterior 1/3rd</strong> of the tongue are provided by the <strong>glossopharyngeal nerve</strong>.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>muscles of the tongue</strong>, with the exception of the <strong>palatoglossus</strong>, are supplied by the <strong>hypoglossal nerve</strong>. The <strong>palatoglossus</strong> is supplied by the <strong>pharyngeal plexus</strong>.</span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The other nerves passing through the <strong>jugular foramen</strong> are the <strong>vagus nerve</strong> (cranial nerve X) and the <strong>accessory nerve</strong> (cranial nerve XI), which may also be involved in cases of jugular canal fracture.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Loss of taste sensation in anterior 2/3rd of tongue</strong>: This sensation is mediated by the <strong>chorda tympani branch</strong> of the <strong>facial nerve</strong>. A fracture of the jugular canal would not affect this part of the tongue.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Loss of general sensation in anterior 2/3rd of tongue</strong>: This is mediated by the <strong>lingual nerve</strong>, a branch of the mandibular division of the <strong>trigeminal nerve (V3)</strong>, which is not involved in jugular canal fractures.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Loss of motor sensation in anterior 2/3rd of tongue</strong>: Motor innervation of the tongue is supplied by the <strong>hypoglossal nerve</strong> (cranial nerve XII), which is not affected by jugular canal fracture.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A <strong>fracture of the jugular canal</strong> can lead to a loss of taste sensation in the <strong>posterior 1/3rd</strong> of the tongue due to damage to the <strong>glossopharyngeal nerve (cranial nerve IX)</strong>.</span></span></p>",
      "correct_choice_id": 200101,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50026,
      "choices": [
        {
          "id": 200104,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Yellow fever</span></span></p>"
        },
        {
          "id": 200105,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Crimean-Congo hemorrhagic fever</span></span></p>"
        },
        {
          "id": 200106,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ebola</span></span></p>"
        },
        {
          "id": 200107,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hendra virus</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following has been reported to have endemic transmission in India? </span></span></p>",
      "unique_key": "Q6150868",
      "question_audio": null,
      "question_video": null,
      "map_id": 34884593,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B) Crimean-Congo hemorrhagic fever</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Crimean-Congo hemorrhagic fever (CCHF) is caused by the <strong>nairovirus</strong> and has been reported to have endemic transmission in India. An outbreak was identified in <strong>Gujarat in 2011</strong>, and antibodies against the virus have been found in both human and animal sera in India. CCHF is primarily transmitted by <strong>Hyalomma ticks</strong> and is associated with a high mortality rate.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Yellow fever</strong>: Yellow fever is primarily found in tropical and subtropical areas of <strong>South America and Africa</strong> and is caused by the <strong>flavivirus</strong>. It is not endemic to India. In urban settings, the disease is transmitted by <strong>Aedes aegypti mosquitoes</strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Ebola</strong>: Ebola virus causes <strong>hemorrhagic fever</strong> and was first reported in Sudan and Zaire. It has caused several outbreaks in <strong>West Africa</strong>, but there has been no endemic transmission of Ebola in India.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Hendra virus</strong>: Hendra virus is primarily a zoonotic disease that affects horses and was first identified in Australia. It is not known to have any transmission in India.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Crimean-Congo hemorrhagic fever (CCHF)</strong> has endemic transmission in India, with the first outbreak reported in Gujarat in 2011. It is transmitted by <strong>Hyalomma ticks</strong> and has a high mortality rate.</span></span></p>",
      "correct_choice_id": 200105,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50027,
      "choices": [
        {
          "id": 200108,
          "text": "<p><span style=\"font-size:12.0pt;\">Resistant leptospirosis</span></p>"
        },
        {
          "id": 200109,
          "text": "<p><span style=\"font-size:12.0pt;\">Penicillin allergy</span></p>"
        },
        {
          "id": 200110,
          "text": "<p><span style=\"font-size:12.0pt;\">Co-infection with dengue</span></p>"
        },
        {
          "id": 200111,
          "text": "<p><span style=\"font-size:12.0pt;\">Jarisch-Herxheimer reaction</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with a history of fever, jaundice, hepatosplenomegaly, and laboratory test result of leptospira IM reactivity, now presented with breathlessness, fever, and jaundice that worsened after treatment with penicillin. What is the possible diagnosis?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p>",
      "unique_key": "Q9569565",
      "question_audio": null,
      "question_video": null,
      "map_id": 34490808,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Jarisch-Herxheimer reaction</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The possible diagnosis based on the given clinical scenario is Jarisch-Herxheimer reaction.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Jarisch-Herxheimer reaction (JHR) is a transient clinical phenomenon that occurs in patients infected by spirochetes who undergo antibiotic treatment. The reaction typically occurs within 24 hours of starting antibiotic treatment for spirochete infections, including syphilis, leptospirosis, Lyme disease, and relapsing fever.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Mechanism:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The breakdown of the spirochetes after antibiotic administration releases endotoxins and cytokines into the bloodstream.</span></li><li><span style=\"font-size:12.0pt;\">This causes an acute inflammatory reaction, characterized by the release of inflammatory cytokines such as interleukin-6 (IL-6), interleukin-8 (IL-8), and tumor necrosis factor-alpha (TNF-alpha).</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Symptoms include fever, chills, rigors, myalgia, headache, tachycardia, hyperventilation, and exacerbation of skin lesions.</span></li><li><span style=\"font-size:12.0pt;\">The symptoms usually begin within 2 hours of antibiotic administration and resolve within 24 hours.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Resistant leptospirosis:</strong> This would present with ongoing symptoms despite appropriate antibiotic treatment, but not typically with acute worsening immediately after starting treatment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Penicillin allergy:</strong> This would typically present with urticaria, pruritus, rash, or anaphylaxis, not with the acute inflammatory symptoms described.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Co-infection with dengue:</strong> This would be considered if there were signs and symptoms consistent with dengue, such as high fever, severe headache, retro-orbital pain, myalgia, and hemorrhagic manifestations, but it does not explain the acute worsening after penicillin treatment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Jarisch-Herxheimer reaction is an acute inflammatory response occurring within 24 hours of initiating antibiotic treatment for spirochete infections, characterized by fever, chills, myalgia, and exacerbation of symptoms due to the release of inflammatory cytokines.</span></p>",
      "correct_choice_id": 200111,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50028,
      "choices": [
        {
          "id": 200112,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a dematiaceous fungus</span></span></span></p>"
        },
        {
          "id": 200113,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Infection can spread and involve underlying subcutaneous tissue, tendon, muscle or joints</span></span></span></p>"
        },
        {
          "id": 200114,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Angioinvasion is common especially in people with hemolytic anemia</span></span></span></p>"
        },
        {
          "id": 200115,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">These bodies are formed by engulfment of the dead fungi by the macrophages</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A forest worker developed skin lesions over the forearm, which initially started as macules but then became nodules. Histology of the nodules shows the following findings. Which of the following is true regarding this condition?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">INICET NOV 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/40.jpg\" style=\"height:307px; width:400px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/40.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5242360",
      "question_audio": null,
      "question_video": null,
      "map_id": 34942901,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) It is a dematiaceous fungus</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chromoblastomycosis (CBM) is defined as a <strong>chronic cutaneous and subcutaneous </strong>fungal infection resulting from traumatic implantation of certain <strong>dematiaceous fungi</strong> through the skin. </span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The most frequent aetiological agents of CBM are the following species: Fonsecaea pedrosoi, Phialophora verrucosa and Cladophialophora carrionii.</span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The aetiological agents gain entrance through transcutaneous puncture wounds, usually by parts of plants. </span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In a typical manifestation the dermal lesions form cauliflower-like nodules. In the infected tissue, characteristic dark-colored, thick-walled, muriform cells i.e. sclerotic cells (Medlar bodies) are observed, which is a histopathological criterion for the diagnosis.</span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The aetiological agent (i.e. fungal fragment) gains entrance through transcutaneous puncture wounds. A primary lesion is represented by an erythematous papule or a <strong>warty growth</strong>, which gradually enlarges from the site of infection assuming various forms and sizes. The infection may occur anywhere on the body, however most frequently it affects limbs, especially feet and shins. Cases of buttock, trunk and face infection have also been reported. In more advanced stages of the disease dissemination may occur in the form of satellite lesions which arise from scratching autoinoculation and spread via the lymphatic system.</span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment – Antifungal therapy with <strong>itraconazole or terbinafine. Surgical excision</strong> is the therapy of choice for small lesions.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt\"><strong>Infection can spread and involve underlying subcutaneous tissue, tendon, muscle, or joints:</strong> This statement is more characteristic of eumycetoma, not chromoblastomycosis. Eumycetoma, caused by various fungal species, can invade deeper tissues including bone, leading to severe deformities.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt\"><strong>Angioinvasion is common especially in people with hemolytic anemia:</strong> Angioinvasion is typically seen in infections caused by Aspergillus species, which can lead to invasive aspergillosis, particularly in immunocompromised individuals. This is not a feature of chromoblastomycosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt\"><strong>These bodies are formed by the engulfment of the dead fungi by the macrophages:</strong> The bodies seen in the histological image (Medlar bodies) are not formed by macrophage engulfment. They are a morphological form of the fungi present in the infected tissue, indicative of chromoblastomycosis.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"><br />\r\n<span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chromoblastomycosis is a chronic fungal infection characterized by the presence of dark-coloured, thick-walled sclerotic cells (Medlar bodies) in histological sections, resulting from traumatic implantation of dematiaceous fungi.</span></span></span></p>",
      "correct_choice_id": 200112,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50029,
      "choices": [
        {
          "id": 200116,
          "text": "<p><span style=\"font-size:12.0pt;\">Emergency room thoracotomy</span></p>"
        },
        {
          "id": 200117,
          "text": "<p><span style=\"font-size:12.0pt;\">ICD placement</span></p>"
        },
        {
          "id": 200118,
          "text": "<p><span style=\"font-size:12.0pt;\">Needle thoracocentesis</span></p>"
        },
        {
          "id": 200119,
          "text": "<p><span style=\"font-size:12.0pt;\">Finger thoracotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 28-year-old male presents to the emergency department with multiple stab injuries to the chest. On examination, there is reduced chest movement on the right side and tracheal deviation to the left side. Additionally, the neck veins are distended. What is the next best step in the management of this patient? (INICET NOV 2022)</span></p>",
      "unique_key": "Q5936460",
      "question_audio": null,
      "question_video": null,
      "map_id": 34463417,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Needle thoracocentesis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Patient with stab to chest with reduced chest movement on right, mediastinal shift to left with distended neck veins is suffering from tension pneumothorax. Next step is placement of wide bore needle in triangle of safety to decompress the pneumothorax, followed by ICD insertion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">This is the correct answer. Needle thoracocentesis is the next best step in the management of the patient with tension pneumothorax. It is a procedure that involves inserting a needle into the pleural space to aspirate the air or fluid. It is performed initially to decompress the tension pneumothorax in the triangle of safety (between Pect. Major anteriorly, Latissimus dorsi posteriorly, 5th intercostal space inferiorly).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Emergency room thoracotomy</strong>: This is not the next best step in the management of the patient with tension pneumothorax. Resuscitative thoracotomy is an emergency surgical procedure that is performed in the presence of cardiac arrest due to penetrating chest trauma.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>B.</strong> <strong>ICD placement</strong>: This is not the next best step in the management of the patient with tension pneumothorax. An ICD (intercostal drainage) is a tube inserted into the pleural space to drain the air or fluid. ICD placement is the definitive management of tension pneumothorax but is not the next step in the management.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D. Finger thoracotomy</strong>: This is not the next best step in the management of the patient with tension pneumothorax. Finger thoracotomy is an alternative approach when needle decompression fails or is not possible. It involves making a small incision in the chest wall and using the finger to manually decompress the pneumothorax. However, needle decompression should be attempted first before considering finger thoracostomy.</span></p>",
      "correct_choice_id": 200118,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50030,
      "choices": [
        {
          "id": 200120,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Robert’s sign</span></span></span></p>"
        },
        {
          "id": 200121,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Spalding sign</span></span></span></p>"
        },
        {
          "id": 200122,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ball sign</span></span></span></p>"
        },
        {
          "id": 200123,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Halo sign</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What is the postmortem sign in which a gas shadow is present in the great vessels of a fetus in the case of intrauterine demise? (</span></span>INICET Nov 2022)</p>",
      "unique_key": "Q8671236",
      "question_audio": null,
      "question_video": null,
      "map_id": 34495169,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Robert</span></span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">‘s </span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">sign</span> </span></span></strong></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Robert sign refers to the presence of a gas shadow within the heart or the greater vessels, in cases of fetal death in utero. It is a rare sign caused by postmortem blood degeneration, usually seen 1-2 days after death; and may be seen as early as 12 hours.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-44.jpg\" style=\"height:274px; width:400px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B. Spalding sign –</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> overlapping of the fetal skull bones caused by collapse of the fetal brain. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">C. Ball sign -</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> hyperflexion of the spine with crowding of ribs seen in intrauterine death.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D. Halo sign -</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> increase in soft tissue width between subcutaneous fat and the cranial vault.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Roberts sign is characterized by the presence of gas shadows in the heart or great vessels of a fetus, indicating intrauterine demise and typically appearing 1-2 days postmortem.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-44.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200120,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50031,
      "choices": [
        {
          "id": 200124,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 3</span></span></span></p>"
        },
        {
          "id": 200125,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 2</span></span></span></p>"
        },
        {
          "id": 200126,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 4</span></span></span></p>"
        },
        {
          "id": 200127,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">3, 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A woman presents at 8 weeks of gestation. Which of the following signs can be elicited at this gestation? </span></span></span>(INICET NOV 2022)</p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Goodell's sign</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Osiander's sign</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Internal ballottement</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Lightening</span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\"> </p>",
      "unique_key": "Q7547282",
      "question_audio": null,
      "question_video": null,
      "map_id": 34213344,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) 1, 2</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Goodell's sign</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This sign is the softening of the cervix, which can be elicited around the 6th week of gestation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Osiander's sign</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This sign refers to the increased pulsation felt through the lateral fornices, which can be detected between 6 to 8 weeks of gestation.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Internal ballottement</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This can be elicited between the 16th and 28th weeks of gestation when the fetus can be felt to move away and return to the fingers upon gentle tap on the cervix.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Lightening</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is a sensation of relief of the pressure symptoms due to the engagement of the presenting part, typically felt around 38 weeks of gestation.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. 1, 3</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Internal ballottement cannot be elicited at 8 weeks of gestation as it is typically felt between 16 and 28 weeks.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. 1, 4</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Lightening is not experienced until about 38 weeks of gestation, making this option incorrect.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. 3, 4</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Neither internal ballottement nor lightening can be elicited at 8 weeks of gestation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The signs that can be elicited at 8 weeks of gestation are Goodell's sign (softening of the cervix) and Osiander's sign (increased pulsation felt through the lateral fornices).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Signs in early pregnancy are as shown below</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/untitled-290.jpg\" style=\"height:580px; width:900px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 74</span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/untitled-290.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200125,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50032,
      "choices": [
        {
          "id": 200128,
          "text": "<p><span style=\"font-size:12.0pt;\">Direct spread from mesenteric lymph nodes</span></p>"
        },
        {
          "id": 200129,
          "text": "<p><span style=\"font-size:12.0pt;\">Hematogenous spread</span></p>"
        },
        {
          "id": 200130,
          "text": "<p><span style=\"font-size:12.0pt;\">Feco-oral route</span></p>"
        },
        {
          "id": 200131,
          "text": "<p><span style=\"font-size:12.0pt;\">Direct contact with infected animal</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Mode of transmission of abdominal TB includes all except?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p>",
      "unique_key": "Q2498625",
      "question_audio": null,
      "question_video": null,
      "map_id": 34009204,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Direct contact with infected animal</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Direct contact with infected animal is not a known mode of transmission for abdominal TB. Tuberculosis is primarily transmitted via inhalation of airborne droplets from a person with active pulmonary TB. While ingestion of Mycobacterium bovis from unpasteurized milk can lead to abdominal TB, Making it a feco-oral route of spread.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Direct spread from mesenteric lymph nodes:</strong> This occurs when TB bacteria spread directly from the mesenteric lymph nodes to the intestines. This form of spread is relatively common in abdominal TB.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Feco-oral route: </strong>Ingestion of Mycobacterium tuberculosis (from contaminated sputum or unpasteurized milk with M. bovis) can lead to intestinal TB.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Direct contact with infected animal:</strong> This is less common but can occur in cases where humans come into contact with animals infected with Mycobacterium bovis, a zoonotic strain of TB.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Modes of spread:</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">By ingesting</span><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Infected food or milk - Primary intestinal tuberculosis</span></li><li><span style=\"font-size:12.0pt;\">Infected sputum - Secondary intestinal tuberculosis</span></li></ol></li><li><span style=\"font-size:12.0pt;\">Hematogenous spread from distant tubercular focus</span></li><li><span style=\"font-size:12.0pt;\">Contagious spread from infected adjacent foci</span></li><li><span style=\"font-size:12.0pt;\">Through lymphatic channel</span></li><li><span style=\"font-size:12.0pt;\">Common site of abdominal TB - Terminal ileum and cecum</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Feco-oral route is not known to spread abdominal TB.</strong></span></p>",
      "correct_choice_id": 200131,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50033,
      "choices": [
        {
          "id": 200132,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Medullary carcinoma of thyroid</span></span></span></p>"
        },
        {
          "id": 200133,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Papillary carcinoma of thyroid</span></span></span></p>"
        },
        {
          "id": 200134,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Follicular carcinoma of thyroid</span></span></span></p>"
        },
        {
          "id": 200135,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Anaplastic carcinoma of thyroid</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 30-year-old male presented in OPD with a swelling in his neck. Given below is the histopathological image. What is the likely diagnosis?  (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture9.jpg\" style=\"height:232px; width:300px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture9.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1593717",
      "question_audio": null,
      "question_video": null,
      "map_id": 34309352,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>A) Medullary carcinoma of thyroid </strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The histopathological image shows Amyloid deposition and nests of polygonal cells, which is suggestive of medullary carcinoma of thyroid. </span><span style=\"font-size:12.0pt\">This type of cancer is associated with the presence of amyloid deposits, which can be seen as pinkish extracellular material in the histological sections. These amyloid deposits are derived from calcitonin produced by the neoplastic C-cells (parafollicular cells).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Medullary thyroid carcinoma (MTC) is a neuroendocrine tumor that arises from the parafollicular C cells of the thyroid gland, which produce calcitonin. The histopathological hallmark of MTC is the presence of amyloid stroma, often stained with Congo red, showing apple-green birefringence under polarized light. Additionally, the tumor cells are often arranged in nests or sheets, with polygonal or spindle-shaped cells.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Papillary carcinoma of the thyroid</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Characterized by the formation of papillae and distinct nuclear features like Orphan-Annie eye nuclei, nuclear grooves, and pseudoinclusions. It typically does not have amyloid deposition.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Follicular carcinoma of the thyroid</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Typically shows follicles filled with colloid, and Hurthle cells may be present. This type is also known for hematogenous spread rather than lymphatic spread.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Anaplastic carcinoma of the thyroid</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: A highly aggressive form of thyroid cancer, characterized by pleomorphic giant cells, spindle cells, and a lack of differentiated features seen in other thyroid carcinomas. It also lacks the amyloid deposits seen in medullary carcinoma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-132838.jpg\" style=\"height:753px; width:1000px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-132838.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200132,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50034,
      "choices": [
        {
          "id": 200136,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 1 for 12 months</span></p>"
        },
        {
          "id": 200137,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 2 for 12 months</span></p>"
        },
        {
          "id": 200138,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 1 for 6 months</span></p>"
        },
        {
          "id": 200139,
          "text": "<p><span style=\"color:black;font-size:12pt;\">Packet 2 for 6 months</span></p>"
        }
      ],
      "text": "<p><span style=\"color:black;font-size:12.0pt;\">A 35-year-old patient presents to the outpatient department with a satellite skin lesion. On examination, the patient has one hypopigmented lesion and one thickened nerve. The images of two blister packs are provided. Based on the WHO / NLEP Guidelines, which treatment is most appropriate for this patient?</span></p><p> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture2_e7rPz6c.jpg\" alt=\"\" width=\"300\" height=\"216\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/picture2_e7rPz6c.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3432709",
      "question_audio": null,
      "question_video": null,
      "map_id": 34479763,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<h3><span style=\"color:#1F3763;font-size:10.5pt;\">Answer:</span></h3><p><span style=\"font-size:10.5pt;\">The correct answer is <strong>B. Packet 2 for 12 months</strong>.</span></p><p><span style=\"font-size:13.5pt;\"><strong>Latest Guidelines for Leprosy: NLEP = WHO (from April 1, 2025)</strong></span></p><p>As of <strong>April 1, 2025</strong>, <strong>India's NLEP has aligned completely with WHO guidelines</strong> for the <strong>diagnosis and treatment of leprosy</strong>. This means that the <strong>same criteria and drug regimens</strong> are now followed globally and in India.</p><p> </p><figure class=\"table\"><table><tbody><tr><td style=\"background-color:#4472C4;border:1.0pt solid #4472C4;height:21.0pt;padding:.75pt;width:494.25pt;\" colspan=\"3\"><span style=\"color:white;font-size:9.0pt;\"><strong>World health organization (WHO) </strong></span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:28.5pt;padding:.75pt;width:288.75pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Cardinal features</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:105.0pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Paucibacillary </strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:100.5pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Multibacillary </strong></span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:35.25pt;padding:.75pt;width:288.75pt;\"><span style=\"font-size:9.0pt;\"><strong>Skin: Hypopigmented/ Hypoanesthetic patches</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:105.0pt;\"><span style=\"font-size:9.0pt;\">1-5 </span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:100.5pt;\"><span style=\"font-size:9.0pt;\">≥6</span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:34.5pt;padding:.75pt;width:288.75pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Nerves thickened +/- tenderness</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:105.0pt;\"><span style=\"color:black;font-size:9.0pt;\">No </span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:100.5pt;\"><span style=\"color:black;font-size:9.0pt;\">≥1 </span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:20.25pt;padding:.75pt;width:288.75pt;\"><span style=\"font-size:9.0pt;\"><strong>SSS AFB</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:105.0pt;\"><span style=\"font-size:9.0pt;\">Absent </span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:100.5pt;\"><span style=\"font-size:9.0pt;\">Present </span></td></tr></tbody></table></figure><p><span style=\"font-size:10.5pt;\"><i>*If a case has any one of the three features suggestive of MB, he/she is classified as MB.</i></span></p><p> </p><p><span style=\"font-size:13.5pt;\"><strong>Treatment Regimen: WHO & NLEP (Post April 1st 2025)</strong></span></p><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_TAhJtvE.png\" alt=\"A chart of medication\r\n\r\n\r\n\r\n\r\n\r\nDescription automatically generated with medium confidence\" width=\"337\" height=\"172\"></span></p><figure class=\"image\"><img style=\"aspect-ratio:184/239;\" src=\"https://tnhealth.tn.gov.in/tngovin/dph/images/mbadultdose.png\" alt=\"Health & Family Welfare Department, Government of Tamil Nadu\" width=\"184\" height=\"239\"></figure><p><span style=\"font-size:10.5pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_QuOAkXI.png\" width=\"463\" height=\"250\"></span></p><p> </p><h3><span style=\"color:#1F3763;font-size:10.5pt;\">Other Options:</span></h3><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option A: Packet 1 for 12 months:</strong> </span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">This packet was used for the treatment of paucibacillary leprosy according to old guidelines of NLEP, which is not suitable for a patient with multibacillary leprosy.</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option C: Packet 1 for 6 months: </strong></span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">This packet was used for the treatment of paucibacillary leprosy according to old guidelines of NLEP, which is not suitable for a patient with multibacillary leprosy.</span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\"><strong>Option D Packet 2 for 6 months:</strong> </span></p><p style=\"margin-left:18.0pt;\"><span style=\"font-size:10.5pt;\">Although Packet 2 contains the correct medications, the treatment duration of 6 months is insufficient for multibacillary leprosy according to WHO guidelines, which recommends 12 months.</span></p><p> </p><p><strong>OLD NLEP GUIDELINES to diagnose Leprosy </strong></p><figure class=\"table\"><table><tbody><tr><td style=\"background-color:#4472C4;border:1.0pt solid #4472C4;height:21.0pt;padding:.75pt;width:469.5pt;\" colspan=\"3\"><span style=\"color:white;font-size:9.0pt;\"><strong>National Leprosy Eradication Programme (NLEP) </strong></span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:28.5pt;padding:.75pt;width:281.9pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Cardinal features</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:91.3pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Paucibacillary </strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:28.5pt;padding:.75pt;width:96.3pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Multibacillary </strong></span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:35.25pt;padding:.75pt;width:281.9pt;\"><span style=\"font-size:9.0pt;\"><strong>Skin: Hypopigmented/ Hypoanesthetic patches</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:91.3pt;\"><span style=\"font-size:9.0pt;\">1-5 </span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:35.25pt;padding:.75pt;width:96.3pt;\"><span style=\"font-size:9.0pt;\">≥6</span></td></tr><tr><td style=\"background-color:#D9E2F3;border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:34.5pt;padding:.75pt;width:281.9pt;\"><span style=\"color:black;font-size:9.0pt;\"><strong>Nerves thickened +/- tenderness</strong></span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:91.3pt;\"><span style=\"color:black;font-size:9.0pt;\">No or 1 nerve</span></td><td style=\"background-color:#D9E2F3;border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:34.5pt;padding:.75pt;width:96.3pt;\"><span style=\"color:black;font-size:9.0pt;\">>1 </span></td></tr><tr><td style=\"border-bottom-style:solid;border-color:#8EAADB;border-left-style:solid;border-right-style:solid;border-top-style:none;border-width:1.0pt;height:20.25pt;padding:.75pt;width:281.9pt;\"><span style=\"font-size:9.0pt;\"><strong>SSS AFB</strong></span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:91.3pt;\"><span style=\"font-size:9.0pt;\">Absent </span></td><td style=\"border-bottom:1.0pt solid #8EAADB;border-left-style:none;border-right:1.0pt solid #8EAADB;border-top-style:none;height:20.25pt;padding:.75pt;width:96.3pt;\"><span style=\"font-size:9.0pt;\">Present </span></td></tr></tbody></table></figure><p><strong>OLD NLEP GUIDELINES to treat Leprosy </strong></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_cv8eRBC.png\" alt=\"A chart of drugs and drugs\r\n\r\nAI-generated content may be incorrect.\" width=\"468\" height=\"243\"></p><p><strong>OLD PB MDT with 2 drugs followed by NLEP:</strong></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_F3OLXAd.png\" alt=\"A green label with black circles and white text\r\n\r\nAI-generated content may be incorrect.\" width=\"468\" height=\"257\"></p><p> </p><p><span style=\"font-size:10.5pt;\"><i><strong>Educational objective:</strong></i></span></p><ul><li>As of <strong>April 1, 2025</strong>, <strong>NLEP follows WHO guidelines</strong> for both <strong>diagnosis and treatment</strong>.</li><li>Classification is based on <strong>skin lesions</strong>, <strong>nerve involvement</strong>, and <strong>skin smear</strong>.</li><li><span style=\"font-size:10.5pt;\">For a patient with <i><strong>multibacillary leprosy</strong></i>, characterized by <i><strong>one or more thickened nerves</strong></i> and <i><strong>multiple skin lesions</strong></i>, the appropriate treatment is with a regimen containing <i><strong>rifampicin, clofazimine, and dapsone (Packet 2)</strong></i> for a duration of <i><strong>12 months.</strong></i></span></li></ul><p> </p><p><span style=\"font-size:10.5pt;\"><strong>References:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>Jopling’s handbook of leprosy, 6<sup>th</sup> edition, page no 10</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong>Andrew’s diseases of the skin: clinical dermatology 13<sup>th</sup> edition page no 338, 339, 345</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/image_TAhJtvE.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200137,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50035,
      "choices": [
        {
          "id": 200140,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 200141,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3 and 4</span></p>"
        },
        {
          "id": 200142,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 4</span></p>"
        },
        {
          "id": 200143,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 9-month-old boy presents with progressive pallor and abdominal distension. The peripheral smear done is as shown below, and the Mentzer index was found to be less than 13. What are the investigations to be done in this patient?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(INICET NOV 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">High-performance liquid chromatography (HPLC)</span></li><li><span style=\"font-size:12.0pt;\">PT and APTT</span></li><li><span style=\"font-size:12.0pt;\">Bone marrow</span></li><li><span style=\"font-size:12.0pt;\">Peripheral blood smear</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/111_BYg1SyJ.jpg\" alt=\"\" width=\"300\" height=\"237\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/111_BYg1SyJ.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5924233",
      "question_audio": null,
      "question_video": null,
      "map_id": 34737563,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1 and 4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The clinical presentation, along with the findings of the peripheral blood smear and a Mentzer index of less than 13, suggests a diagnosis of <strong>thalassemia</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Thalassemia: </strong>A hemoglobinopathy characterized by a deficiency in the synthesis of one of the globin chains, either alpha or beta. In beta-thalassemia, there is reduced synthesis of beta chains, leading to decreased levels of hemoglobin A (HbA) and increased levels of HbA2 and HbF.</span></li><li><span style=\"font-size:12.0pt;\"><strong>High-performance liquid chromatography (HPLC): </strong>This test is crucial for diagnosing thalassemia as it can detect changes in hemoglobin levels, specifically the increased levels of HbA2 and HbF that are characteristic of beta-thalassemia. HPLC is sufficient for diagnosis without the need for bone marrow investigations.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Peripheral Blood Smear: </strong>The smear may reveal aniso-poikilocytosis, target cells, basophilic stippling, and fragmented red cells, which are indicative of thalassemia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Mentzer Index: </strong>The Mentzer index, calculated as MCV/RBC count, helps differentiate thalassemia from iron-deficiency anemia. A value of less than 13 suggests thalassemia, while a value greater than 13 suggests iron-deficiency anemia.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2 (PT and APTT): </strong>These tests are not directly relevant for the diagnosis of thalassemia. PT (Prothrombin Time) is used to assess the extrinsic pathway of coagulation, and APTT (Activated Partial Thromboplastin Time) assesses the intrinsic pathway, typically done when bleeding disorders are suspected.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>3 (Bone Marrow): </strong>Bone marrow examination is not necessary in this case as the diagnosis of thalassemia can be made based on HPLC and peripheral smear findings. Bone marrow investigations are more appropriate for cases of pancytopenia or unexplained anemia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In a child suspected of having thalassemia, High-performance liquid chromatography (HPLC) and a peripheral blood smear are key investigations for diagnosis.</span></p>",
      "correct_choice_id": 200142,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50036,
      "choices": [
        {
          "id": 200144,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rickettsia rickettsii</span></span></span></p>"
        },
        {
          "id": 200145,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rickettsia conorii</span></span></span></p>"
        },
        {
          "id": 200146,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ehrlichia chaffeensis</span></span></span></p>"
        },
        {
          "id": 200147,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Anaplasma</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Image of Rickettsial morula in a monocyte is shown below. Identify the organism? (</span></span></span>INICET Nov 2022)</p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-102120.png\" style=\"height:211px; width:300px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-102120.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q5394286",
      "question_audio": null,
      "question_video": null,
      "map_id": 34480792,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Ehrlichia chaffeensis</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ehrlichia chaffeensis is an obligate intracellular, Gram-negative species of Rickettsiales bacteria. It is a zoonotic pathogen transmitted to humans by the lone star tick (Amblyomma americanum) and is the causative agent of human monocytic ehrlichiosis (HME).</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ehrlichiosis is evidenced by the presence of intracytoplasmic inclusions known as morulae in monocytes, which can be observed on a Giemsa-stained blood film.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Characteristics and Clinical Presentation:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Transmission:</span></strong><span style=\"font-size:12.0pt\"> By the lone star tick (Amblyomma americanum).</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Symptoms:</span></strong><span style=\"font-size:12.0pt\"> Patients typically exhibit symptoms within 1 to 2 weeks after tick infection. Early symptoms include fever, headache, malaise, low-back pain, and gastrointestinal symptoms. Some patients may also have myalgias, arthralgias, coughing, pharyngitis, diarrhea, vomiting, abdominal pain, and changes in mental status.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Diagnosis:</span></strong><span style=\"font-size:12.0pt\"> Besides observing morulae in monocytes, serological tests like indirect fluorescent antibody tests and polymerase chain reaction (PCR) are also used for diagnosis.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Treatment:</span></strong><span style=\"font-size:12.0pt\"> TOC Doxycycline.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Rickettsia rickettsii</span></strong><span style=\"font-size:12.0pt\">: <strong>Incorrect.</strong> Rickettsia rickettsii is the causative agent of Rocky Mountain spotted fever (RMSF), typically associated with rash and vascular endothelial damage, not morulae in monocytes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Rickettsia conorii: Incorrect.</span></strong><span style=\"font-size:12.0pt\"> Rickettsia conorii causes Mediterranean spotted fever, which also does not present with morulae in monocytes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Anaplasma: Incorrect.</span></strong><span style=\"font-size:12.0pt\"> Anaplasma phagocytophilum causes human granulocytic anaplasmosis (HGA), where morulae are found in granulocytes, not monocytes. The presence of morulae in granulocytes is characteristic of Anaplasma infection.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ehrlichia chaffeensis is identified by the presence of morulae in monocytes and is the causative agent of human monocytic ehrlichiosis. The proper treatment is doxycycline, and diagnosis is confirmed through blood smear, serological tests, and PCR.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">GAME – Granulocytes: Anaplasma; Monocytes: Ehrlichiosis</span></strong></span></span></p>",
      "correct_choice_id": 200146,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50037,
      "choices": [
        {
          "id": 200148,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1-D, 2-A, 3-C, 4-B</span></span></p>"
        },
        {
          "id": 200149,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1-D, 2-A, 3-B, 4-C </span></span></p>"
        },
        {
          "id": 200150,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1-C, 2-B, 3-A, 4-D</span></span></p>"
        },
        {
          "id": 200151,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1-B, 2-C, 3-D, 4-A</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the given cellular components with their respective marker enzymes. </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/08/screenshot-2024-10-08-172818.png\" style=\"height:293px; width:700px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/08/screenshot-2024-10-08-172818.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q4346428",
      "question_audio": null,
      "question_video": null,
      "map_id": 34507689,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B) 1-D, 2-A, 3-B, 4-C</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The correctly matched answer is <strong>1-D, 2-A, 3-B, 4-C</strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Each organelle has specific enzymes that act as marker enzymes, which are used to identify them after centrifugation in laboratory settings.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Mitochondria</strong>: <strong>ATP synthase</strong> (D) is a key enzyme of mitochondria involved in the production of ATP during oxidative phosphorylation.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Peroxisomes</strong>: <strong>Catalase</strong> (A) is the enzyme that breaks down hydrogen peroxide (H₂O₂) into water and oxygen, a primary function of peroxisomes.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Golgi complex</strong>: <strong>Galactosyl transferase</strong> (B) is associated with the Golgi complex and is involved in glycosylation, the process of adding sugar residues to proteins and lipids.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Endoplasmic reticulum</strong>: <strong>Glucose-6-phosphatase</strong> (C) is an enzyme located in the endoplasmic reticulum, crucial for glucose homeostasis and the final step in gluconeogenesis and glycogenolysis.</span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A.</strong> Misplaces the enzymes, associating ATP synthase with the wrong organelle (ER), and Catalase with Golgi instead of peroxisomes.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C</strong>. Incorrect pairing of glucose-6-phosphatase with mitochondria and galactosyl transferase with peroxisomes.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D</strong>. Incorrectly matches enzymes, such as pairing ATP synthase with the ER and glucose-6-phosphatase with peroxisomes.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Each cellular organelle can be identified by its specific marker enzyme. Knowing these associations is essential for understanding cell biology and organelle function.</span></span></p>",
      "correct_choice_id": 200149,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50038,
      "choices": [
        {
          "id": 200152,
          "text": "<p><span style=\"font-size:12.0pt;\">Bansdola</span></p>"
        },
        {
          "id": 200153,
          "text": "<p><span style=\"font-size:12.0pt;\">Garroting</span></p>"
        },
        {
          "id": 200154,
          "text": "<p><span style=\"font-size:12.0pt;\">Mugging</span></p>"
        },
        {
          "id": 200155,
          "text": "<p><span style=\"font-size:12.0pt;\">Throttling</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The image below shows strangulation by Spanish windlass method. What type of strangulation method does it belong to? (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-37.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-37.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7330757",
      "question_audio": null,
      "question_video": null,
      "map_id": 34362886,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B. Garroting</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Spanish windlass</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Method:</strong> It involves tightening an iron collar (Spanish windlass) around the neck and forcing a spike against the neck into the spinal cord.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Garroting</strong>- It involves attacking the victim by throwing the ligature from behind over the victim's neck and then tightened by twisting with a lever.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bansdola: </strong>A method of strangulation where a ligature is applied in a different manner, often using a stick or rod to twist and tighten the ligature.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mugging: </strong>Refers to a method where the assailant uses their limbs, such as the crook of their elbow, to compress the neck.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Throttling: </strong>Throttling involves using hands to manually compress the neck, leading to asphyxia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The Spanish windlass method of strangulation, shown in the image, belongs to the category of garroting, which involves the use of a ligature tightened by a lever or similar mechanism.</span></p>",
      "correct_choice_id": 200153,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50039,
      "choices": [
        {
          "id": 200156,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Piperacillin-Tazobactam</span></span></p>"
        },
        {
          "id": 200157,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Amoxicillin-Clavulanate</span></span></p>"
        },
        {
          "id": 200158,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ceftriaxone</span></span></p>"
        },
        {
          "id": 200159,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Nitrofurantoin</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient with diabetes develops a UTI, which gets complicated with hypotension that is resistant to IV fluids. Which of the following antibiotics can be used? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q4027164",
      "question_audio": null,
      "question_video": null,
      "map_id": 34368984,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Piperacillin-Tazobactam</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient with diabetes has developed a urinary tract infection (UTI) complicated by hypotension resistant to IV fluids, indicating septic shock. In cases of septic shock, it is critical to start with empirical broad-spectrum antibiotics. These antibiotics are designed to cover a wide range of potential pathogens until the specific causative organism can be identified and targeted.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Broad-spectrum antibiotics suitable for such severe infections include:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Piperacillin-Tazobactam</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Carbapenems like Meropenem or Imipenem</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Certain third-generation cephalosporins like Ceftazidime</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In this case, Piperacillin-Tazobactam is chosen because it is a broad-spectrum antibiotic that covers many of the common pathogens responsible for severe infections and septic shock. Although a combination of Meropenem with Vancomycin would be ideal, the given options do not include Meropenem. Therefore, Piperacillin-Tazobactam is the best choice among the provided options.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Amoxicillin-Clavulanate:</span></strong><span style=\"font-size:12.0pt\"> This antibiotic is generally not sufficient for treating severe infections or septic shock due to its narrower spectrum of activity compared to Piperacillin-Tazobactam.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ceftriaxone:</span></strong><span style=\"font-size:12.0pt\"> While Ceftriaxone is a third-generation cephalosporin, it is not as broad-spectrum as Ceftazidime and does not provide the same coverage needed for septic shock.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Nitrofurantoin:</span></strong><span style=\"font-size:12.0pt\"> This antibiotic is typically used for uncomplicated lower urinary tract infections and is not effective for severe systemic infections or septic shock.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In the management of septic shock, especially in a patient with diabetes and complicated UTI, broad-spectrum antibiotics such as Piperacillin-Tazobactam are critical for empirical therapy.</span></span></span></p>",
      "correct_choice_id": 200156,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50040,
      "choices": [
        {
          "id": 200160,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lingula</span></span></p>"
        },
        {
          "id": 200161,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Upper part of right inferior lobe</span></span></p>"
        },
        {
          "id": 200162,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Right superior lobe</span></span></p>"
        },
        {
          "id": 200163,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Right middle lobe</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following lobes of the lung is affected when there is aspiration in supine position?</span><span style=\"background-color:lime\"><span style=\"font-family:\"Calibri\",sans-serif\"> </span></span></span></p>",
      "unique_key": "Q2042526",
      "question_audio": null,
      "question_video": null,
      "map_id": 34002302,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B) Upper part of right inferior lobe</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>upper part of the right inferior lobe</strong> is most prone to aspiration in the <strong>supine position</strong>. This is commonly observed in patients with decreased consciousness, such as alcoholics.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>posterior segment</strong> of the <strong>right superior lobe</strong> and the <strong>superior segment</strong> of the <strong>inferior lobes</strong> are the most common sites for aspiration in a recumbent patient.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>position of the patient</strong> affects where the aspirated contents settle due to <strong>gravity dependence</strong>. Aspiration while standing usually affects the <strong>inferior lobes</strong>. In the supine position, aspirated material tends to settle in the <strong>posterior segments</strong> of the lung.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Lingula</strong>: Lingula is incorrect. Aspiration usually does not affect the lingula as it is part of the left lung.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Right superior lobe</strong>: Right superior lobe is incorrect. While aspiration may affect the superior lobe, the posterior segment of the right superior lobe is more commonly affected in supine aspiration, not the superior lobe as a whole.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong> <strong>Right middle lobe</strong>: Right middle lobe is incorrect. Aspiration generally affects the lower lobes more than the middle lobe in the supine position.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In the <strong>supine position</strong>, aspiration typically affects the <strong>upper part of the right inferior lobe</strong> and the <strong>posterior segment of the right superior lobe</strong>. This pattern is due to the gravitational distribution of aspirated material in a recumbent patient.</span></span></p>",
      "correct_choice_id": 200161,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50041,
      "choices": [
        {
          "id": 200164,
          "text": "<p><span style=\"font-size:12.0pt;\">Anopheles</span></p>"
        },
        {
          "id": 200165,
          "text": "<p><span style=\"font-size:12.0pt;\">Aedes</span></p>"
        },
        {
          "id": 200166,
          "text": "<p><span style=\"font-size:12.0pt;\">Mansonia</span></p>"
        },
        {
          "id": 200167,
          "text": "<p><span style=\"font-size:12.0pt;\">Culex</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Water has accumulated in a container from a malfunctioning septic system, and mosquito larvae are observed. Based on the provided larval image, which mosquito species is it likely to be? (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip52.jpg\" alt=\"\" width=\"400\" height=\"241\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip52.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4000798",
      "question_audio": null,
      "question_video": null,
      "map_id": 34762566,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Culex</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Culex mosquito breeds in dirty water. The image shows a Culex larva with head suspended downwards at an angle to water surface and a siphon tube.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">In Culex, siphon tube is long and narrow</span></li><li><span style=\"font-size:12.0pt;\">In Aedes, it is short and broad</span></li><li><span style=\"font-size:12.0pt;\">In Mansonia, larvae are attached through siphon tube to roots of aquatic plants</span></li><li><span style=\"font-size:12.0pt;\">In Anopheles- No siphon tube but only apertures on 8<sup>th</sup>abdominal segment</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Breeding Habitant</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Anopheles → Sophisticated Mosquito; Breeds in clean water</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Culex → Nuisance Mosquito; <strong>Breeds in dirty water</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/untitled-2.jpg\" alt=\"\" width=\"1000\" height=\"709\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/untitled-2.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200167,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50042,
      "choices": [
        {
          "id": 200168,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A, B, C, D</span></span></p>"
        },
        {
          "id": 200169,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A, D</span></span></p>"
        },
        {
          "id": 200170,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">B, C, D</span></span></p>"
        },
        {
          "id": 200171,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A, C, D</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following can be used to calculate the cardiac output? </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">ECHO</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Ventilation-perfusion scan</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Thermodilution</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Fick's principle</span></span></li>\r\n</ol>",
      "unique_key": "Q8459926",
      "question_audio": null,
      "question_video": null,
      "map_id": 34967206,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D) A, C, D</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Fick principle, thermodilution, and ECHO are methods used to measure cardiac output.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Cardiac output</strong> is the volume of blood pumped by the heart per minute into the aorta. The average cardiac output is approximately 5 liters per minute. Various indirect methods are available to measure cardiac output:</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Fick’s principle</strong> calculates cardiac output based on oxygen consumption by the lungs and the arteriovenous difference in oxygen content in the blood. The formula used is:</span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cardiac output (L/min) = (O₂ absorbed per minute by lungs (mL/min)) / (Arteriovenous O₂ difference (mL/L of blood))</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Thermodilution method</strong> involves infusing cold saline into the right atrium through a Swan-Ganz catheter. The pulmonary artery temperature change is measured, and the temperature drop inversely correlates with the cardiac output.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>ECHO (Echocardiography)</strong> measures cardiac output using ultrasound waves to assess blood flow velocity through the heart, particularly the left ventricle. Stroke volume and heart rate are used to calculate the cardiac output via this formula:</span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cardiac Output = Stroke Volume × Heart Rate</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A (ECHO)</strong>: ECHO is correct but by itself is not the only method to calculate cardiac output.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B (Ventilation-perfusion scan)</strong>: Incorrect. This scan assesses pulmonary circulation, not cardiac output.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C (Thermodilution)</strong>: Correct, but not the only method to calculate cardiac output.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ventilation-perfusion scan</strong> is <strong>not used</strong> to measure cardiac output. It is primarily used to evaluate pulmonary circulation and assess conditions like pulmonary embolism.</span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cardiac output can be measured using several methods such as the <strong>Fick principle</strong>, <strong>thermodilution</strong>, and <strong>ECHO</strong>. The average cardiac output in adults is approximately <strong>5 L/min</strong>.</span></span></p>",
      "correct_choice_id": 200171,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50043,
      "choices": [
        {
          "id": 200172,
          "text": "<p><span style=\"font-size:12.0pt;\">6 Fr</span></p>"
        },
        {
          "id": 200173,
          "text": "<p><span style=\"font-size:12.0pt;\">14 Fr</span></p>"
        },
        {
          "id": 200174,
          "text": "<p><span style=\"font-size:12.0pt;\">16 Fr</span></p>"
        },
        {
          "id": 200175,
          "text": "<p><span style=\"font-size:12.0pt;\">22 Fr</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following option is a common size of a Foley catheter used in female patients and patients who have had urethral surgery or who have strictures? (INICET NOV 2022)</span></p>",
      "unique_key": "Q3684912",
      "question_audio": null,
      "question_video": null,
      "map_id": 34624881,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 14 Fr</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">14 Fr Foley catheters with a size of 14 Fr are commonly used in adult female patients. They are also used in patients who have had urethral surgery or who have strictures.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>6 Fr</strong>: 6 Fr Foley catheters with a size of 6 Fr are commonly used in pediatric patients or in adults with narrow urethras. They are also used in urodynamic studies to measure bladder pressures.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>C. 16 Fr</strong>: 16 Fr Foley catheters with a size of 16 Fr are commonly used in adult male patients. They are also used in patients who have had urethral surgery or who have strictures.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D.</strong> <strong>22 Fr</strong>: 22 Fr Foley catheters with a size of 22 Fr are commonly used in patients for suprapubic cystostomy. They are also used in patients who have undergone prostate surgery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>FOLEY’S CATHETER</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The size in French (12F, 14F, 16F etc.) represents the outer diameter. 1 F = 1/3<sup>rd</sup> mm.</strong></span></p><p> </p><p><span style=\"color:black;font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture5_Z8axJaw.jpg\" alt=\"\" width=\"200\" height=\"178\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/picture5_Z8axJaw.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200173,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50044,
      "choices": [
        {
          "id": 200176,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Aromatase</span></span></p>"
        },
        {
          "id": 200177,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">17-hydrolase</span></span></p>"
        },
        {
          "id": 200178,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">5-alpha reductase </span></span></p>"
        },
        {
          "id": 200179,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Phosphodiesterase</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Finasteride is used to treat male-pattern baldness by inhibiting which of the following enzymes?</span><span style=\"background-color:lime\"><span style=\"font-family:\"Calibri\",sans-serif\"> </span></span></span></p>",
      "unique_key": "Q8944439",
      "question_audio": null,
      "question_video": null,
      "map_id": 34715819,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) 5-alpha reductase</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Finasteride is used to treat male pattern baldness by inhibiting <strong>5-alpha reductase</strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Finasteride is a competitive inhibitor of the <strong>5-alpha-reductase</strong> enzyme, which inhibits the conversion of <strong>testosterone</strong> into its more active form, <strong>dihydrotestosterone (DHT)</strong>. DHT is a key factor in the development of male pattern baldness. By inhibiting type 2 5-alpha reductase, finasteride reduces the amount of DHT in the scalp, slowing hair loss and, in some cases, promoting hair regrowth. It is also used to treat benign prostatic hyperplasia (BPH) by reducing prostatic epithelial cell proliferation.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Important Points</strong>:</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The therapeutic effects are usually noticeable after about <strong>6 months</strong> of treatment.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>New hair growth is lost</strong> once the treatment is discontinued, similar to minoxidil.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Adverse effects include decreased libido, erectile dysfunction, and ejaculation disorders.</span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Finasteride is <strong>teratogenic</strong>, meaning it can cause abnormalities in male fetuses. Pregnant women should not be exposed to finasteride due to the risk of genital malformations in male babies.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Aromatase</strong>: Aromatase is an enzyme that converts androgens into estrogens. Inhibition of aromatase is used in the treatment of estrogen-dependent breast cancers, not for male-pattern baldness.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. 17-hydrolase</strong>: 17-hydrolase is involved in steroidogenesis, particularly in the production of cortisol and sex steroids. Inhibition of 17-hydrolase is not related to hair loss treatment.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Phosphodiesterase</strong>: Phosphodiesterase inhibitors are used in the treatment of erectile dysfunction (such as sildenafil) by increasing cyclic GMP levels, leading to smooth muscle relaxation in the penis. It is not involved in the treatment of male-pattern baldness.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Finasteride works by inhibiting <strong>5-alpha reductase</strong>, which blocks the conversion of testosterone to <strong>dihydrotestosterone (DHT)</strong>, a major factor in male-pattern baldness and benign prostatic hyperplasia.</span></span></p>",
      "correct_choice_id": 200178,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50045,
      "choices": [
        {
          "id": 200180,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rosai-Dorfman disease</span></span></span></p>"
        },
        {
          "id": 200181,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Kimura disease</span></span></span></p>"
        },
        {
          "id": 200182,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Langerhans cell histiocytosis</span></span></span></p>"
        },
        {
          "id": 200183,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Juvenile Xanthogranuloma</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 7-year-old child brought to OPD with complaints of fever, erythematous rash, and bone pain. X-ray of the skull revealed multiple lytic lesions. Skin biopsy shows prominent nuclear grooves with eosinophils as in the image below. Immunohistochemistry is positive for S100, CD1a. What is the likely diagnosis?  (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture10.jpg\" style=\"height:264px; width:300px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture10.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3659518",
      "question_audio": null,
      "question_video": null,
      "map_id": 34646079,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Langerhans cell histiocytosis</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The above history along with the histopathological image showing Langerhans cells (image A), <strong>CD1a and positive S100 positive, is suggestive of Langerhans cell histiocytosis (LCH).</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-134845.jpg\" style=\"height:493px; width:1000px\" /></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other option:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Rosai Dorfman disease</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Rosai Dorfman disease doesn’t show histiocytes. It presents with painless lymphadenopathy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Kimura disease</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Kimura disease presents with painless lymphadenopathy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Juvenile Xanthogranuloma</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Juvenile Xanthogranuloma shows multinucleated giant cells. It presents with papular lesions.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective</span></strong><strong><span style=\"font-size:12.0pt\">: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Langerhans cell histiocytosis (LCH)</span></strong><span style=\"font-size:12.0pt\"> is identified by a combination of clinical symptoms (such as bone pain, fever, and rash), characteristic histopathological features (nuclear grooves, eosinophils), and positive immunohistochemical markers (S100, CD1a). The presence of multiple lytic bone lesions, especially in the skull, is a key diagnostic clue.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-134845.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200182,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50046,
      "choices": [
        {
          "id": 200184,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1-b, 2-a, 3-d, 4-c</span></span></p>"
        },
        {
          "id": 200185,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1-a, 2-d, 3-c, 4-b</span></span></p>"
        },
        {
          "id": 200186,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1-b, 2-d, 3-a, 4-c</span></span></p>"
        },
        {
          "id": 200187,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1-a, 2-b, 3-d, 4-c</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following cell types with their associated malignancy. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Popcorn cell</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Faggot cell</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cerebriform nuclei</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Starry sky</span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Acute promyelocytic leukemia</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lymphocyte-predominant Hodgkin's lymphoma</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Burkitt lymphoma</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sezary syndrome</span></span></li>\r\n</ol>",
      "unique_key": "Q9635668",
      "question_audio": null,
      "question_video": null,
      "map_id": 34272270,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) 1-b, 2-a, 3-d, 4-c</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The correct matches are as follows:</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>1. Popcorn cell</strong>: <strong>b. Lymphocyte-predominant Hodgkin's lymphoma</strong></span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Popcorn cells, also known as L&H cells, are seen in nodular lymphocyte-predominant Hodgkin's lymphoma (NLPHL). These cells are large, with lobulated nuclei that resemble popcorn.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>2. Faggot cell</strong>: <strong>a. Acute promyelocytic leukemia</strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Faggot cells are characteristic of acute promyelocytic leukemia (APL). These cells contain multiple Auer rods in their cytoplasm, giving a bundle-like appearance (faggots).</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>3. Cerebriform nuclei</strong>: <strong>d. Sezary syndrome</strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cerebriform nuclei are seen in Sezary syndrome, a type of cutaneous T-cell lymphoma. The nuclei have a characteristic folded appearance resembling the cerebral cortex.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>4. Starry sky</strong>: <strong>c. Burkitt lymphoma</strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The \"starry sky\" pattern is observed in Burkitt lymphoma. It refers to the appearance of macrophages (stars) scattered among a background of malignant lymphocytes (sky), due to rapid tumor turnover and apoptosis.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. 1-a, 2-d, 3-c, 4-b</strong>: Incorrect. Popcorn cells are not seen in acute promyelocytic leukemia; they are associated with lymphocyte-predominant Hodgkin's lymphoma. Similarly, faggot cells are seen in acute promyelocytic leukemia, not Sezary syndrome. Cerebriform nuclei are characteristic of Sezary syndrome, not Burkitt lymphoma.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. 1-b, 2-d, 3-a, 4-c</strong>: Incorrect. While the match for the popcorn cell is correct, faggot cells are seen in acute promyelocytic leukemia, not Sezary syndrome. Cerebriform nuclei are associated with Sezary syndrome, not acute promyelocytic leukemia.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. 1-a, 2-b, 3-d, 4-c</strong>: Incorrect. The popcorn cell is not associated with acute promyelocytic leukemia but with lymphocyte-predominant Hodgkin's lymphoma. Similarly, faggot cells are seen in acute promyelocytic leukemia, not lymphocyte-predominant Hodgkin's lymphoma.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The student must memorize the key associations of specific cell types with their respective malignancies:</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Popcorn cell</strong>: Lymphocyte-predominant Hodgkin's lymphoma</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Faggot cell</strong>: Acute promyelocytic leukemia</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Cerebriform nuclei</strong>: Sezary syndrome</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Starry sky</strong>: Burkitt lymphoma</span></span></li>\r\n</ul>",
      "correct_choice_id": 200184,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50047,
      "choices": [
        {
          "id": 200188,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Beta blockers</span></span></span></p>"
        },
        {
          "id": 200189,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Calcium channel blockers</span></span></span></p>"
        },
        {
          "id": 200190,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Acetaminophen</span></span></span></p>"
        },
        {
          "id": 200191,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Aspirin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Urinary alkalinization will be most useful in toxicity of which of the following drugs? (INICET NOV 2020)</span></span></p>",
      "unique_key": "Q7206827",
      "question_audio": null,
      "question_video": null,
      "map_id": 34271328,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D. Aspirin</span></strong></span></span><br />\r\n </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Urinary alkalinization is a key treatment in aspirin toxicity. Aspirin (salicylate) is a weak acid, and alkalinizing the urine increases the ionization of salicylates. This ionization traps salicylates in the urine, preventing their reabsorption and enhancing their elimination.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Beta blockers:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Urinary alkalinization is not a standard treatment for beta blocker toxicity. Management of beta blocker overdose typically involves supportive care and, in severe cases, specific antidotes like glucagon or high-dose insulin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Calcium channel blockers:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Similar to beta blockers, urinary alkalinization is not a primary treatment for calcium channel blocker overdose. Treatment often includes calcium infusions, glucagon, and other supportive measures.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Acetaminophen:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> For acetaminophen toxicity, the antidote N-acetylcysteine (NAC) is used. Urinary alkalinization is not effective for acetaminophen overdose.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Urinary alkalinization is most useful in the treatment of aspirin (salicylate) toxicity because it increases the elimination of salicylates by trapping them in the urine through ionization. This method is not effective for beta blockers, calcium channel blockers, or acetaminophen toxicity.</span></span></span></p>",
      "correct_choice_id": 200191,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50048,
      "choices": [
        {
          "id": 200192,
          "text": "<p><span style=\"font-size:12.0pt;\">Grommet insertion</span></p>"
        },
        {
          "id": 200193,
          "text": "<p><span style=\"font-size:12.0pt;\">Adenoidectomy with grommet insertion</span></p>"
        },
        {
          "id": 200194,
          "text": "<p><span style=\"font-size:12.0pt;\">Myringotomy with grommet insertion</span></p>"
        },
        {
          "id": 200195,
          "text": "<p><span style=\"font-size:12.0pt;\">Myringotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 6-year-old boy presented with recurrent URTI, poor growth, high-arched palate, and impaired hearing. Tympanogram is given as follows. What would be the most appropriate management?(</span>INICET Nov 2021)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/untitled-23.jpg\" alt=\"\" width=\"300\" height=\"275\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/untitled-23.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6750523",
      "question_audio": null,
      "question_video": null,
      "map_id": 34707201,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Adenoidectomy with grommet insertion </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The presentation of a child with a type B tympanometry curve indicates the likelihood of serous otitis media due to adenoid hypertrophy as the underlying cause.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-114129.png\" alt=\"\" width=\"1000\" height=\"640\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/whatsapp-image-2023-09-13-at-42819-pm.jpeg\" alt=\"\" width=\"600\" height=\"513\"></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-114609.png\" alt=\"\" width=\"1000\" height=\"499\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Grommet insertion</strong>: While this can relieve middle ear effusion, it does not address the underlying adenoid hypertrophy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Myringotomy with grommet insertion</strong>: Similar to grommet insertion alone, this option does not address the root cause of adenoid hypertrophy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Myringotomy</strong>: This procedure involves making an incision in the tympanic membrane to relieve pressure or drain fluid but does not address the cause or provide a lasting solution like adenoidectomy with grommet insertion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Adenoidectomy with grommet insertion is the most appropriate management for a child presenting with serous otitis media due to adenoid hypertrophy, addressing both the immediate symptoms and underlying cause.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-114129.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200193,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50049,
      "choices": [
        {
          "id": 200196,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 3 and 4</span></span></span></p>"
        },
        {
          "id": 200197,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2 and 4</span></span></span></p>"
        },
        {
          "id": 200198,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 3 and 4</span></span></span></p>"
        },
        {
          "id": 200199,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 3 and 4</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following method of disinfection and sterilization can also kill spores?</span> (<span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">INICET NOV 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ol>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glutaraldehyde</span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ethylene oxide</span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pasteurization</span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ortho-phthalaldehyde</span></span></span></li>\r\n</ol>",
      "unique_key": "Q3012646",
      "question_audio": null,
      "question_video": null,
      "map_id": 34005104,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) 1, 2 and 4</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Glutaraldehyde, Ethylene oxide, and Ortho-phthalaldehyde are effective methods of disinfection and sterilization that can kill spores.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1. Glutaraldehyde</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This chemical is a broad-spectrum microbicidal and sporicidal agent. It is known for its compatibility with a variety of medical instruments. However, it requires activation and produces irritant fumes, which are notable disadvantages. Despite these drawbacks, glutaraldehyde is commonly recommended for the disinfection of fibroscopes and respiratory equipment due to its efficacy against spores and other microorganisms.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2. ETO (Ethylene oxide)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> inactivates all microorganisms although bacterial spores (especially B. atrophaeus) are more resistant than other microorganisms. For this reason B. atrophaeus is the recommended biological indicator. ETO is used in healthcare facilities to sterilize critical items (and sometimes semicritical items) that are moisture or heat sensitive and cannot be sterilized by steam sterilization like syringes, needles, catheters, and gloves. Bacillus atrophaeus and Bacillus subtilis are used as sterilization control.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4. Ortho-phthalaldehyde</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Similar to glutaraldehyde, ortho-phthalaldehyde is a broad-spectrum microbicidal and sporicidal agent. It does not require activation and does not produce irritating fumes, which are significant advantages. However, it is costly and can stain medical equipment. It is often used as an alternative to glutaraldehyde for disinfecting scopes.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3. Pasteurization</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> or pasteurization is a process of food preservation in which packaged and non-packaged foods (such as milk and fruit juices) are treated with mild heat, usually to less than 100 °C (212 °F), to eliminate pathogens and extend shelf life. It has no sporicidal activity and kills non-spore-forming bacteria like Mycobacteria, Brucella, and Salmonella. There are two methods-</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ol style=\"list-style-type:lower-alpha\">\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Holder method -  milk is heated at either 63°C for 30 minutes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. Coxiella burnetii is relatively heat resistant and may survive the holder method.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Flash method - milk is heated at 72°C for 15-20 seconds</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> followed by cooling quickly to 13°C or lower. </span></span></span></li>\r\n</ol>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-111846.png\" style=\"height:1047px; width:1000px\" /></span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-111846.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200197,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50050,
      "choices": [
        {
          "id": 200200,
          "text": "<p><span style=\"font-size:12.0pt;\">Zika virus</span></p>"
        },
        {
          "id": 200201,
          "text": "<p><span style=\"font-size:12.0pt;\">Roseola infantum</span></p>"
        },
        {
          "id": 200202,
          "text": "<p><span style=\"font-size:12.0pt;\">Kyasanur forest disease</span></p>"
        },
        {
          "id": 200203,
          "text": "<p><span style=\"font-size:12.0pt;\">West Nile fever</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A petechial rash is associated with all the following, except?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p>",
      "unique_key": "Q4275291",
      "question_audio": null,
      "question_video": null,
      "map_id": 34897703,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Roseola infantum</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Roseola infantum</strong>, also known as exanthem subitum or sixth disease, is a common viral illness caused primarily by human herpesvirus 6 (HHV-6) and sometimes by human herpesvirus 7 (HHV-7). The disease typically affects young children. It is characterized by a high fever lasting for three to five days, which abruptly resolves and is followed by the appearance of a rash. The rash consists of small, rose-pink or red 2 mm to 5 mm papules and macules. A pale halo can occur around the macules and papules in some cases. The rash usually begins on the trunk and can spread to the neck, extremities, and face. It is typically nonpruritic, blanching, and can persist from one to two days.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-112900.png\" alt=\"\" width=\"300\" height=\"200\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In contrast, petechial rashes are small, pinpoint, red or purple spots caused by bleeding into the skin and are associated with the following diseases:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Zika Virus</strong>: Zika virus infection can cause a mild, dengue-like illness, which includes symptoms like fever, rash, joint pain, and conjunctivitis. The rash can be maculopapular, and in some cases, petechiae can be observed.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-112914.png\" alt=\"\" width=\"300\" height=\"170\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Kyasanur Forest Disease</strong>: This is a tick-borne viral hemorrhagic fever endemic to South India. It is caused by the Kyasanur Forest disease virus (KFDV) and presents with high fever, headache, severe muscle pain, vomiting, gastrointestinal symptoms, and hemorrhagic manifestations, including petechiae.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-112924.png\" alt=\"\" width=\"300\" height=\"201\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. West Nile Fever</strong>: This disease is caused by the West Nile virus, which is transmitted by mosquitoes. Symptoms can range from mild to severe, including fever, headache, body aches, skin rash, swollen lymph nodes, and in severe cases, neurological complications. Petechial rashes can occur in some cases.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-112935.png\" alt=\"\" width=\"300\" height=\"170\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Roseola infantum is characterized by a rapid onset of a high fever followed by a rash, but it does not typically present with petechial rashes. In contrast, Zika virus, Kyasanur Forest disease, and West Nile fever can cause petechial rashes as part of their clinical manifestations.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-112900.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200201,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50051,
      "choices": [
        {
          "id": 200204,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Amniotic fluid volume</span></span></span></p>"
        },
        {
          "id": 200205,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Fetal tone</span></span></span></p>"
        },
        {
          "id": 200206,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Daily fetal movement count</span></span></span></p>"
        },
        {
          "id": 200207,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Non-stress test</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is not a component of biophysical profile? </span></span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q8045130",
      "question_audio": null,
      "question_video": null,
      "map_id": 34206027,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) Daily fetal movement count</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Daily fetal movement count (DFMC) is not a component of the BPP. DFMC, often assessed using Cardiff’s count of 10, is a separate method for monitoring fetal movements.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The Biophysical Profile (BPP) is a comprehensive test used in the assessment of fetal wellbeing. It includes five components, which are scored using the Manning score:</span></span></span>\r\n\r\n\t<ol>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Non-stress test (NST)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Amniotic fluid volume (AFV)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Fetal movements</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Fetal tone</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Fetal breathing movements</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A low Manning score is indicative of fetal hypoxia and may necessitate further clinical intervention.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Additionally, the Modified Biophysical Profile (BPP) includes only two components:</span></span></span>\r\n\t<ol>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Non-stress test (NST)</span></span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Amniotic fluid index (AFI)</span></span></span></li>\r\n\t</ol>\r\n\t</li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Amniotic fluid volume</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Amniotic fluid volume is a component of the BPP and helps assess the amount of amniotic fluid surrounding the fetus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Fetal tone</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Fetal tone is another component of the BPP, assessing the baby's muscle tone.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Non-stress test</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Non-stress test (NST) is part of the BPP and evaluates the fetal heart rate in response to fetal movements.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The Biophysical Profile (BPP) consists of five components: NST, AFV, fetal movements, fetal tone, and fetal breathing movements. Daily fetal movement count (DFMC) is not part of the BPP.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg 342, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 122</span></strong></span></span></p>",
      "correct_choice_id": 200206,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50052,
      "choices": [
        {
          "id": 200208,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 4</span></p>"
        },
        {
          "id": 200209,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 200210,
          "text": "<p><span style=\"font-size:12.0pt;\">3 and 4</span></p>"
        },
        {
          "id": 200211,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child is brought to the casualty with a history of choking. On examination, there is decreased air entry in the left lung. What would be the correct management?</span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\">(INICET NOV 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Bronchoscopy</span></li><li><span style=\"font-size:12.0pt;\">Computed tomography scan</span></li><li><span style=\"font-size:12.0pt;\">ICD insertion</span></li><li><span style=\"font-size:12.0pt;\">Chest x-ray</span></li></ol>",
      "unique_key": "Q9924920",
      "question_audio": null,
      "question_video": null,
      "map_id": 34113931,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1 and 4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A child presenting with a history of choking and decreased air entry in the left lung is highly suggestive of a <strong>foreign body lodged in the left bronchus</strong>. The correct management steps include:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. Bronchoscopy: </strong>This is the gold standard for both the diagnosis and removal of the foreign body. Rigid bronchoscopy is typically performed by a specialist, such as an otolaryngologist or pulmonologist, to visualize and extract the foreign body.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>4. Chest X-ray: </strong>This is an essential initial investigation to assess for the presence of a foreign body. Although many foreign bodies are radiolucent, secondary findings such as air trapping, obstructive emphysema, atelectasis, asymmetric hyperinflation, mediastinal shift, and consolidation can be indicative of foreign body aspiration.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2. CT scan: </strong>While a CT scan has high sensitivity and specificity for detecting radiolucent foreign bodies, it is not routinely performed in this situation due to the high radiation exposure, especially in children.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>3. ICD insertion: </strong>Insertion of an intercostal drain (ICD) is not indicated unless there is clinical evidence of pneumothorax or other complications that require it. A chest X-ray is essential before deciding on this intervention.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Clinical Approach:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">A detailed history and physical examination are critical when a child presents with choking.</span></li><li><span style=\"font-size:12.0pt;\">A chest X-ray should be performed to assess for secondary signs of foreign body aspiration.</span></li><li><span style=\"font-size:12.0pt;\">Bronchoscopy should be conducted even if imaging is negative but clinical suspicion remains high.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In a child with suspected foreign body aspiration, a chest X-ray and bronchoscopy are the key steps for diagnosis and management. Bronchoscopy allows for both visualization and removal of the foreign body.</span></p>",
      "correct_choice_id": 200211,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50053,
      "choices": [
        {
          "id": 200212,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Repeat surgery</span></span></p>"
        },
        {
          "id": 200213,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Macrolides for 4 months</span></span></p>"
        },
        {
          "id": 200214,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Steroid irrigation and antihistamines</span></span></p>"
        },
        {
          "id": 200215,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Biological therapy</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 35-year-old female patient presents with complaints of nasal obstruction and post-nasal drip. There is a past history of FESS for failed conservative management 5 years ago. Uncinectomy and maxillary ostium dilation were done during the previous FESS. A DNE done now shows patent ostia and mucosal edema of the maxillary sinus lining. What is the next best step in management?</span><span style=\"background-color:lime\"><span style=\"font-family:\"Calibri\",sans-serif\"> </span></span></span></p>",
      "unique_key": "Q5905253",
      "question_audio": null,
      "question_video": null,
      "map_id": 34680545,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Steroid irrigation and antihistamines</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The history of <strong>nasal obstruction</strong> and <strong>post-nasal drip</strong> with endoscopy findings of <strong>mucosal edema</strong> suggests the presence of <strong>acute rhinosinusitis</strong>. The next best management involves <strong>nasal steroid irrigation</strong> along with <strong>antihistamines</strong> to reduce the mucosal inflammation, congestion, and edema. Even though the patient underwent FESS (Functional Endoscopic Sinus Surgery) 5 years ago, the patent ostia indicate that the surgery was successful in creating drainage pathways, but inflammation persists.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Acute viral rhinosinusitis often leads to <strong>mucosal edema</strong>, which can obstruct the sinus ostia and impair mucociliary clearance, causing symptoms like headache, facial pain, and nasal congestion. <strong>Steroid irrigation</strong> and <strong>antihistamines</strong> are used to reduce this inflammation and promote drainage.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Repeat surgery:</strong> Repeat surgery is not indicated because the DNE (Diagnostic Nasal Endoscopy) findings show <strong>patent ostia</strong>, indicating no structural blockage requiring surgical correction. Surgery is reserved for patients with failed medical management or irreversible anatomical issues.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Macrolides for 4 months:</strong> Macrolides (such as azithromycin) are not routinely used for long-term management of rhinosinusitis unless there is chronic bacterial infection or the patient shows signs of immune deficiency. In this case, no bacterial infection is present, and there are no signs of infection requiring antibiotics.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Biological therapy:</strong> Biological therapies (e.g., monoclonal antibodies) are considered in refractory chronic sinusitis with polyps, especially when associated with conditions like asthma. However, they are not standard treatments for uncomplicated rhinosinusitis with mucosal edema.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Nasal steroid irrigation</strong> and <strong>antihistamines</strong> are the next best step in the management of acute rhinosinusitis with mucosal edema and patent sinus ostia, especially in patients with previous sinus surgery. This approach reduces inflammation and edema to restore normal sinus drainage.</span></span></p>",
      "correct_choice_id": 200214,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50054,
      "choices": [
        {
          "id": 200216,
          "text": "<p><span style=\"font-size:12.0pt;\">Wearing clothes of opposite sex</span></p>"
        },
        {
          "id": 200217,
          "text": "<p><span style=\"font-size:12.0pt;\">Public display of genitalia</span></p>"
        },
        {
          "id": 200218,
          "text": "<p><span style=\"font-size:12.0pt;\">Seeing a male undressing</span></p>"
        },
        {
          "id": 200219,
          "text": "<p><span style=\"font-size:12.0pt;\">Seeing a female undressing</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Eonism can be defined as? </span>(INICET NOVEMBER 2022)</p>",
      "unique_key": "Q9941640",
      "question_audio": null,
      "question_video": null,
      "map_id": 34422996,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>A. Wearing clothes of opposite sex</strong></span></p><p><span style=\"font-size:11pt;\"> </span></p><ul><li><span style=\"font-size:12.0pt;\">Eonism /Transvestism involves wearing clothes of the opposite sex to derive pleasure.</span></li><li><span style=\"font-size:12.0pt;\">Eonism is named for Charles Eon de Beaumont, a French political adventurer who died in 1810 after posing as a woman for many years.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>.<strong> Public display of genitalia</strong> – Exhibitionism, where an individual derives pleasure from exposing their genitals to others in public.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Seeing a male undressing: </strong>This can be a form of voyeurism, though it is not specifically defined as such. Voyeurism typically involves deriving pleasure from secretly observing others who are undressing or engaging in sexual activities.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D</strong>. <strong>Seeing a female undressing</strong>- Voyeurism, where an individual derives pleasure from observing females undressing.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Eonism or transvestism is the act of wearing clothes of the opposite sex for pleasure, named after Charles Eon de Beaumont.</span></p>",
      "correct_choice_id": 200216,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50055,
      "choices": [
        {
          "id": 200220,
          "text": "<p><span style=\"font-size:12.0pt;\">15 minutes of arc</span></p>"
        },
        {
          "id": 200221,
          "text": "<p><span style=\"font-size:12.0pt;\">5 minutes of arc</span></p>"
        },
        {
          "id": 200222,
          "text": "<p><span style=\"font-size:12.0pt;\">10 minutes of arc</span></p>"
        },
        {
          "id": 200223,
          "text": "<p><span style=\"font-size:12.0pt;\">20 minute of arc</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient has presented for a routine eye evaluation. You have checked his visual acuity using Snellen's chart and found it to be 6/6. What is the minimum angle of resolution? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q1324122",
      "question_audio": null,
      "question_video": null,
      "map_id": 34847916,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 5 minutes of arc</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The angle subtended for a patient with 6/6 vision is 5 minutes of arc.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Visual acuity is a measure of the spatial resolution of the eye or an estimation of its ability to discriminate between two points.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Snellen's chart consists of a series of letters arranged in lines, each diminishing in size. Each whole letter will subtend the angle of 5 minutes at the nodal point of the eye at the given distance.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture6_JFtDR2I.jpg\" alt=\"\" width=\"500\" height=\"310\"></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The minimum angle of resolution for someone with a visual acuity of 6/6 using a Snellen chart is 5 minutes of arc. This indicates the precise and detailed visual capability required to resolve fine details at a standard distance, a fundamental concept in understanding and assessing visual acuity in clinical settings.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture6_JFtDR2I.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200221,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50056,
      "choices": [
        {
          "id": 200224,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 5, 6</span></p>"
        },
        {
          "id": 200225,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 5, 6</span></p>"
        },
        {
          "id": 200226,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 5</span></p>"
        },
        {
          "id": 200227,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 6</span></p>"
        }
      ],
      "text": "<p> </p><p><span style=\"font-size:12.0pt;\">A 24-year-old male presents to your clinic after a dog bite earlier in the day. Physical examination reveals a 1.5 cm abrasion with some oozing. Given the nature of the wound and the potential interventions post-exposure, which combination of actions and descriptors best characterizes the appropriate management? (INICET NOV 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Category 3 wound</span></li><li><span style=\"font-size:12.0pt;\">Wash the wound with normal tap water for 15-20 minutes</span></li><li><span style=\"font-size:12.0pt;\">Clean the wound with spirit</span></li><li><span style=\"font-size:12.0pt;\">Loose suturing of the wound with a proper dressing</span></li><li><span style=\"font-size:12.0pt;\">Equine immunoglobin is given at a dose of 40 IU/kg of body weight, twice</span></li><li><span style=\"font-size:12.0pt;\">Intra-dermal vaccine is administered on days 0, 3, 7, 28 </span></li></ol>",
      "unique_key": "Q8534257",
      "question_audio": null,
      "question_video": null,
      "map_id": 34522924,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 2, 3, 6</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The patient with a dog bite presented with an abrasion, which comes under category 3 wound.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The components of post–exposure prophylaxis<strong> </strong>are:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Local treatment of wound</span></li><li><span style=\"font-size:12.0pt;\">Antibiotics and anti-tetanus measures</span></li><li><span style=\"font-size:12.0pt;\">Active immunization against rabies – if indicated</span></li><li><span style=\"font-size:12.0pt;\">Passive immunization with rabies immunoglobulin – if indicated</span></li><li><span style=\"font-size:12.0pt;\">Observe the animal for 10 days from the day of bite:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">If healthy after 10 days: Discontinue post – exposure vaccination</span></li><li><span style=\"font-size:12.0pt;\">If dies within observation period: complete PEP</span></li><li><span style=\"font-size:12.0pt;\">If observation not possible: complete the post – exposure vaccination</span></li></ul></li></ol><p><span style=\"font-size:11pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Option: </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Statement 4 – Abrasion wound doesn’t require suturing</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Statement 5 – Equine Rabies Ig at dose of 40 IU/kg should be given only once.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-125243.png\" alt=\"\" width=\"1000\" height=\"554\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-125243.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200227,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50057,
      "choices": [
        {
          "id": 200228,
          "text": "<p><span style=\"font-size:12.0pt;\">Insulin</span></p>"
        },
        {
          "id": 200229,
          "text": "<p><span style=\"font-size:12.0pt;\">Growth hormone</span></p>"
        },
        {
          "id": 200230,
          "text": "<p><span style=\"font-size:12.0pt;\">Thyroxine</span></p>"
        },
        {
          "id": 200231,
          "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The hormone that does not play a role in the growth of the fetus is: (INICET NOV 2022)</span></p>",
      "unique_key": "Q7206623",
      "question_audio": null,
      "question_video": null,
      "map_id": 34173011,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Growth hormone.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Fetal growth </strong>is a complex process regulated by various hormones, but <strong>growth hormone</strong> does not play a significant role in this process during fetal life. The primary hormones involved in fetal growth include insulin, thyroxine, and glucocorticoids.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Insulin: </strong>Insulin is crucial for fetal growth, especially during the third trimester. It plays a key role in promoting the storage of nutrients and the growth of fetal tissues, particularly adipose tissue and muscle.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Thyroxine: </strong>Fetal production of thyroxine begins around the 12th week of gestation. Thyroxine is vital for the development of the central nervous system and overall growth and differentiation of tissues.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Glucocorticoids: </strong>Glucocorticoids are essential towards the end of gestation, particularly for the maturation of organs such as the lungs, liver, and gastrointestinal tract. They help prepare the fetus for life outside the womb by stimulating the production of surfactant in the lungs and facilitating the maturation of other critical systems.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Growth Hormone: </strong>Unlike in postnatal life, where growth hormone is a key regulator of growth, its role in fetal growth is minimal. Fetal growth is largely driven by insulin and other growth factors rather than growth hormone.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Insulin and Option C. Thyroxine: </strong>Both are crucial for fetal growth, regulating tissue growth and differentiation, especially in the later stages of pregnancy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Glucocorticoids: </strong>These hormones are essential for the maturation of fetal organs before birth, particularly in the liver, lungs, and gastrointestinal tract.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Growth hormone does not play a significant role in fetal growth, which is primarily regulated by insulin, thyroxine, and glucocorticoids.</span></p>",
      "correct_choice_id": 200229,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50058,
      "choices": [
        {
          "id": 200232,
          "text": "<p><span style=\"font-size:12.0pt;\">To break AT bonds high Tm is required</span></p>"
        },
        {
          "id": 200233,
          "text": "<p><span style=\"font-size:12.0pt;\">To break GC bonds low Tm is required</span></p>"
        },
        {
          "id": 200234,
          "text": "<p><span style=\"font-size:12.0pt;\">To break AT bonds low Tm is required</span></p>"
        },
        {
          "id": 200235,
          "text": "<p><span style=\"font-size:12.0pt;\">AT bonds and GC bonds need the same TM</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is true? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2022)</span></p>",
      "unique_key": "Q3487003",
      "question_audio": null,
      "question_video": null,
      "map_id": 34166250,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) To break AT bonds low Tm is required</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">To break AT bonds low Tm is required: This statement is correct. AT bonds are held together by two hydrogen bonds, which are relatively weak compared to GC bonds. Therefore, lower temperatures (low Tm) are required to break AT bonds, causing the DNA to denature.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>To break AT bonds high Tm is required:</strong> This statement is incorrect. The melting temperature (Tm) of DNA is the temperature at which the double-stranded DNA molecule begins to denature or separate into single strands. AT bonds (adenine-thymine) are held together by two hydrogen bonds, which are weaker than the three hydrogen bonds holding GC bonds (guanine-cytosine) together. Therefore, lower temperatures (relatively low Tm) are required to break AT bonds.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>To break GC bonds low Tm is required:</strong> This statement is incorrect. GC bonds have a higher Tm compared to AT bonds because they are held together by three hydrogen bonds, making them more stable. So, higher temperatures (relatively high Tm) are required to break GC bonds.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>AT bonds and GC bonds need the same Tm</strong>: This statement is incorrect. As explained above, AT bonds and GC bonds have different Tm values due to the difference in the number of hydrogen bonds holding them together.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In DNA, there are two hydrogen bonds between A and T and three hydrogen bonds between G and C. So, AT bonds will require a lower Tm (melting temperature) compared to GC bonds as less energy is required for breaking 2 bonds compared to three bonds.</span></p>",
      "correct_choice_id": 200234,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50059,
      "choices": [
        {
          "id": 200236,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperpolarization, increase in neurotransmitter release</span></p>"
        },
        {
          "id": 200237,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperpolarization, decrease in neurotransmitter release</span></p>"
        },
        {
          "id": 200238,
          "text": "<p><span style=\"font-size:12.0pt;\">Depolarization, decrease in neurotransmitter release</span></p>"
        },
        {
          "id": 200239,
          "text": "<p><span style=\"font-size:12.0pt;\">Depolarization, increase in neurotransmitter release</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What event takes place when the retina is exposed to light? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q9799571",
      "question_audio": null,
      "question_video": null,
      "map_id": 34537618,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Hyperpolarization, decrease in neurotransmitter release</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The retina responds to light by initiating a process called phototransduction, which converts light energy into an electrical signal. This process involves the activation of rods and cones, which are the photoreceptor cells in the retina.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In the dark, the cGMP gated channels in the photoreceptor cells are open, allowing a steady release of neurotransmitters such as glutamate. However, when light falls on the retina, a series of biochemical reactions occur, leading to the conversion of 11-cis-retinal to all-trans-retinal. This process activates transducin, which is a G protein-coupled receptor with phosphodiesterase activity, resulting in the breakdown of cGMP. As a result of the decrease in cGMP levels, sodium channels close, causing hyperpolarization of the photoreceptor cell.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The hyperpolarization leads to a decrease in glutamate release, which ultimately triggers the formation of an action potential. This process enables the transmission of visual information from the photoreceptor cells to the brain, allowing us to perceive and interpret visual images.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hyperpolarization, increase in neurotransmitter release: </strong>This is incorrect because hyperpolarization of photoreceptor cells leads to a decrease, not an increase, in neurotransmitter release.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Depolarization, decrease in neurotransmitter release: </strong>This is incorrect because light exposure causes hyperpolarization, not depolarization, of photoreceptor cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Depolarization, increase in neurotransmitter release: </strong>This is also incorrect as it suggests the opposite response of photoreceptors to light. Depolarization and increased neurotransmitter release occur in the absence of light (i.e., in the dark).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Light exposure results in the hyperpolarization of photoreceptor cells in the retina, leading to a decrease in the release of the neurotransmitter glutamate. This process is crucial for converting light signals into electrical signals that can be processed by the brain to form visual images.</span></p>",
      "correct_choice_id": 200237,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50060,
      "choices": [
        {
          "id": 200240,
          "text": "<p><span style=\"font-size:12.0pt;\">Endoscopy</span></p>"
        },
        {
          "id": 200241,
          "text": "<p><span style=\"font-size:12.0pt;\">IgG antibody study</span></p>"
        },
        {
          "id": 200242,
          "text": "<p><span style=\"font-size:12.0pt;\">Urea breath test</span></p>"
        },
        {
          "id": 200243,
          "text": "<p><span style=\"font-size:12.0pt;\">Urease test of biopsy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient was treated for peptic ulcer with an H. pylori regimen. Which of the following is used to assess the success of treatment? (INICET NOV 2022)</span></p>",
      "unique_key": "Q1951358",
      "question_audio": null,
      "question_video": null,
      "map_id": 34533420,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.  C) Urea breath test</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The urea breath test is the preferred non-invasive method to assess the success of H. pylori eradication therapy. It works by detecting the presence of urease, an enzyme produced by H. pylori. During the test, the patient ingests a urea solution labeled with a carbon isotope. If H. pylori is present, the urease enzyme breaks down the urea, releasing labeled carbon dioxide, which is then measured in the patient's breath. This test is highly accurate, non-invasive, and convenient for follow-up, making it the best choice for confirming the eradication of H. pylori after treatment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Endoscopy: </strong>While endoscopy with a biopsy for a rapid urease test can be used to detect H. pylori, it is invasive and not ideal for follow-up assessments when less invasive options are available.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. IgG antibody study: </strong>This test detects antibodies against H. pylori but is not useful for follow-up after treatment. Antibody levels can remain elevated for a long time even after the infection has been eradicated, leading to false-positive results.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urease test of biopsy: </strong>This method, similar to endoscopy, involves an invasive procedure to obtain a gastric tissue sample for a rapid urease test. Although accurate, it is not preferred for follow-up due to its invasiveness compared to non-invasive options like the urea breath test.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The urea breath test is the preferred non-invasive method for assessing the success of H. pylori eradication therapy due to its accuracy and convenience.</span></p>",
      "correct_choice_id": 200242,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50061,
      "choices": [
        {
          "id": 200244,
          "text": "<p><span style=\"font-size:12pt;\">Human immunodeficiency virus</span></p>"
        },
        {
          "id": 200245,
          "text": "<p><span style=\"font-size:12pt;\">Herpes simplex virus</span></p>"
        },
        {
          "id": 200246,
          "text": "<p><span style=\"font-size:12pt;\">Syphilis</span></p>"
        },
        {
          "id": 200247,
          "text": "<p><span style=\"font-size:12pt;\">Parvovirus B19</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Non-immune hydrops is seen in all, except? </span>(INICET NOV 2022)</p>",
      "unique_key": "Q6596932",
      "question_audio": null,
      "question_video": null,
      "map_id": 34503954,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Human immunodeficiency virus</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Non-immune hydrops fetalis is a condition characterized by an abnormal accumulation of fluid in at least two fetal compartments, such as ascites, pleural effusion, pericardial effusion, or skin edema, not caused by maternal alloimmunization.</span></li><li><span style=\"font-size:12pt;\">Pathogenesis includes decreased colloid oncotic pressure, increased hydrostatic or central venous pressure, and enhanced vascular permeability. These factors can lead to the development of fetal effusions and anasarca (generalized edema).</span></li><li><span style=\"font-size:12pt;\">Infectious causes of non-immune hydrops include parvovirus B19, syphilis, cytomegalovirus, toxoplasmosis, rubella, enterovirus, varicella, herpes simplex, coxsackievirus, listeriosis, leptospirosis, Chagas disease, and Lyme disease.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Herpes simplex virus</strong>: This virus can cause non-immune hydrops due to fetal infection leading to systemic inflammation and multiorgan failure.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Syphilis</strong>: A congenital infection with syphilis can cause severe fetal anemia and hydrops fetalis.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Parvovirus B19</strong>: This virus is a well-known cause of non-immune hydrops due to its predilection for infecting red blood cell precursors, leading to severe fetal anemia and hydrops.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Human immunodeficiency virus (HIV) is not a cause of non-immune hydrops fetalis.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Williams Obstetrics 26<sup>th</sup> edition page no 926</strong></span></p>",
      "correct_choice_id": 200244,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50062,
      "choices": [
        {
          "id": 200248,
          "text": "<p><span style=\"font-size:12.0pt;\">Rate of recurrence is 95%.</span></p>"
        },
        {
          "id": 200249,
          "text": "<p><span style=\"font-size:12.0pt;\">It is a fibrovascular growth.</span></p>"
        },
        {
          "id": 200250,
          "text": "<p><span style=\"font-size:12.0pt;\">The parts of a pterygium are Body, head and cap</span></p>"
        },
        {
          "id": 200251,
          "text": "<p><span style=\"font-size:12.0pt;\">Has progressive and regressive types.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a feature of pterygium? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q9790460",
      "question_audio": null,
      "question_video": null,
      "map_id": 34015174,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Rate of recurrence is 95%</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Pterygium is a triangular fibrovascular ingrowth of degenerative conjunctival tissue.</span></li><li><span style=\"font-size:12.0pt;\">It is caused by prolonged exposure to UV rays, dry heat, etc.</span></li><li><span style=\"font-size:12.0pt;\">It has three parts: head (apical part on the cornea, body (region between limbus and canthus), and cap (semilunar white infiltrate in front of the head).</span></li><li><span style=\"font-size:12.0pt;\">Patients may experience itching and grittiness due to Dellen.</span></li><li><span style=\"font-size:12.0pt;\">It can interfere with vision and induce astigmatism.</span></li><li><span style=\"font-size:12.0pt;\">Stocker's line may be associated with pterygium, which is a linear deposition of iron seen in the corneal epithelium, anterior to the head of a pterygium.</span></li><li><span style=\"font-size:12.0pt;\">The recurrence rate after simple surgical excision is around 80%.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture7_mN5l2bY.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Pterygium is of 2 types: </span><ol style=\"list-style-type:lower-roman;\"><li><span style=\"font-size:12.0pt;\">Progressive which is thick, fleshy, and vascular.</span></li><li><span style=\"font-size:12.0pt;\">Regressive which is thin, atrophic, and attenuated.</span></li></ol></li><li><span style=\"font-size:12.0pt;\">This condition can be treated symptomatically with tear substitutes for dry eye symptoms and patients are advised to avoid  exposure to sun.</span></li><li><span style=\"font-size:12.0pt;\">Surgical excision with free conjunctival limbal autograft is the preferred treatment to avoid recurrence.</span></li><li><span style=\"font-size:12.0pt;\">The recurrence rate of pterygium is around 80% after simple surgical excision. Excision together with adjunctive therapies such as mitomycin C or 5-fluorouracil can reduce the risk of recurrence to approximately 10%.</span></li><li><span style=\"font-size:12.0pt;\">Reported Recurrence rate after P.E.R.F.E.C.T technique is 1.6% (Cornelius CR. Recurrence Rate and Complications of Pterygium Extended Removal Followed by Extended Conjunctival Transplant).</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/05/screenshot-2024-07-05-143100.png\" alt=\"\" width=\"1000\" height=\"977\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. It is a fibrovascular growth</strong>: This is accurate. Pterygium consists of fibrovascular tissue that can progressively invade the cornea.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. The parts of a pterygium are Body, head and cap</strong>: This is true. The pterygium is typically described as having three parts: the head (which is the part that extends onto the cornea), the body (the main bulk of the growth), and the cap or leading edge.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Has progressive and regressive types</strong>: This is also true. Pterygium can be classified into progressive, which is active, vascular, and may encroach further onto the cornea, and regressive, which is typically less vascular and more fibrotic.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Pterygium's recurrence after surgical removal depends greatly on the surgical technique and the use of adjuvant therapies, not inherently 95% as previously thought. Effective management includes surgical excision combined with conjunctival autografts and adjuvant therapy to reduce the risk of recurrence significantly.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture7_mN5l2bY.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200248,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50063,
      "choices": [
        {
          "id": 200252,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Poikiloderma</span></span></span></p>"
        },
        {
          "id": 200253,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Salt and Pepper Pigmentation</span></span></span></p>"
        },
        {
          "id": 200254,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Leucotrichia</span></span></span></p>"
        },
        {
          "id": 200255,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitiligo</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient comes to the OPD with the following Skin Manifestation of a Disease associated with Raynaud Phenomenon. What is the manifestation?</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture6_jBW2wUn.jpg\" style=\"height:262px; width:350px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/30/picture6_jBW2wUn.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4695059",
      "question_audio": null,
      "question_video": null,
      "map_id": 34453140,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Salt and Pepper Pigmentation</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B: Salt and Pepper Pigmentation</span></strong><span style=\"font-size:12.0pt\"> </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The clinical scenario is suggestive of <strong>Systemic Sclerosis</strong>, and the skin manifestation shown is a <strong>Salt-and-Pepper Appearance</strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An autoimmune condition with a complex pathogenesis, variable clinical presentations, and an unknown etiology is systemic sclerosis. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Significant disability and mortality are linked to it. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Almost all organs </span></strong><span style=\"font-size:12.0pt\">are impacted. Scleroderma, or <strong>thickened and indurated skin</strong>, is the defining characteristic of systemic sclerosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The typical white discoloration of the fingers brought on by <strong>vasospasm </strong>and the <strong>bluish </strong>discoloration of the fingertips are <strong>Raynaud phenomenon (</strong>first symptom) skin characteristics of systemic sclerosis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The skin has a <strong>salt-and-pepper appearance</strong> when there is a loss of pigmentation, which is most noticeable on the <strong>upper back (</strong>as given in the question), chest, and scalp.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4: 1 female </span></strong><span style=\"font-size:12.0pt\">predominance</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sclerodactyly </span></strong><span style=\"font-size:12.0pt\">and sclerosis extending proximal to the <strong>metacarpophalangeal joints</strong> with or without contractures.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Earliest cutaneous </span></strong><span style=\"font-size:12.0pt\">manifestations are <strong>non-pitting oedema </strong>and <strong>puffiness</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Severe <strong>flexion contractures & </strong><strong>Muscle weakness</strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Loss of <strong>fingertip pulp </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Loss of <strong>sweat glands</strong> in distal extremities</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Vasculopathic ulcers </span></strong><span style=\"font-size:12.0pt\">over the bony prominences </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Expressionless facies</span></strong><span style=\"font-size:12.0pt\">, <strong>mat-like telangiectasias, microstomia</strong>, perioral furrowing, and a beak-like nose</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pruritus correlates </span></strong><span style=\"font-size:12.0pt\">with <strong>severity </strong>of cutaneous sclerosis</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Gastroesophageal reflux disease.</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Interstitial lung disease </span></strong><span style=\"font-size:12.0pt\">is common in patients with <strong>Scl-70 antibodies</strong></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Nucleolar pattern</span></strong><span style=\"font-size:12.0pt\"> of IF (some spots of fluorescence within the nucleus and it represents antibodies to RNA) is seen in systemic sclerosis.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Systemic sclerosis specific autoantibodies: <strong>anti-topoisomerase</strong>, <strong>anti-centromere</strong> and <strong>anti-RNA polymerase </strong></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Limited </span></strong><span style=\"font-size:12.0pt\">cutaneous systemic sclerosis or <strong>CREST</strong> syndrome: <strong>Anti-Centromere</strong> antibodies </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Explanation:</span></u></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Poikiloderma </span></strong><span style=\"font-size:12.0pt\">is a skin disorder characterized by: <strong>(ATP)</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Atrophy</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Telangiectasia</span></strong><span style=\"font-size:12.0pt\">s</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Pigment </span></strong><span style=\"font-size:12.0pt\">abnormalities Hypo and hyper</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is seen in <strong>ionizing radiation-damaged skin</strong> and <strong>dermatomyositis.</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C</span></strong><span style=\"font-size:12.0pt\">. Sometimes the colour of the hair can change to white in the amelanotic lesions of <strong>vitiligo</strong>. It is known as <strong>Leucotrichia.</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D</span></strong><span style=\"font-size:12.0pt\">. Sharply demarcated <strong>depigmented macules</strong> are a hallmark of <strong>vitiligo</strong>. It results from the loss of <strong>melanocytes.</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Educational Objective</span></u></strong><u><span style=\"font-size:12.0pt\">: </span></u></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><strong>'Salt and pepper' pigmentation i</strong>s a skin manifestation associated with <strong>systemic sclerosis</strong>, a condition commonly accompanied by <strong>Raynaud's phenomenon</strong>. This pattern includes both <strong>hyperpigmented</strong> and <strong>hypopigmented</strong> areas interspersed on the skin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span style=\"font-size:12.0pt\">Ref</span></u></strong><strong><span style=\"font-size:12.0pt\">: Rooks Textbook of Dermatology, 9<sup>th</sup> Edition, Chapter 56 Page No 56.1 – 56.23</span></strong></span></span></p>",
      "correct_choice_id": 200253,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50064,
      "choices": [
        {
          "id": 200256,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Amlodipine</span></span></p>"
        },
        {
          "id": 200257,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Telmisartan</span></span></p>"
        },
        {
          "id": 200258,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Metoprolol</span></span></p>"
        },
        {
          "id": 200259,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Olmesartan</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A hypertensive patient who is on losartan develops an HbA1c level of 8.1%. Which of the following drugs would you replace losartan with? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q4040600",
      "question_audio": null,
      "question_video": null,
      "map_id": 34906477,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Telmisartan</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Telmisartan is the appropriate choice for a hypertensive patient with an elevated HbA1c level (8.1%), indicating poorly controlled diabetes. Telmisartan, an angiotensin II receptor blocker (ARB), has unique properties among ARBs due to its partial agonistic activity on peroxisome proliferator-activated receptor-gamma (PPAR-gamma). PPAR-gamma agonists can improve insulin sensitivity and have beneficial effects on glycemic control. This makes Telmisartan particularly useful for patients managing both hypertension and diabetes.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Amlodipine:</span></strong><span style=\"font-size:12.0pt\"> Amlodipine is a calcium channel blocker used for hypertension. It does not have the beneficial effects on glycemic control seen with Telmisartan and would not be the preferred choice in a patient with elevated HbA1c.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Metoprolol:</span></strong><span style=\"font-size:12.0pt\"> Metoprolol is a beta-blocker. While effective for hypertension, beta-blockers can potentially worsen glycemic control and are not ideal for patients with diabetes.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Olmesartan:</span></strong><span style=\"font-size:12.0pt\"> Olmesartan is another ARB, but unlike Telmisartan, it lacks PPAR-gamma agonistic activity. Thus, it does not offer the additional benefit of improving insulin sensitivity and glycemic control.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For hypertensive patients with diabetes and elevated HbA1c levels, Telmisartan is the preferred replacement for losartan due to its PPAR-gamma agonistic activity, which helps improve glycemic control.</span></span></span></p>",
      "correct_choice_id": 200257,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50065,
      "choices": [
        {
          "id": 200260,
          "text": "<p><span style=\"font-size:12.0pt;\">Right superior gluteal nerve palsy</span></p>"
        },
        {
          "id": 200261,
          "text": "<p><span style=\"font-size:12.0pt;\">Left superior gluteal nerve palsy</span></p>"
        },
        {
          "id": 200262,
          "text": "<p><span style=\"font-size:12.0pt;\">Right inferior gluteal nerve palsy</span></p>"
        },
        {
          "id": 200263,
          "text": "<p><span style=\"font-size:12.0pt;\">Left inferior gluteal nerve palsy</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Patient had difficulty in walking upstairs. When he was made to bear weight on right lower limb, the left-sided pelvis dropped down, but when he was standing on the left lower limb, the right-sided pelvis moved up. Which of the following is the likely lesion? (INICET NOV 2022)</span></p>",
      "unique_key": "Q3667502",
      "question_audio": null,
      "question_video": null,
      "map_id": 34632617,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Right superior gluteal nerve palsy</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>WADDLING (GLUTEAL OR TRENDELENBURG) GAIT</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">This gait is <strong>characteristic of the gluteal muscle weakness</strong> that is seen in the progressive muscular dystrophies, but it occurs as well in chronic forms of spinal muscular atrophy, in certain inflammatory myopathies, lumbosacral nerve root compression, and with congenital dislocation of the hips.</span></li><li><span style=\"font-size:12.0pt;\">It can also <strong>occur in neurogenic conditions in which the superior gluteal nerve is involved</strong>.</span></li><li><span style=\"font-size:12.0pt;\">In normal walking, as weight is placed alternately on each leg, the hip is fixated by the gluteal muscles, particularly the gluteus medius, allowing for a slight rise of the opposite hip and tilt of the trunk to the weight-bearing side.</span></li><li><span style=\"font-size:12.0pt;\">With weakness of the glutei, however, there is a failure to stabilize the weight-bearing hip, causing it to bulge outward and the opposite side of the pelvis to drop, with inclination of the trunk to that side.</span></li><li><span style=\"font-size:12.0pt;\"><strong>The alternation in lateral trunk movements results in the roll or waddle</strong>.</span></li><li><span style=\"font-size:12.0pt;\">With unilateral gluteal weakness, often the result of damage to the first sacral nerve root, tilting and dropping of the pelvis <strong>(“pelvic ptosis”)</strong> is apparent on only one side as the patient overlifts the leg when walking.</span></li><li><span style=\"font-size:12.0pt;\">In several of the muscular dystrophies, an accentuation of lumbar lordosis is often seen.</span></li><li><span style=\"font-size:12.0pt;\">Also, childhood cases may be complicated by muscular contractures, leading to an <strong>equinovarus position of the foot</strong>, so that the waddle is combined with walking on the toes <strong>(“toe walking”)</strong>.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102139.jpg\" alt=\"\" width=\"400\" height=\"331\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Left superior gluteal nerve palsy</strong>. When the patient is standing on one leg, the opposite pelvis should be lifted upwards by abduction of the ipsilateral hip joint, in a normal patient. When the abductors are weak due to superior gluteal nerve paresis, the pelvis will sag, called positive Trendelenburg sign. In a patient with a positive Trendelenburg sign, the pelvis sags toward the normal unsupported side, which is the swing leg. When the left superior gluteal nerve is affected, on standing on the left lower limb, the right side pelvis will drop and when the patient stands on the right leg, the left side pelvis will be lifted up.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Right inferior gluteal nerve palsy</strong>. The inferior gluteal nerve supplies the gluteus maximus muscle. It is therefore, responsible for extending the trunk from a forward bending position and extending the hip from sitting-to-standing or during stair-climbing or rising from a squatted position. The nerve does not confer any sensation. Injury to this nerve is most commonly iatrogenic in origin and is the most at risk nerve during total hip arthroplasty via a posterior approach. Injury typically leads to an altered gait pattern known as <strong>gluteus maximus ‘lurch’. </strong>The sequelae of nerve injury are denervation of the ipsilateral gluteus maximus muscle. The lurching gait results from the weakening or absence of an ipsilateral hip extension. Clinically, patients may also report wasting of the ipsilateral gluteus maximus muscle and loss of the defined shape to the affected buttock. In a normal gait cycle, the gluteus maximus begin to contract at the moment of the ipsilateral heel-strike to initiate ipsilateral hip extension. In inferior gluteal nerve injury, the trunk will extend when the heel strikes on the ground on the affected side to compensate for weak/absent hip extension. This backward trunk lurch is present in the whole stance phase of the gait cycle and locks the hip in extension. In some cases, the hamstrings muscle compensates to an extent. Therefore, in the right inferior gluteal nerve palsy, the right side hip will not extend during the initial heel strike and the trunk will lean backwards/extend.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Left inferior gluteal nerve palsy</strong>. In the injury of left sided gluteal nerve, the left hip will not extend during the initial heel strike, leading to backward lurch or extension of the trunk.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">On standing on the right lower limb, the left side pelvis drops and while standing on the left leg, the right side pelvis lifted up. This is indicative of right superior gluteal nerve palsy. This sign is called Trendelenburg Sign.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102139.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200260,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50066,
      "choices": [
        {
          "id": 200264,
          "text": "<p><span style=\"font-size:12.0pt;\">Bromine</span></p>"
        },
        {
          "id": 200265,
          "text": "<p><span style=\"font-size:12.0pt;\">Antimony</span></p>"
        },
        {
          "id": 200266,
          "text": "<p><span style=\"font-size:12.0pt;\">Fluorine</span></p>"
        },
        {
          "id": 200267,
          "text": "<p><span style=\"font-size:12.0pt;\">Phosphorus</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A female working in the matchbox factory presents to the dentist with loose teeth, foul smelling discharge, sinuses and fistulae around mouth and disfigurement of the jaw as shown in the picture below. What is the causative agent for this condition? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2022)</span></p><p style=\"text-align:justify;\"> </p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-47.jpg\" alt=\"\" width=\"500\" height=\"477\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-47.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7315277",
      "question_audio": null,
      "question_video": null,
      "map_id": 34644612,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>D. Phosphorus </strong> </span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The disease mentioned above is phosphorus necrosis of the jaw, commonly called as 'phossy jaw'.</span></li><li><span style=\"font-size:12.0pt;\">It is caused due to </span><span style=\"background-color:white;color:#202124;font-size:12.0pt;\"><strong>exposure to white phosphorus during the manufacture of matches</strong>. They were made by dipping the match ends into a mixture containing white phosphorus.</span></li><li><span style=\"font-size:12.0pt;\">Features of phossy jaw- Osteomyelitis and necrosis of the jaw, with foul-smelling pus discharging multiple sinuses.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Bromine:</strong> Bromine exposure does not cause the described condition.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Antimony:</strong> Antimony poisoning can cause various health issues but is not known to cause phossy jaw.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fluorine:</strong> Fluorine toxicity can cause skeletal and dental fluorosis but does not cause the specific symptoms of phossy jaw.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Phossy jaw is caused by exposure to white phosphorus, leading to osteomyelitis, necrosis of the jaw, foul-smelling discharge, and significant disfigurement.</span></p>",
      "correct_choice_id": 200267,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50067,
      "choices": [
        {
          "id": 200268,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A - Aspirin, B -Vorapaxar, C - Prasugrel</span></span></span></span></span></p>"
        },
        {
          "id": 200269,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A - Aspirin, B - Eptifibatide, C - Vorapaxar</span></span></span></span></span></p>"
        },
        {
          "id": 200270,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿A - Aspirin, B - Eptifibatide, C - Prasugrel</span></span></span></span></span></p>"
        },
        {
          "id": 200271,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿A - Aspirin, B - Prasugrel, C - Eptifibatide</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Identify the drugs marked as A, B, and C:</span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/14.jpg\" style=\"height:285px; width:300px\" /></span></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/14.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2640321",
      "question_audio": null,
      "question_video": null,
      "map_id": 34981695,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B. <span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">A - Aspirin, B - Eptifibatide, C - Vorapaxar</span></strong></span></span></span></strong></span></span><br />\r\n </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The drugs marked A, B and C are aspirin, eptifibatide, and vorapaxar, respectively.</span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Aspirin exhibits its antiplatelet action by inhibiting the COX-1 enzyme and decreasing the synthesis of Thromboxane A2.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Eptifibatide is a Gp IIb/IIIa receptor blocker. Others being Abciximab and Tirofiban.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Vorapaxar acts on the thrombin receptors on the platelets- the PAR-1 (Protease Activated Receptor-1). Thrombin binds to the platelets with the help of this receptor and leads to platelet aggregation.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The correct identification of antiplatelet drugs and their mechanisms of action is crucial for understanding their roles in preventing platelet aggregation and managing cardiovascular conditions. Aspirin inhibits COX-1, Eptifibatide blocks Gp IIb/IIIa receptors, and Vorapaxar inhibits the PAR-1 receptor.</span></span></span></p>",
      "correct_choice_id": 200269,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50068,
      "choices": [
        {
          "id": 200272,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Anterior infiltration in females </span></span></p>"
        },
        {
          "id": 200273,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Anterior infiltration in males </span></span></p>"
        },
        {
          "id": 200274,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Lateral infiltration </span></span></p>"
        },
        {
          "id": 200275,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Posterior infiltration</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Which of the following best describes the reason for severe intractable pain in the leg due to sciatica in a patient with rectal carcinoma? </span></span></p>",
      "unique_key": "Q4330452",
      "question_audio": null,
      "question_video": null,
      "map_id": 34595944,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A. Anterior infiltration in females </strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">In patients with rectal carcinoma, sciatica and severe intractable pain in the leg occurs due to perineural invasion of the inferior hypogastric plexus, from which the sciatic nerve arises. The location of the plexus differs in males and females. The inferior hypogastric plexus is located anterolateral to the rectum in females and lateral to the rectum in males. Therefore, the most appropriate answer would be \"A) Anterior infiltration in females\" as it specifically identifies the location and sex of the patient.</span></span></p>",
      "correct_choice_id": 200272,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50069,
      "choices": [
        {
          "id": 200276,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A, B</span></span></p>"
        },
        {
          "id": 200277,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A, B, C, D</span></span></p>"
        },
        {
          "id": 200278,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A, B, D</span></span></p>"
        },
        {
          "id": 200279,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A, D</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following muscles form the pelvic diaphragm? </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Iliococcygeus</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Pubococcygeus</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Obturator internus</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Deep transverse perinei</span></span></li>\r\n</ol>",
      "unique_key": "Q3062293",
      "question_audio": null,
      "question_video": null,
      "map_id": 34897364,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) A, B</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Iliococcygeus and pubococcygeus</strong> are parts of the pelvic diaphragm, which is also known as the <strong>levator ani</strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>levator ani muscle</strong> is a complex unit that consists of <strong>three muscle components</strong>:</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Pubococcygeus</strong>:</span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Pubovaginalis</strong>: Elevates the urethra and contributes to urinary continence.</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Puboperinealis</strong>: Draws the perineal body toward the pubic symphysis.</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Puboanalis</strong>: Elevates the anus and keeps the urogenital hiatus narrowed.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Puborectalis</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Iliococcygeus</strong></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>levator ani muscles</strong> are the most important muscles in the pelvic floor and maintain a constant state of contraction. They provide a <strong>stable floor</strong> and support the weight of the abdominopelvic contents against intra-abdominal forces. <strong>Weakening</strong> of the levator ani and pelvic fascia, such as through <strong>stretching or tearing during childbirth</strong>, may decrease support for the vagina, bladder, uterus, or rectum, or alter the position of the neck of the bladder and urethra.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Obturator internus: </strong>The <strong>obturator internus</strong> forms the lateral wall of the ischioanal fossa and is <strong>not a part of the levator ani</strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Deep transverse perinei: </strong>The <strong>deep transverse perineal muscle</strong> is located in the deep perineal space and contributes to the formation of the <strong>perineal body</strong>. It is <strong>not part of the pelvic diaphragm</strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>pelvic diaphragm</strong>, also known as the <strong>levator ani</strong>, consists of the <strong>iliococcygeus</strong>, <strong>pubococcygeus</strong>, and <strong>puborectalis</strong> muscles. These muscles provide essential support to the pelvic organs and play a critical role in maintaining continence and pelvic stability.</span></span></p>",
      "correct_choice_id": 200276,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50070,
      "choices": [
        {
          "id": 200280,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Inj. Amphotericin B for 4-8 weeks, followed by oral itraconazole</span></span></span></span></span></p>"
        },
        {
          "id": 200281,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Inj. Amphotericin B for 8 weeks, followed by oral posaconazole</span></span></span></span></span></p>"
        },
        {
          "id": 200282,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Inj. Fluconazole, followed by oral fluconazole</span></span></span></span></span></p>"
        },
        {
          "id": 200283,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Inj. Amphotericin B, followed by flucytosine</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient presented with periorbital pain and nasal discharge. On examination, the findings shown in the image below. She is an immunocompromised patient currently on HAART. Which of the following antifungal regimen should be prescribed to this patient along with HAART? (</span></span></span></span>INICET Nov 2022)</p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/759.jpg\" style=\"height:338px; width:300px\" /></span></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/759.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1719599",
      "question_audio": null,
      "question_video": null,
      "map_id": 34452900,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> <span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Inj. Amphotericin B for 8 weeks, followed by oral posaconazole</span></strong></span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">An immunocompromised patient presenting with peri-orbital swelling and black necrosed lesion is suggestive of mucormycosis, an opportunistic fungal infection.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Amphotericin B is the first-line treatment for mucormycosis due to its broad-spectrum antifungal activity. Posaconazole is used for consolidation therapy following initial treatment with Amphotericin B, especially in cases of severe infection or in immunocompromised patients.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Treatment of the underlying immunodeficiency along with surgical debridement might be needed.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Inj. Amphotericin B for 4-8 weeks, followed by oral itraconazole: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">This regimen is not the most recommended for mucormycosis. Itraconazole is less effective compared to posaconazole for mucormycosis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Inj. Fluconazole, followed by oral fluconazole: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Fluconazole is not effective against mucormycosis. It is primarily used for infections caused by Candida and Cryptococcus species.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Inj. Amphotericin B, followed by flucytosine: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Flucytosine is used in combination with Amphotericin B for the treatment of cryptococcal meningitis, not mucormycosis.</span></span></span></p>\r\n\r\n<h3> </h3>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Mucormycosis</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> requires aggressive treatment with Amphotericin B followed by consolidation therapy with posaconazole, particularly in immunocompromised patients. This combination helps ensure both initial and sustained control of the fungal infection.</span></span></span></p>",
      "correct_choice_id": 200281,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50071,
      "choices": [
        {
          "id": 200284,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Efficacy of drug A is more than that of drug B.</span></span></span></span></span></p>"
        },
        {
          "id": 200285,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Potency of drug B is more than that of drug A.</span></span></span></span></span></p>"
        },
        {
          "id": 200286,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Drug A and drug B are agonists</span></span></span><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></span></span></span></p>"
        },
        {
          "id": 200287,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Drug C is a non-competitive antagonist.</span></span></span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The dose-response curve for three drugs in the same tissue is shown in the image below. Which of the following statements is true?</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-15.jpg\" style=\"height:201px; width:300px\" /></span></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-15.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1777273",
      "question_audio": null,
      "question_video": null,
      "map_id": 34826199,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C. </span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Drug A and drug B are agonists</span></span></strong></span><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">From the given image, it can be understood that the Drug A and Drug B are agonists, i.e., they will bind to the receptor and produce the action after activating it. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The drug A is more potent than drug B but the efficacy of both the drugs are the same.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The Drug C also produces the action after binding to the receptor, but the degree of the response is less than that of Drugs A and B, or in other words its intrinsic efficacy is not equal to that of drugs A and B. Hence it is a partial agonist. In the presence of full agonists, the partial agonist behaves as an antagonist.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Drug C can be a competitive irreversible antagonist (not non-competitive) as the curve is shifting to right and down.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Statement A: Efficacy of drug A is more than that of drug B: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This statement is false. The efficacy of a drug is determined by the maximum response it can produce. From the graph, both Drug A and Drug B achieve the same maximum response, indicating that their efficacies are the same.</span></span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Statement B: Potency of drug B is more than that of drug A: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This statement is false. Potency is determined by the position of the dose-response curve along the concentration axis. The lower the ED50 (the concentration required to achieve 50% of the maximum response), the more potent the drug. From the graph, Drug A reaches its ED50 at a lower concentration than Drug B, indicating that Drug A is more potent than Drug B.</span></span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Statement D: Drug C is a non-competitive antagonist: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">This statement is false. Drug C achieves only a partial response compared to Drugs A and B, indicating that Drug C is a partial agonist, not a non-competitive antagonist. Non-competitive antagonists would typically reduce the efficacy of an agonist without affecting the potency in such a dose-response curve. The curve for Drug C does not align with the expected behavior of a non-competitive antagonist.</span></span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Key Points: </span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Agonists:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Drugs A and B are full agonists because they can achieve the maximum response.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Partial Agonist:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Drug C produces a submaximal response compared to Drugs A and B, which indicates it is a partial agonist.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Potency:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Drug A is more potent than Drug B because it achieves 50% of its maximum response at a lower concentration.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Non-competitive Antagonist:</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Drug C is not a non-competitive antagonist, as it does not simply reduce the efficacy of another agonist but instead acts as a partial agonist on its own.</span></span></span></li>\r\n</ol>",
      "correct_choice_id": 200286,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50072,
      "choices": [
        {
          "id": 200288,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Muscarinic action of acetyIcholine</span></span></span></span></span></p>"
        },
        {
          "id": 200289,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Potentiation of acetylcholine</span></span></span></span></span></p>"
        },
        {
          "id": 200290,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Antagonism of acetylcholine</span></span></span></span></span></p>"
        },
        {
          "id": 200291,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Nicotinic action of acetylcholine</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">An experiment is being conducted on a dog blood pressure to study the effect of acetylcholine. The blood pressure is recorded at each intervention and is shown below. What does phase 4 in the graph indicate? (</span></span></span></span></span>INICET Nov 2022)</p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-9.jpg\" style=\"height:190px; width:300px\" /></span></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-9.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7408638",
      "question_audio": null,
      "question_video": null,
      "map_id": 34925775,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D.</span></span></strong></span><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> <span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Nicotinic action of acetylcholine</span></strong></span></span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">For demonstrating nicotinic actions (on ganglia) of acetylcholine, two criteria are required:</span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">High dose of acetylcholine (around 5 mg).</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Muscarinic receptors must be blocked by giving atropine (to avoid death of the animal due to overactivity of muscarinic receptors)</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">About the given graph:</span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture1_2v4u1Uh.jpg\" style=\"height:316px; width:500px\" /></span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In phases 1 and 2, Acetylcholine is given at doses of 2 mcg and 50 mcg. This leads to a drop in the BP due to its action in the muscarinic receptors.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">In phase 3 when its muscarinic action is blocked by atropine, administration of 50 mcg of Acetylcholine does not cause a fall in BP.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">But in phase 4, when Ach is administered at higher dose of 5 mg, it acts on the Neuronal Nicotinic receptors located in CNS, ganglia and adrenals, leading to their stimulation and release of norepinephrine, which causes the BP to shoot up. Thus, Phase 4 in the graph indicates the nicotinic action of acetylcholine at higher doses.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. Muscarinic action of acetylcholine</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Muscarinic actions are demonstrated in Phases 1 and 2, where acetylcholine causes a drop in blood pressure. This option is incorrect for Phase 4.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Potentiation of acetylcholine: </span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Potentiation would suggest an increased effect due to repeated or combined actions, which is not the primary mechanism demonstrated in Phase 4.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Antagonism of acetylcholine</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Antagonism would imply inhibition of acetylcholine’s effects. Phase 3 demonstrates antagonism (by atropine) but not Phase 4.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase 4 in the graph indicates the nicotinic action of acetylcholine, characterized by a rise in blood pressure due to the stimulation of neuronal nicotinic receptors after administering a high dose of acetylcholine (5 mg) following the blockade of muscarinic receptors with atropine.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/picture1_2v4u1Uh.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200291,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50073,
      "choices": [
        {
          "id": 200292,
          "text": "<p>1, 2, 3, 4</p>"
        },
        {
          "id": 200293,
          "text": "<p>2, 1, 4, 3</p>"
        },
        {
          "id": 200294,
          "text": "<p>1, 3, 4, 2</p>"
        },
        {
          "id": 200295,
          "text": "<p>1, 2, 4, 3</p>"
        }
      ],
      "text": "<p>How would you manage a child with status epilepticus? (INICET NOV 2022)</p><p> </p><ol><li>Airway and breathing</li><li>IV Lorazepam</li><li>Midazolam, Propofol, Thiopentone</li><li>IV Fosphenytoin</li></ol>",
      "unique_key": "Q1881015",
      "question_audio": null,
      "question_video": null,
      "map_id": 34799640,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><strong>Ans. D) 1, 2, 4, 3</strong></p><p> </p><p>Status epilepticus is defined as continuous or recurrent seizure activity lasting for more than 5 minutes without regaining consciousness.</p><p> </p><p><strong>Status epilepticus </strong>is a neurological emergency defined as continuous or recurrent seizure activity lasting for more than 5 minutes without regaining consciousness between episodes. Prompt and systematic management is essential to prevent long-term neurological damage or death.</p><p> </p><p><strong>Management Sequence:</strong></p><p> </p><p><strong>1. Airway and Breathing: </strong>The first priority is to ensure that the airway is open and that the child is breathing adequately. This may involve positioning the child, providing oxygen, and, if necessary, securing the airway with advanced airway management techniques.</p><p> </p><p><strong>2. IV Lorazepam: </strong>Benzodiazepines, such as lorazepam, are the first-line treatment for status epilepticus due to their rapid onset of action and effectiveness in terminating seizures. Lorazepam is typically administered intravenously.</p><p> </p><p><strong>4. IV Fosphenytoin: </strong>If seizures continue after the administration of a benzodiazepine, IV fosphenytoin (or phenytoin) is used as a second-line agent. It helps to stabilize neuronal membranes and prevent further seizure activity.</p><p> </p><p><strong>3. Midazolam, Propofol, Thiopentone: </strong>These agents are used if seizures persist despite initial treatments. Midazolam can be administered intramuscularly or intravenously, while propofol and thiopentone are typically reserved for refractory status epilepticus and may require the child to be in an intensive care setting due to the need for mechanical ventilation and close monitoring.</p><p> </p><p><strong>Educational Objective:</strong></p><p> </p><p>The management of status epilepticus in children should follow a systematic approach: securing the airway and ensuring breathing, administering a benzodiazepine, followed by fosphenytoin if seizures persist, and considering more potent agents like midazolam, propofol, or thiopentone if the status epilepticus is refractory to initial treatments.</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture122.jpg\" alt=\"\" width=\"600\" height=\"739\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture122.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200295,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50074,
      "choices": [
        {
          "id": 200296,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Succenturiate lobe</span></span></span></p>"
        },
        {
          "id": 200297,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Velamentous insertion of the cord</span></span></span></p>"
        },
        {
          "id": 200298,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Both succenturiate lobe and velamentous insertion</span></span></span></p>"
        },
        {
          "id": 200299,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Normal placenta</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The given image depicts: </span></span>(INICET NOV 2022)</p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/inicet-obg-nov-2022-1.jpg\" style=\"height:328px; width:300px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/03/inicet-obg-nov-2022-1.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7466234",
      "question_audio": null,
      "question_video": null,
      "map_id": 34419479,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) Both succenturiate lobe and velamentous insertion</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Succenturiate lobe</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This refers to a placenta with one or more accessory lobes connected to the main part of the placenta by blood vessels. It is characterized by the presence of a smaller, separate lobe in addition to the main placental mass.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Velamentous insertion of the cord</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This occurs when the umbilical cord inserts into the fetal membranes (chorioamnion) rather than directly into the placental mass. The vessels then travel through the membranes to reach the placenta, making them vulnerable to rupture.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The image shows both conditions: a smaller accessory lobe (succenturiate lobe) and the cord inserting into the membranes rather than the placenta (velamentous insertion).</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Succenturiate lobe</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This option is partially correct but does not account for the velamentous insertion.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Velamentous insertion of the cord</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This option is partially correct but does not account for the succenturiate lobe.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Normal placenta</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is incorrect as the image shows abnormalities not seen in a normal placenta.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A placenta with both a succenturiate lobe and velamentous insertion of the cord is characterized by the presence of a smaller accessory lobe and the umbilical cord inserting into the fetal membranes.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: William’s textbook of obstetrics 24<sup>th</sup> edition pg122, 117, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 251,253</span></strong></span></span></p>",
      "correct_choice_id": 200298,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50075,
      "choices": [
        {
          "id": 200300,
          "text": "<p><span style=\"font-size:12.0pt;\">5</span></p>"
        },
        {
          "id": 200301,
          "text": "<p><span style=\"font-size:12.0pt;\">4.5</span></p>"
        },
        {
          "id": 200302,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 200303,
          "text": "<p><span style=\"font-size:12.0pt;\">1.8</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What will the corrected reticulocyte count if Hb is 5 g/dl and absolute reticulocyte count is 9%? (INICET NOV 2022)</span></p>",
      "unique_key": "Q2621565",
      "question_audio": null,
      "question_video": null,
      "map_id": 34549254,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 3</strong></span><span style=\"font-size:11pt;\"> </span></p><p> </p><p><span style=\"font-size:12.0pt;\">Calculation:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Average Hb value to be taken as 15 g/dl.</span></p><p> </p><p><span style=\"font-size:11pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-183759.png\" alt=\"\" width=\"1000\" height=\"264\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The corrected reticulocyte count is essential in evaluating the bone marrow response in anemic patients. It is calculated by adjusting the absolute reticulocyte count according to the degree of anemia (using actual and normal hemoglobin values).</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-183759.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200302,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50076,
      "choices": [
        {
          "id": 200304,
          "text": "<p><span style=\"font-size:12.0pt;\">Ileocolic artery</span></p>"
        },
        {
          "id": 200305,
          "text": "<p><span style=\"font-size:12.0pt;\">Right colic artery</span></p>"
        },
        {
          "id": 200306,
          "text": "<p><span style=\"font-size:12.0pt;\">Superior rectal artery</span></p>"
        },
        {
          "id": 200307,
          "text": "<p><span style=\"font-size:12.0pt;\">Superior mesenteric artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 25-year-old female patient undergoes an appendicectomy procedure. Two days later, she complains of severe abdominal pain and is found to have a collection of blood in the abdomen on examination. On exploration, it is discovered that a particular artery should have been ligated during the surgery to prevent this complication. Which of the following arteries should have been ligated during the appendicectomy procedure to prevent postoperative hemorrhage in this patient? (INICET NOV 2022)</span></p>",
      "unique_key": "Q1224760",
      "question_audio": null,
      "question_video": null,
      "map_id": 34185633,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Ileocolic artery</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The ileocolic artery is a branch of the superior mesenteric artery (SMA) that supplies blood to the appendix and the cecum. During an appendicectomy procedure, it is crucial to identify and ligate the appendicular branch of ileocolic artery to prevent postoperative hemorrhage. Failure to do so can result in bleeding complications.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Right colic artery</strong>: The right colic artery is another branch of the SMA that supplies blood to the ascending colon and the right side of the transverse colon. Ligating the right colic artery is not a standard part of an appendicectomy procedure.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>C. Superior rectal artery</strong>: The superior rectal artery is a branch of the inferior mesenteric artery and supplies blood to the rectum. It is not directly related to an appendicectomy procedure.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Superior mesenteric artery</strong>: The superior mesenteric artery is a major blood vessel that supplies blood to various parts of the small intestine, including the jejunum and ileum.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">During the removal of the appendix, the inferior branch of the ileocolic artery needs to be ligated at the base of the appendix to prevent postoperative hemorrhage. The appendicular artery typically arises directly from the ileocolic artery and supplies the appendix through multiple small branches. If not ligated, the appendicular artery may cause bleeding complications.</span></p>",
      "correct_choice_id": 200304,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50077,
      "choices": [
        {
          "id": 200308,
          "text": "<p><span style=\"font-size:12.0pt;\">Both assertion and reason are independently false statements.</span></p>"
        },
        {
          "id": 200309,
          "text": "<p><span style=\"font-size:12.0pt;\">The assertion is independently a true statement, but the reason is independently a false statement.</span></p>"
        },
        {
          "id": 200310,
          "text": "<p><span style=\"font-size:12.0pt;\">Both assertion and reason are independently true statements, but the reason is not the correct explanation for the assertion.</span></p>"
        },
        {
          "id": 200311,
          "text": "<p><span style=\"font-size:12.0pt;\">Both assertion and reason are independently true statements, and the reason is the correct explanation for the assertion.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Choose the most appropriate answer: (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Assertion: </strong>In phenylketonuria, the urine has a mousy odor.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reason: </strong>The serum levels of tyrosine, dopamine, and norepinephrine are decreased in phenylketonuria.</span></p>",
      "unique_key": "Q1982676",
      "question_audio": null,
      "question_video": null,
      "map_id": 34354379,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Both assertion and reason are independently true statements, but the reason is not the correct explanation for the assertion.</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Assertion: </strong>The statement that \"In phenylketonuria, the urine has a mousy odor\" is <strong>true</strong>. The mousy or musty odor of the urine in phenylketonuria (PKU) is due to the accumulation of phenylacetate, one of the metabolites of phenylalanine.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Reason: </strong>The statement that \"The serum levels of tyrosine, dopamine, and norepinephrine are decreased in phenylketonuria\" is also <strong>true</strong>. Phenylketonuria is characterized by a deficiency of the enzyme phenylalanine hydroxylase, which converts phenylalanine to tyrosine. Consequently, low levels of tyrosine lead to reduced synthesis of catecholamines such as dopamine, norepinephrine, and epinephrine.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">However, <strong>the reason provided is not the correct explanation for the assertion</strong>. The mousy odor in PKU is directly related to the accumulation of phenylacetate, not to the decreased levels of tyrosine or catecholamines.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Detailed Mechanism:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Phenylketonuria (PKU): </strong>PKU is an inborn error of metabolism caused by a deficiency of the enzyme phenylalanine hydroxylase or, less commonly, a defect in enzymes responsible for producing tetrahydrobiopterin (BH4). This defect results in impaired conversion of phenylalanine to tyrosine, leading to the accumulation of phenylalanine and its metabolites, such as phenylpyruvate and phenylacetate, which are excreted in the urine.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Tyrosine and Catecholamine Synthesis: </strong>Tyrosine is a precursor for the synthesis of catecholamines, including dopamine, norepinephrine, and epinephrine. In PKU, the deficiency of tyrosine leads to reduced synthesis of these neurotransmitters.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In phenylketonuria, the mousy odor of urine is due to the accumulation of phenylacetate, while decreased levels of tyrosine and catecholamines are a result of the impaired conversion of phenylalanine to tyrosine. However, the two phenomena are not causally related.</span></p>",
      "correct_choice_id": 200310,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50078,
      "choices": [
        {
          "id": 200312,
          "text": "<p><span style=\"font-size:12.0pt;\">Loose tourniquet</span></p>"
        },
        {
          "id": 200313,
          "text": "<p><span style=\"font-size:12.0pt;\">Debride to avoid the spread</span></p>"
        },
        {
          "id": 200314,
          "text": "<p><span style=\"font-size:12.0pt;\">Kill the snake</span></p>"
        },
        {
          "id": 200315,
          "text": "<p><span style=\"font-size:12.0pt;\">Hospitalize for anti-venom administration and immobilization</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of these steps is included in the management of snake bite?</span></p>",
      "unique_key": "Q5230437",
      "question_audio": null,
      "question_video": null,
      "map_id": 34737514,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Hospitalize for anti-venom administration and immobilization</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Management of snake bite:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-48.jpg\" alt=\"\" width=\"1000\" height=\"672\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Immobilization is done to minimize the spread of the venom. Hospitalization, followed by AS administration is the definitive management of snake bites.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Measures that can be taken in the case of snakebite:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Apply firm pressure over the bitten area, which delays the absorption of venom</span></li><li><span style=\"font-size:12.0pt;\">Pressure immobilization is recommended for elapid and sea-snake bites, but not for viper bites as it may cause local necrosis</span></li><li><span style=\"font-size:12.0pt;\">Immediately apply a broad firm bandage (Sutherland wrap on the bitten area and around the limb. As much of the limb should be bandaged as possible. It should be tight enough to occlude the superficial venous and lymphatic return, but not the arterial or deep venous flow. A pressure of 50 to 70 mm Hg is maintained.</span></li><li><span style=\"font-size:12.0pt;\">In bites on the trunk, head, or neck, apply firm pressure over the bitten area</span></li><li><span style=\"font-size:12.0pt;\">Immobilize the limb, as movement can accelerate the spread of venom</span></li><li><span style=\"font-size:12.0pt;\">Make the patient lie on one side in the recovery position so that the airway is clear, in case of vomiting or fainting.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Measures contraindicated in the case of snakebite:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Suction and incision of the wound</span></li><li><span style=\"font-size:12.0pt;\">Electric shock treatment of wound site</span></li><li><span style=\"font-size:12.0pt;\">Application of tourniquets because they obstruct arterial flow and cause ischemia</span></li><li><span style=\"font-size:12.0pt;\">Ice water immersion of the bitten limb</span></li><li><span style=\"font-size:12.0pt;\">Do not attempt to kill or catch the snake as it may be dangerous.</span></li><li><span style=\"font-size:12.0pt;\">Administration of AS locally at the wound site.</span></li><li><span style=\"font-size:12.0pt;\">Herbal/local remedies</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options :</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Loose Tourniquet:</strong> Not recommended as it can cause ischemia and increase the risk of complications.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Debridement:</strong> Not advisable as it can exacerbate the spread of venom.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Killing the Snake:</strong> Attempting to kill or catch the snake can be dangerous and is not necessary for treatment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective </strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The management of snake bites primarily involves hospitalization for the administration of anti-venom and immobilization of the affected limb to minimize the spread of venom.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-48.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200315,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50079,
      "choices": [
        {
          "id": 200316,
          "text": "<p><span style=\"font-size:12pt;\">Platinum resistant if recurrence > 12 months</span></p>"
        },
        {
          "id": 200317,
          "text": "<p><span style=\"font-size:12pt;\">Partial platinum resistant if recurrence is within 6-12 months</span></p>"
        },
        {
          "id": 200318,
          "text": "<p><span style=\"font-size:12pt;\">Platinum sensitive if recurrence > 6 months of starting primary therapy</span></p><p> </p>"
        },
        {
          "id": 200319,
          "text": "<p><span style=\"font-size:12pt;\">All of the above</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements is true regarding the treatment of recurrent ovarian cancer? </span>(INICET NOV 2022)</p>",
      "unique_key": "Q6636458",
      "question_audio": null,
      "question_video": null,
      "map_id": 34719511,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Platinum sensitive if recurrence > 6 months  of starting primary therapy</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Platinum-refractory disease</strong>: This includes women who progress during primary chemotherapy. It has the worst prognosis, as these patients do not respond to platinum-based chemotherapy at all.</span></li><li><span style=\"font-size:12pt;\"><strong>Platinum-resistant disease</strong>: This includes women who relapse within 6 months of completing primary therapy. Bevacizumab has been approved for the treatment of platinum-resistant disease due to its ability to inhibit angiogenesis, which is crucial for tumor growth and metastasis.</span></li><li><span style=\"font-size:12pt;\"><strong>Platinum-sensitive disease</strong>: This includes women who relapse more than 6 months after completing primary therapy. These patients are considered to have a better prognosis and are treated with a platinum-based combination such as carboplatin and paclitaxel or gemcitabine.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Platinum resistant if recurrence > 12 months</strong>: This statement is incorrect. If the recurrence occurs more than 12 months after treatment, it is considered platinum-sensitive, not resistant.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Partial platinum resistant if recurrence is within 6-12 months</strong>: This statement is not a recognized classification. The classification focuses on the 6-month mark to distinguish between resistant and sensitive.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Platinum-sensitive recurrent ovarian cancer is characterized by a recurrence occurring more than 6 months after completing primary therapy.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/al-35.jpg\" alt=\"\" width=\"500\" height=\"275\"></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Berek and Novak’s gynecology 15<sup>th</sup> edition pg 1387</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/al-35.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200318,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50080,
      "choices": [
        {
          "id": 200320,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Rectum</span></span></p>"
        },
        {
          "id": 200321,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Colon</span></span></p>"
        },
        {
          "id": 200322,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Small intestine</span></span></p>"
        },
        {
          "id": 200323,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ileocecal junction</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">What is the most common site of abdominal tuberculosis? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q4083016",
      "question_audio": null,
      "question_video": null,
      "map_id": 34221620,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Ileocecal junction</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The ileocecal junction is the most common site of abdominal tuberculosis. This area, which includes the terminal ileum and the beginning of the large intestine (cecum), is particularly susceptible to infection by Mycobacterium tuberculosis. The lymphoid tissue in this region provides a favorable environment for the bacteria to proliferate.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Abdominal tuberculosis can present in two primary forms: <strong>hypertrophic and ulcerative. </strong>The hypertrophic form involves thickening of the intestinal wall, while the ulcerative form leads to the formation of ulcers. Clinically, differentiating abdominal tuberculosis from Crohn's disease can be challenging due to overlapping symptoms and similar radiologic findings. In some cases, empirical anti-tubercular therapy (ATP) may be initiated, with subsequent monitoring for clinical improvement to help distinguish between the two conditions.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Rectum:</span></strong><span style=\"font-size:12.0pt\"> The rectum is not a common site for abdominal tuberculosis. Tuberculosis primarily affects the ileocecal region and less frequently involves other parts of the gastrointestinal tract.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Colon:</span></strong><span style=\"font-size:12.0pt\"> While tuberculosis can affect the colon, it is not the most common site. The ileocecal junction is more frequently involved in abdominal tuberculosis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Small intestine:</span></strong><span style=\"font-size:12.0pt\"> Although the small intestine can be affected, the terminal ileum specifically, which is part of the ileocecal junction, is the most common site for tuberculosis within the small intestine.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The most common site of abdominal tuberculosis is the ileocecal junction, particularly near the terminal ileum. This region's lymphoid tissue creates a favorable environment for Mycobacterium tuberculosis to proliferate.</span></span></span></p>",
      "correct_choice_id": 200323,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50081,
      "choices": [
        {
          "id": 200324,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">TNF alpha</span></span></span></p>"
        },
        {
          "id": 200325,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IL-6</span></span></span></p>"
        },
        {
          "id": 200326,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IL-8</span></span></span></p>"
        },
        {
          "id": 200327,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">INF- y</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">All of the following are responsible for Jarisch-Herxheimer reaction except? </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(INICET NOV 2022)</span></span></p>",
      "unique_key": "Q9633997",
      "question_audio": null,
      "question_video": null,
      "map_id": 34219124,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>D) INF- y </strong> </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Jarisch-Herxheimer reaction (JHR) is associated with a transient, marked rise in circulating tumor necrosis factor alpha (TNF alpha), interleukin 6 (IL-6) and interleukin 8 (IL-8).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is an inflammatory reaction that can occur after treatment for syphilis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The symptoms usually begin 2 hours from the administration of the antibiotic and resolve within 24 hours.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. TNF alpha</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Directly involved in the inflammatory response associated with JHR.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. IL-6</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Also directly involved in JHR, promoting inflammatory processes.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. IL-8</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Plays a role in recruiting neutrophils to sites of infection, contributing to the inflammatory reaction in JHR.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The Jarisch-Herxheimer reaction is primarily driven by a surge in pro-inflammatory cytokines such as TNF alpha, IL-6, and IL-8, but not by INF-γ.</span></span></span></p>",
      "correct_choice_id": 200327,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50082,
      "choices": [
        {
          "id": 200328,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IFN gamma (Interferon-gamma)</span></span></span></p>"
        },
        {
          "id": 200329,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IL- 2 (Interleukin-2)</span></span></span></p>"
        },
        {
          "id": 200330,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IL- 12 (Interleukin-12)</span></span></span></p>"
        },
        {
          "id": 200331,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">IL- 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following cytokines is not involved in Th1 response? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q3402143",
      "question_audio": null,
      "question_video": null,
      "map_id": 34181061,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) IL- 4</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The cytokine not involved in TH1 response is IL-4.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">T-cell response in this early stage is dominated by TH1 cells that produce IFN-γ, which stimulates macrophages to secrete high levels of the cytokines TNF, IL-1, and IL-6 that cause fever.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">IL-12 is secreted by macrophages and promotes the proliferation of TH1 cells.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The 1 cells secrete IL-2 which activates natural killer cells (NK cells) and cytotoxic T cells.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/3_GQmj9YH.jpg\" style=\"height:242px; width:577px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. IFN-γ (Interferon-gamma)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IFN-γ (Interferon-gamma) is a key cytokine produced by Th1 cells. It activates macrophages and enhances their ability to destroy ingested microbes, and it also promotes the production of IgG antibodies that are essential for opsonization and phagocytosis of pathogens.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. IL-2 (Interleukin-2)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IL-2 (Interleukin-2) is produced by Th1 cells and plays a critical role in the activation and proliferation of T cells, including natural killer (NK) cells and cytotoxic T lymphocytes (CTLs), which are crucial for the immune response against intracellular pathogens.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. IL-12 (Interleukin-12)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: IL-12 (Interleukin-12) is produced by antigen-presenting cells (like dendritic cells and macrophages) and is essential for the differentiation of naive T cells into Th1 cells. It also stimulates the production of IFN-γ by these Th1 cells.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-114325.jpg\" style=\"height:562px; width:1000px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/3_GQmj9YH.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200331,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50083,
      "choices": [
        {
          "id": 200332,
          "text": "<p><span style=\"font-size:12pt;\">B, A, C, D</span></p>"
        },
        {
          "id": 200333,
          "text": "<p><span style=\"font-size:12pt;\">B, A, D, C</span></p>"
        },
        {
          "id": 200334,
          "text": "<p><span style=\"font-size:12pt;\">B, C, A, D</span></p>"
        },
        {
          "id": 200335,
          "text": "<p><span style=\"font-size:12pt;\">B, D, A, C</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Arrange the following in sequence? </span>(INICET NOV 2022)</p><p> </p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12pt;\">Crowning</span></li><li><span style=\"font-size:12pt;\">Engagement</span></li><li><span style=\"font-size:12pt;\">Restitution</span></li><li><span style=\"font-size:12pt;\">External rotation</span></li></ol>",
      "unique_key": "Q1744882",
      "question_audio": null,
      "question_video": null,
      "map_id": 34169138,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) B, A, C, D</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The sequence of cardinal movements in the mechanism of labor is a series of positions and motions that the fetus goes through as it navigates through the birth canal. These movements are:</span></p><p> </p><ol><li><span style=\"font-size:12pt;\"><strong>Engagement</strong>: This is when the fetal head enters the pelvic inlet and the widest part of the head has passed through the pelvic brim.</span></li><li><span style=\"font-size:12pt;\"><strong>Descent</strong>: The downward movement of the fetal head within the pelvic inlet.</span></li><li><span style=\"font-size:12pt;\"><strong>Flexion</strong>: The fetal head bends so the chin is brought closer to the chest, presenting the smallest diameter to the birth canal.</span></li><li><span style=\"font-size:12pt;\"><strong>Internal Rotation</strong>: The fetal head rotates to align with the maternal pelvis.</span></li><li><span style=\"font-size:12pt;\"><strong>Crowning</strong>: The fetal head is visible at the vulva without slipping back.</span></li><li><span style=\"font-size:12pt;\"><strong>Extension</strong>: The fetal head extends as it passes under the symphysis pubis.</span></li><li><span style=\"font-size:12pt;\"><strong>Restitution</strong>: The fetal head rotates to the position it was in when it engaged in the pelvis.</span></li><li><span style=\"font-size:12pt;\"><strong>External Rotation</strong>: The fetal shoulders rotate to align with the head.</span></li><li><span style=\"font-size:12pt;\"><strong>Expulsion of the rest of the body</strong>: The remainder of the fetal body is delivered.</span></li></ol><p> </p><p><span style=\"font-size:12pt;\"><strong>Other options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. B, A, D, C</strong>: This sequence incorrectly places external rotation before restitution.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. B, C, A, D</strong>: This sequence incorrectly places restitution before crowning.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. B, D, A, C</strong>: This sequence incorrectly places external rotation before crowning and restitution.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The cardinal movements in the mechanism of labor occur in the following sequence: engagement, descent, flexion, internal rotation, extension (preceded by crowning), restitution, external rotation, and expulsion of the rest of the body.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 145</strong></span></p>",
      "correct_choice_id": 200332,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50084,
      "choices": [
        {
          "id": 200336,
          "text": "<p><span style=\"font-size:12pt;\">Stop MDT and start oral steroids</span></p>"
        },
        {
          "id": 200337,
          "text": "<p><span style=\"font-size:12pt;\">Antibiotics</span></p>"
        },
        {
          "id": 200338,
          "text": "<p><span style=\"font-size:12pt;\">Thalidomide</span></p>"
        },
        {
          "id": 200339,
          "text": "<p><span style=\"font-size:12pt;\">Continue MDT and add oral steroids</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In a pregnant woman at 12 weeks of gestation, who is currently undergoing multidrug therapy (MDT) for leprosy, she now presents with type 2 lepra reaction. What is the preferred treatment for this patient? </span> (INICET NOVEMBER 2022)</p>",
      "unique_key": "Q8454908",
      "question_audio": null,
      "question_video": null,
      "map_id": 34765664,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D. Continue MDT and add oral steroids</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">To manage a <strong>pregnant woman </strong>experiencing a <strong>type 2 lepra reaction</strong>, it is essential to <strong>continue the multidrug therapy (MDT)</strong> while adding <strong>oral steroids </strong>as an <strong>additional</strong> treatment.</span></p><p> </p><ul><li><span style=\"font-size:12pt;\">In the management of leprosy, it is crucial to <strong>continue </strong>multidrug therapy <strong>(MDT) </strong>to effectively treat the <strong>underlying infection </strong>caused by <strong>Mycobacterium leprae.</strong></span></li><li><span style=\"font-size:12pt;\">A <strong>Type 2 lepra </strong>reaction, also known as <strong>erythema nodosum leprosum (ENL), </strong>is a complex <strong>immunological reaction </strong>that occurs in <strong>lepromatous and borderline lepromatous leprosy</strong>, which can present with <strong>painful nodules</strong>, <strong>fever, malaise</strong>, and other <strong>systemic </strong>symptoms.</span></li><li><span style=\"font-size:12pt;\"><strong>Oral steroids</strong>, such as <strong>prednisone</strong>, are the treatment of choice for controlling <strong>acute inflammatory complications </strong>associated with Type 2 lepra reaction. They help <strong>reduce inflammation </strong>and <strong>immune</strong> response.</span></li><li><span style=\"font-size:12pt;\">It is important to manage the reaction <strong>without discontinuing </strong>the <strong>MDT</strong> to <strong>prevent </strong>the development of <strong>drug resistance </strong>and further progression of the disease.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Erythema nodosum leprosum (ENL)</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">It is a <strong>type 3 hypersensitive immune complex-mediated reaction</strong> that affects the <strong>skin, nerves, and other organs.</strong></span></li><li><span style=\"font-size:12pt;\">It is typically r<strong>ecurrent</strong> and commonly observed in individuals with <strong>multibacillary</strong> leprosy. ENL may occur <strong>before treatment</strong>, <strong>during treatment</strong> or <strong>after</strong> completion of treatment.</span></li><li><span style=\"font-size:12pt;\">It is characterized by <strong>painful, erythematous nodules</strong> appearing on the extensor surfaces of the <strong>limbs and face.</strong></span></li></ul><p> </p><p><span style=\"font-size:12pt;\">In a type 2 lepra reaction, <strong>systemic symptoms </strong>such as <strong>iritis, orchitis</strong>, and the appearance of <strong>fresh </strong>skin lesions can be observed.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Treatment includes:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">High doses of <strong>glucocorticoids</strong> are frequently administered to all patients which assist in <strong>reducing</strong> the acute signs and symptoms of <strong>inflammation.</strong></span></li><li><span style=\"font-size:12pt;\">In patients with lepra reactions, <strong>MDT is never discontinued</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Only severe cases of type-2 lepra reaction or erythema nodosum Leprosum are treated with thalidomide. </strong>Thalidomide is <strong>gold standard for type II Lepra</strong> reaction, but it is <strong>NOT the Drug of Choice</strong> due to its <strong>cost</strong> factor & also its <strong>Adverse drug reactions profile.</strong></span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Type I & II lepra reactions (ENL= Erythema Nodosum Leprosum):</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-175436.png\" alt=\"\" width=\"900\" height=\"339\"></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Stop MDT and start oral steroids: </strong>Stopping MDT is <strong>not advisable</strong> because it can lead to the <strong>proliferation</strong> of <strong>Mycobacterium leprae</strong> and risk the development of <strong>drug resistance.</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Antibiotics: </strong>While <strong>antibiotics</strong> are a <strong>part of MDT</strong> to treat the <strong>bacterial infection</strong>, they alone are <strong>not sufficient</strong> to address the <strong>acute inflammatory symptoms</strong> of a Type 2 lepra reaction.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Thalidomide:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Thalidomide is an effective treatment for Type 2 lepra reactions due to its potent anti-inflammatory properties.</span></li><li><span style=\"font-size:12pt;\">However, it is <strong>absolutely contraindicated</strong> in <strong>pregnant</strong> women due to its <strong>teratogenic effects</strong>, which can cause <strong>severe birth defects as seen in the below image</strong>.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-175555.png\" alt=\"\" width=\"500\" height=\"618\"></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Phocomelia</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">In a pregnant woman with leprosy who presents with a <strong>Type 2 lepra</strong> reaction, the preferred treatment is to <strong>continue multidrug therapy</strong> and <strong>add oral steroids</strong> to manage the <strong>acute inflammatory symptoms</strong>.</span></li><li><span style=\"font-size:12pt;\"><strong>Thalidomide </strong>is c<strong>ontraindicated</strong> in pregnancy due to its <strong>teratogenicity.</strong></span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref - Rook's Textbook of Dermatology -9th Edition Chapter 28 Page no 28.16</strong></span></p><p><span style=\"font-size:12pt;\"><strong>Harrison’s principles of internal medicine 21<sup>st</sup> edition page no 1387, 1390</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/18/screenshot-2024-06-18-175436.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200339,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50085,
      "choices": [
        {
          "id": 200340,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clean cut incised wound</span></span></span></p>"
        },
        {
          "id": 200341,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lacerated wound</span></span></span></p>"
        },
        {
          "id": 200342,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chop wound</span></span></span></p>"
        },
        {
          "id": 200343,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Avulsion injury</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A man was brought to the emergency department after he was attacked by his lover’s husband with an axe. On examination, crushing of the hair bull was seen. Identify the type of wound? (</span></span>INICET Nov 2022)</p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-45.jpg\" style=\"height:169px; width:300px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-45.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1440733",
      "question_audio": null,
      "question_video": null,
      "map_id": 34715204,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>B. Lacerated wound </strong> </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The type of wound in which the crushing of the hair bulb is seen is a lacerated wound.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Laceration- A laceration is a wound that is produced by the tearing of soft body tissue. This type of wound is often irregular and jagged</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is produced by blunt weapons or heavy relatively sharp-edged weapons such as axe.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In scalp lacerations hair bulbs, nerves, and vessels, are irregularly torn and crushed</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Clean cut incised wound:</span></strong><span style=\"font-size:12.0pt\"> Typically has clean, sharp edges caused by sharp instruments like knives or razors.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Chop wound:</span></strong><span style=\"font-size:12.0pt\"> While an axe can cause a chop wound, the presence of crushed hair bulbs suggests more of a laceration pattern.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Avulsion injury:</span></strong><span style=\"font-size:12.0pt\"> Involves the skin and underlying tissues being forcibly detached from the body.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Classification of a Laceration:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Split laceration (incised-like laceration</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">): When the skin is crushed between two hard objects.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Incised-looking lacerated wound</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> It is seen where the skin overlies an area of the bone where there is scanty underlying subcutaneous tissue such as the scalp, forehead, shin.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Avulsed laceration:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> A lesion where the skin separates or peels off by tearing from the underlying tissues. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tears:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Tearing of skin and subcutaneous tissue from localized impact </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Stretch laceration:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> It occurs due to the over-stretching of the skin, beyond its elasticity. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cut laceration:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Injury by a heavy sharp-edged instrument like axe.</span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200341,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50086,
      "choices": [
        {
          "id": 200344,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver iron concentration</span></p>"
        },
        {
          "id": 200345,
          "text": "<p><span style=\"font-size:12.0pt;\">MRI T2 myocardium</span></p>"
        },
        {
          "id": 200346,
          "text": "<p><span style=\"font-size:12.0pt;\">Serum ferritin</span></p>"
        },
        {
          "id": 200347,
          "text": "<p><span style=\"font-size:12.0pt;\">NTBI</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child with thalassemia is undergoing multiple blood transfusions. What is the best method to detect iron overload? (INICET NOV 2022)</span></p>",
      "unique_key": "Q6174738",
      "question_audio": null,
      "question_video": null,
      "map_id": 34236263,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Liver iron concentration</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Children with thalassemia who undergo multiple blood transfusions are at risk of iron overload, which can cause significant damage to organs such as the liver, heart, and endocrine glands.</span></li><li><span style=\"font-size:12.0pt;\">Monitoring liver iron concentration is the best method to assess iron overload in such children, as it is an indicator of total body iron stores.</span></li><li><span style=\"font-size:12.0pt;\">Liver iron concentration can be measured invasively using a liver biopsy or non-invasively using T2 MRI of the liver. The latter is preferred due to its non-invasiveness.</span></li><li><span style=\"font-size:12.0pt;\">Treatment for iron overload in thalassemia patients typically involves the use of chelation therapy, which helps to remove excess iron from the body. Deferoxamine is typically given through intravenous or subcutaneous infusion, while deferasirox and deferiprone can be given orally.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. MRI T2 myocardium</strong>: Quantitative iron overload in the heart is determined using a T2 MRI of the myocardium. However, it can be done sooner if there are symptoms of severe iron overload. It is often performed in children older than 10 years. If the patient's transfusion and chelation histories are unknown, it can still be done.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Serum ferritin</strong>: Although serum ferritin is elevated, other inflammatory disorders also cause it to be elevated, making it a less sensitive marker.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. NTBI (Non-transferrin-bound iron)</strong>: Iron in plasma is typically bound to cccc. However, when there is an excess of iron, it is unable to bind to transferrin, which results in the formation of non-transferrin-bound iron. (NTBI). It may serve as a marker for iron excess, however albumin, citrate, and uric acid in the plasma all have an impact. As a result, it cannot be utilized as a tool to quantify iron overload and serve as a guide for designing chelation therapy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The best method to detect iron overload in a patient receiving repeated blood transfusions is Liver iron concentration.</span></p>",
      "correct_choice_id": 200344,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50087,
      "choices": [
        {
          "id": 200348,
          "text": "<p><span style=\"font-size:12.0pt;\">Septic shock</span></p>"
        },
        {
          "id": 200349,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiogenic shock</span></p>"
        },
        {
          "id": 200350,
          "text": "<p><span style=\"font-size:12.0pt;\">Myxedema coma</span></p>"
        },
        {
          "id": 200351,
          "text": "<p><span style=\"font-size:12.0pt;\">Hyperthyroidism</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 67-year-old woman presents with altered sensorium, breathlessness, hypotension, and bradycardia. Examination revealed non-pitting edema of the extremities. She has a long-standing history of weight gain, constipation, cold intolerance, and menorrhagia. What is the most likely diagnosis? (INICET NOV 2022)</span></p>",
      "unique_key": "Q8641280",
      "question_audio": null,
      "question_video": null,
      "map_id": 34442084,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Myxedema coma</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The patient presents with several symptoms indicative of severe hypothyroidism. These include altered sensorium, breathlessness, hypotension, bradycardia, non-pitting edema, weight gain, constipation, cold intolerance, and menorrhagia. In hypothyroid patients, a severe, life-threatening condition called myxedema coma can develop. This is characterized by a profound deficiency of thyroid hormones, leading to critical manifestations such as altered mental status, hypothermia, bradycardia, hypotension, and edema.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Myxedema coma requires immediate medical intervention. The treatment of choice involves intravenous administration of thyroxine (IV T4) and IV hydrocortisone. IV hydrocortisone is essential because many patients with myxedema coma have subtle adrenal insufficiency, which can become overt with the initiation of thyroid hormone replacement. This combination helps stabilize the patient's condition and addresses both thyroid and potential adrenal insufficiencies.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Septic shock:</strong> While this condition involves hypotension and altered sensorium, it is usually associated with signs of infection, fever, and a source of sepsis, which are not described in this patient's presentation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cardiogenic shock:</strong> This condition involves heart failure and typically presents with signs of fluid overload, severe breathlessness, and possibly chest pain, none of which are noted in this patient’s history.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hyperthyroidism:</strong> The symptoms of hyperthyroidism include weight loss, heat intolerance, tachycardia, and increased bowel movements, which are opposite to the symptoms exhibited by this patient.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Myxedema coma is a severe, life-threatening condition of profound hypothyroidism, characterized by symptoms such as altered sensorium, bradycardia, hypotension, and non-pitting edema. Immediate treatment involves IV thyroxine and IV hydrocortisone to manage both thyroid and potential adrenal insufficiency</span></p>",
      "correct_choice_id": 200350,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50088,
      "choices": [
        {
          "id": 200352,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Trichodysplasia spinulosa</span></span></span></p>"
        },
        {
          "id": 200353,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Condyloma accuminata</span></span></span></p>"
        },
        {
          "id": 200354,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Molluscum contagiosum</span></span></span></p>"
        },
        {
          "id": 200355,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Donovanosis</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A woman presents with lesions on the inner thighs and peri-anal region. They are nodular, 4-6 mm in size, and appear pale. The histopathological image shows multiple intracytoplasmic inclusion bodies consistent with Henderson-Patterson bodies. The diagnosis is: (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture14.jpg\" style=\"height:265px; width:300px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture14.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8254170",
      "question_audio": null,
      "question_video": null,
      "map_id": 34397785,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Molluscum contagiosum</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical history along with histological image showing <strong>intracytoplasmic inclusion bodies suggests a diagnosis of Molluscum contagiosum.</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Molluscum contagiosum <strong>is a poxvirus infection</strong> of the skin and the mucous membranes. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">There are four types of molluscum contagiosum viruses (MCVs), MCV-1 to -4, with <strong>MCV-1 being the most prevalent and MCV-2 being most often sexually transmitted. </strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The infections are common in young children between 2 and 12 years of age and are transmitted through direct contact or shared articles (e.g., towels). </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Molluscum may affect any area of the skin but is most common on the trunk, arms, and legs. In adults, molluscum infections are typically sexually transmitted and affect the genitals, lower abdomen, buttocks, and inner thighs. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The average incubation period is 6 weeks. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diagnosis is based on the characteristic clinical appearance of pearly, <strong>domeshaped papules with a dimpled center</strong>. The papules measure 1 to 5 mm in diameter, and their central waxy core contains cells with intracytoplasmic viral inclusions called as <strong>Molluscum bodies or Henderson Patterson bodies.</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture15.jpg\" style=\"height:122px; width:600px\" /></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Trichodysplasia spinulosa</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is a rare viral infection associated with immunosuppression and does not typically present with the described clinical or histopathological features.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Condyloma accuminata</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Caused by human papillomavirus (HPV), this condition presents as warty growths, typically on the genital and perianal regions, but it does not produce Henderson-Patterson bodies.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Donovanosis</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Also known as granuloma inguinale, this sexually transmitted infection caused by <em>Klebsiella granulomatis</em> presents with ulcerative lesions rather than nodular papules and does not show the characteristic Henderson-Patterson bodies.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Molluscum contagiosum</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is a viral skin infection that presents with dome-shaped papules containing Henderson-Patterson bodies, which are diagnostic of this condition.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture15.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200354,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50089,
      "choices": [
        {
          "id": 200356,
          "text": "<p><span style=\"font-size:12.0pt;\">Wrist drop</span></p>"
        },
        {
          "id": 200357,
          "text": "<p><span style=\"font-size:12.0pt;\">Ape thumb deformity</span></p>"
        },
        {
          "id": 200358,
          "text": "<p><span style=\"font-size:12.0pt;\">Claw hand</span></p>"
        },
        {
          "id": 200359,
          "text": "<p><span style=\"font-size:12.0pt;\">Porter’s tip deformity</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a feature of Klumpke’s palsy?</span>(INICET NOVEMBER 2022)</p>",
      "unique_key": "Q3273390",
      "question_audio": null,
      "question_video": null,
      "map_id": 34744059,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Claw hand</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Klumpke’s palsy is the lower brachial plexus injury involving C8 and T1 nerve roots.</span></li><li><span style=\"font-size:12.0pt;\">It is less common, but more severe.</span></li><li><span style=\"font-size:12.0pt;\">It involves weakness of wrist and finger flexors and the intrinsic hand muscles.</span></li><li><span style=\"font-size:12.0pt;\">Sensation is lost on ulnar side of the forearm.</span></li><li><span style=\"font-size:12.0pt;\">There may also be vasomotor impairment and unilateral Horner’s syndrome.</span></li><li><span style=\"font-size:12.0pt;\">Claw hand deformity is the usual outcome.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102428.jpg\" alt=\"\" width=\"300\" height=\"318\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102559.jpg\" alt=\"\" width=\"894\" height=\"774\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Wrist drop. </strong>The radial nerve is responsible for innervating the extensor muscles of the wrist and digits. Consequently, injury to the radial nerve results in the inability to properly utilize these extensor muscles. As a result, the hand hangs flaccidly in a position of flexion when the patient attempts to bring the arm to a horizontal position. This is known as <strong>wrist drop</strong>.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102619.jpg\" alt=\"\" width=\"300\" height=\"201\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ape thumb deformity. </strong>Ape thumb deformity is a condition in which the thumb is permanently rotated and adducted, resulting in a loss of its opposable function. This deformity is caused by damage to the distal median nerve, which supplies the muscles that control the thumb.<sup> </sup>The thumb may also experience limited flexion and extension.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102631.jpg\" alt=\"\" width=\"500\" height=\"187\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Porter’s tip deformity. </strong>Injury to the upper trunk of the brachial plexus (mainly C5, partially C6) causes Erb's Paralysis. This causes paralysis of biceps, deltoid, brachialis and brachioradialis mainly; and supraspinatus, infraspinatus, supinator partially. The muscle paralysis causes the arm to hang by the side in adduction and medial rotation with forearm extended and pronated. This deformity is called as “<strong>policeman’s tip</strong>” or “<strong>porter’s tip hand</strong>”.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102646.jpg\" alt=\"\" width=\"300\" height=\"214\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The characteristic deformity of Klumpke’s palsy is Claw hand due to paralysis of intrinsic hand muscles and weakness of wrist and finger flexors.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102428.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200358,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50090,
      "choices": [
        {
          "id": 200360,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4</span></p>"
        },
        {
          "id": 200361,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3</span></p>"
        },
        {
          "id": 200362,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3</span></p>"
        },
        {
          "id": 200363,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man has been diagnosed with tuberculosis. As part of his treatment plan, he is prescribed a combination of antitubercular drugs. While counseling him on the drug regimen, you explain the mechanisms of action of each drug. Which of the following combinations of statements accurately describe the mechanisms of some of the drugs used in treating tuberculosis? (INICET NOV 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Isoniazid inhibits mycolic acid synthesis</span></li><li><span style=\"font-size:12.0pt;\">Pyrazinamide is an enzyme inducer</span></li><li><span style=\"font-size:12.0pt;\">Rifampicin is used only in the treatment of tuberculosis</span></li><li><span style=\"font-size:12.0pt;\">Bedaquiline inhibits ATP synthase</span></li></ol>",
      "unique_key": "Q7893742",
      "question_audio": null,
      "question_video": null,
      "map_id": 34112771,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. lsoniazid - </strong>INH is activated by catalase peroxidase (formed by Kat G) enzyme of mycobacteria. It acts by inhibiting the formation of mycolic acid.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>4. Bedaquiline -</strong> Act by inhibiting ATP synthase enzyme, can result in QT prolongation</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2. Pyrazinamide - </strong>Possess the best sterilizing activity (can kill slow growing bacteria) and makes the medium sterile. Pyrazinamide inhibits trans-translation in Mycobacterium tuberculosis. It is not an enzyme inducer.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>3. Rifampicin - </strong>Act by inhibiting RNA polymerase of mycobacteria by binding to its β-subunit. It thus inhibits transcription.<strong> </strong>Uses of Rifampicin are:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Tuberculosis</span></li><li><span style=\"font-size:12.0pt;\">Leprosy</span></li><li><span style=\"font-size:12.0pt;\">DOC for Brucella (doxycycline + rifampicin)</span></li><li><span style=\"font-size:12.0pt;\">Effective against Gram positive bacteria (including MRSA)</span></li><li><span style=\"font-size:12.0pt;\">Effective against Gram negative bacteria (including Pseudomonas)</span></li><li><span style=\"font-size:12.0pt;\">It was used for prophylaxis of meningococcus meningitis</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Isoniazid inhibits mycolic acid synthesis.</span></li><li><span style=\"font-size:12.0pt;\">Bedaquiline inhibits ATP synthase enzyme.</span></li><li><span style=\"font-size:12.0pt;\">Pyrazinamide inhibits trans-translation</span></li><li><span style=\"font-size:12.0pt;\">Rifampicin inhibit RNA polymerase</span></li></ul>",
      "correct_choice_id": 200363,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50091,
      "choices": [
        {
          "id": 200364,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 3</span></span></span></p>"
        },
        {
          "id": 200365,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 2, 3, 4</span></span></span></p>"
        },
        {
          "id": 200366,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2, 3</span></span></span></p>"
        },
        {
          "id": 200367,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2, 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following statements are true regarding sirtuins? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases insulin sensitivity and thus glucose metabolism.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Promotes genes that increase longevity.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are of 7 types.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are one of the types of histone deacetylases. </span></span></span></li>\r\n</ol>",
      "unique_key": "Q5071256",
      "question_audio": null,
      "question_video": null,
      "map_id": 34306043,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) 1, 2, 3, 4</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sirtuins</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> are a family of proteins that have been widely studied for their role in regulating various cellular processes, including aging, metabolism, and stress responses. Here's a detailed breakdown of each statement:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases insulin sensitivity and thus glucose metabolism:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sirtuins, particularly SIRT1, have been shown to enhance insulin sensitivity and promote glucose metabolism, which is crucial for maintaining energy homeostasis.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Promotes genes that increase longevity:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sirtuins are known to regulate gene expression in ways that promote longevity. They are involved in the deacetylation of proteins that contribute to cell survival, repair, and metabolism, which are associated with extended lifespan in various organisms.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are of 7 types:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> There are seven known sirtuins in humans, designated SIRT1 through SIRT7, each with specific functions in different cellular compartments.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">They are one of the types of histone deacetylases:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Sirtuins function as NAD+-dependent deacetylases, a class of enzymes that remove acetyl groups from histone and non-histone proteins, influencing gene expression and protein activity.</span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sirtuins </span></strong><span style=\"font-size:12.0pt\">are a family of seven histone deacetylases involved in increasing insulin sensitivity, glucose metabolism, promoting genes associated with longevity, and playing a significant role in various cellular processes.</span></span></span></p>",
      "correct_choice_id": 200365,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50092,
      "choices": [
        {
          "id": 200368,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brown-Sequard syndrome</span></span></span></p>"
        },
        {
          "id": 200369,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Tabes dorsalis</span></span></span></p>"
        },
        {
          "id": 200370,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringobulbia</span></span></span></p>"
        },
        {
          "id": 200371,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringomyelia</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A female presented with loss of pain and temperature, but her touch sensation was intact. Imaging showed cavitation around the central canal. What is the probable diagnosis? (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q6374389",
      "question_audio": null,
      "question_video": null,
      "map_id": 34237407,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. </span></strong><span style=\"font-size:12.0pt\"> <strong>D) Syringomyelia</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringomyelia is characterized by the presence of a fluid-filled cavity or syrinx within the spinal cord, which typically expands over time. This condition most commonly affects the cervical and thoracic regions of the spinal cord. The classic presentation includes a loss of pain and temperature sensation in a \"cape-like\" distribution over the shoulders and back, while touch, vibration, and proprioception (posterior column sensations) remain intact. This pattern of sensory loss is due to the disruption of the decussating (crossing) fibers of the spinothalamic tract, which carry pain and temperature sensations. The cavitation around the central canal of the spinal cord is a hallmark of syringomyelia and leads to the aforementioned symptoms.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Brown-Sequard syndrome: </span></strong><span style=\"font-size:12.0pt\">This condition results from hemisection or damage to one half of the spinal cord. It typically presents with ipsilateral motor loss and loss of proprioception and vibration sense, and contralateral loss of pain and temperature sensation below the level of the lesion. This does not match the described symptoms and imaging findings.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tabes dorsalis: </span></strong><span style=\"font-size:12.0pt\">This is a late manifestation of neurosyphilis, characterized by degeneration of the dorsal columns of the spinal cord, leading to impaired proprioception and vibration sense, ataxia, and lightning pains. It does not cause cavitation around the central canal or the specific dissociated sensory loss seen in this patient.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Syringobulbia: </span></strong><span style=\"font-size:12.0pt\">This is a similar condition to syringomyelia but involves the brainstem (medulla oblongata) rather than the spinal cord. It presents with symptoms related to cranial nerve involvement such as dysphagia, dysarthria, and facial pain. The patient's symptoms and imaging findings are more consistent with syringomyelia, not syringobulbia</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Syringomyelia presents with a loss of pain and temperature sensation while preserving touch sensation, and is characterized by cavitation around the central canal of the spinal cord.</span></span></span></p>",
      "correct_choice_id": 200371,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50093,
      "choices": [
        {
          "id": 200372,
          "text": "<p><span style=\"font-size:12pt;\">Vulval dystrophy</span></p>"
        },
        {
          "id": 200373,
          "text": "<p><span style=\"font-size:12pt;\">Vulval hamartoma</span></p>"
        },
        {
          "id": 200374,
          "text": "<p><span style=\"font-size:12pt;\">Smoking</span></p>"
        },
        {
          "id": 200375,
          "text": "<p><span style=\"font-size:12pt;\">Vulval warts</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">All of the following are risk factors of vulval cancer except? </span>(INICET NOV 2022)</p>",
      "unique_key": "Q6415668",
      "question_audio": null,
      "question_video": null,
      "map_id": 34550060,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Vulval hamartoma</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Vulval cancer has several known risk factors, which include:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Chronic vulval irritation</strong>: Persistent irritation and inflammation can contribute to the development of vulval cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>Immunosuppressive conditions</strong>: Conditions such as pregnancy and HIV infection can compromise the immune system, increasing the risk of vulval cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>HPV (Human Papillomavirus)</strong>: Infection with HPV, particularly strains 16 and 18, is a significant risk factor.</span></li><li><span style=\"font-size:12pt;\"><strong>Smoking</strong>: Smoking is a known risk factor for various cancers, including vulval cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>Condyloma (anogenital warts)</strong>: Caused by HPV, these warts can lead to changes in vulval cells that may progress to cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>Sexually transmitted diseases (STDs)</strong>: History of STDs can increase the risk due to the association with HPV and chronic inflammation.</span></li><li><span style=\"font-size:12pt;\"><strong>Vulvar dystrophies</strong>: Conditions like lichen sclerosus can predispose individuals to vulval cancer.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Vulval hamartoma</strong> is not a risk factor for vulval cancer. Hamartomas are benign, disorganized clusters of tissue that do not typically transform into malignant tumors.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Vulval dystrophy</strong>: Vulval dystrophies, such as lichen sclerosus, are risk factors for vulval cancer due to chronic irritation and inflammation.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Smoking</strong>: Smoking is a well-documented risk factor for many cancers, including vulval cancer.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Vulval warts</strong>: Vulval warts, often caused by HPV, can lead to cellular changes that increase the risk of vulval cancer.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Vulval hamartomas are not a risk factor for vulval cancer, while chronic irritation, immunosuppressive conditions, HPV infection, smoking, anogenital warts, STDs, and vulvar dystrophies are known risk factors.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of gynecology 3<sup>rd</sup> edition pg 680, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 334</strong></span></p>",
      "correct_choice_id": 200373,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50094,
      "choices": [
        {
          "id": 200376,
          "text": "<p><span style=\"font-size:12.0pt;\">Tumor size < 4cm, with N1 axillary metastasis</span></p>"
        },
        {
          "id": 200377,
          "text": "<p><span style=\"font-size:12.0pt;\">Tumor size exceeding the size of the breast</span></p>"
        },
        {
          "id": 200378,
          "text": "<p><span style=\"font-size:12.0pt;\">Previous chest irradiation</span></p>"
        },
        {
          "id": 200379,
          "text": "<p><span style=\"font-size:12.0pt;\">Presence of multiple tumors</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the options below is an acceptable condition for breast conservative surgery? (INICET NOV 2022)</span></p>",
      "unique_key": "Q6808029",
      "question_audio": null,
      "question_video": null,
      "map_id": 34332987,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Tumor size <4cm, with N1 axillary metastasis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Options B, C, and D are contraindications for breast conservative surgery, whereas option A is an acceptable condition for breast conservative surgery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Breast-conserving surgery, also known as lumpectomy or partial mastectomy, is a suitable option when the primary tumor in the breast is relatively small (typically less than 4 cm). Presence of N1 disease (ipsilateral mobile axillary lymph node metastasis) is not a contra-indicated. However, since LN are already involved, a sentinel lymph biopsy is not needed, and up front axillary lymphadenectomy is done.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>B. Tumor size exceeding the size of the breast</strong>: Breast-conserving surgery aims to remove the tumor while preserving as much of the breast tissue as possible. If the tumor size exceeds the size of the breast, it may not be feasible to perform breast-conserving surgery, as there would be insufficient healthy breast tissue remaining.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Previous chest irradiation</strong>: Previous chest irradiation, especially at high doses, can affect the breast tissue's tolerance to additional radiation. It may limit the use of breast-conserving surgery due to concerns about radiation toxicity.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>D.</strong> <strong>Presence of multiple tumors</strong>: Breast-conserving surgery is typically performed for a single primary tumor in the breast. If there are multiple tumors in different areas of the breast, it may not be suitable for breast-conserving surgery, as it may be challenging to achieve clear margins and preserve breast tissue.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"> Breast conservative surgery involves the removal of the primary breast cancer with adequate normal breast tissue, followed by adjuvant radiotherapy and assessment of regional lymph nodes through a separate axillary incision.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Absolute contraindications for breast conservative surgery include pregnancy, persistently positive margins, multicentric lumps, diffuse microcalcification, extensive ductal carcinoma in situ, and inflammatory breast cancer.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Relative contraindications include active systemic lupus erythematosus, scleroderma, a large lump-to-breast ratio (>5 cm size lump), known or suspected genetic predisposition to breast cancer (i.e., BRCA1, BRCA2), multifocal disease, and prior radiation therapy to the chest wall or breast.</span></p>",
      "correct_choice_id": 200376,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50095,
      "choices": [
        {
          "id": 200380,
          "text": "<p><span style=\"font-size:12pt;\">Only 3</span></p>"
        },
        {
          "id": 200381,
          "text": "<p><span style=\"font-size:12pt;\">1 and 3</span></p>"
        },
        {
          "id": 200382,
          "text": "<p><span style=\"font-size:12pt;\">1, 3, and 4</span></p>"
        },
        {
          "id": 200383,
          "text": "<p><span style=\"font-size:12pt;\">2, 3, and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is false regarding disulfiram?</span></p><p> </p><p><span style=\"font-size:12pt;\">1. Stops alcohol craving</span></p><p> </p><p><span style=\"font-size:12pt;\">2. Accumulates acetaldehyde</span></p><p> </p><p><span style=\"font-size:12pt;\">3. Inhibits alcohol dehydrogenase</span></p><p> </p><p><span style=\"font-size:12pt;\">4. Starting dose is 500 mg</span></p><p> </p>",
      "unique_key": "Q6995963",
      "question_audio": null,
      "question_video": null,
      "map_id": 34425037,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B.  1 and 3</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Alcohol is metabolized in the body with the help of alcohol dehydrogenase to aldehyde and further to acid with the help of aldehyde dehydrogenase.</span></li><li><span style=\"font-size:12pt;\">Disulfiram inhibits Acetaldehyde dehydrogenase, which leads to accumulation of aldehyde in the body. This causes unpleasant symptoms like headache, vomiting, blurring of vision, etc. after consumption of alcohol due to the accumulated acetaldehyde.</span></li><li><span style=\"font-size:12pt;\">So, disulfiram is used in alcohol aversion therapy, however it does not stop craving.</span></li><li><span style=\"font-size:12pt;\">It should not be administered until the person has abstained from alcohol for at least 12 hours.</span></li><li><span style=\"font-size:12pt;\">The disulfiram-alcohol reaction may persist as long as 14 days after the last dose of disulfiram.</span></li><li><span style=\"font-size:12pt;\">Starting dose of disulfiram is 250 mg is also wrong as starting dose is 500mg/day for 1 week followed by 250 mg /day.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">2.  <strong>Accumulates acetaldehyde</strong>: True. Disulfiram works by inhibiting aldehyde dehydrogenase, an enzyme involved in metabolizing alcohol. This inhibition leads to the accumulation of acetaldehyde when alcohol is consumed, causing the unpleasant effects.</span></p><p> </p><p><span style=\"font-size:12pt;\">4.  <strong>Starting dose is 500 mg</strong>: True. Starting dose of disulfiram is 250 mg is also wrong as starting dose is 500 mg/day for 1 week followed by 250 mg/day.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Disulfiram does not reduce alcohol cravings; it works by causing adverse reactions when alcohol is consumed, thereby discouraging drinking. It inhibits aldehyde dehydrogenase, not alcohol dehydrogenase, leading to the accumulation of acetaldehyde and subsequent unpleasant symptoms. The starting dose for disulfiram therapy is typically 250 mg per day.</span></p>",
      "correct_choice_id": 200381,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50096,
      "choices": [
        {
          "id": 200384,
          "text": "<p><span style=\"font-size:12pt;\">A-4, B-3, C-2, D-1</span></p>"
        },
        {
          "id": 200385,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿A-2, B-3, C-1, D-4</span></p>"
        },
        {
          "id": 200386,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿A-4, B-1, C-2, D-3</span></p>"
        },
        {
          "id": 200387,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿A-3, B-2, C-4, D-1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following:(</span>INICET Nov 2022)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/untitled-292.jpg\" alt=\"\" width=\"600\" height=\"112\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/untitled-292.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1171644",
      "question_audio": null,
      "question_video": null,
      "map_id": 34549759,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) A-4, B-1, C-2, D-3</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The correct matching of the procedures with their respective characteristics is as follows:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Amniocentesis (A-4)</strong>: This procedure involves the assessment of amniotic fluid, often for detecting alpha-fetoprotein (AFP) and other genetic conditions. It is generally performed between 15-18 weeks but may be done later as well.</span></li><li><span style=\"font-size:12pt;\"><strong>Chorionic Villous Sampling (B-1)</strong>: CVS is performed earlier in pregnancy, typically between 10-13 weeks. It involves sampling of placental tissue to test for chromosomal abnormalities and genetic conditions.</span></li><li><span style=\"font-size:12pt;\"><strong>Fetal Blood Sampling (C-2)</strong>: Also known as cordocentesis or percutaneous umbilical blood sampling (PUBS), this procedure is done around 19-20 weeks to obtain fetal blood, often for testing fetal anemia, infections, or genetic conditions.</span></li><li><span style=\"font-size:12pt;\"><strong>Fetoscopy (D-3)</strong>: This procedure involves visualizing the fetus directly in utero and is used in specific circumstances to assess fetal anatomy and perform interventions.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. A-4, B-3, C-2, D-1</strong>: Incorrect because Chorionic Villous Sampling (CVS) is not done at 19-20 weeks, and fetoscopy does not typically involve amniotic fluid assessment.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. A-2, B-3, C-1, D-4</strong>: Incorrect because Amniocentesis is not done at 19-20 weeks, and fetal blood sampling is not done at 8-12 weeks.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. A-3, B-2, C-4, D-1</strong>: Incorrect because Amniocentesis is not used to visualize fetal organs, and Chorionic Villous Sampling is not done at 19-20 weeks.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Understand the appropriate timing and purpose of various prenatal diagnostic procedures such as Amniocentesis, Chorionic Villous Sampling, Fetal Blood Sampling, and Fetoscopy.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 26<sup>th</sup> edition pg 882, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 741</strong></span></p>",
      "correct_choice_id": 200386,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50097,
      "choices": [
        {
          "id": 200388,
          "text": "<p><span style=\"font-size:12.0pt;\">a, c</span></p>"
        },
        {
          "id": 200389,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c, d</span></p>"
        },
        {
          "id": 200390,
          "text": "<p><span style=\"font-size:12.0pt;\">b, c, d</span></p>"
        },
        {
          "id": 200391,
          "text": "<p><span style=\"font-size:12.0pt;\">a, b, c</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A pregnant mother was on SSRIs. The risk of which of the following is increased in the newborn? (</span>INICET Nov 2022)</p><ol style=\"list-style-type:lower-alpha;\"><li><span style=\"font-size:12.0pt;\">Low APGAR score.</span></li><li><span style=\"font-size:12.0pt;\">ADHD.</span></li><li><span style=\"font-size:12.0pt;\">Persistent pulmonary hypertension.</span></li><li><span style=\"font-size:12.0pt;\">Delayed developmental milestones.</span></li></ol><p> </p>",
      "unique_key": "Q2132385",
      "question_audio": null,
      "question_video": null,
      "map_id": 34457134,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) a, b, c, d</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p><span style=\"font-size:10.5pt;\"><strong> </strong></span></p><p><span style=\"font-size:12.0pt;\"><strong>a. Low APGAR score</strong>: SSRIs in late pregnancy can lead to neonatal adaptation syndrome, impacting the APGAR score.</span></p><p><span style=\"font-size:10.5pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><strong>b. ADHD:</strong> Some research suggests a potential link between prenatal SSRI exposure and ADHD.</span></p><p><span style=\"font-size:10.5pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><strong>c. Persistent pulmonary hypertension:</strong> Late-pregnancy SSRI exposure is associated with this risk.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>d. Delayed developmental milestones: </strong>There's some evidence linking SSRIs to delayed milestones, though it's less consistent.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective: </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">SSRIs during pregnancy are linked to multiple neonatal risks. They may increase the risk of cardiac birth defects, decreased gestational age, spontaneous abortion, decreased birth weight, suboptimal fetal growth, low APGAR scores, autism spectrum disorders, ADHD and persistent pulmonary hypertension (SSRIs and SNRIs).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference: The Maudsley Prescribing Guidelines in Psychiatry, 14th edition, Page No 687-688</strong></span></p>",
      "correct_choice_id": 200389,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50098,
      "choices": [
        {
          "id": 200392,
          "text": "<p><span style=\"font-size:12.0pt;\">B, A, C, D</span></p>"
        },
        {
          "id": 200393,
          "text": "<p><span style=\"font-size:12.0pt;\">D, C, B, A</span></p>"
        },
        {
          "id": 200394,
          "text": "<p><span style=\"font-size:12.0pt;\">C, D, A, B</span></p>"
        },
        {
          "id": 200395,
          "text": "<p><span style=\"font-size:12.0pt;\">A, B, C, D</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Arrange the following steps of ventricular action potential in the correct order: (</span>INICET Nov 2022)</p><p> </p><ol style=\"list-style-type:upper-alpha;\"><li><span style=\"font-size:12.0pt;\">Opening of voltage-gated calcium channels</span></li><li><span style=\"font-size:12.0pt;\">Repolarizing K+ currents</span></li><li><span style=\"font-size:12.0pt;\">Opening of voltage-gated sodium channels</span></li><li><span style=\"font-size:12.0pt;\">Transient outward flow of potassium</span></li></ol>",
      "unique_key": "Q5691716",
      "question_audio": null,
      "question_video": null,
      "map_id": 34722853,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong></span><span style=\"font-size:11pt;\"><strong> </strong></span><span style=\"font-size:12.0pt;\"><strong>C) C, D, A, B</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The ventricular action potential is characterized by a sequence of changes in membrane potential and ionic currents. The correct sequence is as follows:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>C. Opening of voltage-gated sodium channels:</strong> This is the initial depolarization phase (Phase 0). When the membrane potential reaches the threshold, voltage-gated sodium channels open, leading to a rapid influx of Na+ ions and a sharp rise in membrane potential.</span></li><li><span style=\"font-size:12.0pt;\"><strong>D. Transient outward flow of potassium:</strong> This corresponds to Phase 1. Shortly after the peak of the action potential, transient outward K+ channels open, causing a brief efflux of K+ ions which results in a slight repolarization.</span></li><li><span style=\"font-size:12.0pt;\"><strong>A. Opening of voltage-gated calcium channels:</strong> This is Phase 2, the plateau phase. Voltage-gated L-type calcium channels open, allowing Ca2+ to enter the cell. The influx of Ca2+ is balanced by the efflux of K+ through delayed rectifier K+ channels, maintaining a plateau in the membrane potential.</span></li><li><span style=\"font-size:12.0pt;\"><strong>B. Repolarizing K+ currents:</strong> This is Phase 3. The Ca2+ channels close, but the delayed rectifier K+ channels remain open, leading to a net efflux of K+ and returning the membrane potential to its resting value.</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/physiology-5_1-5.jpg\" alt=\"\" width=\"600\" height=\"467\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The correct sequence for ventricular action potential is as follows:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">C. Opening of voltage-gated sodium channels</span></p><p><span style=\"font-size:12.0pt;\">D. Transient outward flow of potassium</span></p><p><span style=\"font-size:12.0pt;\">A. Opening of voltage-gated calcium channels</span></p><p><span style=\"font-size:12.0pt;\">B. Repolarizing K+ currents</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/05/physiology-5_1-5.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200394,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50099,
      "choices": [
        {
          "id": 200396,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alkaline hematin</span></span></span></p>"
        },
        {
          "id": 200397,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acid hematin</span></span></span></p>"
        },
        {
          "id": 200398,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Oxyhemoglobin</span></span></span></p>"
        },
        {
          "id": 200399,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Deoxyhemoglobin</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The instrument shown below is used for estimating for hemoglobin levels. What does it measure? (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/51_BqIE09s.jpg\" style=\"height:225px; width:300px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/12/51_BqIE09s.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4750808",
      "question_audio": null,
      "question_video": null,
      "map_id": 34549418,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) Acid hematin</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The instrument shown in the image is a <strong>Sahli’s Hemoglobinometer</strong>, which is used to estimate hemoglobin levels in the blood. The principle of this method is based on the conversion of hemoglobin into acid hematin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">PRINCIPLE OF SAHLI’S HEMOGLOBINOMETER</span></u></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Blood is mixed with an acid solution so that hemoglobin is converted to brown-colored acid hematin. This is then diluted with water till the brown color matches that of the brown glass standard. The hemoglobin value is read directly from the scale.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture13.jpg\" style=\"height:281px; width:500px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Sahli’s Hemoglobinometer estimates hemoglobin levels by converting hemoglobin into acid hematin, which is then compared to a color standard.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/picture13.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200397,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50100,
      "choices": [
        {
          "id": 200400,
          "text": "<p><span style=\"font-size:12.0pt;\">Asphyxia</span></p>"
        },
        {
          "id": 200401,
          "text": "<p><span style=\"font-size:12.0pt;\">Laryngeal spasm</span></p>"
        },
        {
          "id": 200402,
          "text": "<p><span style=\"font-size:12.0pt;\">Vagal inhibition</span></p>"
        },
        {
          "id": 200403,
          "text": "<p><span style=\"font-size:12.0pt;\">Cardiac arrest</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Pick the mechanism of death in cold water drowning? </span>(INICET NOVEMBER 2022)</p>",
      "unique_key": "Q5529049",
      "question_audio": null,
      "question_video": null,
      "map_id": 34480468,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.</strong> <strong>C. Vagal inhibition</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">In cold water drowning cause of death is Cold shock response/ hydrocution / immersion syndrome.</span></li><li><span style=\"font-size:12.0pt;\">It is a series of neurogenic cardio-respiratory responses caused by sudden immersion in cold water.</span></li><li><span style=\"font-size:12.0pt;\">Death results from vagal inhibition of the heart, i.e., cardiac arrest occurring due to increased stimulation of the vagus nerve by</span></li><li><span style=\"font-size:12.0pt;\">Sudden entry of water into the nasopharynx or larynx</span></li><li><span style=\"font-size:12.0pt;\">Diving into the water in a manner that is suddenly strikes the abdomen</span></li><li><span style=\"font-size:12.0pt;\">Sudden in-rush of cold water into the ears</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Asphyxia:</strong> Common in other types of drowning but not the primary cause in cold water drowning.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Laryngeal spasm:</strong> Can contribute to asphyxia but is not the primary mechanism in cold water drowning.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Cardiac arrest:</strong> While cardiac arrest occurs, it is due to vagal inhibition, not directly from cold water exposure.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In cold water drowning, the primary cause of death is vagal inhibition, leading to cardiac arrest due to the sudden stimulation of the vagus nerve from cold water immersion.</span></p>",
      "correct_choice_id": 200402,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50101,
      "choices": [
        {
          "id": 200404,
          "text": "<p><span style=\"font-size:12.0pt;\">Krukenberg spindle</span></p>"
        },
        {
          "id": 200405,
          "text": "<p><span style=\"font-size:12.0pt;\">Polychromatic lusture</span></p>"
        },
        {
          "id": 200406,
          "text": "<p><span style=\"font-size:12.0pt;\">Occurs after uveitis</span></p>"
        },
        {
          "id": 200407,
          "text": "<p><span style=\"font-size:12.0pt;\">Breadcrumb appearance</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a feature of complicated cataracts? (</span><span style=\"background-color:rgb(255,255,255);color:rgb(111,126,149);font-size:14px;\">INICET Nov 2022)</span></p>",
      "unique_key": "Q2460838",
      "question_audio": null,
      "question_video": null,
      "map_id": 34617458,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Krukenberg spindle</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Krukenberg spindle is not a feature of complicated cataracts. The slit lamp examination in pigmentary glaucoma shows a pattern of pigment deposition on the back of the cornea-endothelium called Krukenberg spindles.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture8_yKFm9vd.jpg\" alt=\"\" width=\"300\" height=\"257\"></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Complicated or secondary cataracts develop due to inflammatory or degenerative conditions of the lens or other parts of the eye.</span></li><li><span style=\"font-size:12.0pt;\">Causes of these cataracts include iridocyclitis and ciliary body tumors which disturb the nutrition of the lens.</span></li><li><span style=\"font-size:12.0pt;\">These cataracts present with a breadcrumb appearance and polychromatic luster.</span></li><li><span style=\"font-size:12.0pt;\">Vision impairment occurs even in the early stages due to location of the cataract at the nodal point.</span></li><li><span style=\"font-size:12.0pt;\">Inflammation of the posterior segment causes posterior subcapsular cataract.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Polychromatic lustre</strong>: This is a feature seen in complicated cataracts where the lens exhibits a colorful sheen, often described as having a \"christmas tree\" or polychromatic appearance, particularly noticeable under slit-lamp examination.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Occurs after uveitis</strong>: Uveitis, an inflammatory disease affecting the uveal tract of the eye, can lead to the development of complicated cataracts. Chronic inflammation can disrupt the lens, leading to cataract formation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Breadcrumb appearance</strong>: This refers to the appearance of small opacities within the lens, resembling breadcrumbs, commonly seen in complicated cataracts due to intraocular inflammation or other degenerative changes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Krukenberg spindle is a vertical, spindle-shaped deposit of pigment on the posterior surface of the cornea, commonly seen in pigmentary glaucoma. It results from the dispersion of pigment granules from the iris that adhere to the corneal endothelium.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture8_yKFm9vd.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200404,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50102,
      "choices": [
        {
          "id": 200408,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The earth to all leads is in the right leg.</span></span></p>"
        },
        {
          "id": 200409,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lead I: Positive pole to the right and negative pole towards the left.</span></span></p>"
        },
        {
          "id": 200410,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lead III: Positive pole on the left and negative pole towards the right.</span></span></p>"
        },
        {
          "id": 200411,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lead II: Positive pole on the right and negative pole towards the left.</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is true regarding the placement of ECG leads?</span><span style=\"background-color:lime\"><span style=\"font-family:\"Calibri\",sans-serif\"> </span></span></span></p>",
      "unique_key": "Q1186679",
      "question_audio": null,
      "question_video": null,
      "map_id": 34732999,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) The earth to all leads is in the right leg.</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The statement \"The earth to all leads is in the right leg\" is correct. In the ECG setup, the right leg (RL) lead acts as the neutral or ground lead, often referred to as the \"earth,\" and is used to stabilize the recordings by providing a reference point for all leads.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Bipolar limb leads for ECG recording:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Lead I:</strong> Positive input (LA), Negative input (RA)</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Lead II:</strong> Positive input (LL), Negative input (RA)</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Lead III:</strong> Positive input (LL), Negative input (LA)</span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The correct arrangement ensures accurate detection of electrical activity across the limbs for proper ECG interpretation.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Lead I: Positive pole to the right and negative pole towards the left: </strong>This is incorrect. In Lead I, the positive pole is on the left arm (LA), and the negative pole is on the right arm (RA). The current travels from right to left across the chest.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Lead III: Positive pole on the left and negative pole towards the right: </strong>This is incorrect. In Lead III, the positive pole is on the left leg (LL), and the negative pole is on the left arm (LA). The current travels from the left arm down to the left leg.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Lead II: Positive pole on the right and negative pole towards the left: </strong>This is incorrect. In Lead II, the positive pole is on the left leg (LL), and the negative pole is on the right arm (RA). The current travels diagonally from the right arm down to the left leg.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The right leg (RL) is used as the ground or neutral electrode in ECG lead placement, stabilizing the readings for the limb leads. Familiarity with the bipolar lead configuration is essential for correct ECG interpretation.</span></span></p>",
      "correct_choice_id": 200408,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50103,
      "choices": [
        {
          "id": 200412,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">E1, E2, E5</span></span></span></p>"
        },
        {
          "id": 200413,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">E6, E7</span></span></span></p>"
        },
        {
          "id": 200414,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">L1, L2</span></span></span></p>"
        },
        {
          "id": 200415,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E1, E2</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The image below shows the life cycle of a virus. Which of the proteins of the virus act as oncogenes? </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">INICET NOV 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-83.jpg\" style=\"height:459px; width:400px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-83.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8787795",
      "question_audio": null,
      "question_video": null,
      "map_id": 34772374,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) E6, E7</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The image shows the life cycle of the human papilloma virus, and the E6 and E7 proteins act as oncogenes</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-84.jpg\" style=\"height:556px; width:728px\" /></span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">HPV oncogenes <strong>E6 and E7 deregulate host cell cycle by binding and inactivating tumor suppressor genes p53 and pRb</strong>. </span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Binding of E6 gene to p53 causes degradation of p53. </span></span></span></li>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E7 gene binds to pRb and disrupts the complex between pRb and E2F leading to uncontrolled proliferation. HPV, human papilloma virus.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-85.jpg\" style=\"height:486px; width:783px\" /></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective </span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ul>\r\n\t<li style=\"text-align: left;\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">E6 and E7 proteins of HPV are the primary oncogenes responsible for the virus's ability to cause cancer. They do this by inactivating key tumor suppressor proteins, p53 and pRb, leading to uncontrolled cell growth and proliferation.</span></span></span></li>\r\n</ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-84.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200413,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50104,
      "choices": [
        {
          "id": 200416,
          "text": "<p><span style=\"font-size:12.0pt;\">Closed reduction and internal fixation</span></p>"
        },
        {
          "id": 200417,
          "text": "<p><span style=\"font-size:12.0pt;\">Open reduction and internal fixation</span></p>"
        },
        {
          "id": 200418,
          "text": "<p><span style=\"font-size:12.0pt;\">Open reduction and external fixation</span></p>"
        },
        {
          "id": 200419,
          "text": "<p><span style=\"font-size:12.0pt;\">Closed reduction and external fixation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Treatment of open fracture of femur: </span>(INICET NOVEMBER 2022)</p>",
      "unique_key": "Q5789335",
      "question_audio": null,
      "question_video": null,
      "map_id": 34056196,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:16px;\"><strong>Ans. C) Open reduction and external fixation </strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>OPEN FRACTURES</strong></span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">An open fracture occurs when the <strong>bone breaks through the skin</strong>. </span></li><li><span style=\"font-size:16px;\">These typically result from high-energy injuries and are often associated with <strong>significant damage to the surrounding soft tissues and contamination of the wound</strong>. </span></li><li><span style=\"font-size:16px;\">These injuries are classified into three types according to the <strong>Gustillo-Anderson Classification:</strong></span></li></ul><p> </p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-12%20162955.jpeg\" width=\"1091\" height=\"655\"></strong></span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\">All open fractures are emergencies.</span></li><li><span style=\"font-size:16px;\">These injuries require immediate administration of antibiotics and irrigation and debridement of the wound. </span></li><li><span style=\"font-size:16px;\">The goal of the treatment is to <strong>achieve fracture healing and to prevent wound infections and osteomyelitis.</strong> </span></li><li><span style=\"font-size:16px;\">They are frequently associated with injuries to surrounding vessels and nerves, which must be addressed as well. </span></li><li><span style=\"font-size:16px;\"><strong>When the wound is contaminated, an external fixator is initially used. </strong></span></li><li><span style=\"font-size:16px;\">Early coverage of the wound is important to avoid infection. </span></li><li><span style=\"font-size:16px;\">Immediately debride the wound of contaminated and devitalized tissue, copiously irrigate, and repeat debridement within 24-72 hours (Delayed wound closure is preferable).</span></li><li><span style=\"font-size:16px;\"><strong>Type and method of fixation:</strong></span></li></ul><p> </p><p><span style=\"font-size:16px;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-12%20163054.jpeg\" width=\"1355\" height=\"359\"></strong></span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:16px;\"><strong>In External fixation, the fixation device is external to skin –Ilizarov fixator.</strong></span></li></ul><p> </p><p><span style=\"font-size:16px;\"><strong>Other Options: </strong></span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option A. Closed reduction and internal fixation: </strong>Closed reduction is not done for an open fracture. An open fracture inherently involves a break in the skin and contamination. It requires surgical exploration, debridement, and irrigation of the wound in the operating room. Attempting a closed reduction would significantly increase the risk of deep infection (osteomyelitis). Internal fixation<strong> </strong>(e.g., with an intramedullary nail) can be used for less severe open fractures (Gustilo-Anderson Type I, II, and sometimes IIIA), after thorough open debridement. However, the combination with closed reduction makes this option incorrect for an open fracture.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Option</strong> <strong>D. Closed reduction and external fixation:</strong> Closed reduction is incorrect for an open fracture due to the necessity of open wound management. External fixation is a valid and often preferred method of stabilization for open fractures, particularly severe ones or as a temporary measure. However, the initial phase must involve open management of the wound.</span></p><p> </p><p><span style=\"font-size:16px;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:16px;\">The open fractures are best treated with open reduction and external fixation with the use of external fixators like ilizarov fixator. </span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/Screenshot%202025-08-12%20162955.jpeg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200418,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50105,
      "choices": [
        {
          "id": 200420,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">ER +, PR +, HER2 – </span></span></span></p>"
        },
        {
          "id": 200421,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">ER +, PR -, HER2 – </span></span></span></p>"
        },
        {
          "id": 200422,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">ER -, PR -, HER2 – </span></span></span></p>"
        },
        {
          "id": 200423,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">ER -, PR -, HER2 +</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">What finding on immunohistochemical staining is consistent with basal-like breast cancer in a 59-year-old female presenting with a breast lump?</span></span></span></p>",
      "unique_key": "Q9254473",
      "question_audio": null,
      "question_video": null,
      "map_id": 34154107,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) ER-, PR-, HER2- </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">ER -, PR -, HER2 –: Basal-like breast cancer is characterized by being negative for estrogen receptor (ER -), progesterone receptor (PR -), and HER2 (HER2 –). This profile is consistent with basal-like breast cancer.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> <strong>A. ER +, PR +, HER2 –:</strong> This profile indicates that the tumor is estrogen receptor-positive (ER +) and progesterone receptor-positive (PR +) but HER2-negative (HER2 –). This profile is not consistent with basal-like breast cancer.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. ER +, PR -, HER2 –: This profile suggests that the tumor is estrogen receptor-positive (ER +) but progesterone receptor-negative (PR -) and HER2-negative (HER2 –). This is not consistent with basal-like breast cancer.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> <strong>D</strong>. <strong>ER -, PR -, HER2 +:</strong> This profile indicates that the tumor is negative for estrogen receptor (ER -) and progesterone receptor (PR -) but HER2-positive (HER2 +). This profile is not consistent with basal-like breast cancer.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Basal-like or triple-negative breast cancer is characterized by the absence of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor type 2 (HER2) on immunohistochemical staining. Positive staining is indicated by the presence of brown-coloured tissue, with ER and PR staining the nucleus brown, while HER2 staining the cell membrane brown.</span></span></span></p>",
      "correct_choice_id": 200422,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50106,
      "choices": [
        {
          "id": 200424,
          "text": "<p><span style=\"font-size:12.0pt;\">RCC</span></p>"
        },
        {
          "id": 200425,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal oncocytoma</span></p>"
        },
        {
          "id": 200426,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal angiomyolipoma</span></p>"
        },
        {
          "id": 200427,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal cyst</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old banker presented with vague abdominal pain. On USG, he was found to have a renal mass lesion. CECT was done, as shown below. What is the diagnosis? (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/27/untitled-184.jpg\" alt=\"\" width=\"376\" height=\"349\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/27/untitled-184.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7621696",
      "question_audio": null,
      "question_video": null,
      "map_id": 34169906,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Renal angiomyolipoma</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The CT image presented here shows well-circumscribed lesions with low attenuation (black in color) that indicate fatty tissue. The presence of macroscopic fat is strongly suggestive angiomyolipoma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. RCC (Renal Cell Carcinoma):</strong> Typically appears as a solid renal mass that may enhance heterogeneously after contrast administration and generally does not contain macroscopic fat.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Renal oncocytoma:</strong> A benign renal tumor that typically appears as a well-circumscribed, homogeneously enhancing mass on imaging, without the characteristic fat component seen in angiomyolipomas.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Renal cyst:</strong> Would appear as a fluid-filled, round structure with no enhancement; the lesion in the image is solid with fatty components, inconsistent with a simple cyst.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/27/untitled-144.jpg\" alt=\"\" width=\"760\" height=\"187\"></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-164700.png\" alt=\"\" width=\"800\" height=\"346\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/27/untitled-144.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200426,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50107,
      "choices": [
        {
          "id": 200428,
          "text": "<p><span style=\"font-size:12.0pt;\">Carboxyhemoglobinemia</span></p>"
        },
        {
          "id": 200429,
          "text": "<p><span style=\"font-size:12.0pt;\">Sideroblastic anemia</span></p>"
        },
        {
          "id": 200430,
          "text": "<p><span style=\"font-size:12.0pt;\">Methemoglobinemia</span></p>"
        },
        {
          "id": 200431,
          "text": "<p><span style=\"font-size:12.0pt;\">Sulfhemoglobinemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A female patient presents to the AIIMS emergency department with severe fatigue and prostration. She is a known case of chronic stable angina. While collecting a blood sample, you notice the blood has a brownish hue. What is the underlying diagnosis? (INICET NOV 2022)</span></p>",
      "unique_key": "Q1959446",
      "question_audio": null,
      "question_video": null,
      "map_id": 34362097,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.  C) Methemoglobinemia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The patient presenting with a brownish hue in the blood, coupled with a history of chronic stable angina, points towards methemoglobinemia. Patients with chronic stable angina are often on nitrate therapy, which is a known risk factor for developing methemoglobinemia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Methemoglobinemia occurs when the iron in hemoglobin is oxidized from the ferrous (Fe²⁺) state to the ferric (Fe³⁺) state, which is unable to bind oxygen effectively. This results in reduced oxygen delivery to tissues, leading to symptoms such as fatigue and cyanosis. The brownish hue of the blood, often described as chocolate-colored, is characteristic of methemoglobinemia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Carboxyhemoglobinemia:</strong> Carboxyhemoglobinemia is caused by carbon monoxide poisoning, typically associated with exposure to fire or automobile exhaust. The blood in this condition has a cherry red color, not brownish.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Sideroblastic anemia:</strong> Sideroblastic anemia is a form of anemia where the bone marrow produces ringed sideroblasts rather than healthy red blood cells. It does not cause a brownish hue in the blood.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sulfhemoglobinemia:</strong> Sulfhemoglobinemia results from the incorporation of sulfur into hemoglobin, leading to a greenish or bluish color of the blood, rather than brownish.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A brownish hue in the blood, especially in a patient on nitrate therapy, is indicative of methemoglobinemia, a condition where hemoglobin is oxidized, impairing its ability to carry oxygen effectively.</span></p>",
      "correct_choice_id": 200430,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50108,
      "choices": [
        {
          "id": 200432,
          "text": "<p><span style=\"font-size:12pt;\">Immature teratoma</span></p>"
        },
        {
          "id": 200433,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Mature cystic teratoma</span></p>"
        },
        {
          "id": 200434,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Mucinous cystadenoma</span></p>"
        },
        {
          "id": 200435,
          "text": "<p><span style=\"font-size:12pt;\">﻿﻿﻿Serous cystadenoma</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A surgically resected specimen of an ovarian mass is shown below. What is the likely diagnosis? </span>(INICET NOV 2022)</p><p style=\"text-align:justify;\"> </p><p><span style=\"color:black;font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_xUY8Y7x.jpg\" alt=\"\" width=\"300\" height=\"363\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/02/1_xUY8Y7x.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4605858",
      "question_audio": null,
      "question_video": null,
      "map_id": 34440195,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) Mature cystic teratoma</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The specimen shows an ovarian mass with a tuft of hair in a cystic space, which is characteristic of a mature cystic teratoma. Key points about mature cystic teratomas include:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Teratomas are germ cell tumors</strong>: They contain various types of tissues derived from the three germ layers: ectoderm, mesoderm, and endoderm.</span></li><li><span style=\"font-size:12pt;\"><strong>Mature cystic teratomas (dermoid cysts)</strong>: Typically unilocular and contain sebaceous material, hair, and sometimes other tissues such as teeth, bone, cartilage, thyroid tissue, and neural tissues.</span></li><li><span style=\"font-size:12pt;\"><strong>Presentation</strong>: Most patients are asymptomatic, but they may present with an abdominal mass, acute pain due to torsion of the ovary, or rarely due to rupture of the cyst.</span></li><li><span style=\"font-size:12pt;\"><strong>Treatment</strong>: Laparoscopic ovarian cystectomy is the treatment of choice for mature teratomas.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Immature teratoma</strong>: These are malignant and contain immature embryonic tissues, often neuroectodermal. They usually occur in younger patients and are more aggressive.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Mucinous cystadenoma</strong>: A benign epithelial tumor of the ovary that typically contains mucinous material and does not contain hair or other tissues.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Serous cystadenoma</strong>: A benign epithelial tumor of the ovary that typically contains clear serous fluid and lacks the complex tissues found in teratomas.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Mature cystic teratomas (dermoid cysts) are characterized by the presence of multiple tissue types such as hair, sebaceous material, and sometimes teeth or bone within a cystic ovarian mass.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of gynecology 3<sup>rd</sup> edition pg, Dutta’s textbook of gynecology 6 th edition pg</strong></span></p>",
      "correct_choice_id": 200433,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50109,
      "choices": [
        {
          "id": 200436,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1, 3</span></span></p>"
        },
        {
          "id": 200437,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">1, 4</span></span></p>"
        },
        {
          "id": 200438,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">2, 3</span></span></p>"
        },
        {
          "id": 200439,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">2, 4</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Consider the following statements about sympathetic, parasympathetic, and motor nerves. Which of the following statements are true? </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sympathetic efferents are distributed all over the body/ extensively whereas parasympathetic distribution is limited.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sympathetic fibers travel long distances after leaving the sympathetic chain, before finally synapsing and then a shorter distance to effector organs.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Parasympathetic fibers travel a shorter distance to their respective ganglia which are located close to the target organs.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Motor neurons are located in the ventral horn of the spinal cord from where the axons come out and divide into several branches, each of which supplies an individual muscle fiber.</span></span></li>\r\n</ol>",
      "unique_key": "Q1855452",
      "question_audio": null,
      "question_video": null,
      "map_id": 34059102,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B) 1, 4</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The true statements are <strong>1 and 4</strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Sympathetic efferents</strong> are distributed <strong>extensively</strong> all over the body, whereas <strong>parasympathetic</strong> distribution is <strong>limited</strong> to the head, neck, and trunk regions.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sympathetic fibers travel <strong>short distances</strong> to the sympathetic ganglionic chain, before finally synapsing and then have a <strong>long course</strong> to supply the target organs. Parasympathetic fibers travel a <strong>longer distance</strong> to their respective ganglia, which are located close to the target organs.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Motor neurons</strong> are located in the <strong>ventral horn</strong> of the spinal cord from where the axons come out and divide into several branches, each of which supplies an <strong>individual muscle fiber</strong>. A motor unit comprises a motor neuron and a group of skeletal muscle fibers it innervates.</span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A (1,3)</strong> is incorrect because <strong>Statement 3</strong> is wrong. Parasympathetic fibers travel longer distances to their respective ganglia.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C (2,3)</strong> is incorrect because <strong>Statement 3</strong> is wrong, and <strong>Statement 2</strong> inaccurately describes sympathetic fibers.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D (2,4)</strong> is incorrect because <strong>Statement 2</strong> is incorrect as sympathetic fibers travel shorter distances to ganglia.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The sympathetic nervous system has an extensive distribution throughout the body, while the parasympathetic nervous system has a limited distribution. Motor neurons located in the ventral horn of the spinal cord supply individual muscle fibers.</span></span></p>",
      "correct_choice_id": 200437,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50110,
      "choices": [
        {
          "id": 200440,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Wegener's granulomatosis</span></span></p>"
        },
        {
          "id": 200441,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Tuberculosis</span></span></p>"
        },
        {
          "id": 200442,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Syphilis</span></span></p>"
        },
        {
          "id": 200443,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sarcoidosis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A gentleman presents to the OPD with a saddle nose deformity. He gives a past history of cough, on/off fever, and hemoptysis. On examination, septal perforation is present with pale granuloma. His chest x-ray showed multiple cavitary lesions, and the biopsy showed granuloma, multinucleate giant cells, and caseous necrosis. What would be the probable cause? </span></span></p>",
      "unique_key": "Q1605673",
      "question_audio": null,
      "question_video": null,
      "map_id": 34295036,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B) Tuberculosis</strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In a patient with <strong>saddle nose deformity</strong>, septal perforation with pale granuloma and <strong>caseous necrosis</strong> on biopsy is consistent with tuberculosis (TB). The history of <strong>fever, cough, and hemoptysis</strong> along with <strong>cavitary lesions</strong> on chest x-ray supports the diagnosis of TB.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">While other conditions like Wegener's granulomatosis (Option A), syphilis (Option C), and sarcoidosis (Option D) can also cause saddle nose deformity, the <strong>caseous necrosis</strong> on biopsy makes <strong>TB</strong> a more likely diagnosis.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Saddle-nose deformity refers to a <strong>depressed nasal dorsum</strong> that can involve either the bony, cartilaginous, or both components.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The most common cause is <strong>nasal trauma</strong> resulting in depressed fractures. Other causes include excessive submucosal resection, destruction of septal cartilage due to <strong>hematoma</strong> or abscess, and infections such as <strong>leprosy, tuberculosis</strong>, or syphilis, as well as inflammatory conditions like granulomatosis with polyangiitis (Wegener granulomatosis) and sarcoidosis.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Chronic granulomatous conditions such as lupus, tuberculosis, and leprosy can affect the cartilaginous part, <strong>syphilis</strong> primarily affects the bony part, and <strong>Wegener's granulomatosis</strong> and T-cell lymphoma can lead to total (bony and cartilaginous) septal destruction involving both the bony and cartilaginous portions.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">TB is an infectious disease caused by <strong>Mycobacterium tuberculosis</strong> and primarily affects the lungs but can also involve the nose and sinuses.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Common symptoms</strong> of TB include fever, productive cough, weight loss, night sweats, and hemoptysis. Chest x-ray often shows multiple <strong>cavitation lesions</strong> affecting the <strong>upper lobe</strong> and <strong>hilar lymphadenopathy</strong>. Biopsy findings in tuberculosis typically reveal <strong>granulomas, caseous necrosis</strong>, and multinucleate giant cells (Langhan's giant cells).</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Wegener's granulomatosis</strong>: This can cause saddle-nose deformity and cavitary lesions, but biopsy would show <strong>necrotizing granulomatous vasculitis</strong> rather than <strong>caseous necrosis</strong>, which is seen in tuberculosis.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Syphilis</strong>: Syphilis can cause saddle-nose deformity, but typically affects the <strong>bony part</strong> of the nose, and biopsy would reveal <strong>gumma formation</strong> rather than the caseous necrosis seen in tuberculosis.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Sarcoidosis</strong>: Sarcoidosis can cause granulomas but lacks the <strong>caseous necrosis</strong> typically associated with tuberculosis.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Saddle-nose deformity with <strong>granuloma</strong> and <strong>caseous necrosis</strong> on biopsy is highly suggestive of <strong>tuberculosis</strong>.</span></span></p>",
      "correct_choice_id": 200441,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50111,
      "choices": [
        {
          "id": 200444,
          "text": "<p><span style=\"font-size:12.0pt;\">Gall bladder thickness >3 mm on USG</span></p>"
        },
        {
          "id": 200445,
          "text": "<p><span style=\"font-size:12.0pt;\">Murphy's sign positive</span></p>"
        },
        {
          "id": 200446,
          "text": "<p><span style=\"font-size:12.0pt;\">Leukocytosis</span></p>"
        },
        {
          "id": 200447,
          "text": "<p><span style=\"font-size:12.0pt;\">Preferential visualization of gall bladder in HIDA scan</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">50-year-old obese female presents to the emergency department with severe right upper quadrant pain, fever, and nausea. The physician suspects acute cholecystitis and orders imaging studies to confirm the diagnosis. Which of the following statements is not true about acute cholecystitis? (INICET NOV 2022)</span></p>",
      "unique_key": "Q5952446",
      "question_audio": null,
      "question_video": null,
      "map_id": 34591589,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Preferential visualization of gall bladder in HIDA scan.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">This statement is not true. In a Hepatobiliary Iminodiacetic Acid (HIDA) scan, the gallbladder is not preferentially visualized in acute cholecystitis. Instead, one of the hallmark findings in acute cholecystitis on a HIDA scan is non-visualization of the gallbladder due to inflammation and obstruction of the cystic duct.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Gall bladder thickness >3 mm on USG</strong>: This statement is true and is a common finding in acute cholecystitis. On ultrasound (USG), a thickened gallbladder wall, typically greater than 3 mm, is indicative of inflammation and is a characteristic feature of acute cholecystitis.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>B. Murphy's sign positive</strong>: This statement is true. Murphy's sign is a clinical maneuver used to assess for acute cholecystitis. It involves palpation of the right upper quadrant during inspiration, and if the patient experiences pain or stops breathing due to pain during this maneuver, it is considered a positive Murphy's sign, suggesting inflammation of the gallbladder.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option</strong> </span><span style=\"font-size:12.0pt;\"><strong>C.</strong> <strong>Leukocytosis</strong>: This statement is true. Acute cholecystitis is associated with an inflammatory response, leading to an elevation in white blood cell count, which is known as leukocytosis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Acute cholecystitis is a common condition characterized by inflammation of the gallbladder, typically due to the presence of gallstones obstructing the cystic duct. Clinical features of acute cholecystitis include right upper quadrant pain, fever, and leukocytosis. A positive Murphy's sign is right upper quadrant tenderness on palpation. On ultrasound imaging, gall bladder thickness >3 mm is a common finding in acute cholecystitis. The HIDA scan is a diagnostic tool for acute cholecystitis, showing non-visualization of the gall bladder 3 hours after radioisotope administration. Preferential visualization of the gall bladder on a HIDA scan is not a feature of acute cholecystitis. It is important to diagnose and treat acute cholecystitis promptly to prevent complications such as gallbladder perforation or gangrene.</span></p>",
      "correct_choice_id": 200447,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50112,
      "choices": [
        {
          "id": 200448,
          "text": "<p><span style=\"font-size:12.0pt;\">Pharmacological index</span></p>"
        },
        {
          "id": 200449,
          "text": "<p><span style=\"font-size:12.0pt;\">Pearl index</span></p>"
        },
        {
          "id": 200450,
          "text": "<p><span style=\"font-size:12.0pt;\">Performance index</span></p>"
        },
        {
          "id": 200451,
          "text": "<p><span style=\"font-size:12.0pt;\">Efficacy index</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A clinician is examining various approaches to determine the rate at which a contraceptive method fails. Which index is specifically employed for this purpose? (INICET NOV 2022)</span></p>",
      "unique_key": "Q7303588",
      "question_audio": null,
      "question_video": null,
      "map_id": 34889410,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Pearl index</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Pearl index is the common method used to measure contraceptive failure rate.</span></li><li><span style=\"font-size:12.0pt;\">It is defined as the number of failures per 100 woman-years of exposure (HWY). This rate is given by the formula:</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture7888.jpg\" alt=\"\" width=\"700\" height=\"463\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Pharmacological index</strong>: This term is generally refers to the study and categorization of drugs based on their effects and properties.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Performance index</strong>: This may refer to various metrics used to evaluate the performance of processes or systems in different fields.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Efficacy index</strong>: While this might be used to measure the effectiveness of a treatment or intervention.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">The Pearl Index is the standard measure used to determine the contraceptive failure rate, defined as the number of failures per 100 woman-years of exposure.</span></li><li><span style=\"font-size:12pt;\">This index helps in evaluating the reliability and effectiveness of various contraceptive methods</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture7888.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200449,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50113,
      "choices": [
        {
          "id": 200452,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Folate deficiency</span></span></p>"
        },
        {
          "id": 200453,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Alcohol-induced macrocytosis</span></span></p>"
        },
        {
          "id": 200454,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vitamin B12 deficiency</span></span></p>"
        },
        {
          "id": 200455,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Thiamine deficiency</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">An elderly patient on a vegetarian diet presenting with easy fatigability and pallor was investigated. Peripheral smear showed findings of macrocytic anemia. What is the probable cause of anemia in this patient? Other lab findings are as follows:</span><span style=\"background-color:lime\"><span style=\"font-family:\"Calibri\",sans-serif\"> </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Hemoglobin: 9 g/dL</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Mean corpuscular volume (MCV): 112 fL</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Serum homocysteine: Elevated</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Serum methylmalonic acid: Normal</span></span></li>\r\n</ul>",
      "unique_key": "Q6682862",
      "question_audio": null,
      "question_video": null,
      "map_id": 34192243,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Folate deficiency</strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The most probable cause of anemia in this patient is <strong>folate deficiency</strong>. The clinical scenario of macrocytic anemia in a vegetarian patient with elevated homocysteine levels points to <strong>megaloblastic anemia</strong>. Megaloblastic anemia can be caused by either vitamin B12 or folate deficiency. However, normal methylmalonic acid (MMA) levels in this case suggest folate deficiency as the cause.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Vitamin B12 deficiency is usually associated with elevated MMA levels, which are absent here, further supporting folate deficiency as the correct diagnosis.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Folate deficiency is associated with the following laboratory findings:</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Increased MCV</strong> (macrocytosis)</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Elevated homocysteine levels</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Normal MMA levels</strong></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Decreased reticulocyte count</span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Alcohol-induced macrocytosis</strong>: Although alcohol can cause macrocytosis, it is typically associated with chronic alcohol use. The patient’s history of being on a vegetarian diet and elevated homocysteine levels point away from this as the cause.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Vitamin B12 deficiency</strong>: This is a possible cause of macrocytic anemia. However, vitamin B12 deficiency is associated with elevated <strong>both homocysteine and methylmalonic acid (MMA)</strong> levels. The patient’s normal MMA level makes this option unlikely.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Thiamine deficiency</strong>: Thiamine deficiency is primarily associated with neurological issues (e.g., Wernicke-Korsakoff syndrome) and is not known to cause macrocytic anemia. Therefore, this is not the correct cause of anemia in this patient.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In cases of macrocytic anemia with elevated homocysteine and <strong>normal methylmalonic acid (MMA) levels</strong>, folate deficiency should be suspected. In contrast, both elevated homocysteine and MMA levels suggest vitamin B12 deficiency.</span></span></p>",
      "correct_choice_id": 200452,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50114,
      "choices": [
        {
          "id": 200456,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Cry of baby in the womb</span></span></span></p>"
        },
        {
          "id": 200457,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Infection of vagina</span></span></span></p>"
        },
        {
          "id": 200458,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Infection of uterus</span></span></span></p>"
        },
        {
          "id": 200459,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Infection of both vagina and uterus</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What is vagitus uterinus? </span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q2002990",
      "question_audio": null,
      "question_video": null,
      "map_id": 34937907,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Cry of baby in the womb</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Vagitus uterinus</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is the term used to describe the cry of a baby in the womb. It is a rare phenomenon but can occur if there is a rupture of the amniotic sac with air entry, allowing the baby to make crying sounds while still in utero.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Vagitus vaginus</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is the term for the cry of the baby in the vagina, which can be heard during delivery.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Infection of the vagina</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> causes vaginitis.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Infection of the uterus</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> may affect its layers, leading to conditions such as endometritis (infection of the endometrium), myometritis (infection of the myometrium), and perimetritis (infection of the perimetrium).</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Infection of vagina</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Infection of the vagina causes vaginitis, which is not related to the term vagitus uterinus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Infection of uterus</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Infection of the uterus can lead to endometritis, myometritis, or perimetritis, which are not related to the term vagitus uterinus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Infection of both vagina and uterus</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Infection of both the vagina and uterus involves conditions such as vaginitis and endometritis/myometritis/perimetritis, which are not related to the term vagitus uterinus.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Vagitus uterinus refers to the cry of a baby in the womb, which is a rare phenomenon that can occur if there is a rupture of the amniotic sac with air entry.</span></span></span></p>",
      "correct_choice_id": 200456,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50115,
      "choices": [
        {
          "id": 200460,
          "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary vasoconstriction</span></p>"
        },
        {
          "id": 200461,
          "text": "<p><span style=\"font-size:12.0pt;\">Polycythemia</span></p>"
        },
        {
          "id": 200462,
          "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
        },
        {
          "id": 200463,
          "text": "<p><span style=\"font-size:12.0pt;\">Hypoxia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following physiological adaptations is generally not observed at high altitudes? (INICET NOV 2022)</span></p>",
      "unique_key": "Q3972262",
      "question_audio": null,
      "question_video": null,
      "map_id": 34583796,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Respiratory acidosis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The physiological adaptation that does not happen at high altitudes is respiratory acidosis. Respiratory alkalosis is the physiological adaptation seen at high altitudes due to hyperventilation.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Pulmonary vasoconstriction</strong>: Correct, as it is a physiological response to low oxygen levels to improve gas exchange.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Polycythemia</strong>: Correct, as it increases the blood's oxygen-carrying capacity.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Hypoxia</strong>: Correct, as it is the primary condition caused by low oxygen levels at high altitudes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The principal means by which acclimatization to high altitude comes about are</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">A great increase in pulmonary ventilation - increase in pulmonary ventilation on rising to a high altitude blows off large quantities of carbon dioxide, reducing the Pco2 and increasing the ph of the body fluids.</span></li><li><span style=\"font-size:12.0pt;\">Increased numbers of red blood cells,</span></li><li><span style=\"font-size:12.0pt;\">Increased diffusing capacity of the lungs,</span></li><li><span style=\"font-size:12.0pt;\">Increased vascularity of the peripheral tissues</span></li><li><span style=\"font-size:12.0pt;\">Increased ability of the tissue cells to use oxygen despite low Po2.</span></li><li><span style=\"font-size:12.0pt;\">Cellular Acclimatization - cell mitochondria and cellular oxidative enzyme systems are slightly more plentiful than in sea-level inhabitants</span></li></ol>",
      "correct_choice_id": 200462,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50116,
      "choices": [
        {
          "id": 200464,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Polyclonal antibody which acts against CD20</span></span></p>"
        },
        {
          "id": 200465,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Polyclonal antibody which acts against CD50</span></span></p>"
        },
        {
          "id": 200466,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Monoclonal antibody which acts against CD20 </span></span></p>"
        },
        {
          "id": 200467,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Monoclonal antibody which acts against CD50</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Rituximab is a: </span></span></p>",
      "unique_key": "Q2159248",
      "question_audio": null,
      "question_video": null,
      "map_id": 34486038,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Monoclonal antibody which acts against CD20</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Rituximab is a <strong>monoclonal antibody</strong> that acts against <strong>CD20 B-cell antigen</strong>, which is expressed on the surface of B-lymphocytes, plasma cells, and certain B-cell lymphomas.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">By binding to CD20, rituximab promotes <strong>apoptosis</strong> through transmembrane signaling and enhances <strong>antibody-dependent cellular cytotoxicity (ADCC)</strong> as well as <strong>complement-dependent cytotoxicity (CDC)</strong>. Rituximab is widely used in the treatment of various B-cell malignancies, including <strong>B-cell lymphoma</strong>, <strong>non-Hodgkin lymphoma</strong>, and <strong>chronic lymphocytic leukemia (CLL)</strong>. It can be used alone or in combination with chemotherapy.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Adverse effects</strong> include infusion-related reactions such as chills, fever, urticaria, rashes, dyspnea, and hypotension. To mitigate these, pretreatment with antihistamines and corticosteroids is recommended.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Polyclonal antibody which acts against CD20</strong>: Rituximab is not a polyclonal antibody. Polyclonal antibodies are derived from multiple B-cell clones and bind to various epitopes on the antigen. Rituximab is a monoclonal antibody, meaning it is derived from a single clone and binds specifically to one epitope on the CD20 antigen.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Polyclonal antibody which acts against CD50</strong>: Rituximab does not act against CD50, nor is it a polyclonal antibody. CD50 (ICAM-3) is involved in T-cell activation and leukocyte adhesion, not in B-cell lymphomas or chronic lymphocytic leukemia.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Monoclonal antibody which acts against CD50</strong>: Rituximab specifically targets <strong>CD20</strong>, not CD50. CD50 is associated with T-cell interactions, while rituximab is involved in targeting B-cell antigens.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Rituximab is a <strong>monoclonal antibody</strong> that targets <strong>CD20</strong> on B-cells, used in treating <strong>B-cell lymphomas</strong> and <strong>chronic lymphocytic leukemia</strong>.</span></span></p>",
      "correct_choice_id": 200466,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50117,
      "choices": [
        {
          "id": 200468,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
        },
        {
          "id": 200469,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 200470,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3</span></p>"
        },
        {
          "id": 200471,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are signs of heart failure? (INICET NOV 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Non-pulsatile rise of JVP</span></li><li><span style=\"font-size:12.0pt;\">Orthopnea</span></li><li><span style=\"font-size:12.0pt;\">Dyspnea after 2 hours of sleep</span></li><li><span style=\"font-size:12.0pt;\">Right upper quadrant pain/Right hypochondrial pain</span></li></ol>",
      "unique_key": "Q8566490",
      "question_audio": null,
      "question_video": null,
      "map_id": 34443697,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 2, 3, 4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Heart failure presents with a range of symptoms due to the inability of the heart to pump blood effectively. The following signs are indicative of heart failure:</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Orthopnea (Option 2):</strong> This is difficulty breathing when lying flat and is a common symptom of left-sided heart failure.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Dyspnea after 2 hours of sleep (Option 3):</strong> Also known as paroxysmal nocturnal dyspnea (PND), this occurs due to fluid redistribution during sleep, leading to pulmonary congestion.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Right upper quadrant pain/Right hypochondrial pain (Option 4):</strong> This is associated with right-sided heart failure leading to congestive hepatomegaly.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option 1 (Non-pulsatile rise of JVP):</strong> This is incorrect as heart failure typically causes a pulsatile rise in jugular venous pressure (JVP). A non-pulsatile rise in JVP is usually indicative of superior vena cava (SVC) obstruction, not heart failure.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Signs of heart failure include orthopnea, paroxysmal nocturnal dyspnea (PND), and right upper quadrant pain due to congestive hepatomegaly.</span></p>",
      "correct_choice_id": 200469,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50118,
      "choices": [
        {
          "id": 200472,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">LH</span></span></span></p>"
        },
        {
          "id": 200473,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">hCG</span></span></span></p>"
        },
        {
          "id": 200474,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">FSH</span></span></span></p>"
        },
        {
          "id": 200475,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">GnRH</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which hormone is secreted by placenta? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q9489779",
      "question_audio": null,
      "question_video": null,
      "map_id": 34765087,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) hCG</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Human chorionic gonadotropin (hCG)</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is the hormone secreted by the placenta. It is a glycoprotein produced by the syncytiotrophoblast cells of the placenta.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">hCG can be detected in the maternal serum or urine as early as 8-9 days post-fertilization using radioimmunoassay. In early pregnancy, hCG concentrations in plasma double every 1.4-2 days.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The primary role of hCG is to maintain the corpus luteum during the beginning of pregnancy, ensuring the continued production of progesterone, which is critical for maintaining the uterine lining and supporting pregnancy.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. LH</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Luteinizing Hormone is produced by the anterior pituitary gland, not by the placenta. It plays a key role in regulating the menstrual cycle and ovulation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. FSH</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Follicle-Stimulating Hormone is also produced by the anterior pituitary gland. It is involved in the development of ovarian follicles and the regulation of the menstrual cycle.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. GnRH</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Gonadotropin-Releasing Hormone is produced by the hypothalamus, it stimulates the anterior pituitary gland to release FSH and LH.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Human chorionic gonadotropin (hCG) is a hormone secreted by the placenta, crucial for maintaining early pregnancy by supporting the corpus luteum and progesterone production.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: William’s textbook of obstetrics 26<sup>th</sup> edition pg266, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 66</span></strong></span></span></p>",
      "correct_choice_id": 200473,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50119,
      "choices": [
        {
          "id": 200476,
          "text": "<p><span style=\"font-size:12pt;\">Reduction in the risk of ovarian cancer</span></p>"
        },
        {
          "id": 200477,
          "text": "<p><span style=\"font-size:12pt;\">Ectopic pregnancy</span></p>"
        },
        {
          "id": 200478,
          "text": "<p><span style=\"font-size:12pt;\">Protection against sexually transmitted diseases including HIV</span></p>"
        },
        {
          "id": 200479,
          "text": "<p><span style=\"font-size:12pt;\">Reduction in the risk of endometrial cancer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The non-contraceptive uses of oral contraceptives include all of the following except?</span>(INICET NOV 2022)</p>",
      "unique_key": "Q2600410",
      "question_audio": null,
      "question_video": null,
      "map_id": 34816963,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Protection against sexually transmitted diseases including HIV</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The non-contraceptive benefits of combined oral contraceptive pills (COCPs) include:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Reduction in the risk of ovarian cancer</strong>: COCPs reduce the incidence of ovarian cancer.</span></li><li><span style=\"font-size:12pt;\"><strong>Reduction in the risk of endometrial cancer</strong>: COCPs lower the incidence of endometrial malignancy.</span></li><li><span style=\"font-size:12pt;\"><strong>Reduction in the incidence of ectopic pregnancy</strong>: COCPs decrease the likelihood of ectopic pregnancies by preventing ovulation and thickening cervical mucus.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\">However, COCPs do not provide protection against sexually transmitted diseases (STDs), including HIV.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Reduction in the risk of ovarian cancer</strong>: COCPs are known to reduce the incidence of ovarian cancer.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Ectopic pregnancy</strong>: COCPs lower the risk of ectopic pregnancy by preventing ovulation and thickening the cervical mucus.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Reduction in the risk of endometrial cancer</strong>: COCPs decrease the risk of endometrial cancer.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Combined oral contraceptive pills do not provide protection against sexually transmitted diseases (STDs), including HIV.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of gynecology 3<sup>rd</sup> edition pg 124, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 489</strong></span></p>",
      "correct_choice_id": 200478,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50120,
      "choices": [
        {
          "id": 200480,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ligature mark</span></span></span></p>"
        },
        {
          "id": 200481,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Graze abrasion</span></span></span></p>"
        },
        {
          "id": 200482,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Brush burns</span></span></span></p>"
        },
        {
          "id": 200483,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Imprint abrasion</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Identify the pattern of abrasion shown in the image below? (</span></span></span>INICET Nov 2022)</p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-42.jpg\" style=\"height:219px; width:300px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-42.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9868899",
      "question_audio": null,
      "question_video": null,
      "map_id": 34967409,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> <strong>A. Ligature mark </strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A ligature mark is a well-known pressure mark on the neck underneath a ligature. It is a common injury in cases of hanging and strangulation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ligature Mark:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Appearance:</span></strong><span style=\"font-size:12.0pt\"> Typically presents as a horizontal or slightly diagonal mark around the neck.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Cause:</span></strong><span style=\"font-size:12.0pt\"> Caused by the application of a ligature (e.g., rope, cord, or similar object) under tension.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Context:</span></strong><span style=\"font-size:12.0pt\"> Commonly associated with homicidal, suicidal, or accidental hanging and strangulation.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Graze abrasion: </span></strong><span style=\"font-size:12.0pt\">Caused by scraping or sliding friction against a rough surface, resulting in superficial loss of skin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Brush burns: </span></strong><span style=\"font-size:12.0pt\">Result from friction burns, often appearing as red, inflamed, and abraded areas of skin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Imprint abrasion: </span></strong><span style=\"font-size:12.0pt\">Caused by the impact of a patterned object, leaving an imprint on the skin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Types of abrasions:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-43.jpg\" style=\"height:530px; width:500px\" /></span></strong></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-43.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200480,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50121,
      "choices": [
        {
          "id": 200484,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\">3, 4</span></span></span></p>"
        },
        {
          "id": 200485,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\">1, 2</span></span></span></p>"
        },
        {
          "id": 200486,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\">1, 2, 3, 4, 5</span></span></span></p>"
        },
        {
          "id": 200487,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\">5, 6</span></span></span></p>"
        }
      ],
      "text": "<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A healthcare worker in a remote primary healthcare clinic is reviewing the Vaccine Vial Monitor (VVM) on a vial of a vaccine that has been stored in the clinic for some time. Which of the following statements regarding the utility and interpretation of the VVM is/are correct?\" (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It is used for monitoring heat exposure of the vaccine by healthcare workers in primary healthcare.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It shows cumulative exposure of the vaccine to the heat.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">It can be used to assess the potential efficacy of the vaccine.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Calculation of the expiry date can be done using VVM.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The expiry date of the vaccine can be relaxed if VVM is in an acceptable range.</span></span></span></li>\r\n\t<li><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">If the square and the circle are the same in color, then the vaccine can be safely used.</span></span></li>\r\n</ol>",
      "unique_key": "Q7917741",
      "question_audio": null,
      "question_video": null,
      "map_id": 34351771,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"FR\" style=\"font-size:12.0pt\">Ans. B) 1, 2</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vaccine vial monitors (VVM) are heat-sensitive indicators routinely used to monitor heat exposure of the vaccine and determine vaccine viability as the vaccine vial moves across the supply chain. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">VVMs change color as the vaccine is exposed to cumulative heat. If the color of inner square is similar or darker than the outer circle, the vaccine vial should be discarded.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3. A VVM can be used to assess vaccine potency and not vaccine efficacy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">4 & 5. Expiry date can’t be determined by VVM and has no relation to extend the expiry date.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">6. If the square and the circle are the same in color, then the vaccine should be discarded.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture3555.jpg\" style=\"height:319px; width:500px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/screenshot-2023-10-27-130342.jpg\" style=\"height:643px; width:900px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture3555.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200485,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50122,
      "choices": [
        {
          "id": 200488,
          "text": "<p><span style=\"font-size:12.0pt;\">Disaster response</span></p>"
        },
        {
          "id": 200489,
          "text": "<p><span style=\"font-size:12.0pt;\">Disaster reconstruction</span></p>"
        },
        {
          "id": 200490,
          "text": "<p><span style=\"font-size:12.0pt;\">Disaster rehabilitation</span></p>"
        },
        {
          "id": 200491,
          "text": "<p><span style=\"font-size:12.0pt;\">Disaster mitigation</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 38-year-old civil engineer is working on a construction project in an area recently affected by a devastating earthquake. To prevent future devastation, the local government has amended the building codes. These changes are aimed at ensuring structures in the area can better withstand seismic activity. The engineer reviews the changes to determine the best approach for the new construction project. This modification to the building codes is primarily an example of which phase of disaster management? (INICET NOV 2022)</span></p>",
      "unique_key": "Q7858696",
      "question_audio": null,
      "question_video": null,
      "map_id": 34566295,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Disaster mitigation</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The measures that are taken to prevent disasters from causing emergencies or to lessen the likely effects of emergencies are part of disaster mitigation.</span></li><li><span style=\"font-size:12.0pt;\">Mitigation involves measures designed either to prevent hazards from causing an emergency or to lessen the likely effects of emergencies. In most cases mitigation measures aim to reduce the vulnerability of the system.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">In Disaster Cycle, the steps involved are –</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\"><strong>Disaster Impact and Response: </strong>it involves search, rescue, first aid of the patients, triaging them according to the severity of their injuries and their likelihood of survival with prompt medical intervention, tagging and identification of dead.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Relief Phase or Disaster Containment </strong>by prompt assistance, epidemiological surveillance and disease control, vaccination, nutritional support.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Rehabilitation </strong>involves restoration of the pre-disaster conditions. It takes into account assessment and restoration of water supply, food safety and supply, basic sanitation, personal hygiene, vector control.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Disaster Mitigation </strong>involves<strong> </strong>measures<strong> </strong>aimed at reducing or preventing the hazards from causing any emergency or to dampen the effects of emergencies. It involves flood mitigation works, appropriate land-use planning, improved building codes and reduction or protection of vulnerable population and structures.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Disaster Preparedness </strong>is a long-term programme of developmental activities which aims at strengthening the overall capacity and capability of the country to efficiently and effectively manage all the emergencies.<strong> </strong> </span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">    <img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/whatsapp-image-2023-10-20-at-173957.jpeg\" alt=\"\" width=\"500\" height=\"534\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Disaster mitigation involves proactive measures such as improved building codes to reduce the impact of future disasters, aiming to lessen vulnerability and enhance resilience against potential hazards.</span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/whatsapp-image-2023-10-20-at-173957.jpeg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200491,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50123,
      "choices": [
        {
          "id": 200492,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Osteomalacia </span></span></span></p>"
        },
        {
          "id": 200493,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Osteogenesis imperfecta </span></span></span></p>"
        },
        {
          "id": 200494,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rickets </span></span></span></p>"
        },
        {
          "id": 200495,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Paget’s disease </span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A child presented with difficulty in walking. The wrist radiograph is shown below. What is the diagnosis? </span></span></span>(INICET NOVEMBER 2022)</p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103055.jpg\" style=\"height:368px; width:250px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103055.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4803815",
      "question_audio": null,
      "question_video": null,
      "map_id": 34349875,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C. Rickets </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">RICKETS</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Osteoid matrix is secreted at normal rate but the mineralization is decreased (i.e. decrease in mineral apposition rate). </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This leads to increased osteoid maturation time <strong>(mineralization). </strong></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Osteoid is increased in thickness, volume and total surface area. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bone tissue throughout skeleton is incompletely calcified and therefore softened. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Rickets </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">refers to condition where it occurs <strong>before closure of growth plates </strong>so that abnormalities of skeletal growth are superimposed.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Pathology:</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Osteoid is laid down irregularly with widened osteoid seams and osteoid islets may even persist down into the diaphysis.</span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The new trabeculae are thin and weak (as bundle of collagen fibers instead of running parallel to Haversian canal, coarse perpendicularly) and with joint loading, the juxta-epiphyseal metaphysis becomes broad and ‘cup-shaped'.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Clinical features:</span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Generalized muscular hypotonia</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> of an unknown mechanism is observed in most patients with clinical (as opposed to biochemical and radiographic) signs of rickets. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Craniotabes</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (areas of thinning and softening of bones of the skull) manifests early in infants with vitamin D deficiency, although this feature may not be present in infants, especially those born prematurely. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">If rickets occurs at a later age, thickening of the skull develops. This produces <strong>frontal bossing</strong> <strong>and delays the closure of the anterior fontanelle</strong>. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the long bones, laying down of uncalcified osteoid at the metaphyses leads to spreading of those areas, producing knobby deformity, which is visualized on radiography as <strong>cupping and flaring of the metaphyses</strong>. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103111.jpg\" style=\"height:245px; width:500px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Weight bearing produces deformities such as <strong>bow-legs and knock-knees</strong>. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the chest, knobby deformities result in the so-called <strong>rachitic rosary</strong> <strong>along the costochondral junctions.</strong> The weakened ribs pulled by muscles also produce flaring over the diaphragm, which is known as <strong>Harrison groove</strong>. The sternum may be pulled into a <strong>pigeon-breast deformity</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103123.jpg\" style=\"height:293px; width:250px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In more severe instances in children older than 2 years, vertebral softening leads to kyphoscoliosis. The ends of the long bones demonstrate the same knobby thickening. </span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">At the ankle, palpation of the tibial malleolus gives the impression of a double epiphysis <strong>(Marfan sign)</strong>. </span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103133.jpg\" style=\"height:379px; width:293px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<ul style=\"list-style-type:circle\">\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Because the softened long bones may bend, they may fracture on one side of the cortex (i.e., greenstick fracture). </span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">X-rays:</span></strong></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metaphyseal fraying and splaying along with cupping, thickening and widening of growth plate. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Bowing of legs and deformities occur at later stages. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Investigations: </span></strong></span></span>\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Serum calcium, phosphate, 25-OH vitamin D are reduced</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">. </span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased ALP and diminished urinary excretion of calcium. </span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment:</span></strong></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Treatment with <strong>vitamin D (400-1000 IU per day) and calcium supplements</strong> are usually effective. </span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Osteomalacia. </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Often referred to as \"<strong>soft bone disease</strong>,\" is a metabolic bone disorder characterized by the inadequate mineralization of bone tissue. There is adult onset of bone softening and muscle weakness. This condition results from a deficiency in vitamin D, calcium, or phosphate, weakening and softening bones. Symptoms are non-specific and may include low back and thigh pain, proximal muscle weakness and wasting; Myalgia and arthralgia; Muscle spasms; waddling gait; Spinal, limb, or pelvic deformities; Aching bone pain aggravated by activity and weight-bearing; Increased falls; Hypocalcemic seizures or tetany. <strong>Triradiate pelvis, protrusion acetabular </strong>(acetabulum protrudes into pelvis due to bone softening. When bilateral, it is called as <strong>Otto Pelvis</strong>), <strong>pseudofracture </strong>are seen on x-ray. There is <strong>waddling gait </strong>due to muscular weakness.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103151.jpg\" style=\"height:248px; width:300px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">A. Triradiate pelvis; B. Protrusio acetabuli</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Osteogenesis imperfecta. </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is a genetic disorder of connective tissue determined by <strong>quantitative and qualitative defect in type I collagen formation. </strong>There is alteration in the structural integrity, or a reduction in the total amount of type I collagen. Most common cause of multiple fractures in childhood. It is inherited from a parent in autosomal dominant (AD) fashion, or may occur as spontaneous mutation, or, rarely as autosomal recessive (AR) trait. The defining clinical feature is osteopenia, causing repeated propensity to fracture, generally after minor trauma and often without much pain or swelling. According to the severity of disease, fractures may occur in uterus, at birth, or after birth prior to or after walking age. Lower limb fractures are more common than upper limb. Femur is commonest bone fractured followed by tibia. Hyperlaxity of ligaments, with resultant hypermobility of joint is common. Blue/gray sclera due to uveal pigment visible through thin collagen layer. Deafness due to otosclerosis/pressure on auditory nerve. Dentinogenesis imperfect/crumbling of teeth i.e., deciduous and permanent teeth break easily and become prone to carries. Lower incisors severely affected. Skin becomes thin and translucent. Muscles are hypotonic due to multiple fractures and deformities. Wormian bones (detached portions of primary ossification centers of adjacent membrane bones) are seen in skull X-ray. Ring-shaped epiphysis is seen. Skeleton: White crumpled-bone shaped not maintained. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103206.jpg\" style=\"height:417px; width:250px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. Paget’s disease. </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">It is characterized by <strong>excessive disorganized bone turnover, </strong>that encompasses excessive osteoclastic activity initially followed by disorganized excessive new bone formation. <strong>Osteoclast appears larger and irregular </strong>whereas <strong>osteoblast are relatively normal. </strong>The new bone formed is abnormal, very vascular and larger (deforms and fractures) than preexisting bone which leads to cortical widening and contributes to the deformity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103218.jpg\" style=\"height:144px; width:300px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The diagnostic histological feature is irregular area of lamellar bone fitting together like a jigsaw with randomly distributed cement lines. It either occurs in one bone (monostotic) or multiple bones (polyostotic).</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103228.jpg\" style=\"height:256px; width:300px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Most people are asymptomatic. </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The sites most commonly involved are <strong>pelvis</strong>, tibia, followed by skull, spine, clavicle and femur. <strong>Pain is most common presenting symptom. </strong>Limb looks bent and feels thick, and skin is unduly warm due to high vascularity. X-ray shows deformity, enlargement or expansion of bone with cortical thickening, coarsening of trabecular markings and lytic and sclerotic changes. Blade of grass lesion is seen.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103243.jpg\" style=\"height:308px; width:300px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The image given in the question shows cupping, fraying and splaying of metaphysis of the distal end of both the radius and ulna, which are characteristic of rickets, alongwith walking difficulty. </span></span></span></li>\r\n</ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-103111.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200494,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50124,
      "choices": [
        {
          "id": 200496,
          "text": "<p><span style=\"font-size:12.0pt;\">Nocardia</span></p>"
        },
        {
          "id": 200497,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycobacterium tuberculosis</span></p>"
        },
        {
          "id": 200498,
          "text": "<p><span style=\"font-size:12.0pt;\">Mycobacterium leprae</span></p>"
        },
        {
          "id": 200499,
          "text": "<p><span style=\"font-size:12.0pt;\">Actinomyces</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is a gram-positive organism that shows the following appearance on Ziehl-Neelsen staining?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/30.jpg\" alt=\"\" width=\"300\" height=\"193\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/30.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5538534",
      "question_audio": null,
      "question_video": null,
      "map_id": 34123791,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Nocardia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The characteristic morphology of Nocardia is a <strong>branching, filamentous, gram-positive rod</strong> when observed under the microscope. Nocardia can resemble Actinomyces species on gram stain.  However, <strong>Nocardia is an obligate aerobe</strong> that stains weakly positive on acid-fast staining.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Nocardia is typically <strong>weakly acid-fast</strong> after traditional carbol-fuchsin staining and positive on modified acid-fast staining due to the presence of mycolic acid in the cell wall. Unlike mycobacteria (also acid-fast positive), <strong>Nocardia has a “beaded” appearance on acid-fast staining</strong>. Nocardia is <strong>catalase-positive and urease positive</strong>.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-114237.png\" alt=\"\" width=\"300\" height=\"228\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Mycobacterium tuberculosis</strong> bacilli are acid fast but non-branching</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/31.jpg\" alt=\"\" width=\"500\" height=\"356\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Mycobacterium leprae</strong> bacilli are less acid and alcohol fast than the tubercle bacillus; therefore, 10% sulphuric acid is used as a decolorizer in place of acid/alcohol solution.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/32.jpg\" alt=\"\" width=\"400\" height=\"300\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Actinomyces</strong> are gram-positive but non-acid-fast in contrast to Nocardia.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The following image shows the filamentous gram-positive stained actinomyces:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/33.jpg\" alt=\"\" width=\"400\" height=\"266\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Nocardia can be identified by its branching filamentous structure on gram stain and weak acid-fast positivity due to the presence of mycolic acid in its cell wall, distinguishing it from other gram-positive and acid-fast organisms.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-114237.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200496,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50125,
      "choices": [
        {
          "id": 200500,
          "text": "<p><span style=\"font-size:12.0pt;\">Cavus</span></p>"
        },
        {
          "id": 200501,
          "text": "<p><span style=\"font-size:12.0pt;\">Forefoot adduction</span></p>"
        },
        {
          "id": 200502,
          "text": "<p><span style=\"font-size:12.0pt;\">Varus</span></p>"
        },
        {
          "id": 200503,
          "text": "<p><span style=\"font-size:12.0pt;\">Equinus</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">First deformity corrected in CTEV is:(INICET NOV 2022)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102714.jpg\" alt=\"\" width=\"300\" height=\"227\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102714.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5191396",
      "question_audio": null,
      "question_video": null,
      "map_id": 34277064,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A. Cavus</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>CLUB FOOT/CONGENITAL TALIPES EQUINO VARUS (CTEV)</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Incidence</strong>: 1:1000 live births</span></li><li><span style=\"font-size:12.0pt;\"><strong>M:F – 2.5:1</strong></span></li><li><span style=\"font-size:12.0pt;\">50% are bilateral</span></li><li><span style=\"font-size:12.0pt;\">In its most characteristic form, there are <strong>four elements of deformity – Equinus of ankle, inversion of foot, adduction of fore foot and medial rotation of tibia.</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102726.jpg\" alt=\"\" width=\"400\" height=\"209\"></strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Conservative Management:</strong></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102757.jpg\" alt=\"\" width=\"1000\" height=\"381\"></strong></span></p><p> </p><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\">First cast in CTEV is applied in supination to correct cavus.</span></li><li><span style=\"font-size:12.0pt;\">Subsequently in kites, one deformity is corrected at a time, adduction first then varus and then equinus (CAVE).</span></li><li><span style=\"font-size:12.0pt;\">In ponsetti method, adduction and Varus are corrected simultaneously and Equinus is corrected at last.</span></li><li><span style=\"font-size:12.0pt;\">Thus in Kites method, one deformity is corrected at a time but in ponsetti adduction and varus are corrected simultaneously, <i>equinus is corrected at end in both.</i></span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><i><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102812.jpg\" alt=\"\" width=\"300\" height=\"305\"></i></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Sequential correction</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102825.jpg\" alt=\"\" width=\"400\" height=\"148\"></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other options</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Forefoot adduction</strong>. This is corrected after the correction of the cavus deformity of the foot. (C<strong>A</strong>VE)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Varus</strong>. This is corrected after the correction of cavus followed by forefoot adduction. (CA<strong>V</strong>E)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Equinus</strong>. This is corrected in the last because it is the most resistant deformity. (CAV<strong>E</strong>)</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/05/screenshot-2024-01-05-102726.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200500,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50126,
      "choices": [
        {
          "id": 200504,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-1, B-3, C-2, D-4</span></span></span></span></span></p>"
        },
        {
          "id": 200505,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-4, B-1, C-3, D-2</span></span></span></span></span></p>"
        },
        {
          "id": 200506,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿A-2, B-4, C-1, D-3</span></span></span></span></span></p>"
        },
        {
          "id": 200507,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A-3, B-2, C-4, D-1</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following drugs in Column A with their contraindications in Column B? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-180006.jpg\" style=\"height:312px; width:700px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-180006.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5739092",
      "question_audio": null,
      "question_video": null,
      "map_id": 34681108,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B. <span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">A-4, B-1, C-3, D-2</span></strong></span></span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Morphine is contraindicated in head injury due to the following reasons:</span></span></strong></span></span></span>\r\n\r\n\t<ul>\r\n\t\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">It causes miosis and in patients with head injury who are in a comatose state, the progress of the patient after giving drugs is assessed by pupillary reaction. So, if the pupil already remains constricted due to morphine, the assessment of progress cannot be done.</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Morphine leads to respiratory depression and if in the patients with head injury, if the respiratory rate is already depressed, it will get aggravated.</span></span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Respiratory depression will lead to accumulation of CO2, leading to vasodilatation and increased intracranial pressure.</span></span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Amiodarone can cause QT prolongation and even precipitate Torsade de pointes.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Vigabatrin is contraindicated in pregnancy as it is teratogenic.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Estrogen preparations are known to increase the risk of thromboembolism.</span></span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Morphine is contraindicated in head injury due to its effects on pupil size and respiratory depression. Amiodarone is associated with QT prolongation and potential arrhythmias. Vigabatrin is teratogenic and contraindicated in pregnancy. Estrogen increases the risk of thromboembolic events.</span></span></span></span></span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200505,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50127,
      "choices": [
        {
          "id": 200508,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Superior meatus</span></span></p>"
        },
        {
          "id": 200509,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Middle meatus</span></span></p>"
        },
        {
          "id": 200510,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Inferior meatus</span></span></p>"
        },
        {
          "id": 200511,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sphenoethmoidal recess</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What is the site of drainage of the structure marked in green?</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/08/screenshot-2024-10-08-154036.png\" style=\"height:190px; width:300px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/08/screenshot-2024-10-08-154036.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q9546178",
      "question_audio": null,
      "question_video": null,
      "map_id": 34721436,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D) Sphenoethmoidal recess</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The marked structure in the given image is the <strong>sphenoid sinus</strong>, and it drains into the <strong>sphenoethmoidal recess</strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>paranasal sinuses</strong> are air-containing cavities within the skull bones. These sinuses are divided into two main groups:</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Anterior group</strong>:</span></span>\r\n\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">These sinuses drain into the <strong>middle meatus</strong> (Option B) via a common drainage pathway known as the <strong>osteomeatal unit</strong>.</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The anterior group includes:</span></span>\r\n\t\t<ul style=\"list-style-type:square\">\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Maxillary sinus</strong> (antrum of Highmore)</span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Frontal sinus</strong></span></span></li>\r\n\t\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Anterior ethmoidal sinus</strong></span></span></li>\r\n\t\t</ul>\r\n\t\t</li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Posterior group</strong>:</span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Posterior ethmoidal sinuses</strong>: These open into the <strong>superior meatus</strong> (Option A).</span></span></li>\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Sphenoid sinus</strong>: This sinus drains into the <strong>sphenoethmoidal recess</strong>.</span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>inferior meatus</strong> (Option C) contains the opening of the <strong>nasolacrimal duct</strong>, which is guarded by <strong>Hasner's valve</strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Superior meatus</strong>:<strong> </strong>The <strong>superior meatus</strong> receives drainage from the <strong>posterior ethmoidal sinuses</strong>, but it is not the correct location for the sphenoid sinus drainage.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Middle meatus</strong>:<strong> </strong>The <strong>middle meatus</strong> is the drainage site for the <strong>maxillary</strong>, <strong>frontal</strong>, and <strong>anterior ethmoidal sinuses</strong>, but not for the sphenoid sinus.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Inferior meatus</strong>:<strong> </strong>The <strong>inferior meatus</strong> is associated with the <strong>nasolacrimal duct</strong>, which drains tears from the eye into the nasal cavity. It is not related to the drainage of the sphenoid sinus.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>sphenoid sinus</strong> drains into the <strong>sphenoethmoidal recess</strong>, which is located above the superior concha. Understanding the drainage pathways of the paranasal sinuses is important in diagnosing and treating sinus infections and related conditions.</span></span></p>",
      "correct_choice_id": 200511,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50128,
      "choices": [
        {
          "id": 200512,
          "text": "<p><span style=\"font-size:12.0pt;\">CD21</span></p>"
        },
        {
          "id": 200513,
          "text": "<p><span style=\"font-size:12.0pt;\">CD20</span></p>"
        },
        {
          "id": 200514,
          "text": "<p><span style=\"font-size:12.0pt;\">CD19</span></p>"
        },
        {
          "id": 200515,
          "text": "<p><span style=\"font-size:12.0pt;\">CD23</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The Epstein-Barr virus interacts with B cells via which of the following?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p>",
      "unique_key": "Q8986243",
      "question_audio": null,
      "question_video": null,
      "map_id": 34616597,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) CD21</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The Epstein-Barr virus (EBV) primarily infects B cells by binding to the CD21 receptor on the cell surface. CD21, also known as complement receptor 2 (CR2), is a receptor for the C3d fragment of the complement system and serves as the entry point for EBV into B cells. This interaction facilitates the virus's ability to infect and establish latency within B cells.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CD20</strong>: This is a protein expressed on the surface of all B cells and is involved in B cell activation and proliferation. It is not used by EBV for cell entry.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CD19</strong>: This is a surface protein that acts as a co-receptor in B cell receptor signaling, but it is not directly involved in EBV entry.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CD23</strong>: This is the low-affinity receptor for IgE and does not play a role in EBV infection of B cells.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Epstein-Barr virus (EBV) infects B cells by binding to the CD21 receptor, which is the primary entry point for the virus into these cells.</span></li></ul>",
      "correct_choice_id": 200512,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50129,
      "choices": [
        {
          "id": 200516,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1,3</span></span></span><br />\r\n </p>"
        },
        {
          "id": 200517,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1,4</span></span></span></p>"
        },
        {
          "id": 200518,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1,2,4</span></span></span></p>"
        },
        {
          "id": 200519,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">1,2,3,4</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Choose the correctly matched pairs regarding the drugs used in schizophrenia:(</span></span></span></span></span>INICET Nov 2022)</p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p style=\"text-align:justify\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-173217.jpg\" style=\"height:207px; width:700px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/22/screenshot-2024-10-22-173217.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6756386",
      "question_audio": null,
      "question_video": null,
      "map_id": 34353450,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C.</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> <strong>1,2,4</strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Schizophrenia</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is managed with antipsychotic drugs that act on various neurotransmitter systems. Understanding their mechanisms of action and effects is essential for appropriate treatment. Here's a detailed look at each pair:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">1. D2 antagonism – Reduces positive symptoms</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"list-style-type:none\"> </li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">True</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. Positive symptoms of schizophrenia, such as hallucinations and delusions, are primarily managed by blocking dopamine D2 receptors. Typical antipsychotics like haloperidol and chlorpromazine are potent D2 antagonists and effectively reduce these symptoms.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">2. 5HT2A antagonism – Reduces negative symptoms</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"list-style-type:none\"> </li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">True</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. Atypical antipsychotics (e.g., clozapine, olanzapine) act by blocking serotonin 5HT2A receptors. This action helps to improve both the positive and negative symptoms of schizophrenia, with a significant impact on negative symptoms like social withdrawal and apathy.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">4. Muscarinic receptor antagonism – Reduces extrapyramidal symptoms</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></span></p>\r\n\r\n<ul>\r\n\t<li style=\"list-style-type:none\"> </li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">True</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. Antagonism of muscarinic receptors can help reduce extrapyramidal side effects (EPS) caused by D2 antagonism. Drugs like benztropine, which are anticholinergics, are used to manage EPS by balancing the cholinergic and dopaminergic activities in the brain.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options</span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">3. 5HT1A agonism – Weight loss</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li style=\"list-style-type:none\">\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">False</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">. The 5HT1A receptor agonism is not directly associated with weight loss. In fact, weight gain is a common side effect of many atypical antipsychotics, which act on multiple serotonin and dopamine receptors. The statement should be regarding 5HT2C antagonism, which is associated with weight gain, not loss.</span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Antipsychotic drugs </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">manage schizophrenia by targeting various neurotransmitter systems. D2 antagonism helps reduce positive symptoms, while 5HT2A antagonism improves negative symptoms. Muscarinic receptor antagonism can help mitigate extrapyramidal side effects. Misconceptions about receptor effects, such as 5HT1A agonism causing weight loss, need to be corrected.</span></span></span></span></p>",
      "correct_choice_id": 200518,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50130,
      "choices": [
        {
          "id": 200520,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal angiomyolipoma</span></p>"
        },
        {
          "id": 200521,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal oncocytoma</span></p>"
        },
        {
          "id": 200522,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal cell carcinoma</span></p>"
        },
        {
          "id": 200523,
          "text": "<p><span style=\"font-size:12.0pt;\">Renal cyst</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 55-year-old man presents with a mass in the right kidney on a CECT scan, as shown below. What is the diagnosis? (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/27/untitled-187.jpg\" alt=\"\" width=\"402\" height=\"261\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/27/untitled-187.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3124957",
      "question_audio": null,
      "question_video": null,
      "map_id": 34492819,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Renal cell carcinoma        </strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The case of an elderly man with a heterogeneous large renal mass in the CECT image suggests renal cell carcinoma (RCC). RCC often appears as a solid renal mass with areas of necrosis or hemorrhage that cause the heterogeneity in density seen on CT images. This type of cancer is the most common type of kidney cancer in adults and can present with various imaging appearances, but a large, irregular, and heterogeneous mass is highly suggestive.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Renal angiomyolipoma:</strong> Typically appears as a well-circumscribed mass with a significant fat component, which should show negative Hounsfield units (HU) on CT, which is not evident in the presented image.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Renal oncocytoma:</strong> Generally presents as a well-circumscribed, homogenous mass with a central scar. It does not typically appear as heterogeneous as RCC.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Renal cyst:</strong> Would appear as a fluid-filled structure with very well-defined borders and no solid components, which does not match the characteristics of the mass show</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/27/untitled-144_IwptMAR.jpg\" alt=\"\" width=\"760\" height=\"187\"></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/05/23/screenshot-2024-05-23-165250.png\" alt=\"\" width=\"800\" height=\"348\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/27/untitled-144_IwptMAR.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200522,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50131,
      "choices": [
        {
          "id": 200524,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 3</span></p>"
        },
        {
          "id": 200525,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 5</span></p>"
        },
        {
          "id": 200526,
          "text": "<p><span style=\"font-size:12.0pt;\">1 and 4</span></p>"
        },
        {
          "id": 200527,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3 and 4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Oculocephalic reflex assesses the integrity of which of the following cranial nerves?</span> <span style=\"font-size:12.0pt;\">(INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\">1. III</span></p><p><span style=\"font-size:12.0pt;\">2. IV</span></p><p><span style=\"font-size:12.0pt;\">3. VI</span></p><p><span style=\"font-size:12.0pt;\">4. VIII</span></p><p><span style=\"font-size:12.0pt;\">5. VII</span></p>",
      "unique_key": "Q1054854",
      "question_audio": null,
      "question_video": null,
      "map_id": 34004998,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 3 and 4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The oculocephalic reflex, also known as the doll's eye reflex, is a brainstem reflex useful test for evaluating the function of cranial nerves III, VI, and VIII to determine brainstem function and assess brain death.</span></p><p> </p><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">It is elicited by the examiner rapidly rotating the patient's head and observing the resulting eye movements. The test is performed in both lateral directions, as well as during flexion and extension of the neck. </span></li><li><span style=\"font-size:12.0pt;\">The oculomotor (III) nerve receives input from the vestibular (VIII) and abducens (VI) nerves, which relay signals to the brainstem nuclei responsible for generating conjugate eye movements. </span></li><li><span style=\"font-size:12.0pt;\">In a <strong>normal reflex</strong>, the eyes move in the opposite direction of head movement to maintain their orientation in space.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">A <strong>negative reflex</strong> can indicate cranial nerve palsies or brainstem damage if the eyes do not move or move in the same direction as head movement. </span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture9_Z665ajL.jpg\" alt=\"\" width=\"600\" height=\"385\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The oculocephalic reflex assesses the integrity of cranial nerves III (oculomotor), VI (abducens), and VIII (vestibulocochlear), which are crucial for coordinated eye movements in response to head motion.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture9_Z665ajL.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200527,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50132,
      "choices": [
        {
          "id": 200528,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">cAMP</span></span></p>"
        },
        {
          "id": 200529,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">cGMP</span></span></p>"
        },
        {
          "id": 200530,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Na+ inflow through a channel</span></span></p>"
        },
        {
          "id": 200531,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IP3</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following primary second messengers is involved in the contraction of ciliary muscles while focusing on near objects? </span></span></p>",
      "unique_key": "Q4232843",
      "question_audio": null,
      "question_video": null,
      "map_id": 34008101,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. D) IP3</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">IP₃ (inositol 1,4,5-triphosphate) is the primary second messenger involved in the contraction of ciliary muscles when focusing on near objects.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">When focusing on a near object, the parasympathetic nerve fibers are stimulated, leading to the contraction of bilateral ciliary muscles via short ciliary nerves. This contraction relaxes the lens ligaments, thickening the lens and increasing its refractive power to help focus on a near object. This physiological process is known as the <em>accommodation reflex</em>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The contraction of ciliary muscles is mediated through M₃ receptors (muscarinic receptors), and the parasympathetic signaling pathway activates the IP₃-DAG (diacylglycerol) cascade. This leads to the release of intracellular calcium (Ca²⁺), which in turn causes contraction of the ciliary smooth muscle, allowing accommodation.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Thus, the contraction of the ciliary muscles during near focusing is driven by IP₃ as the second messenger, via the parasympathetic nervous system.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. cAMP</strong>: This second messenger typically mediates relaxation, not contraction, of smooth muscles. It works via the β-adrenergic receptors, which would lead to relaxation of ciliary muscles.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. cGMP</strong>: This messenger is more associated with the nitric oxide pathway and vascular smooth muscle relaxation rather than ciliary muscle contraction.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Na+ inflow through a channel</strong>: Sodium ions (Na⁺) do not directly function as a primary second messenger in ciliary muscle contraction. They are involved in generating action potentials but not in the intracellular signaling pathways for muscle contraction.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The second messenger <em>inositol 1,4,5-triphosphate (IP₃)</em> plays a crucial role in ciliary muscle contraction during the accommodation reflex, particularly when focusing on near objects. This mechanism involves parasympathetic stimulation of M₃ receptors and the subsequent increase in intracellular calcium.</span></span></p>",
      "correct_choice_id": 200531,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50133,
      "choices": [
        {
          "id": 200532,
          "text": "<p><span style=\"font-size:12.0pt;\">Haab's striae</span></p>"
        },
        {
          "id": 200533,
          "text": "<p><span style=\"font-size:12.0pt;\">Munson's sign</span></p>"
        },
        {
          "id": 200534,
          "text": "<p><span style=\"font-size:12.0pt;\">Irregular astigmatism</span></p>"
        },
        {
          "id": 200535,
          "text": "<p><span style=\"font-size:12.0pt;\">Scissoring reflex</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a feature of keratoconus? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q1869735",
      "question_audio": null,
      "question_video": null,
      "map_id": 34742109,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong> </span><span style=\"font-size:12.0pt;\"><strong>A) Haab's striae </strong> </span></p><p> </p><p><span style=\"font-size:12.0pt;\">Haab’s striae are not a feature of Keratoconus. Haab's striae are seen in buphthalmos where the intraocular pressure is raised and the eyeball is enlarged as a whole. The enlarged cornea is associated with tears in Descemet's membrane called Haab's striae.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Munson's sign:</strong> Directly associated with keratoconus. It is observed when the patient looks down, causing the lower eyelid to bulge out due to the cone-shaped cornea.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Irregular Astigmatism:</strong> A hallmark of keratoconus, resulting from the irregular thinning and bulging of the cornea.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Scissoring Reflex:</strong> This is a characteristic finding in keratoconus observed during retinoscopy due to the irregular shape of the cornea.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Following signs may be elicited in keratoconus –</span></p><p><span style=\"font-size:12.0pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/24/picture87.jpg\" alt=\"\" width=\"1000\" height=\"540\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/24/picture87.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200532,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50134,
      "choices": [
        {
          "id": 200536,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">C1 inhibitor</span></span></span></p>"
        },
        {
          "id": 200537,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Decay accelerating factor</span></span></span></p>"
        },
        {
          "id": 200538,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">CD59</span></span></span></p>"
        },
        {
          "id": 200539,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">C5 convertase</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following protein deficiency is responsible for Hereditary Angioedema? </span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">(INICET NOV 2022)</span></span></p>",
      "unique_key": "Q7204046",
      "question_audio": null,
      "question_video": null,
      "map_id": 34635920,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Ans.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>A) C1 inhibitor </strong> </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hereditary angioedema (HAE) is a rare genetic disorder characterized by recurrent episodes of severe swelling (angioedema). The condition is caused by a deficiency or dysfunction of the <strong>C1 inhibitor</strong> protein. C1 inhibitor is crucial in regulating the complement system, particularly the classical pathway, by inhibiting the activity of C1 esterase. In the absence or dysfunction of C1 inhibitor, uncontrolled activation of the complement pathway occurs, leading to excessive production of bradykinin, a potent vasodilator that causes the symptoms of angioedema.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Decay accelerating factor</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Also known as CD55, this protein is responsible for regulating the complement system on cell surfaces, preventing damage to host cells. Deficiency of CD55 is associated with <strong>Paroxysmal Nocturnal Hemoglobinuria (PNH)</strong>, not hereditary angioedema.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. CD59</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This protein is also involved in the regulation of the complement system by inhibiting the formation of the membrane attack complex (MAC). Like CD55, CD59 deficiency is associated with <strong>Paroxysmal Nocturnal Hemoglobinuria (PNH)</strong>, not hereditary angioedema.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option D. C5 convertase</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is an enzyme complex that plays a role in the complement cascade by cleaving C5 into C5a and C5b, leading to the formation of the membrane attack complex. Deficiencies in components of C5 convertase can lead to increased susceptibility to infections, particularly with Neisseria species, but it is not associated with hereditary angioedema.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-150719.jpg\" style=\"height:451px; width:1000px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-150719.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200536,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50135,
      "choices": [
        {
          "id": 200540,
          "text": "<p><span style=\"font-size:12.0pt;\">Glimepiride</span></p>"
        },
        {
          "id": 200541,
          "text": "<p><span style=\"font-size:12.0pt;\">Exenatide</span></p>"
        },
        {
          "id": 200542,
          "text": "<p><span style=\"font-size:12.0pt;\">Vildagliptin</span></p>"
        },
        {
          "id": 200543,
          "text": "<p><span style=\"font-size:12.0pt;\">Linagliptin</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient with diabetes, hypertension, and chronic kidney disease has elevated serum creatinine and urea levels. Which of the following oral hypoglycemic agents is safe to use? (INICET NOV 2022)</span></p>",
      "unique_key": "Q8455070",
      "question_audio": null,
      "question_video": null,
      "map_id": 34885730,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Linagliptin</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Patients with chronic kidney disease (CKD) require careful selection of hypoglycemic agents due to altered drug excretion and the risk of further renal impairment. Among the given options, linagliptin is the safest choice for such patients. Linagliptin is a DPP-4 inhibitor that does not require dose adjustment in patients with renal impairment, including those on hemodialysis. This is because linagliptin is primarily excreted via the liver rather than the kidneys.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Note –</strong> Certain GLP-1 receptor agonists like liraglutide, dulaglutide, and semaglutide can be used without dose adjustment according to the latest studies. Additionally, pioglitazone can also be used without dose adjustment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Glimepiride:</strong> This sulfonylurea can cause hypoglycemia and requires dose adjustment in patients with renal impairment, making it less suitable for those with elevated serum creatinine and urea levels.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Exenatide:</strong> This GLP-1 receptor agonist is contraindicated in patients with severe renal impairment (creatinine clearance <30 mL/min) due to the risk of accumulation and potential toxicity.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Vildagliptin:</strong> Another DPP-4 inhibitor, vildagliptin requires dose adjustment in renal impairment, making it less favorable compared to linagliptin for patients with CKD.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Linagliptin is the preferred oral hypoglycemic agent for patients with diabetes and chronic kidney disease, as it does not require dose adjustment and is safely excreted by the liver.</span></p><p> </p>",
      "correct_choice_id": 200543,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50136,
      "choices": [
        {
          "id": 200544,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Marbling</span></span></span></p>"
        },
        {
          "id": 200545,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tattooing</span></span></span></p>"
        },
        {
          "id": 200546,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Lividity</span></span></span></p>"
        },
        {
          "id": 200547,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Filigree burns</span></span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Identify the postmortem change given in the image below? (</span></span>INICET Nov 2022)</p>\r\n\r\n<p> </p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-46.jpg\" style=\"height:300px; width:300px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/image-46.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4189527",
      "question_audio": null,
      "question_video": null,
      "map_id": 34838824,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A. Marbling</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The picture above shows a postmortem change called Marbling.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In marbling, blood vessels are visible on the skin as greenish-black streaks and eventually results in skin discoloration ranging from green to black, due to the formation of sulphmethemoglobin, which starts in 24 hours and becomes prominent in 36-48 hours.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Tattooing:</span></strong><span style=\"font-size:12.0pt\"> Refers to punctate abrasions from unburned gunpowder particles, seen in gunshot wounds, not related to postmortem changes.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Lividity:</span></strong><span style=\"font-size:12.0pt\"> Also known as livor mortis, this refers to the settling of blood in dependent parts of the body, causing a purplish-red discoloration.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Filigree burns:</span></strong><span style=\"font-size:12.0pt\"> Caused by electrical burns, producing a lace-like pattern on the skin.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Marbling is characterized by the appearance of greenish-black streaks on the skin due to the formation of sulfmethemoglobin, typically becoming prominent 24-48 hours postmortem.</span></span></span></p>",
      "correct_choice_id": 200544,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50137,
      "choices": [
        {
          "id": 200548,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">CAMP</span></span></span></p>"
        },
        {
          "id": 200549,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">cGMP</span></span></span></p>"
        },
        {
          "id": 200550,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Calcium</span></span></span></p>"
        },
        {
          "id": 200551,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phosphatidyl glycerol and inositol phosphate</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient with erectile dysfunction is given sildenafil. Which of the following mediates the action of sildenafil? (</span></span>INICET Nov 2022)</p>",
      "unique_key": "Q7639461",
      "question_audio": null,
      "question_video": null,
      "map_id": 34427120,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B. cGMP</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Sildenafil is a phosphodiesterase 5 inhibitor.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The corpus cavernosum produces nitric oxide during arousal that stimulates the formation of cGMP. cGMP causes relaxation of the smooth muscle of the corpus cavernosum and penile arteries, engorgement of the corpus cavernosum, and erection.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">By inhibiting PDE 5, the hydrolysis if cGMP is prevented, thus leading to erection.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. cAMP</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: cAMP (cyclic adenosine monophosphate) is another second messenger involved in various biological processes, but it is not the primary mediator in the mechanism of action of sildenafil for erectile dysfunction.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Calcium</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Calcium plays a critical role in muscle contraction and various cellular functions, but it is not directly involved in the mechanism of action of sildenafil for treating erectile dysfunction.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Phosphatidyl glycerol and inositol phosphate</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: These molecules are involved in different signaling pathways, such as the phosphatidylinositol pathway, but they are not relevant to the action of sildenafil.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Sildenafil, a PDE5 inhibitor, enhances and prolongs erections by preventing the breakdown of cGMP, which is the primary mediator responsible for smooth muscle relaxation and increased blood flow in the corpus cavernosum of the penis during arousal.</span></span></span></p>",
      "correct_choice_id": 200549,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50138,
      "choices": [
        {
          "id": 200552,
          "text": "<p><span style=\"font-size:12.0pt;\">Mitochondria</span></p>"
        },
        {
          "id": 200553,
          "text": "<p><span style=\"font-size:12.0pt;\">Lysosomes</span></p>"
        },
        {
          "id": 200554,
          "text": "<p><span style=\"font-size:12.0pt;\">Peroxisomes</span></p>"
        },
        {
          "id": 200555,
          "text": "<p><span style=\"font-size:12.0pt;\">Nucleus</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Zellweger syndrome is caused by the defect of which of the following organelles?</span></p>",
      "unique_key": "Q3227356",
      "question_audio": null,
      "question_video": null,
      "map_id": 34198637,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Peroxisomes</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Zellweger syndrome is a peroxisome biogenesis disorder caused by defects in peroxisomes. Peroxisomes are essential organelles involved in various metabolic processes, and their dysfunction leads to Zellweger syndrome.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Mitochondria: </strong>Zellweger syndrome is not caused by a defect in mitochondria. Mitochondria are responsible for energy production in cells, and defects in mitochondria lead to different diseases, not Zellweger syndrome.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Lysosomes: </strong>Zellweger syndrome is not caused by a defect in lysosomes. Lysosomes are responsible for breaking down cellular waste and are associated with lysosomal storage disorders, which are different from peroxisomal disorders like Zellweger syndrome.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Nucleus: </strong>Zellweger syndrome is not primarily caused by a defect in the nucleus. It is a peroxisomal disorder, and the genetic mutations associated with Zellweger syndrome typically affect genes related to peroxisome biogenesis, not nuclear genes.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In Zellweger syndrome, there are empty peroxisomes in all body cells causing defect in alpha-oxidation and oxidation of VLCFA. So, both phytanic acid and VLCFA accumulate. It is the most severe Peroxisomal Biogenesis Disorder (PBD).</span></p>",
      "correct_choice_id": 200554,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50139,
      "choices": [
        {
          "id": 200556,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hostile</span></span></span></p>"
        },
        {
          "id": 200557,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Indirect</span></span></span></p>"
        },
        {
          "id": 200558,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Direct</span></span></span></p>"
        },
        {
          "id": 200559,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hearsay</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Sameer was tried in a court in the case of Sanjay’s murder in the park. Sahil appeared in court and stated that he saw Sameer with an axe in his hand while passing the park. What is this evidence known as? (</span></span>INICET Nov 2022)</p>",
      "unique_key": "Q7285039",
      "question_audio": null,
      "question_video": null,
      "map_id": 34248963,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B. Indirect</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">This type of evidence in known as an indirect evidence or circumstantial evidence.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This evidence providing only a basis for inference about the fact in dispute and it is not an eyewitness.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hostile:</span></strong><span style=\"font-size:12.0pt\"> Refers to a witness who is antagonistic or adverse to the party who called them to testify.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Direct:</span></strong><span style=\"font-size:12.0pt\"> Evidence that directly proves a fact, such as an eyewitness account of the crime being committed.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hearsay:</span></strong><span style=\"font-size:12.0pt\"> Evidence based on what someone else said, not on the direct knowledge of the witness, and typically inadmissible in court due to its second-hand nature.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Indirect or circumstantial evidence suggests a fact but does not directly prove it. In this case, seeing Sameer with an axe near the park suggests involvement but does not directly prove his guilt.</span></span></span></p>",
      "correct_choice_id": 200557,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50140,
      "choices": [
        {
          "id": 200560,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-b, 3-a, 4-c</span></p>"
        },
        {
          "id": 200561,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿1-a, 2-c, 3-d, 4-b</span></p>"
        },
        {
          "id": 200562,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿1-b, 2-a, 3-d, 4-c</span></p>"
        },
        {
          "id": 200563,
          "text": "<p><span style=\"font-size:12.0pt;\">﻿﻿﻿1-d, 2-c, 3-a, 4-b</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following:(INICET NOV 2022)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/05/screenshot-2024-07-05-130045.png\" alt=\"\" width=\"700\" height=\"233\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/05/screenshot-2024-07-05-130045.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q3984282",
      "question_audio": null,
      "question_video": null,
      "map_id": 34550659,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 1-b, 2-a, 3-d, 4-c</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1-b: Colour vision - Ishihara chart</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Colour vision</strong> is tested with Ishihara plates, which is a pseudoisochromatic chart. There are patterns of coloured and grey dots that reveal one pattern to persons with normal colour vision and another to those with the colour deficiency.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The below image shows a representative plate of the Ishihara chart.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture4_7qyUR70.jpg\" alt=\"\" width=\"300\" height=\"300\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Limitation of ischihara chart</strong>: Ischihara chart is useful as a screening tool for colour blindness. It mainly tests for red-green blindness.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">In order to check blue-yellow blindness other tests such as 100 Hue Test are required.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>2-a: Intraocular pressure - Applanation tonometer</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">An <strong>applanation tonometer</strong> is used to measure the intraocular pressure. It is based on the Imbert-Fick law, which states that the pressure inside a sphere(P) is equal to the force (W) required to flatten its surface divided by the area of flattening (A).</span></p><p> </p><p><span style=\"font-size:12.0pt;\">P = W/A</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The following is an image of the applanation tonometer:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture5_t8ZnLw9.jpg\" alt=\"\" width=\"300\" height=\"200\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">There are two types of applanation tonometers:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">(1) In which the surface area of the prism is constant – Eg</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Goldmann Applanation Tonometer (GAT):</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The Goldmann tonometer is one of the most widely used and considered the gold standard for measuring intraocular pressure.</span></li><li><span style=\"font-size:12.0pt;\">It consists of a prism that is gently applied to the anesthetized cornea, flattening a small area.</span></li><li><span style=\"font-size:12.0pt;\">The amount of force required to flatten the cornea is directly related to intraocular pressure.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Perkins Applanation Tonometer:</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The Perkins tonometer is a handheld, portable device used for measuring intraocular pressure.</span></li><li><span style=\"font-size:12.0pt;\">It is similar in principle to the Goldmann tonometer but is more compact and easier to transport.</span></li></ul></li><li><span style=\"font-size:12.0pt;\">Tono-Pen (Reichert Tonometer):</span><ul style=\"list-style-type:disc;\"><li><span style=\"font-size:12.0pt;\">The Tono-Pen is a handheld electronic applanation tonometer.</span></li><li><span style=\"font-size:12.0pt;\">It works by measuring the force required to flatten the cornea, and the reading is displayed electronically.</span></li><li><span style=\"font-size:12.0pt;\">It is often used in clinical settings due to its ease of use and portability.</span></li></ul></li></ol><p> </p><p><span style=\"font-size:12.0pt;\">(2) Tonometer with constant pressure and variable area – eg. MALAKOFF’S Tonometer.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>3-d: Peripheral vision - Perimetry</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Perimetry </strong>is a diagnostic procedure used to chart the boundaries of a person's visual field. There are two main types of perimetry: kinetic and static perimetry. Kinetic perimetry involves moving a target with a specific luminance from a non-seeing area in the periphery towards the center until the person perceives it. In contrast, static perimetry involves presenting a stationary stimulus and adjusting its intensity until the person either reaches a threshold of detection or can no longer detect it. One type of static perimetry is <strong>tangent screen perimetry</strong>, which tests the central 30 degrees field at 1 meter and evaluates a person's central vision.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Examples of Kinetic Perimetry – Goldmann perimetry and Bjerrum Perimetry</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Examples of Static Perimetry – Static Automated perimetry – Humphrey Visual Field analyser and Octopus Visual field analyser.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>4-c: Central vision - Tangent screen test</strong>:</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The tangent screen test is a specific method used to assess central visual field up to 30 degrees from fixation. It involves using a black screen and white or colored targets to determine the sensitivity of central vision, particularly useful in detecting central visual field defects.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Colour vision - <strong>Ishihara chart</strong></span></li><li><span style=\"font-size:12.0pt;\">Intraocular pressure - <strong>Applanation tonometer</strong></span></li><li><span style=\"font-size:12.0pt;\">Peripheral vision - <strong>Perimetry</strong></span></li><li><span style=\"font-size:12.0pt;\">Central vision - <strong>Tangent screen test</strong></span></li></ul><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/29/picture4_7qyUR70.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200562,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50141,
      "choices": [
        {
          "id": 200564,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Methyl alcohol</span></span></span></p>"
        },
        {
          "id": 200565,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ethyl alcohol</span></span></span></p>"
        },
        {
          "id": 200566,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ethylene glycol</span></span></span></p>"
        },
        {
          "id": 200567,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyporglycin</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hooch tragedy is related to which of the following alcohols?</span></span></span></p>",
      "unique_key": "Q9427694",
      "question_audio": null,
      "question_video": null,
      "map_id": 34523970,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Methyl alcohol</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Methyl alcohol (Correct Answer):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Hooch tragedies are typically associated with the consumption of illicit liquor that contains methanol. Methanol is toxic to the human body and can lead to serious health issues, including organ damage and even death, when consumed in significant amounts.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option B.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Ethyl alcohol: </strong>Ethyl alcohol, also known as ethanol, is the type of alcohol commonly found in alcoholic beverages that are legally produced and regulated. It is not typically associated with hooch tragedies.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option C.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Ethylene glycol: </strong>Ethylene glycol is not related to hooch tragedies. It is a chemical compound used in products such as antifreeze and is highly toxic when ingested.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12pt\"><strong>Option D.</strong> </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><strong>Hypoglycin: </strong>Hypoglycin is a naturally occurring toxin found in certain plants, such as the ackee fruit, and is not directly related to hooch tragedies.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective</span></strong><span style=\"font-size:12.0pt\">: </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Country liquor can be categorised as spurious liquor or hooch when the amount of methane added could turn fatal. There are number of death cases reported every year due to consumption of such alcohol.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The metabolism of methyl alcohol is shown in figure below:</span></span></strong></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:#212529\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture13_OiM4P0s.jpg\" style=\"height:183px; width:500px\" /></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The formaldehyde and formic acid formed as products during the metabolism can cause severe metabolic acidosis, blindness and neurologic damage. </span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The treatment involves administration of ethanol or Fomepizole which act as competitive inhibitors of enzyme ADH and prevent the formation of these two products.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/01/01/picture13_OiM4P0s.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200564,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50142,
      "choices": [
        {
          "id": 200568,
          "text": "<p><span style=\"font-size:12.0pt;\">3, 4</span></p>"
        },
        {
          "id": 200569,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
        },
        {
          "id": 200570,
          "text": "<p><span style=\"font-size:12.0pt;\">2, 4</span></p>"
        },
        {
          "id": 200571,
          "text": "<p><span style=\"font-size:12.0pt;\">1, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following statements are true regarding cytomegalovirus (CMV) infection? (INICET NOV 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Neonates who are asymptomatic at birth have a lesser risk of later sequelae.</span></li><li><span style=\"font-size:12.0pt;\">20-40% are symptomatic at birth.</span></li><li><span style=\"font-size:12.0pt;\">In developing countries, the rate of transmission of CMV infection to the infant is more common from primary maternal infection than reactivation.</span></li><li><span style=\"font-size:12.0pt;\">Diagnosis by urine specimen at 4 weeks of age</span></li></ol>",
      "unique_key": "Q6028923",
      "question_audio": null,
      "question_video": null,
      "map_id": 34255115,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1, 3</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Cytomegalovirus (CMV) is a common congenital infection, and understanding the nuances of its transmission, diagnosis, and clinical implications is important.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Congenital CMV Infection:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Transmission: </strong>Congenital CMV infection can occur from either primary maternal infection (which is when the mother is infected with CMV for the first time during pregnancy) or from reactivation of a prior CMV infection in the mother. The risk of transmission to the fetus is significantly higher in cases of primary maternal infection (around 30%) compared to reactivation (about 1-2%). In developing countries, the prevalence of CMV reactivation is higher, but primary infection remains the more significant source of transmission to the fetus.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Asymptomatic vs. Symptomatic: </strong>The majority of neonates with congenital CMV are asymptomatic at birth, and these asymptomatic infants have a lower risk of developing long-term sequelae such as sensorineural hearing loss compared to those who are symptomatic at birth.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Presentation: </strong>About 10% of neonates with congenital CMV infection are symptomatic at birth. Symptoms can include hepatosplenomegaly, petechial rash, jaundice, chorioretinitis, microcephaly, and thrombocytopenia. These symptoms are associated with a higher risk of long-term complications.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Diagnosis: </strong>CMV infection can be diagnosed by detecting the virus in urine, saliva, or blood within the first three weeks of life. Diagnosis at four weeks, as mentioned in option 4, is less likely to be reliable because it may represent postnatal infection rather than congenital infection.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B (1, 2): </strong>The percentage of neonates symptomatic at birth is around 10%, not 20-40%.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C (2, 4): </strong>The diagnosis by urine specimen at four weeks is not ideal, and the percentage of symptomatic neonates at birth is incorrect.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Neonates who are asymptomatic at birth from congenital CMV infection have a lower risk of long-term sequelae, and transmission is more common from primary maternal infection than from reactivation, especially in developing countries.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-155140.png\" alt=\"\" width=\"400\" height=\"188\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/17/screenshot-2024-09-17-155140.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200571,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50143,
      "choices": [
        {
          "id": 200572,
          "text": "<p><span style=\"font-size:12.0pt;\">3-1-2-5-4</span></p>"
        },
        {
          "id": 200573,
          "text": "<p><span style=\"font-size:12.0pt;\">1-2-3-4-5</span></p>"
        },
        {
          "id": 200574,
          "text": "<p><span style=\"font-size:12.0pt;\">3-1-2-4-5</span></p>"
        },
        {
          "id": 200575,
          "text": "<p><span style=\"font-size:12.0pt;\">1-2-4-3-5</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">An unconscious child is brought to the casualty. What is the correct sequence of the management? (INICET NOV 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Assess breathing</span></li><li><span style=\"font-size:12.0pt;\">Assess pulse</span></li><li><span style=\"font-size:12.0pt;\">Assess response</span></li><li><span style=\"font-size:12.0pt;\">Start compressions</span></li><li><span style=\"font-size:12.0pt;\">Bag and mask ventilation</span></li></ol>",
      "unique_key": "Q1601771",
      "question_audio": null,
      "question_video": null,
      "map_id": 34376823,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 3-1-2-4-5</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">When managing an unconscious child, especially in a potential cardiac or respiratory arrest scenario, it is crucial to follow the steps of <strong>Basic Life Support (BLS)</strong> in the correct sequence to ensure the best chance of recovery.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-06-17%20at%2016.35.35_1a8b87e8.jpg\" width=\"1280\" height=\"718\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Sequence Justification:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The correct sequence is <strong>3-1-2-4-5</strong>, which means:</span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>3: </strong>First, assess response (to determine unresponsiveness).</span></li><li><span style=\"font-size:12.0pt;\"><strong>1: </strong>Then assess breathing (to check for normal breathing).</span></li><li><span style=\"font-size:12.0pt;\"><strong>2: </strong>Followed by assessing the pulse (to check for circulation).</span></li><li><span style=\"font-size:12.0pt;\"><strong>4: </strong>Start compressions if necessary (if no pulse or poor perfusion).</span></li><li><span style=\"font-size:12.0pt;\"><strong>5: </strong>Provide bag and mask ventilation to support breathing.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In BLS, the correct sequence of actions is crucial for effective management. Start by assessing response, followed by breathing and pulse, then initiate compressions and ventilation as needed.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/WhatsApp%20Image%202025-06-17%20at%2016.35.35_1a8b87e8.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200574,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50144,
      "choices": [
        {
          "id": 200576,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1-a, 2-b, 3-c, 4-d</span></span></span></span></span></p>"
        },
        {
          "id": 200577,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿1-c, 2-d, 3-a, 4-b</span></span></span></span></span></p>"
        },
        {
          "id": 200578,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿1-d, 2-a, 3-d, 4-c</span></span></span></span></span></p>"
        },
        {
          "id": 200579,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿1-d, 2-c, 3-b, 4-a</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Match the following teratogenic drugs with their teratogenic effects: (</span></span></span>INICET Nov 2022)</p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p style=\"text-align:justify\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-181740.jpg\" style=\"height:290px; width:1000px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/01/screenshot-2023-12-01-181740.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q2802793",
      "question_audio": null,
      "question_video": null,
      "map_id": 34708436,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. D.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> <span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">1-d, 2-c, 3-b, 4-a</span></strong></span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The correctly matched pairs of teratogenic drugs and their effects is 1-d, 2-c, 3-b, 4-a.</span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Lithium is used in the treatment of bipolar disorders and prophylaxis of mania. It is c/I in pregnancy as it leads to Ebstein’s anomaly in the fetus, which is characterised by arterialization of the right ventricle and a box shaped heart.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Warfarin leads to defect in the growth of the cartilage (chondrodysplasia punctata) characterized by depressed nasal bridge, stippled epiphyses etc. Warfarin embryopathy is maximally seen when it is used between 6-9 weeks.</span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Thalidomide causes proximal limb defect or Phocomelia. Thalidomide acts via inhibiting angio-genesis, inhibiting cereblon and suppressing immune responses. </span></span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Chloramphenicol inhibits peptidyl transferase. It causes Bone Marrow suppression and leads to grey baby syndrome.</span></span></span></span></span></li>\r\n</ol>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The teratogenic effects of certain drugs is crucial for managing medication use during pregnancy. Lithium can cause Ebstein’s anomaly, Warfarin is associated with saddle nose and growth retardation, Thalidomide causes limb malformations, and Chloramphenicol can lead to Grey Baby Syndrome.</span></span></span></p>",
      "correct_choice_id": 200579,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50145,
      "choices": [
        {
          "id": 200580,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 3</span></span></span></p>"
        },
        {
          "id": 200581,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 4</span></span></span></p>"
        },
        {
          "id": 200582,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3, 4</span></span></span></p>"
        },
        {
          "id": 200583,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2, 3</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A 55-year-old chronic smoker presents to the OPD with complaints of shortness of breath and cough. A mass is noted at the lower lobe periphery of the lung. A diagnosis of lung adenocarcinoma is made. What will be the biopsy finding? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thyroid transcription factor-1</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">P40</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Napsin A</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Chromogranin</span></span></span></li>\r\n</ol>",
      "unique_key": "Q4963007",
      "question_audio": null,
      "question_video": null,
      "map_id": 34970686,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) 1, 3</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">In the context of lung adenocarcinoma, particularly in a chronic smoker presenting with a peripheral lung mass, specific markers on the biopsy can confirm the diagnosis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1. Thyroid transcription factor-1 (TTF-1)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: TTF-1 is a nuclear transcription factor commonly expressed in lung adenocarcinoma and is used as a diagnostic marker to differentiate primary lung adenocarcinoma from other types of lung cancer.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3. Napsin A</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Napsin A is another marker often expressed in lung adenocarcinoma, associated with the protein's role in the proteolytic processing of surfactant precursors in the lung.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">These markers are both used to identify lung adenocarcinoma, particularly in cases where the tumor presents in the lung periphery.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2. P40</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: P40 is a marker associated with squamous cell carcinoma of the lung, not adenocarcinoma. Its presence would suggest a different subtype of lung cancer.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4. Chromogranin</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Chromogranin is a marker used in neuroendocrine tumors, such as small cell lung cancer, and is not typically found in lung adenocarcinoma.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-113157_j7U5sRU.jpg\" style=\"height:747px; width:1000px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-113157_j7U5sRU.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200580,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50146,
      "choices": [
        {
          "id": 200584,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">This action can be reversed by phenylephrine.</span></span></span></span></span></p>"
        },
        {
          "id": 200585,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿It cannot be reversed by levallorphan.</span></span></span></span></span></p>"
        },
        {
          "id": 200586,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">It is caused by activation of the Edinger-Westphal nucleus.</span></span></span></span></span></p>"
        },
        {
          "id": 200587,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Tolerance develops to this adverse effect on long-term use.</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient with a history of substance addiction is admitted to the hospital due to the overdose of the addictive substance. The patient has slow heart rate, respiratory depression, and low blood pressure. His ocular findings are shown below. Which of the following statements is true regarding this condition? (INICET NOV 2022)</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/750.jpg\" style=\"height:202px; width:300px\" /></span></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/750.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1255999",
      "question_audio": null,
      "question_video": null,
      "map_id": 34435571,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C.<span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\"> It is caused by activation of the Edinger-Westphal nucleus.</span></strong></span></span></span></strong></span></span><br />\r\n </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The pupil is constricted in the given image and as the history describes the patient to be an addict, who is brought to the hospital in an intoxicated state. The clinical features like pin-point pupils, bradycardia, hypotension, respiratory depression suggests that this is a case of opioid intoxication.</span></span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><strong>Opioid induced miosis:</strong></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The pupillary constriction caused by opioids result due to the activation of the Edinger Westphal Nucleus. Therefore, topical use of opioids in the eye does not induce miosis. It will be seen only on systemic administration of opioids. </span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The miosis induced by opioids cannot be reversed by mydriatic drugs like phenylephrine or anticholinergic drugs. Rather it can be reversed by opioid antagonists like naloxone and levallorphan.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Tolerance does not develop to opioid induced miosis even on long term use. </span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. This action can be reversed by phenylephrine</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Phenylephrine is a mydriatic agent that causes dilation of the pupil by stimulating alpha-1 adrenergic receptors. It would not reverse opioid-induced miosis, which is due to central nervous system effects rather than direct effects on the iris muscles.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. It cannot be reversed by levallorphan</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Levallorphan is an opioid antagonist that can reverse the effects of opioid toxicity, including miosis. Therefore, this statement is incorrect.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Tolerance develops to this adverse effect on long-term use:</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> Tolerance to opioid-induced miosis does not typically develop, even with long-term use of opioids. Therefore, this statement is incorrect.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Opioid-induced miosis is caused by activation of the Edinger-Westphal nucleus, and it is a characteristic sign of opioid intoxication. This effect cannot be reversed by phenylephrine, and tolerance does not develop to this effect with long-term opioid use. Opioid antagonists like naloxone and levallorphan can reverse the miosis caused by opioid overdose</span></span></span></p>",
      "correct_choice_id": 200586,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50147,
      "choices": [
        {
          "id": 200588,
          "text": "<p><span style=\"font-size:12.0pt;\">12 mmHg</span></p>"
        },
        {
          "id": 200589,
          "text": "<p><span style=\"font-size:12.0pt;\">25 mmHg</span></p>"
        },
        {
          "id": 200590,
          "text": "<p><span style=\"font-size:12.0pt;\">32 mmHg</span></p>"
        },
        {
          "id": 200591,
          "text": "<p><span style=\"font-size:12.0pt;\">54 mmHg</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the value of normal Glomerular oncotic pressure?</span></p>",
      "unique_key": "Q6958236",
      "question_audio": null,
      "question_video": null,
      "map_id": 34237106,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 32 mmHg</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The value of normal Glomerular capillary oncotic pressure is 32 mmHg.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Oncotic pressure, or colloid osmotic-pressure, is a form of osmotic pressure induced by the proteins, notably albumin, in a blood vessel's plasma (blood/liquid. that causes a pull-on fluid back into the capillary. Participating colloids displace water molecules, thus creating a relative water molecule deficit with water molecules moving back into the circulatory system within the lower venous pressure end of capillaries.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">It is mostly negligible, but sometimes can be as high as 6 mmHg in the brain. The values are also positive in the liver and kidneys.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The normal glomerular oncotic pressure is approximately 32 mmHg, which helps maintain fluid balance by drawing water back into the capillaries.</span></p>",
      "correct_choice_id": 200590,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50148,
      "choices": [
        {
          "id": 200592,
          "text": "<p><span style=\"font-size:12.0pt;\">Lateral rectus</span></p>"
        },
        {
          "id": 200593,
          "text": "<p><span style=\"font-size:12.0pt;\">Superior oblique</span></p>"
        },
        {
          "id": 200594,
          "text": "<p><span style=\"font-size:12.0pt;\">Risorius</span></p>"
        },
        {
          "id": 200595,
          "text": "<p><span style=\"font-size:12.0pt;\">Levator palpebrae superioris</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Identify the structure which is responsible for elevation and is supplied by the nerve emergency from the structure shown in the image? (</span>INICET Nov 2022)</p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/1.jpg\" alt=\"\" width=\"300\" height=\"378\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/1.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q4226647",
      "question_audio": null,
      "question_video": null,
      "map_id": 34996170,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Risorius</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Risorius is supplied by the facial nerve, resulting in the marked elevation. The image depicts the floor of the fourth ventricle, as well as the facial colliculus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/2.jpg\" alt=\"\" width=\"500\" height=\"390\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The facial colliculus is a raised area on the floor of the fourth ventricle in the brainstem, and it is associated with the motor nucleus of the facial nerve (cranial nerve VII). The facial nerve is responsible for the motor innervation of the muscles of facial expression, including the risorius muscle, which is one of the muscles that can cause elevation of the corner of the mouth in smiling. Therefore, the structure that is supplied by the nerve causing this elevation would be the risorius muscle.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/3.jpg\" alt=\"\" width=\"500\" height=\"429\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/1.1_NIFgYDP.jpg\" width=\"2087\" height=\"2238\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lateral rectus:</strong> Is an extraocular muscle that arises from the lateral part of the common tendinous ring. It is innervated by the abducens nerve.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Superior oblique:</strong> Is an extraocular muscle that arises from the body of the sphenoid. It is innervated by the trochlear nerve.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Levator palpebrae superioris:</strong></span><span style=\"color:#374151;font-size:12.0pt;\"> The levator palpebrae superioris muscle is supplied by the oculomotor nerve (cranial nerve III). This muscle is responsible for raising the upper eyelid (levator means \"elevator\"), allowing you to open your eyes.</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\">The oculomotor nerve also innervates several other muscles that control eye movement and pupil constriction, making it an important cranial nerve for eye function</span></p><p> </p><p><span style=\"color:#374151;font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"color:#0d0d0d;font-size:11pt;\">The risorius muscle, responsible for pulling the corner of the mouth laterally and aiding in expressions like smiling, is innervated by the facial nerve.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/2.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200594,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50149,
      "choices": [
        {
          "id": 200596,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Fixed drug eruption </span></span></p>"
        },
        {
          "id": 200597,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Urticaria</span></span></p>"
        },
        {
          "id": 200598,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Maculopapular rash</span></span></p>"
        },
        {
          "id": 200599,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Atopic dermatitis</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Skin manifestations caused by the drug administered for amebic dysentery are due to ______. </span></span></p>",
      "unique_key": "Q2555139",
      "question_audio": null,
      "question_video": null,
      "map_id": 34685825,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A) Fixed drug eruption</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The skin manifestations are most commonly due to <strong><span style=\"font-family:\"Calibri\",sans-serif\">metronidazole</span></strong>, which is associated with <strong><span style=\"font-family:\"Calibri\",sans-serif\">fixed drug eruption (FDE)</span></strong>.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Although <strong><span style=\"font-family:\"Calibri\",sans-serif\">maculopapular rashes</span></strong> can also be seen with metronidazole, the incidence of a <strong><span style=\"font-family:\"Calibri\",sans-serif\">fixed drug eruption</span></strong> is higher with metronidazole.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Fixed drug eruptions </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">are characterized by <strong><span style=\"font-family:\"Calibri\",sans-serif\">sharply demarcated, dull red to brown lesions</span></strong>. They typically occur on the <strong><span style=\"font-family:\"Calibri\",sans-serif\">lips, hands, legs, face, genitalia</span></strong>, and <strong><span style=\"font-family:\"Calibri\",sans-serif\">oral mucosa</span></strong>, and can cause a burning sensation. These lesions are usually solitary or few in number and <strong><span style=\"font-family:\"Calibri\",sans-serif\">recur at the same location</span></strong> when the patient is re-exposed to the drug.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">FDE is a type of <strong><span style=\"font-family:\"Calibri\",sans-serif\">delayed hypersensitivity reaction</span></strong>. Drugs like <strong><span style=\"font-family:\"Calibri\",sans-serif\">NSAIDs</span></strong> and <strong><span style=\"font-family:\"Calibri\",sans-serif\">paracetamol</span></strong> are some of the most common culprits causing FDE.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h4><span style=\"font-size:12pt\"><span style=\"font-family:\"Calibri Light\",sans-serif\"><em><span style=\"font-family:\"Calibri\",sans-serif\">Drug-specific clinical patterns of FDE:</span></em></span></span></h4>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">NSAIDs</span></strong>: Lips and genitals</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Tetracycline/Trimethoprim-sulfamethoxazole</span></strong>: Genitals</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Metamizole</span></strong>: Trunk and extremities</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Carbocysteine</span></strong>: Face</span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Diagnosis </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">is based on clinical history and lesion morphology. The first step in management is <strong><span style=\"font-family:\"Calibri\",sans-serif\">discontinuation of the offending drug</span></strong>. The image below shows a <strong><span style=\"font-family:\"Calibri\",sans-serif\">well-defined hyperpigmented patch</span></strong> of a fixed drug eruption.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Urticaria: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Urticaria is characterized by <strong><span style=\"font-family:\"Calibri\",sans-serif\">hives</span></strong> or raised, itchy welts, which is a different presentation than FDE. It is typically not associated with metronidazole in the context of amebic dysentery treatment.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option C. Maculopapular rash: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">While maculopapular rashes can occur with metronidazole, <strong><span style=\"font-family:\"Calibri\",sans-serif\">fixed drug eruption</span></strong> is more commonly associated with it in cases of amebic dysentery treatment.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Atopic dermatitis: </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">Atopic dermatitis presents as chronic, itchy, and inflamed skin, often linked to allergens or irritants. This is not related to drug reactions like fixed drug eruptions seen with metronidazole.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<h3><span style=\"font-size:13.5pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">:</span></span></strong></span></span></h3>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Fixed drug eruption (FDE) </span></strong><span style=\"font-family:\"Calibri\",sans-serif\">is a common drug reaction, especially with medications like <strong><span style=\"font-family:\"Calibri\",sans-serif\">metronidazole</span></strong>. It presents as <strong><span style=\"font-family:\"Calibri\",sans-serif\">sharply demarcated, recurrent lesions</span></strong> at the same location upon re-exposure to the drug. Recognizing this pattern is essential for diagnosis and discontinuation of the offending drug.</span></span></span></p>",
      "correct_choice_id": 200596,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50150,
      "choices": [
        {
          "id": 200600,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Tocainide</span></span></span></span></span></p>"
        },
        {
          "id": 200601,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Propranolol</span></span></span></span></span></p>"
        },
        {
          "id": 200602,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\">﻿﻿﻿<span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Quinidine</span></span></span></span></span></p>"
        },
        {
          "id": 200603,
          "text": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">﻿﻿﻿Lignocaine</span></span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:\"Calibri\",sans-serif\">An anti-arrhythmic drug, which is effective in both atrial and ventricular arrhythmias, is shown to have the following effect on action potential. Which of the following is the most likely drug? (</span></span></span></span>INICET Nov 2022)</p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-family:Helvetica\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-10.jpg\" style=\"height:150px; width:300px\" /></span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-10.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3112058",
      "question_audio": null,
      "question_video": null,
      "map_id": 34259144,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans.  C. Quinidine</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Quinidine and procainamide are class IA anti-arrhythmic agents. These blocks Na+ channel along with potassium channel as well. This increases action potential duration (APD), which leads to QT prolongation.</span></span></span></span></span><br />\r\n\t<br />\r\n\t </li>\r\n</ul>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica\"><span style=\"font-family:Helvetica\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-11.jpg\" style=\"height:201px; width:400px\" /></span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">A. Tocainide</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Tocainide is a Class IB anti-arrhythmic drug. These drugs block Na+ channels and open K+ channels, reducing the slope of phase 4 of the action potential. This effect shortens the action potential duration.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-180023.png\" style=\"height:241px; width:400px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Propranolol</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Propranolol is a beta-receptor blocker and a Class II anti-arrhythmic. It works primarily by inhibiting sympathetic input to the heart, reducing heart rate, and decreasing the force of contraction. It does not directly affect the action potential duration in the same way as Class I drugs.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Lignocaine</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Lignocaine (Lidocaine) is a Class IB anti-arrhythmic drug. It shortens the action potential duration by blocking Na+ channels and opening K+ channels. This effect is the opposite of what is shown in the graph.</span></span></span></p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-180053.png\" style=\"height:246px; width:400px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Note – </span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Class 1c agents like Flecainide and Encainide block sodium channels with no action on potassium channel. The image below illustrates the action potential changes when a class 1c anti-arrhythmic is used.</span></span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-180124.png\" style=\"height:240px; width:400px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-family:Helvetica,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:9pt\"><span style=\"font-family:Helvetica,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Class IA anti-arrhythmic agents like Quinidine prolong the action potential duration by blocking sodium and potassium channels, making them effective in treating both atrial and ventricular arrhythmias. This effect is clearly reflected in the graph provided, distinguishing it from other classes of anti-arrhythmic drugs.</span></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/06/pharmc-1-11.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200602,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50151,
      "choices": [
        {
          "id": 200604,
          "text": "<p><span style=\"font-size:12.0pt;\">3 iron and folic acid (IFA) tablets, taken OD</span></p>"
        },
        {
          "id": 200605,
          "text": "<p><span style=\"font-size:12.0pt;\">IV iron sucrose for non-compliance with oral tablets</span></p>"
        },
        {
          "id": 200606,
          "text": "<p><span style=\"font-size:12.0pt;\">2 iron and folic acid tablets OD + IV iron sucrose</span></p>"
        },
        {
          "id": 200607,
          "text": "<p><span style=\"font-size:12.0pt;\">IM ferric carboxy maltose (FCM)</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman presenting at less than 34 weeks of gestation displays signs of mild to moderate anemia. Under the \"Anemia Mukh Bharat\" initiative, which therapeutic approach would be the most appropriate? (INICET NOV 2022)</span></p>",
      "unique_key": "Q9161245",
      "question_audio": null,
      "question_video": null,
      "map_id": 34296112,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) IV iron sucrose for non-compliance with oral tablets</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The best treatment among the given options is IV iron sucrose for non-compliance with oral tablets.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Severity of Anemia according to Anemia Mukt Bharat campaign,</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Mild – 10-10.9 g%</span></li><li><span style=\"font-size:12.0pt;\">Moderate – 7-9 g%</span></li><li><span style=\"font-size:12.0pt;\">Severe – <7 g %</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Testing and treating Mild and Moderate Anemia:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">If mild anemia OR moderate anemia: Give 2 tablets of iron and folic acid</span></li><li><span style=\"font-size:12.0pt;\">If patient presents late in pregnancy or is unable to tolerate oral iron: Parenteral iron – IV Iron sucrose or Ferric carboxymaltose (FeCM).</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Treating Severe anemia:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Hb < 7g%: Parenteral iron – IV Iron sucrose or Ferric carboxymaltose (FeCM).</span></li><li><span style=\"font-size:12.0pt;\">If patient presents late in the third trimester with severe anemia or Hb is less than 5 g%: ADMIT</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>Anemia Mukt Bharat (2018)</u></strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Aim: Reduce anemia by 3% per year</span></p><p> </p><p><span style=\"font-size:12.0pt;\">6 x 6 x 6 strategy</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/psm-pyq-17.jpg\" alt=\"\" width=\"558\" height=\"101\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture10777.jpg\" alt=\"\" width=\"500\" height=\"369\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture1133.jpg\" alt=\"\" width=\"800\" height=\"425\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/psm-pyq-17.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200605,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50152,
      "choices": [
        {
          "id": 200608,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Primaquine</span></span></span></p>"
        },
        {
          "id": 200609,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Chloroquine</span></span></span></p>"
        },
        {
          "id": 200610,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Penicillin</span></span></span></p>"
        },
        {
          "id": 200611,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Tetracycline</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following drug should not be prescribed in a patient with G6PD deficiency due to risk of development of hemolysis?</span></span></p>",
      "unique_key": "Q5847568",
      "question_audio": null,
      "question_video": null,
      "map_id": 34830177,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. A. Primaquine</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">G6PD is an enzyme in the hexose monophosphate pathway (HMP) that regulates NADPH levels in the cell. NADPH is required for the conversion of oxidized glutathione to reduced glutathione, which is required to protect the cell from oxidative damage. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">When drugs like Primaquine are administered in a patient with G6PD deficiency, it causes free radical formation, leading to oxidative stress. This results in intravascular hemolysis. </span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Therefore, Primaquine is contraindicated in G6PD deficiency.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">B. Chloroquine</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Chloroquine is also an antimalarial drug but does not generally cause oxidative stress to the extent that primaquine does. It is less likely to cause hemolysis in patients with G6PD deficiency.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">C. Penicillin</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Penicillin is an antibiotic that is not typically associated with causing oxidative stress or hemolysis in patients with G6PD deficiency.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option <strong><span style=\"font-family:\"Calibri\",sans-serif\">D. Tetracycline</span></strong></span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Tetracycline is an antibiotic that is also not associated with causing hemolysis in patients with G6PD deficiency.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Drugs contraindicated in G6PD deficiency are –</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Primaquine (Tafenoquine)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Dapsone</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Sulfonamides (including cotrimoxazole)</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Nitrofurantoin </span></span></span></li>\r\n</ul>",
      "correct_choice_id": 200608,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50153,
      "choices": [
        {
          "id": 200612,
          "text": "<p><span style=\"font-size:12.0pt;\">Silicosis</span></p>"
        },
        {
          "id": 200613,
          "text": "<p><span style=\"font-size:12.0pt;\">Sarcoidosis</span></p>"
        },
        {
          "id": 200614,
          "text": "<p><span style=\"font-size:12.0pt;\">Post-radiation therapy lymph nodes</span></p>"
        },
        {
          "id": 200615,
          "text": "<p><span style=\"font-size:12.0pt;\">Metastatic lymph nodes</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Egg shell calcification is seen in all the following, except? (INICET NOV 2022)</span></p>",
      "unique_key": "Q4423648",
      "question_audio": null,
      "question_video": null,
      "map_id": 34304322,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Metastatic lymph node</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">A ring of calcification at the periphery of a lymph node is known as eggshell calcification.</span></p><p> </p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\">While calcifications can occur in metastatic nodes, they usually do not form the classic eggshell pattern. Instead, calcifications in metastatic nodes are often more irregular or diffusely distributed.</span></p><p> </p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\"><strong>Option A. Silicosis:</strong> This condition, often seen in individuals exposed to silica dust, can lead to eggshell calcification of the lymph nodes due to chronic inflammation and fibrosis.</span></p><p> </p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\"><strong>Option B. Sarcoidosis:</strong> Another granulomatous disease that can lead to eggshell calcification in lymph nodes as part of its systemic manifestation affecting the lungs and lymphatic system.</span></p><p> </p><p><span style=\"background-color:white;color:#0d0d0d;font-size:12.0pt;\"><strong>Option C. Post-radiation therapy lymph nodes:</strong> Radiation can induce changes in lymph node structure including calcifications, commonly in a peripheral pattern, as a late sequela of treatment.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"background-color:white;color:#0d0d0d;font-size:10.5pt;\">Eggshell calcification is a specific radiologic sign associated with certain granulomatous diseases and post-treatment changes but is not commonly seen in metastatic lymph nodes. </span><span style=\"font-size:12.0pt;\">It may be seen in:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Silicosis</span></li><li><span style=\"font-size:12.0pt;\">Sarcoidosis</span></li><li><span style=\"font-size:12.0pt;\">post-radiation therapy in lymph nodes</span></li><li><span style=\"font-size:12.0pt;\">post-ATT in lymph nodes in TB</span></li></ol>",
      "correct_choice_id": 200615,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50154,
      "choices": [
        {
          "id": 200616,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior cerebral artery and middle cerebral artery</span></p>"
        },
        {
          "id": 200617,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior cerebral artery and posterior cerebral artery</span></p>"
        },
        {
          "id": 200618,
          "text": "<p><span style=\"font-size:12.0pt;\">Anterior cerebral artery and anterior communicating artery</span></p>"
        },
        {
          "id": 200619,
          "text": "<p><span style=\"font-size:12.0pt;\">Middle cerebral artery and posterior cerebral artery</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the blood supply of the structure marked with the arrow in the image below?</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/28/whatsapp-image-2023-06-12-at-1901260.jpg\" alt=\"\" width=\"300\" height=\"225\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/06/28/whatsapp-image-2023-06-12-at-1901260.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q8048811",
      "question_audio": null,
      "question_video": null,
      "map_id": 34334767,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C. Anterior cerebral artery and anterior communicating artery</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The corpus callosum is the largest fibre pathway in the brain. The corpus callosum is composed of the rostrum, genu, trunk or body, and splenium.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The corpus callosum is a large bundle of nerve fibers that connects the two hemispheres of the brain and allows for communication between them. It is supplied with blood by the anterior cerebral artery and the anterior communicating artery, which are both branches of the internal carotid artery.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The anterior cerebral artery supplies blood to the front and top of the brain, including the medial surface of the cerebral hemispheres, which is where the corpus callosum is located. The anterior communicating artery connects the two anterior cerebral arteries and provides additional blood supply to the corpus callosum. Damage to the corpus callosum, such as from a stroke or traumatic brain injury, can disrupt communication between the two hemispheres and lead to a range of neurological symptoms depending on the location and severity of the damage.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The corpus callosum is the major commissural pathway connecting the cerebral hemispheres that receives its blood supply from anterior communicating artery, pericallosal artery, and posterior pericallosal artery”.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">“Pericallosal artery is formed by branches of from anterior and posterior cerebral arteries (Mainly anterior cerebral artery). Pericallosal arteries which are derived from anterior cerebral arteries supply the anterior 4/5th of corpus callosum and posterior 1/5th is supplied by pericallosal artery derived from posterior cerebral artery.”</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Since the arrow is near the posterior end of body answer is ACommA + ACA</span><br><span style=\"font-size:12.0pt;\">If the arrow was near the anterior end, answer will be ACommA + ACA</span><br><span style=\"font-size:12.0pt;\">If the arrow is on splenium, the answer will be ACA + PCA</span><br> </p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/12.jpg\" alt=\"\" width=\"500\" height=\"331\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">    <img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/13.jpg\" alt=\"\" width=\"500\" height=\"256\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A</strong>. <strong>Anterior cerebral artery and middle cerebral artery:</strong> The anterior cerebral artery does supply the corpus callosum, but the middle cerebral artery does not play a significant role in its blood supply.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Anterior cerebral artery and posterior cerebral artery:</strong> While the anterior cerebral artery supplies the corpus callosum, the posterior cerebral artery primarily supplies the posterior parts of the brain, including the occipital lobes. It doesn't contribute significantly to the blood supply of the corpus callosum.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Middle cerebral artery and posterior cerebral artery:</strong> Neither the middle cerebral artery nor the posterior cerebral artery is the primary supplier of blood to the corpus callosum.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"background-color:white;color:#0d0d0d;font-size:11.0pt;\">The corpus callosum's blood supply is primarily provided by the anterior cerebral artery, with additional support from the anterior communicating artery. This knowledge is crucial in understanding potential impacts of circulatory issues within the brain, such as strokes, which could affect interhemispheric communication.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/09/12.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200618,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50155,
      "choices": [
        {
          "id": 200620,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anterior infiltration in females</span></span></p>"
        },
        {
          "id": 200621,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anterior infiltration in males</span></span></p>"
        },
        {
          "id": 200622,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lateral infiltration</span></span></p>"
        },
        {
          "id": 200623,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Posterior infiltration</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Severe intractable pain in the leg due to sciatica in a patient with carcinoma rectum is due to: </span></span></p>",
      "unique_key": "Q1548127",
      "question_audio": null,
      "question_video": null,
      "map_id": 34707819,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Anterior infiltration in females</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The most appropriate and specific answer is that sciatica in patients with rectal carcinoma occurs due to <strong>anterior infiltration in females</strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sciatica associated with rectal carcinoma is a result of <em>perineural invasion</em> of the <strong>inferior hypogastric plexus</strong>, which gives rise to the sciatic nerve. The location of this plexus differs between males and females:</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In <strong>females</strong>, the inferior hypogastric plexus lies <strong>anterolateral</strong> to the rectum.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In <strong>males</strong>, the plexus is located <strong>lateral</strong> to the rectum.</span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Thus, in females, infiltration occurs anteriorly, making <strong>anterior infiltration in females</strong> the most specific answer for this condition.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Anterior infiltration in males</strong>: The inferior hypogastric plexus lies lateral, not anterior, to the rectum in males.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Lateral infiltration</strong>: While the hypogastric plexus is lateral in males, lateral infiltration does not explain sciatica due to rectal carcinoma in females.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Posterior infiltration</strong>: The hypogastric plexus is not located posteriorly in relation to the rectum in either males or females, making this option incorrect.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Sciatica in rectal carcinoma patients, particularly in females, is often due to <em>anterior infiltration</em> of the inferior hypogastric plexus, which supplies the sciatic nerve. Understanding the anatomical differences in the positioning of the plexus between males and females is crucial in diagnosing the cause of sciatic pain in these patients.</span></span></p>",
      "correct_choice_id": 200620,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50156,
      "choices": [
        {
          "id": 200624,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Decreased oxidative phosphorylation</span></span></span></p>"
        },
        {
          "id": 200625,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased ATP production</span></span></span></p>"
        },
        {
          "id": 200626,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Reduced chemiosmosis</span></span></span></p>"
        },
        {
          "id": 200627,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Water retention in inner mitochondrial space</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increased H<sup>+</sup> ions in the intermembrane space of mitochondria are due to? (</span></span></span>INICET Nov 2022)</p>",
      "unique_key": "Q7552389",
      "question_audio": null,
      "question_video": null,
      "map_id": 34472062,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. A) Decreased oxidative phosphorylation</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Decreased oxidative phosphorylation:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">This is the correct answer. Oxidative phosphorylation is a crucial process in the mitochondria where electrons are transferred through the electron transport chain (ETC), leading to the pumping of H+ ions into the intermembrane space. The flow of electrons and the pumping of H+ ions create a proton gradient across the inner mitochondrial membrane, which is essential for ATP synthesis through chemiosmosis. If oxidative phosphorylation is decreased or inhibited, as in conditions like anoxia or the use of certain inhibitors, it leads to an accumulation of H+ ions in the intermembrane space without their subsequent utilization for ATP production.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Increased ATP production:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Increased ATP production would lead to the consumption of H+ ions in the intermembrane space, not their accumulation. So, this option is not correct.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Reduced chemiosmosis:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Chemiosmosis is the process by which H+ ions flow back into the mitochondrial matrix through ATP synthase, driving the synthesis of ATP. A reduction in chemiosmosis would actually lead to a buildup of H+ ions in the intermembrane space, not a decrease. Therefore, this option is not correct.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Water retention in the inner mitochondrial space:</span></strong></span></span></p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Water retention does not directly affect the concentration of H+ ions in the intermembrane space or oxidative phosphorylation. This option is not directly related to the accumulation of H+ ions in the intermembrane space.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">ATP is synthesized in mitochondria by a process called <strong>oxidative phosphorylation</strong>. The oxidation of substrates like carbohydrates, amino acids, or fats produces <strong>reducing equivalents (NADH, FADH<sub>2</sub>).</strong> <strong>These equivalents enter the electron transport chain and transfer a proton (H<sup>+</sup>) to the inter-membrane space</strong>. The inner mitochondrial membrane is not permeable to protons leading to the accumulation of H<sup>+</sup> in the intermembrane space. The flow of these protons through the F<sub>o</sub> releases the energy that phosphorylates ADP to form ATP.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Drugs that inhibit oxidative phosphorylation like oligomycin inhibit the flow of protons through F<sub>o</sub> causing an increase in H<sup>+</sup> ions in the intermembrane space</span></span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">.</span></span></p>",
      "correct_choice_id": 200624,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50157,
      "choices": [
        {
          "id": 200628,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Uterine tenderness</span></span></span></p>"
        },
        {
          "id": 200629,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Frequent contractions</span></span></span></p>"
        },
        {
          "id": 200630,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Painless vaginal bleeding</span></span></span></p>"
        },
        {
          "id": 200631,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Mild to moderate vaginal bleeding</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Antepartum hemorrhage due to abruption shows all except? </span></span>(INICET NOV 2022)</p>",
      "unique_key": "Q2165510",
      "question_audio": null,
      "question_video": null,
      "map_id": 34807798,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. C) Painless vaginal bleeding</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Explanation:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Painless vaginal bleeding</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is not a feature of abruption of the placenta. It is a characteristic feature of placenta previa.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Patients with placental abruption present with sudden-onset abdominal pain, vaginal bleeding, uterine tenderness, and frequent contractions.</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Abruptio placenta</span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> is the partial or total separation of a normally implanted placenta before delivery, leading to bleeding and other complications.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Other options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option A. Uterine tenderness</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: This is a common feature of placental abruption due to the separation of the placenta from the uterine wall.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option B. Frequent contractions</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Increased frequency of uterine contractions is associated with placental abruption.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Option D. Mild to moderate vaginal bleeding</span></strong><span style=\"font-family:\"Calibri\",sans-serif\">: Vaginal bleeding of varying degrees, from mild to severe, is typically seen in placental abruption.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Placental abruption presents with sudden-onset abdominal pain, vaginal bleeding, uterine tenderness, and frequent contractions, but not with painless vaginal bleeding, which is characteristic of placenta previa.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ref: William’s textbook of obstetrics 26<sup>th</sup> edition pg1944,  Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 297</span></strong></span></span></p>",
      "correct_choice_id": 200630,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50158,
      "choices": [
        {
          "id": 200632,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hyperresonance on percussion</span></span></p>"
        },
        {
          "id": 200633,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Coarse crackles</span></span></p>"
        },
        {
          "id": 200634,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Dull note on percussion</span></span></p>"
        },
        {
          "id": 200635,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Pleural rub</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient has a fever, cough, and cold. The chest X-ray is given below. What will be the examination finding in the infra-scapular region? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103848-am.jpeg\" style=\"height:212px; width:300px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103848-am.jpeg\" alt=\"Question Image\"></p>",
      "unique_key": "Q1374087",
      "question_audio": null,
      "question_video": null,
      "map_id": 34985839,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Dull note on percussion</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The patient's symptoms and the chest X-ray findings indicate pleural effusion. Key features of pleural effusion on a chest X-ray include the meniscus sign and blunting of the costophrenic angle. Clinically, pleural effusion leads to reduced or absent air entry in the affected area.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A dull note on percussion is a hallmark sign of pleural effusion. This occurs due to the accumulation of fluid in the pleural space, which does not transmit sound vibrations as efficiently as air-filled lung tissue.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Hyperresonance on percussion:</span></strong><span style=\"font-size:12.0pt\"> This finding is characteristic of pneumothorax, where there is an excess of air in the pleural space, leading to increased resonance.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Coarse crackles:</span></strong><span style=\"font-size:12.0pt\"> Coarse crackles can be heard in various conditions such as bronchiectasis</span></span></span><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">, the resolving phase of pneumonia, or pulmonary edema. However, they are not typically associated with pleural effusion.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Pleural rub:</span></strong><span style=\"font-size:12.0pt\"> Pleural rub is a sign of pleuritis or inflammation of the pleura. It is usually absent in pleural effusion due to the separation of pleural surfaces by fluid.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A dull note on percussion is a key clinical finding in pleural effusion, indicating the presence of fluid in the pleural space.</span></span></span></p>\r\n\r\n<p> </p>",
      "correct_choice_id": 200634,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50159,
      "choices": [
        {
          "id": 200636,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">It is mostly hereditary</span></span></p>"
        },
        {
          "id": 200637,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Diffuse type of gastric cancer is characterised by k-RAS mutation</span></span></p>"
        },
        {
          "id": 200638,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Wnt signaling pathway defect is seen in intestinal-type gastric CA</span></span></p>"
        },
        {
          "id": 200639,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Depth of cancer has no role in prognosis</span></span></p>"
        }
      ],
      "text": "<p><span dir=\"ltr\" lang=\"EN-IN\" style=\"font-size:11.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A 65-year-old male presents to the gastroenterology clinic with complaints of weight loss, early satiety, and anorexia. The physician suspects gastric carcinoma and orders further investigations to confirm the diagnosis. Which of the following statements regarding gastric carcinoma is correct? </span></span></p>",
      "unique_key": "Q7158977",
      "question_audio": null,
      "question_video": null,
      "map_id": 34320875,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C. Wnt signaling pathway defect is seen in intestinal-type gastric CA.</strong></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Gastric carcinoma, or stomach cancer, is a malignant tumor of the stomach lining. Most cases of gastric cancer are sporadic, and only a small percentage are due to genetic predisposition. Lauren's system classifies gastric cancer into two types: Type I - intestinal and Type II - diffuse.</span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"> At the molecular level, the intestinal type of cancer is characterized by mutations in the APC gene or beta-catenin causes increased signalling via the Wnt pathway (Option C). </span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">On the other hand, diffuse-type is characterized by decreased E-cadherin mainly due to loss-of-function mutations in the CDH1 gene (Option B). </span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Symptoms of both types include nausea, dyspepsia, dysphagia, weight loss, anorexia, early satiety, and anemia. </span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">The most widely used staging system for gastric cancer is TNM, which uses depth of invasion, nodal and distant metastases as prognostic indicators (Option D). </span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\">Local invasion into the duodenum, pancreas, and retroperitoneum is common, where chemo or radiation therapy with palliative care is the treatment. When possible, surgery remains the preferred treatment approach.</span></span></p>",
      "correct_choice_id": 200638,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50160,
      "choices": [
        {
          "id": 200640,
          "text": "<p><span style=\"font-size:12pt;\">LSCS</span></p>"
        },
        {
          "id": 200641,
          "text": "<p><span style=\"font-size:12pt;\">Pfannenstiel incision</span></p>"
        },
        {
          "id": 200642,
          "text": "<p><span style=\"font-size:12pt;\">Upper segment cesarean section</span></p>"
        },
        {
          "id": 200643,
          "text": "<p><span style=\"font-size:12pt;\">Done in OT</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is true regarding perimortem cesarean section? </span>(INICET NOV 2022)</p>",
      "unique_key": "Q8775156",
      "question_audio": null,
      "question_video": null,
      "map_id": 34415321,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) Upper segment cesarean section</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">An upper segment cesarean section is performed during a perimortem cesarean section (PMCS). PMCS is an emergency cesarean delivery of a woman who is expected to die within the next few moments or has just died.</span></p><p> </p><p><span style=\"font-size:12pt;\">Key points about PMCS:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Timing</strong>: According to the AHA 2020 Guidelines for CPR, perimortem cesarean should be considered if there is no return of spontaneous circulation within 5 minutes in a pregnant woman who has experienced total cardiopulmonary arrest.</span></li><li><span style=\"font-size:12pt;\"><strong>Purpose</strong>: The goal of PMCS is to improve maternal and fetal outcomes by relieving the compression of the inferior vena cava (IVC) by the gravid uterus, which enhances venous return and diaphragmatic displacement. This, in turn, improves respiratory dynamics and resuscitative efforts.</span></li><li><span style=\"font-size:12pt;\"><strong>Fetal Outcome</strong>: The infant has a higher chance of survival if PMCS is performed within 10 minutes of maternal death.</span></li><li><span style=\"font-size:12pt;\"><strong>Surgical Technique</strong>: A classical upper-segment cesarean section with a vertical uterine incision is performed.</span></li><li><span style=\"font-size:12pt;\"><strong>Location</strong>: PMCS does not need to be done in the operating theatre (OT); it can be done wherever the patient is located to expedite the process.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. LSCS</strong>: Lower segment cesarean section (LSCS) is not typically used in PMCS.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Pfannenstiel incision</strong>: This is a horizontal incision typically used in elective cesarean sections, not in emergency PMCS.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Done in OT</strong>: PMCS does not need to be performed in the operating theatre; it can be done immediately at the site of the patient to save time.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Perimortem cesarean section (PMCS) involves performing a classical upper-segment cesarean section with a vertical uterine incision in an emergency situation to improve maternal and fetal outcomes.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: </strong></span><a href=\"https://www.ncbi.nlm.nih.gov/books/NBK459265/\"><span style=\"font-size:12pt;\"><strong><u>https://www.ncbi.nlm.nih.gov/books/NBK459265/</u></strong></span></a></p>",
      "correct_choice_id": 200642,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50161,
      "choices": [
        {
          "id": 200644,
          "text": "<p><span style=\"font-size:12.0pt;\">Left Rinne's test negative, Weber's test lateralized to right ear</span></p>"
        },
        {
          "id": 200645,
          "text": "<p><span style=\"font-size:12.0pt;\">Left Rinne's test negative, Weber's test lateralized to left ear</span></p>"
        },
        {
          "id": 200646,
          "text": "<p><span style=\"font-size:12.0pt;\">Left Rinne's test positive, Weber's test lateralized to right ear</span></p>"
        },
        {
          "id": 200647,
          "text": "<p><span style=\"font-size:12.0pt;\">Left Rinne's test positive, Weber's test lateralized to left ear</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A woman presents with impaired hearing. Her audiometry findings are given below:  (</span>INICET Nov 2021)</p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/image_NA8q83V.png\" width=\"300\" height=\"262\"></p><p> </p><p><span style=\"font-size:12.0pt;\">Pick the right combination of tuning fork test results that would be seen in this patient. </span>(INICET NOVEMBER 2022)</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/image_NA8q83V.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q1586058",
      "question_audio": null,
      "question_video": null,
      "map_id": 34410517,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Left Rinne’s test positive, Weber’s test lateralized to right ear</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Based on the provided tympanogram findings, it is likely that the tuning fork tests for this patient would reveal a positive left Rinne test and Weber test lateralized to the right ear (normal ear).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/untitled-24.jpg\" alt=\"\" width=\"500\" height=\"320\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><u>INTERPRETATION OF AUDIOGRAM</u></strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Whenever a PTA is given, <strong>first see whether there is air-bone gap </strong>(AC & BC curves are separated by a long gap) or not</span></li><li><span style=\"font-size:12.0pt;\">If there is no air-bone gap or very little gap, then it could be sensorineural hearing loss.</span></li><li><span style=\"font-size:12.0pt;\">If there is a long separation in between the AC & BC curves, then it could be either conductive or mixed.</span></li><li><span style=\"font-size:12.0pt;\">First see whether the distantly separated curves are present in the upper part of the graph or lower part.</span></li><li><span style=\"font-size:12.0pt;\">If occupying upper part, then it is conductive hearing loss and if occupying lower part, then it could be mixed.</span></li><li><span style=\"font-size:12.0pt;\">In the question given above, left sided air conduction and bone conduction curves do not have any gap and they are occupying middle part of the graph. Hence, it is left SNHL.</span></li></ul><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/20/screenshot-2024-06-20-115232.png\" alt=\"\" width=\"1000\" height=\"271\"></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Left Rinne's test negative, Weber's test lateralized to right ear</strong>: This result would be expected in conductive hearing loss, not SNHL.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Left Rinne's test negative, Weber's test lateralized to left ear</strong>: This also indicates conductive hearing loss, which is not supported by the audiogram findings.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Left Rinne's test positive, Weber's test lateralized to left ear</strong>: This would indicate normal hearing or mild hearing loss in the right ear, which does not match the audiogram showing significant SNHL in the left ear.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In sensorineural hearing loss, Rinne's test remains positive, and Weber's test lateralizes to the better-hearing ear. The provided audiogram indicates left-sided SNHL, resulting in a positive Rinne test on the left and Weber lateralizing to the right ear.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Ref - Dhingra 7<sup>th</sup> edition, Page No. 24, 25</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/09/13/untitled-24.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200646,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50162,
      "choices": [
        {
          "id": 200648,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Isospora</span></span></span></p>"
        },
        {
          "id": 200649,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Cryptosporidium</span></span></span></p>"
        },
        {
          "id": 200650,
          "text": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Cyclospora</span></span></span></p>"
        },
        {
          "id": 200651,
          "text": "<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Microspora</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">On Ziehl-Neelsen (ZN) staining oocysts of size 8-10 µm cysts are visible. Identify the organism?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:10.5pt\"><span style=\"font-family:\"Calibri\",sans-serif\"> (</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">INICET NOV 2022)</span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-120408.png\" style=\"height:324px; width:400px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-120408.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q1956860",
      "question_audio": null,
      "question_video": null,
      "map_id": 34294162,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Ans. C) Cyclospora</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cyclospora cayetanensis is a coccidian parasite that causes the gastrointestinal disease cyclosporiasis. The organism produces oocysts that are 8-10 µm in diameter, which can be detected by Ziehl-Neelsen staining. The oocysts exhibit a variable acid-fast staining property and can also autofluoresce under ultraviolet light.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Cyclospora oocysts have the following characteristics:</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<ul>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Size</span></strong><span style=\"font-size:12.0pt\">: 8-10 µm in diameter.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Staining</span></strong><span style=\"font-size:12.0pt\">: They show variable acid-fast staining.</span></span></span></li>\r\n\t<li style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Autofluorescence</span></strong><span style=\"font-size:12.0pt\">: They exhibit blue-green autofluorescence under ultraviolet light.</span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-120540.png\" style=\"height:787px; width:600px\" /></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Isospora</span></strong><span style=\"font-size:12.0pt\">: Isospora (now known as Cystoisospora) produces larger oocysts, typically 20-30 µm in size, and contains two sporocysts with four sporozoites each. It does not match the 8-10 µm size described.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Cryptosporidium</span></strong><span style=\"font-size:12.0pt\">: Cryptosporidium oocysts are smaller, measuring 4-6 µm in diameter, and consistently exhibit acid-fast staining and bright auramine fluorescence. They do not match the size range described.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Microspora</span></strong><span style=\"font-size:12.0pt\">: Microspora are a group of spore-forming unicellular parasites that do not fit the description of having 8-10 µm oocysts visible with Ziehl-Neelsen staining.</span></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">Educational Objective</span></strong></span></span></p>\r\n\r\n<p style=\"text-align:left\"> </p>\r\n\r\n<p style=\"text-align:left\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/04/06-1.jpg\" style=\"height:323px; width:600px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-120540.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200650,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50163,
      "choices": [
        {
          "id": 200652,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        },
        {
          "id": 200653,
          "text": "<p><span style=\"font-size:12.0pt;\">3</span></p>"
        },
        {
          "id": 200654,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        },
        {
          "id": 200655,
          "text": "<p><span style=\"font-size:12.0pt;\">2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">The following are parvovirus-related manifestations. Identify the incorrect pair?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Pure red cell aplasia - chronic hemolytic anemia</span></li><li><span style=\"font-size:12.0pt;\">Polymyalgia rheumatica - young women</span></li><li><span style=\"font-size:12.0pt;\">Hydrops fetalis - pregnant women</span></li><li><span style=\"font-size:12.0pt;\">Erythema infectiosum - infants</span></li></ol>",
      "unique_key": "Q2765610",
      "question_audio": null,
      "question_video": null,
      "map_id": 34781631,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 2</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Polymyalgia rheumatica is closely associated with giant cell arteritis in women above 50yrs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>1. Pure red cell aplasia - chronic hemolytic anemia: </strong>Parvovirus B19 can cause pure red cell aplasia, particularly in patients with chronic hemolytic anemia. The virus affects erythroid precursors in the bone marrow, leading to severe anemia in these patients.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>3. Hydrops fetalis - pregnant women: </strong>Parvovirus B19 infection during pregnancy can lead to severe fetal complications, including hydrops fetalis, which is a life-threatening condition characterized by severe edema in the fetus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>4. Erythema infectiosum - infants: </strong>Erythema infectiosum, also known as fifth disease or slapped-cheek disease, is a common manifestation of parvovirus B19 infection in young children, not just infants. It presents with a characteristic \"slapped cheek\" rash.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Polymyalgia rheumatica is typically seen in women above 50 years old and is not related to parvovirus infection in young women. Parvovirus B19 is more commonly associated with conditions such as erythema infectiosum in children, pure red cell aplasia in patients with chronic hemolytic anemia, and hydrops fetalis in pregnant women.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Parvo virus infection -</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Common symptoms of parvovirus B19 (B19V) infection include a mild nonspecific prodromal illness that may consist of fever (15-30% of patients), malaise, headache, myalgia, nausea, and rhinorrhea; typically beginning 5-7 days after initial infection</span></p><p> </p><p><span style=\"font-size:12.0pt;\">A diffuse maculopapular rash can appear 1-4 days later and fades to a <strong>lacy erythematous rash,</strong> which may be pruritic and may spread gradually toward the distal extremities. Most seropositive patients have no history of this classic biphasic illness. The clinical symptoms widely vary, and the classic <strong>\"slapped cheek\" rash</strong> is much more common in young children called as erythema infectiosum, also known as fifth disease or slapped-cheek disease,</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/picture3_yezpQKZ.jpg\" alt=\"\" width=\"400\" height=\"210\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Alternatively, parvovirus B19 infection may manifest with purpuric rash, erythema multiforme, or pruritus of the soles of the feet. Parvovirus B19 may cause a <strong>papular-purpuric \"gloves-and-socks\" syndrome (PPGSS</strong>), which manifests as an erythematous exanthem of the hands and feet with a distinct margin at the wrist and ankle joints.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Transient <strong>small joint arthropathy</strong> may be the main clinical presentation of parvovirus B19 in adults.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Pure red cell aplasia and chronic hemolytic anemia</strong> is seen  in patients with immunosuppression.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Patients with severe anemia due to <strong>transient aplastic crisis (TAC</strong>) may present with pallor, fatigue, or signs of an aplastic crisis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Parvovirus B19V infection during pregnancy can lead to <strong>hydrops fetalis and/or fetal loss</strong>.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/picture3_yezpQKZ.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200655,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50164,
      "choices": [
        {
          "id": 200656,
          "text": "<p><span style=\"font-size:12.0pt;\">1</span></p>"
        },
        {
          "id": 200657,
          "text": "<p><span style=\"font-size:12.0pt;\">2</span></p>"
        },
        {
          "id": 200658,
          "text": "<p>3</p>"
        },
        {
          "id": 200659,
          "text": "<p><span style=\"font-size:12.0pt;\">4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Choose the egg belonging to the following parasite from the column B?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/28.jpg\" alt=\"\" width=\"400\" height=\"650\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/28.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q3203798",
      "question_audio": null,
      "question_video": null,
      "map_id": 34879346,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) 3</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The above worm is <strong>Enterobius vermicularis</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Adults are short, white, fusiform worms with pointed ends, looking like bits of white thread. The <strong>mouth is surrounded by three wing-like curricular expansions (cervical alae</strong>), which are <strong>transversely striated.</strong> as seen in the image provided in the question. The esophagus has a double bulb structure, a feature unique to this worm.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-89.jpg\" alt=\"\" width=\"500\" height=\"590\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The egg is colorless and not bile-stained. It floats in saturated salt solution. It has a characteristic shape, being elongated ovoid, flattened on one side and convex on the other (planoconvex), measuring 50-60 μm by 20-30 μm. The eggshell is double-layered and relatively thick, though transparent. The outer albuminous layer makes the eggs stick to each other and to clothing and other objects. The egg contains a tadpole-shaped coiled embryo, which is fully formed, but becomes infectious only 6 hours after being deposited on the skin. Under cool moist conditions, the egg remains viable for about 2 weeks.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-90.jpg\" alt=\"\" width=\"500\" height=\"371\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The correctly matched egg for the given parasite - Enterobius vermicularis is 3</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other choices:</strong></span><br> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A: Egg of Hymenolepsis nana</strong></span><br> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B: Egg of Tenia species </strong></span><br> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D: Fertilized egg of ascaris</strong></span><br> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Enterobius vermicularis eggs are elongated ovoid, flattened on one side and convex on the other, with a double-layered, thick, transparent shell and contain a tadpole-shaped coiled embryo.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-89.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200658,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50165,
      "choices": [
        {
          "id": 200660,
          "text": "<p><span style=\"font-size:12.0pt;\">Interferon gamma</span></p>"
        },
        {
          "id": 200661,
          "text": "<p><span style=\"font-size:12.0pt;\">Interleukin-2</span></p>"
        },
        {
          "id": 200662,
          "text": "<p><span style=\"font-size:12.0pt;\">Interleukin-12</span></p>"
        },
        {
          "id": 200663,
          "text": "<p><span style=\"font-size:12.0pt;\">Interleukin-4</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Delayed hypersensitivity is due to?</span><span style=\"font-size:10.5pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET NOVEMBER 2022)</span></p>",
      "unique_key": "Q2756917",
      "question_audio": null,
      "question_video": null,
      "map_id": 34198515,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Interferon gamma</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Delayed-type hypersensitivity (DTH) is a form of cell-mediated immune response that occurs typically 24-72 hours after exposure to the antigen. This response is primarily mediated by T-helper 1 (Th1) cells which secrete a variety of cytokines, including Interferon gamma (IFN-γ). IFN-γ is crucial in activating macrophages and enhancing their microbicidal activity, which is a key component of the DTH response. This type of hypersensitivity is important in defense against intracellular pathogens such as Mycobacterium tuberculosis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-105707.png\" alt=\"\" width=\"500\" height=\"439\"></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/03/31/1-micro-87.jpg\" alt=\"\" width=\"500\" height=\"376\"></strong></span></p><p> </p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Interleukin-2 (IL-2)</strong> - IL-2 is primarily involved in the activation and proliferation of T cells but is not the primary mediator of delayed hypersensitivity reactions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Interleukin-12 (IL-12)</strong> - IL-12 plays a role in the differentiation of naive T cells into Th1 cells and can promote IFN-γ production, but it is not the direct mediator of DTH.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Interleukin-4 (IL-4)</strong> - IL-4 is associated with the differentiation of naive T cells into Th2 cells and promotes humoral immunity, which is not involved in delayed-type hypersensitivity reactions.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Interferon gamma is the key cytokine responsible for mediating delayed hypersensitivity reactions by activating macrophages and enhancing their pathogen-killing capabilities.</span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/03/screenshot-2024-07-03-105707.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200660,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50166,
      "choices": [
        {
          "id": 200664,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Renal failure</span></span></span></p>"
        },
        {
          "id": 200665,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Accumulation of calcium phosphate</span></span></span></p>"
        },
        {
          "id": 200666,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Vitamin D deficiency</span></span></span></p>"
        },
        {
          "id": 200667,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Parathyroid activation secretion</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">All of the following conditions are associated with Metastatic calcification except: (INICET Nov 2022)</span></span></p>",
      "unique_key": "Q6060148",
      "question_audio": null,
      "question_video": null,
      "map_id": 34902784,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. C) Vitamin D deficiency</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Metastatic calcification is associated with Hypercalcemia (Vitamin D toxicity), not Vitamin D deficiency.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-131920.jpg\" style=\"height:403px; width:1000px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><u><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Tumors having Dystrophic calcification: Psammoma bodies present</span></u></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">M – M</span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">eningioma, <strong>M</strong>esothelioma</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">O – O</span></strong><span dir=\"ltr\" lang=\"PT-BR\" style=\"font-size:12.0pt\">vary (Serous cystadenoma)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">S – S</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">alivary gland tumor</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">T – T</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">hyroid (Papillary thyroid cancer)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">P – P</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">rolactinoma</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">G – G</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">lucagonoma</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Renal failure</span></strong><span style=\"font-size:12.0pt\">: Chronic kidney disease can lead to secondary hyperparathyroidism and hyperphosphatemia, both of which contribute to hypercalcemia and subsequent metastatic calcification.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Accumulation of calcium phosphate</span></strong><span style=\"font-size:12.0pt\">: This typically occurs in the context of renal failure or parathyroid hormone-related issues, leading to metastatic calcification.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D Parathyroid activation secretion</span></strong><span style=\"font-size:12.0pt\">: Hyperparathyroidism, whether primary or secondary, causes an increase in serum calcium, leading to metastatic calcification.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Metastatic calcification is associated with conditions that lead to hypercalcemia, not with conditions that result in normal or low calcium levels, such as Vitamin D deficiency.</span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-131920.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200666,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50167,
      "choices": [
        {
          "id": 200668,
          "text": "<p><span style=\"font-size:12.0pt;\">External pressure</span></p>"
        },
        {
          "id": 200669,
          "text": "<p><span style=\"font-size:12.0pt;\">Mental tension</span></p>"
        },
        {
          "id": 200670,
          "text": "<p><span style=\"font-size:12.0pt;\">It is the body's response to anything that requires attention or action causing physical, emotional, or psychological strain</span></p>"
        },
        {
          "id": 200671,
          "text": "<p><span style=\"font-size:12.0pt;\">Internal strain</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following is the most appropriate definition of stress? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q2054869",
      "question_audio": null,
      "question_video": null,
      "map_id": 34264399,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) It is the body's response to anything that requires attention or action causing physical, emotional, or psychological strain.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Stress is a broad term that encompasses the body's physical, emotional, and psychological responses to any demand or threat, whether real or perceived.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. External stress: </strong>It is inaccurate as not all stress arises from external pressure. Personal thoughts, emotions, and internal conflicts can also induce stress.</span></p><p><span style=\"font-size:10.5pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Muscle tension:</strong> It simplifies stress to just \"mental tension.\" While mental tension can be a component of stress, the definition doesn't capture the breadth of physiological and psychological reactions associated with stress.</span></p><p><span style=\"font-size:10.5pt;\"> </span></p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Internal strain:</strong> It refers to the outcome of the stress rather than the cause or process of stress itself.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong> </span></p><p> </p><p><span style=\"font-size:12.0pt;\">Stress can be conceptualized as the body's adaptive response to demands or threats. It's not just a psychological phenomenon; it has physiological correlates as well. Stressors can be external (e.g., environmental pressures) or internal (e.g., illness, or undergoing a medical procedure), and they can be short-lived (acute) or long-term (chronic).</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Reference: Kaplan and Sadock’s Comprehensive Textbook of Psychiatry, 10th edition, Page No 2117</strong></span></p>",
      "correct_choice_id": 200670,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50168,
      "choices": [
        {
          "id": 200672,
          "text": "<p><span style=\"font-size:12.0pt;\">BIRADS 1 or 2</span></p>"
        },
        {
          "id": 200673,
          "text": "<p><span style=\"font-size:12.0pt;\">BIRADS 2 or 4</span></p>"
        },
        {
          "id": 200674,
          "text": "<p><span style=\"font-size:12.0pt;\">BIRADS 2, 3, or 4</span></p>"
        },
        {
          "id": 200675,
          "text": "<p><span style=\"font-size:12.0pt;\">BIRADS 2</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What is the appropriate BIRADS category for a 23-year-old woman with a breast lump, no skin changes, and no indurations, whose histology shows a fibroadenoma appearance? (INICET NOV 2022)</span></p>",
      "unique_key": "Q1910679",
      "question_audio": null,
      "question_video": null,
      "map_id": 34502977,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) BIRADS 2</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">BIRADS 2 is used for benign findings. Given that the histology shows a fibroadenoma appearance, which is a well-recognized benign breast condition, BIRADS 2 is the most suitable category for this scenario.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. BIRADS 1 or 2</strong>: BIRADS 1 is assigned to a category when there is no suspicion of malignancy, and BIRADS 2 is used when there is a benign finding. In this case, since the histology shows a fibroadenoma appearance, which is a benign breast condition, BIRADS 2 is the most appropriate category.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. BIRADS 2 or 4</strong>: BIRADS 4 is used when there is a suspicious abnormality that may or may not be cancerous. Since the histology in this case indicates a fibroadenoma appearance, which is benign, BIRADS 4 would not be appropriate.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>BIRADS 2, 3, or 4</strong>: BIRADS 3 is assigned when there is a probably benign finding that requires short-term follow-up. In this case, since the histology indicates a fibroadenoma appearance (a benign finding), BIRADS 3 and BIRADS 4 would not be applicable.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">In the case of a 23-year-old woman with a breast lump, no skin changes, and no indurations, whose histology shows a fibroadenoma appearance, the appropriate BIRADS category is BIRADS 2.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Fibroadenoma is a benign tumor that poses a low risk of malignancy. The Breast Imaging Reporting and Data System (BIRADS) categories are used to assess the likelihood of malignancy of breast lesions seen on mammograms, ultrasounds, or MRI. Grades 1 and 2 have a very low probability of being malignant, while grade 3 has a slightly higher probability of malignancy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Grades 4 and 5 are considered suspicious and warrant further investigation as they have a higher probability of malignancy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-171804.jpg\" alt=\"\" width=\"1000\" height=\"494\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-171804.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200675,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50169,
      "choices": [
        {
          "id": 200676,
          "text": "<p><span style=\"font-size:12.0pt;\">Hemoperitoneum leads to reddish discoloration of the flanks of the abdomen.</span></p>"
        },
        {
          "id": 200677,
          "text": "<p><span style=\"font-size:12.0pt;\">Cullen’s sign refers to discoloration around the umbilicus.</span></p>"
        },
        {
          "id": 200678,
          "text": "<p><span style=\"font-size:12.0pt;\">Palpation begins at the site of pain.</span></p>"
        },
        {
          "id": 200679,
          "text": "<p><span style=\"font-size:12.0pt;\">Guarding and rigidity indicate peritoneal irritation.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with severe abdominal pain. Identify the false statement given about the examination of the abdomen: (INICET NOV 2022)</span></p>",
      "unique_key": "Q9609694",
      "question_audio": null,
      "question_video": null,
      "map_id": 34619529,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Palpation begins at the site of pain.</strong></span></p><p><span style=\"font-size:11pt;\"><strong> </strong></span></p><p><span style=\"font-size:12.0pt;\">Palpation in the examination of a patient with abdominal pain should never start at the site of pain. Instead, it should begin away from the painful area to avoid causing the patient unnecessary discomfort and to prevent muscle guarding that might obscure findings. This approach allows the examiner to gather information about the non-painful areas first and approach the painful site last, ensuring a more accurate and less distressing examination.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hemoperitoneum leads to reddish discoloration of the flanks of the abdomen: </strong>This statement is correct. Hemoperitoneum, which is bleeding into the peritoneal cavity, can cause reddish or purplish discoloration on the flanks, known as Grey Turner’s sign. This is a significant indicator of internal bleeding, particularly in cases of acute pancreatitis or trauma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Cullen’s sign refers to discoloration around the umbilicus: </strong>This statement is correct. Cullen’s sign is the appearance of bluish discoloration around the umbilicus, which indicates intraperitoneal hemorrhage. It is often associated with conditions such as ruptured ectopic pregnancy or acute pancreatitis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Guarding and rigidity indicate peritoneal irritation: </strong>This statement is correct. Guarding (voluntary or involuntary muscle contraction) and rigidity (a constant, board-like hardness of the abdominal muscles) are classic signs of peritoneal irritation or inflammation, such as that seen in peritonitis. These signs suggest that there may be an underlying acute inflammatory or infectious process in the abdomen.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">When examining a patient with abdominal pain, always begin palpation away from the site of pain to ensure a more accurate and less distressing assessment.</span></p>",
      "correct_choice_id": 200678,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50170,
      "choices": [
        {
          "id": 200680,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-d, 3-a, 4-d</span></p>"
        },
        {
          "id": 200681,
          "text": "<p><span style=\"font-size:12.0pt;\">1-d, 2-b, 3-a, 4-c</span></p>"
        },
        {
          "id": 200682,
          "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-d, 3-c, 4-d</span></p>"
        },
        {
          "id": 200683,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-c, 3-d, 4-b</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old man from Mumbai presents to a clinic with fatigue and weakness. His family has a history of chronic diseases, but he himself has been asymptomatic until recently. The physician explains the different stages of disease progression and the interventions required. Which of the following best matches the stages with their relevant descriptions? (INICET NOV 2022)</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-123815.png\" alt=\"\" width=\"700\" height=\"142\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-123815.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q1309943",
      "question_audio": null,
      "question_video": null,
      "map_id": 34278408,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1-d, 2-b, 3-a, 4-c</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Natural history of disease refers to the progression of a disease in an individual over time, in the absence of treatment. It has two phases, a period of pre-pathogenesis and a period of pathogenesis.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip48.jpg\" alt=\"\" width=\"700\" height=\"344\"></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The period of pre-pathogenesis is before the onset of disease in humans.</span></li><li><span style=\"font-size:12.0pt;\">An interaction between the agent, host and the environment occurs in this phase before the pathogenesis.</span></li><li><span style=\"font-size:12.0pt;\">It starts with appropriate exposure to or accumulation of factors sufficient for the disease process to begin in a susceptible host.</span></li><li><span style=\"font-size:12.0pt;\">The exposure is a microorganism in an infectious disease. For lung cancer, it is any factor that initiates the process, such as asbestos fibres or components in tobacco smoke.</span></li><li><span style=\"font-size:12.0pt;\">Primary prevention (health promotion and specific protection) is applicable in this period.</span></li><li><span style=\"font-size:12.0pt;\">The period of pathogenesis starts after the disease process has been triggered and pathological changes occur without the individual being aware of it.</span></li><li><span style=\"font-size:12.0pt;\">It begins with the entry of the organism till recovery, death, or disability.</span></li><li><span style=\"font-size:12.0pt;\">The subclinical or asymptomatic period between exposure and onset of symptoms is called the incubation period for infectious diseases, and the latency period for chronic diseases.</span></li><li><span style=\"font-size:12.0pt;\">The onset of clinical symptoms is the beginning of the clinical stage of the disease.</span></li><li><span style=\"font-size:12.0pt;\">Secondary (halting of the disease process) and tertiary prevention (measures to limit disability) are applicable in this period.</span></li><li><span style=\"font-size:12.0pt;\">Rehabilitation has been defined as the use of medical, social, educational, and vocational measures for training the individual to the highest possible level of functional ability.</span></li><li><span style=\"font-size:12.0pt;\">It is a part of tertiary prevention like providing callipers for walking patients and arranging schooling after being affected by polio.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture6555.jpg\" alt=\"\" width=\"900\" height=\"495\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/23/ip48.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200681,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50171,
      "choices": [
        {
          "id": 200684,
          "text": "<p><span style=\"font-size:12pt;\">Warning bleeds</span></p>"
        },
        {
          "id": 200685,
          "text": "<p><span style=\"font-size:12pt;\">Dark painful bleeding</span></p>"
        },
        {
          "id": 200686,
          "text": "<p><span style=\"font-size:12pt;\">Uterine tenderness</span></p>"
        },
        {
          "id": 200687,
          "text": "<p><span style=\"font-size:12pt;\">Increased large uterine size</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Which of the following is seen in placenta previa? </span>(INICET NOV 2022)</p>",
      "unique_key": "Q5416402",
      "question_audio": null,
      "question_video": null,
      "map_id": 34566152,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Warning bleeds</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Placenta previa is a condition where the placenta is implanted in the lower uterine segment, either over or close to the internal cervical os. Key features of placenta previa include:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Warning bleeds</strong>: Also known as sentinel bleeds, are sudden-onset, recurrent, painless vaginal bleeding episodes that typically begin in the third trimester or during labor.</span></li><li><span style=\"font-size:12pt;\"><strong>Soft, non-tender uterus</strong>: The abdominal examination reveals a soft and non-tender uterus, with the fundal height proportionate to the gestational age.</span></li><li><span style=\"font-size:12pt;\"><strong>Normal fetal heart rate</strong>: The fetal heart rate is usually normal unless there is severe bleeding due to a large separation.</span></li><li><span style=\"font-size:12pt;\"><strong>Malpresentations are common</strong>: Due to the lower placement of the placenta.</span></li><li><span style=\"font-size:12pt;\"><strong>Diagnosis</strong>: Confirmed via transabdominal sonography or transvaginal sonography, which is safe and more accurate.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Dark painful bleeding</strong>: This is characteristic of placental abruption, not placenta previa. Placental abruption presents with painful, dark vaginal bleeding due to the premature separation of the placenta.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Uterine tenderness</strong>: Uterine tenderness is also a feature of placental abruption, where the uterus becomes firm and tender due to bleeding and clot formation behind the placenta.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Increased large uterine size</strong>: This is not a specific feature of placenta previa. Uterine size in placenta previa is proportionate to the gestational age.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Placenta previa typically presents with painless, recurrent vaginal bleeding (warning bleeds) in the third trimester or during labor, with a soft, non-tender uterus.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of obstetrics 26<sup>th</sup> edition pg1940, Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg 307</strong></span></p>",
      "correct_choice_id": 200684,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50172,
      "choices": [
        {
          "id": 200688,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Inside the membrane at the N-terminal end</span></span></p>"
        },
        {
          "id": 200689,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Inside the membrane at the C-terminal end</span></span></p>"
        },
        {
          "id": 200690,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Outside the membrane at the N-terminal end</span></span></p>"
        },
        {
          "id": 200691,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Outside the membrane at the C-terminal end</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Where is the signaling sequence in a type 2 membrane protein located?</span><span style=\"background-color:lime\"><span style=\"font-family:\"Calibri\",sans-serif\"> </span></span></span></p>",
      "unique_key": "Q7875696",
      "question_audio": null,
      "question_video": null,
      "map_id": 34453787,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans.</strong> <strong>A) Inside the membrane at the N-terminal end</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The signaling sequence in a type 2 membrane protein is located <strong>inside the membrane</strong> (transmembrane region) <strong>at the N-terminal end</strong>. This is important for the proper function and orientation of the protein in the cell membrane.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A membrane protein can either be an integral protein (spanning the membrane) or a peripheral protein (attached to one side of the membrane).</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Integral membrane proteins</strong> span the entire membrane and are embedded in it. They are crucial for various functions such as signaling, transport, and cell communication.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Peripheral proteins</strong> attach to only one surface of the membrane and do not penetrate fully.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Signaling sequences</strong> are short chains of amino acids located at the <strong>N-terminal end</strong> of the membrane proteins. These sequences anchor the protein to the membrane and are either cleaved or act as membrane anchors for transporting proteins across the membrane.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Type II integral proteins</strong> specifically have a non-cleavable N-terminal signal/anchor sequence. Examples include transferrin receptors and glycosyl transferases.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Inside the membrane at the C-terminal end: </strong>This option is incorrect because type II integral proteins have their signaling sequences located at the <strong>N-terminal end</strong>, not the C-terminal end.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Outside the membrane at the N-terminal end: </strong>This option is incorrect because signaling sequences are <strong>inside the membrane</strong>, not outside.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Outside the membrane at the C-terminal end: </strong>This is incorrect because the signaling sequence for type 2 proteins is located at the N-terminal end inside the membrane.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The signaling sequence for a type 2 membrane protein is located <strong>inside the membrane at the N-terminal end</strong>, which anchors the protein to the membrane.</span></span></p>",
      "correct_choice_id": 200688,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50173,
      "choices": [
        {
          "id": 200692,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis with high anion gap</span></p>"
        },
        {
          "id": 200693,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis with high anion gap</span></p>"
        },
        {
          "id": 200694,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis with normal anion gap</span></p>"
        },
        {
          "id": 200695,
          "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis with normal anion gap</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following electrolyte abnormalities is seen in methanol intoxication? (INICET NOV 2022)</span></p>",
      "unique_key": "Q5267336",
      "question_audio": null,
      "question_video": null,
      "map_id": 34929174,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Metabolic acidosis with high anion gap</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Methanol intoxication leads to metabolic acidosis with a high anion gap & high osmolal gap. Methanol is metabolized in the body to formic acid, which is a strong acid. The accumulation of formic acid in the bloodstream results in an increase in hydrogen ion concentration, leading to acidosis. The high anion gap indicates that there are unmeasured anions (such as formate) contributing to the acidosis. In addition to causing a high anion gap, methanol intoxication also leads to a high osmolal gap, which is another diagnostic clue in cases of toxic alcohol ingestion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Metabolic alkalosis with high anion gap: </strong>This statement is incorrect because methanol intoxication does not cause alkalosis. Instead, it causes acidosis due to the production of formic acid.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Metabolic acidosis with normal anion gap: </strong>This statement is incorrect because the acidosis caused by methanol intoxication is characterized by a high anion gap due to the accumulation of formate, a byproduct of methanol metabolism.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Metabolic alkalosis with normal anion gap: </strong>This statement is incorrect because methanol intoxication leads to acidosis, not alkalosis, and the anion gap is elevated, not normal.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Methanol intoxication causes metabolic acidosis with a high anion gap due to the accumulation of formic acid.</span></p>",
      "correct_choice_id": 200693,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50174,
      "choices": [
        {
          "id": 200696,
          "text": "<p><span style=\"font-size:12.0pt;\">CT Head</span></p>"
        },
        {
          "id": 200697,
          "text": "<p><span style=\"font-size:12.0pt;\">CT Cervical spine</span></p>"
        },
        {
          "id": 200698,
          "text": "<p><span style=\"font-size:12.0pt;\">CT Limbs</span></p>"
        },
        {
          "id": 200699,
          "text": "<p><span style=\"font-size:12.0pt;\">CT Abdomen</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Whole- body CT scan protocol for a trauma patient includes all, except? (INICET NOV 2022)</span></p>",
      "unique_key": "Q2746525",
      "question_audio": null,
      "question_video": null,
      "map_id": 34074615,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) CT limbs</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">CT Limbs is not included in the whole-body CT of a trauma patient.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. CT Head:</strong> Non-contrast CT (NCCT) of the head to check for any intracranial hemorrhages or fractures.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. CT Cervical Spine:</strong> NCCT of the cervical spine to assess for any fractures or dislocations that may compromise the spinal cord.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. CT Abdomen:</strong> Contrast-enhanced CT of the torso, including the abdomen and pelvis, to evaluate for internal injuries such as organ lacerations, bleeding, or other trauma-related abnormalities.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Whole-body CT or trauma CT includes:</span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">NCCT head</span></li><li><span style=\"font-size:12.0pt;\">NCCT C-spine</span></li><li><span style=\"font-size:12.0pt;\">Contrast-enhanced CT of torso</span></li></ol>",
      "correct_choice_id": 200698,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50175,
      "choices": [
        {
          "id": 200700,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 4</span></p>"
        },
        {
          "id": 200701,
          "text": "<p><span style=\"font-size:12pt;\">1, 3, 4</span></p>"
        },
        {
          "id": 200702,
          "text": "<p><span style=\"font-size:12pt;\">2, 3, 4</span></p>"
        },
        {
          "id": 200703,
          "text": "<p><span style=\"font-size:12pt;\">1, 2, 3</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt;\">Chemoprophylaxis for leprosy should be given to which of the following persons?</span>(INICET NOVEMBER 2022)</p><p> </p><ol><li><span style=\"font-size:12pt;\">Sharing the same clothes, towels</span></li><li><span style=\"font-size:12pt;\">Living with a patient with leprosy for > 6 month</span></li><li><span style=\"font-size:12pt;\">Contact of age more than 2 years</span></li><li><span style=\"font-size:12pt;\">Contact for more than 20 hours per week. </span></li></ol><p> </p>",
      "unique_key": "Q7757259",
      "question_audio": null,
      "question_video": null,
      "map_id": 34058198,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. C) 2, 3, 4</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Chemoprophylaxis for leprosy should be given to contacts 2, 3 and 4.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Chemoprophylaxis for leprosy should be given to the following contacts:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">Being identified as a contact, i.e., a person who has been in close contact with the index case for <strong>20 hours (option 4) or more per week for more than 3 months</strong> <strong>(option 2)</strong> (Exception is <strong>blanket approach</strong> where no link with an index case needs to be established.)</span></li><li><span style=\"font-size:12pt;\"><strong>Age:</strong> <strong>More than 2 years (option 3);</strong> if younger than 2 years, the child can be given SDR at the age of 2, in follow up visits of contacts (if meeting all other inclusion criteria.)</span></li><li><span style=\"font-size:12pt;\"><strong>Consent of the contact obtained</strong>. Depending on the country situation, this can be <strong>written</strong> or a <strong>verbal consent</strong>. In case of children, consent should be obtained from the <strong>parent</strong> or <strong>guardian,</strong> and sometimes an <strong>assent</strong> from the <strong>grown-up</strong> <strong>children.</strong></span></li><li><span style=\"color:#0f0f0f;font-size:12pt;\"><strong>Sharing </strong>the same <strong>clothes and</strong> <strong>towels (Option 1),</strong> while a potential <strong>route of transmission</strong>, is <strong>not</strong> generally considered a primary <strong>criterion</strong> for <strong>chemoprophylaxis.</strong></span></li></ul><p> </p><p><span style=\"color:black;font-size:12pt;\"><strong>Exclusion criteria</strong></span></p><p> </p><ul><li><span style=\"color:black;font-size:12pt;\">Persons with possible signs and/or symptoms of <strong>leprosy;</strong></span></li><li><span style=\"color:black;font-size:12pt;\">Persons with possible signs and/or symptoms of <strong>TB</strong> <strong>or confirmed with TB;</strong></span></li><li><span style=\"color:black;font-size:12pt;\">Persons with a history of <strong>liver or kidney disorders</strong>;</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Pregnancy</strong>; SDR can be <strong>given after the delivery</strong>;</span></li><li><span style=\"color:black;font-size:12pt;\">Persons who have received <strong>rifampicin in the last two years</strong> e.g. as treatment of TB, leprosy or as prophylaxis (e.g. contact of another index case);</span></li><li><span style=\"color:black;font-size:12pt;\">Persons with history of <strong>allergy to rifampicin</strong>;</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Refusal to take SDR.</strong></span></li></ul><p> </p><p><span style=\"color:black;font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Chemoprophylaxis for leprosy is crucial for contacts who have had significant exposure to an individual with leprosy, particularly those living in the same household or in close contact for extended periods.</span></p><p> </p><p><span style=\"color:black;font-size:12pt;\"><strong>Rifampicin:</strong></span></p><p> </p><ul><li><span style=\"font-size:12pt;\">A <strong>single dose of 600 mg</strong> kills more than <strong>99%</strong> of the <strong>susceptible organisms</strong> present at the start of treatment, that is as much as <strong>3 to 6 months</strong> of daily treatment with the combination <strong>dapsone plus Clofazimine.</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Rifampicin </strong>has become established as a <strong>highly potent bactericidal drug</strong>, and it acts by <strong>inhibiting</strong> the <strong>bacterial DNA dependent RNA polymerase</strong>.</span></li><li><span style=\"color:black;font-size:12pt;\"><strong>Single Dose of Rifampicin </strong>(SDR) is used in <strong>chemoprophylaxis.</strong></span></li><li><span style=\"color:black;font-size:12pt;\">Chemoprophylaxis must be initiated only <strong>4 weeks after treatment for leprosy</strong> has begun in the <strong>patient</strong> so as to ensure the <strong>patient is non-infectious</strong>.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><i><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-22-160933.jpg\" alt=\"\" width=\"1000\" height=\"405\"></i></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref - </strong></span><span style=\"color:black;font-size:12pt;\"><strong>Jopling’s Handbook of Leprosy 6<sup>th</sup> Edition Page no 242</strong></span></p><p><span style=\"color:#3c4245;font-size:12pt;\"><strong>Leprosy/Hansen disease: Contact tracing and post-exposure prophylaxis</strong></span></p><p><a href=\"https://www.who.int/publications/i/item/9789290228073\"><span style=\"font-size:12pt;\"><strong><u>https://www.who.int/publications/i/item/9789290228073</u></strong></span></a><span style=\"font-size:12pt;\"><strong> (page 23, 24)</strong></span></p><p><a href=\"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051288/\"><span style=\"font-size:12pt;\"><strong><u>https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3051288/</u></strong></span></a></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/22/screenshot-2023-11-22-160933.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200702,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50176,
      "choices": [
        {
          "id": 200704,
          "text": "<p><span style=\"font-size:12.0pt;\">A-1, B-2, C-3, D-4</span></p>"
        },
        {
          "id": 200705,
          "text": "<p><span style=\"font-size:12.0pt;\">A-2, B-4, C-1, D-3</span></p>"
        },
        {
          "id": 200706,
          "text": "<p><span style=\"font-size:12.0pt;\">A-3, B-2, C-1, D-4</span></p>"
        },
        {
          "id": 200707,
          "text": "<p><span style=\"font-size:12.0pt;\">A-4, B-2, C-3, D-1</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following cancers with their corresponding criteria for the minimum number of lymph nodes required for pathological staging: (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-162903.jpg\" alt=\"\" width=\"600\" height=\"241\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/17/screenshot-2023-11-17-162903.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6489807",
      "question_audio": null,
      "question_video": null,
      "map_id": 34630989,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) A-1, B-2, C-3, D-4</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The minimum number of lymph nodes required for accurate staging are 16 for stomach carcinoma, 12 for colon carcinoma, 6 for gall bladder carcinoma, and 10 for breast carcinoma.</span></p>",
      "correct_choice_id": 200704,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50177,
      "choices": [
        {
          "id": 200708,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Varenicline</span></span></p>"
        },
        {
          "id": 200709,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Cevimeline</span></span></p>"
        },
        {
          "id": 200710,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Muscarine</span></span></p>"
        },
        {
          "id": 200711,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Atropine</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following is the most effective oral drug in smoking cessation? </span></span></p>",
      "unique_key": "Q5840115",
      "question_audio": null,
      "question_video": null,
      "map_id": 34879086,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Varenicline</strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Varenicline</strong> is the most effective oral drug for smoking cessation.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Nicotine</strong> is the principal constituent of tobacco responsible for its addictive behavior. Varenicline works by blocking the effects of nicotine on the brain. It blocks <strong>α4 and β2 nicotinic acetylcholine receptor</strong> subtypes and inhibits <strong>dopaminergic activation</strong> produced by smoking through their <strong>partial agonism</strong>. This mechanism decreases the craving and withdrawal syndrome that occurs with cessation attempts. It prevents nicotine stimulation of the mesolimbic dopamine system associated with nicotine addiction, thus helping to occlude the rewarding effect of smoking.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Varenicline is prescribed only to patients <strong>18 years or older</strong>. It is taken <strong>orally</strong>, and the dose is 0.5 mg once daily on days 1 to 3, increased to 0.5 mg twice daily on days 4 through 7, and 1 mg twice daily after day 8 for 11 weeks. Therapy should start one week before the target quit date. It can be continued for another 12 weeks (1 mg BD) to maintain abstinence.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The adverse effects include <strong>nausea</strong>, disturbed sleep, sleepwalking, agitation, drowsiness, and constipation, and it may also increase the risk of pancreatitis. Varenicline has been implicated in specific skin syndromes such as <strong>Stevens-Johnson syndrome</strong>, erythema multiforme, and photosensitivity. Varenicline can cause renal failure and kidney stones, so renal function must be monitored.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>FDA</strong> has issued a warning about mood and behavioral changes associated with its use, and there is some evidence of increased cardiovascular risk.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Cevimeline: </strong>Cevimeline is a muscarinic agonist with an affinity for both <strong>M1 and M3 receptors</strong> on the lacrimal and salivary glands. While <strong>M1 activation</strong> results in increased secretion, <strong>M3 activation</strong> results in smooth muscle contraction and expulsion of the secretions. Cevimeline enhances <strong>lacrimal secretions</strong> in <strong>Sjogren’s syndrome</strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Muscarine: </strong>Muscarine is a natural alkaloid that acts on <strong>muscarinic acetylcholine receptors</strong> but is not involved in smoking cessation.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Atropine: </strong>Atropine is an <strong>antimuscarinic agent</strong> that blocks the action of acetylcholine at muscarinic receptors and is not used for smoking cessation.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Varenicline</strong> is a partial agonist of the α4 and β2 nicotinic acetylcholine receptors and is the most effective oral drug for smoking cessation. It blocks dopaminergic stimulation and reduces the rewarding effects of nicotine.</span></span></p>",
      "correct_choice_id": 200708,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50178,
      "choices": [
        {
          "id": 200712,
          "text": "<p><span style=\"font-size:12.0pt;\">Liver</span></p>"
        },
        {
          "id": 200713,
          "text": "<p><span style=\"font-size:12.0pt;\">Pancreas</span></p>"
        },
        {
          "id": 200714,
          "text": "<p><span style=\"color:#212529;font-size:12.0pt;\">Muscle and adipose tissues</span></p>"
        },
        {
          "id": 200715,
          "text": "<p><span style=\"font-size:12.0pt;\">Placenta</span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">Which of the following tissues are dependent on insulin for glucose uptake? </span>(INICET NOV 2022)</p>",
      "unique_key": "Q2001465",
      "question_audio": null,
      "question_video": null,
      "map_id": 34021404,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Muscle and adipose tissues</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">GLUT-4 glucose transporter is insulin dependent and is the only GLUT present in muscle and adipose tissues. So, muscles and adipose tissues are totally dependent on Insulin for glucose uptake.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Liver:</strong> The liver uses GLUT-2 transporters for glucose uptake, which are not insulin-dependent. GLUT-2 allows the liver to take up glucose and store it as glycogen or use it for energy production, independent of insulin.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pancreas:</strong> The pancreas also uses GLUT-2 transporters for glucose uptake, which are not insulin-dependent. In the pancreas, GLUT-2 plays a role in sensing blood glucose levels and regulating insulin secretion.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Placenta:</strong> The placenta uses GLUT-1 and GLUT-3 transporters for glucose uptake, which are not insulin-dependent. These transporters facilitate the basal uptake of glucose to support the energy needs of the placenta and fetus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-115921.jpg\" alt=\"\" width=\"1000\" height=\"549\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-115921.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200714,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50179,
      "choices": [
        {
          "id": 200716,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Pneumoperitoneum</span></span></p>"
        },
        {
          "id": 200717,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Pneumopericardium</span></span></p>"
        },
        {
          "id": 200718,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Pneumomediastinum</span></span></p>"
        },
        {
          "id": 200719,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Hydropneumothorax</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hamman sign is seen in: (INICET NOV 2022)</span></span></span></p>",
      "unique_key": "Q9279268",
      "question_audio": null,
      "question_video": null,
      "map_id": 34367519,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.  C) Pneumomediastinum</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hamman sign, also known as Hamman's mediastinal crunch, is a crunching, rasping sound, synchronous with the heartbeat, heard over the precordium in cases of pneumomediastinum. This sign is caused by air in the mediastinum, which is the central compartment of the thoracic cavity. The presence of air in this area leads to a characteristic sound as the heart beats, which can be heard on auscultation.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Pneumoperitoneum:</span></strong><span style=\"font-size:12.0pt\"> Pneumoperitoneum refers to the presence of air within the peritoneal cavity, usually due to gastrointestinal perforation. Clinical signs include guarding, rigidity, and air under the diaphragm visible on imaging. Hamman sign is not associated with pneumoperitoneum.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Pneumopericardium:</span></strong><span style=\"font-size:12.0pt\"> This condition involves air within the pericardial cavity surrounding the heart. While it can cause similar auscultatory findings, it does not specifically present with Hamman sign.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Hydropneumothorax:</span></strong><span style=\"font-size:12.0pt\"> This condition involves both air and fluid in the pleural space. A significant clinical finding here is straight-line dullness on percussion, not Hamman sign.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hamman sign, or Hamman's crunch, is a specific clinical sign heard in cases of pneumomediastinum, characterized by a crunching sound synchronous with the heartbeat due to the presence of air in the mediastinum.</span></span></span></p>",
      "correct_choice_id": 200718,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50180,
      "choices": [
        {
          "id": 200720,
          "text": "<p><span style=\"font-size:12.0pt;\">1-a, 2-b, 3-c</span></p>"
        },
        {
          "id": 200721,
          "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-a, 3-c</span></p>"
        },
        {
          "id": 200722,
          "text": "<p><span style=\"font-size:12.0pt;\">1-c, 2-b, 3-a</span></p>"
        },
        {
          "id": 200723,
          "text": "<p><span style=\"font-size:12.0pt;\">1-b, 2-c, 3-a</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Match the following scientists with their discoveries: (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/screenshot-2023-10-27-132715.jpg\" alt=\"\" width=\"700\" height=\"222\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/screenshot-2023-10-27-132715.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q7578778",
      "question_audio": null,
      "question_video": null,
      "map_id": 34818898,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) 1-b, 2-c, 3-a</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>The correctly matched pairs are as follows:</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Walter Reed showed that yellow fever is transmitted by the Aedes mosquito.</span></li><li><span style=\"font-size:12.0pt;\">Edward Jenner - smallpox vaccination</span></li><li><span style=\"font-size:12.0pt;\">James Lind - prevention of scurvy by intake of citrus fruits</span></li></ol><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-124747.png\" alt=\"\" width=\"1000\" height=\"527\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/20/screenshot-2024-09-20-124747.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200723,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50181,
      "choices": [
        {
          "id": 200724,
          "text": "<p><span style=\"font-size:12pt;\">Conservative management</span></p>"
        },
        {
          "id": 200725,
          "text": "<p><span style=\"font-size:12pt;\">Administer tocolytics and deliver at 37 wks</span></p>"
        },
        {
          "id": 200726,
          "text": "<p><span style=\"font-size:12pt;\">Give steroid cover and wait until steroid cover is complete.</span></p>"
        },
        {
          "id": 200727,
          "text": "<p><span style=\"font-size:12pt;\">Treat hypertension, administer MgSO4, and consider termination of pregnancy.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A pregnant woman with 35 weeks+5 days gestation complains of epigastric pain, headache, and blurring of vision. Her blood pressure is 170/110 mmHg. She is in labor pain. Examination of the cervix shows a 3 cm dilatation with a bag of liquor. What is the appropriate management? </span>(INICET NOV 2022)</p>",
      "unique_key": "Q9101477",
      "question_audio": null,
      "question_video": null,
      "map_id": 34882660,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. D) Treat hypertension, administer MgSO4, and consider termination of pregnancy.</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">This pregnant woman is presenting with symptoms and signs of severe pre-eclampsia, which include:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Epigastric pain</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Headache</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Blurring of vision</strong></span></li><li><span style=\"font-size:12pt;\"><strong>Severe hypertension</strong>: Blood pressure of 170/110 mmHg.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\">In the context of severe pre-eclampsia at 35 weeks+5 days gestation, the management should include:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Treating hypertension</strong>: Immediate blood pressure control is crucial to prevent complications such as eclampsia, stroke, or placental abruption.</span></li><li><span style=\"font-size:12pt;\"><strong>Administering magnesium sulfate (MgSO4)</strong>: This is done to prevent eclamptic seizures.</span></li><li><span style=\"font-size:12pt;\"><strong>Consideration for termination of pregnancy</strong>: In cases of severe pre-eclampsia at or beyond 34 weeks, the recommended course of action is to expedite delivery to prevent further maternal and fetal complications.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option A. Conservative management</strong>: Conservative management is not appropriate for severe pre-eclampsia due to the high risk of complications for both the mother and the fetus.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Administer tocolytics and deliver at 37 weeks</strong>: Tocolytics are contraindicated in severe pre-eclampsia as the goal is to deliver the baby as soon as the condition is stable, rather than delaying delivery.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Give steroid cover and wait until steroid cover is complete</strong>: As the patient is already beyond 34 weeks of gestation, steroid administration for fetal lung maturity is not necessary, and immediate delivery is preferred.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">In cases of severe pre-eclampsia at or beyond 34 weeks of gestation, immediate management involves controlling hypertension, administering magnesium sulfate to prevent seizures, and expediting delivery.</span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/untitled-291.jpg\" alt=\"\" width=\"500\" height=\"593\"></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: Williams textbook of obstetrics 26<sup>th</sup> edition pg 1850,  Dutta’s textbook of obstetrics 8<sup>th</sup> edition pg267</strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/02/untitled-291.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200727,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50182,
      "choices": [
        {
          "id": 200728,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Amlodipine</span></span></p>"
        },
        {
          "id": 200729,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Metoprolol</span></span></p>"
        },
        {
          "id": 200730,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Losartan</span></span></p>"
        },
        {
          "id": 200731,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Furosemide</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A hypertensive patient on medication presents with the following lab values:</span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">K⁺: 6.5 meq/L</span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Na⁺: 137 meq/L</span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Urea: 42 mg/dL</span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Creatinine: 3.8 mg/dL</span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following drugs should be stopped?</span><span style=\"background-color:lime\"><span style=\"font-family:\"Calibri\",sans-serif\"> </span></span></span></p>",
      "unique_key": "Q4232783",
      "question_audio": null,
      "question_video": null,
      "map_id": 34759168,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Losartan</strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">In this hypertensive patient with hyperkalemia, <strong>losartan</strong> must be stopped.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Losartan is a competitive <strong>angiotensin II (AT1) receptor antagonist</strong>, which binds to the AT1 receptor with high affinity. Uses of losartan include:</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Antihypertensive</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Renoprotective drug in diabetes mellitus</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Stroke prophylaxis</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Portal hypertension in cirrhosis without compromising renal function</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Anti-aggregant as it is a competitive antagonist of the thromboxane A2 receptor.</span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Hyperkalemia</strong> is an important side effect of ARBs. Losartan appears to be a safe and efficacious agent to lower serum uric acid levels in patients with hyperuricemia.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Amlodipine</strong>:<strong> </strong>Gingival hyperplasia and ankle swelling are side effects of calcium channel blockers like amlodipine. Ankle edema occurs due to increased hydrostatic pressure in the capillaries present in the dependent parts of the body. This is due to reflex constriction of postcapillary vessels. Other common side effects of amlodipine include headache, dizziness, and abdominal pain.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Metoprolol</strong>:<strong> </strong>Metoprolol is a cardioselective beta-blocker. Cardioselective beta-blockers are <strong>less likely to cause hyperkalemia</strong> as an adverse effect. The risk of metoprolol-induced hyperkalemia is increased if the patient is also diabetic.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Furosemide</strong>:<strong> </strong>Furosemide is a <strong>loop diuretic</strong>. It acts by inhibiting the Na⁺-K⁺-2Cl⁻ symporter in the thick ascending limb of the loop of Henle, resulting in increased excretion of sodium, potassium, and chloride. <strong>Hypokalemia</strong>, hyperuricemia, hypocalcemia, and hypomagnesemia are the important side effects.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Losartan, an ARB (angiotensin receptor blocker), should be discontinued in hypertensive patients with hyperkalemia as it can worsen potassium retention.</span></span></p>",
      "correct_choice_id": 200730,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50183,
      "choices": [
        {
          "id": 200732,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 3</span></span></span></span></p>"
        },
        {
          "id": 200733,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">2, 4</span></span></span></span></p>"
        },
        {
          "id": 200734,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">2, 3</span></span></span></span></p>"
        },
        {
          "id": 200735,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">1, 4</span></span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following statements is true regarding the tape shown in the image? (INICET NOV 2022)</span></span></p>\r\n\r\n<p style=\"text-align:justify\"> </p>\r\n\r\n<p><span style=\"font-size:10.5pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/121.jpg\" style=\"height:40px; width:495px\" /></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">It is called Shelter's tape.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">It is used to assess severe acute malnutrition.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Reading of 13.5 to 14.5 cm is considered undernourished.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">It is useful mainly for frontline field workers.</span></span></span></span></li>\r\n</ol><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/13/121.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q6155772",
      "question_audio": null,
      "question_video": null,
      "map_id": 34326902,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B) 2, 4</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The tape shown in the image is known as <strong>Shakir's tape</strong> (not Shelter's tape). It is a tool primarily used to assess <strong>Severe Acute Malnutrition (SAM)</strong> in children aged 6-59 months by measuring the <strong>Mid-Upper Arm Circumference (MUAC)</strong>.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Key Points:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Severe Acute Malnutrition (SAM): </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Shakir's tape is specifically designed to measure the MUAC, which is an important indicator of malnutrition. MUAC is a quick and reliable method for assessing malnutrition, especially in resource-limited settings.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">MUAC Readings and Color Coding:</span></span></strong></span></span>\r\n\t<ul style=\"list-style-type:circle\">\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Red: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Less than 11.5 cm, indicating severe acute malnutrition (SAM).</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Yellow: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">11.5 to 12.5 cm, indicating moderate malnutrition or risk of malnutrition.</span></span></span></span></li>\r\n\t\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Green: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Greater than 12.5 cm, indicating a normal nutritional status.</span></span></span></span></li>\r\n\t</ul>\r\n\t</li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Frontline Field Workers: </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">The tape is especially useful for frontline field workers who are often responsible for screening large numbers of children in community settings. It is simple to use, does not require advanced training, and can quickly identify children who need nutritional intervention.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option 1 (Shelter's tape): </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">This is incorrect; the tape is correctly called Shakir's tape.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Option 3 (Reading of 13.5 to 14.5 cm): </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">This range is not considered undernourished according to the color coding system used in Shakir's tape. A reading below 11.5 cm is considered severe acute malnutrition.</span></span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Aptos,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Shakir's tape is a tool used to assess severe acute malnutrition by measuring the mid-upper arm circumference, particularly useful for frontline field workers in resource-limited settings.</span></span></span></span></p>",
      "correct_choice_id": 200733,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50184,
      "choices": [
        {
          "id": 200736,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Electrical alternans</span></span></p>"
        },
        {
          "id": 200737,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">P pulmonale</span></span></p>"
        },
        {
          "id": 200738,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Ventricular bigeminy</span></span></p>"
        },
        {
          "id": 200739,
          "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Improper calibration</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What does the ECG show? (INICET NOV 2022)</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103852-am.jpeg\" style=\"height:209px; width:300px\" /></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/whatsapp-image-2024-09-13-at-103852-am.jpeg\" alt=\"Question Image\"></p>",
      "unique_key": "Q9939853",
      "question_audio": null,
      "question_video": null,
      "map_id": 34942593,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans.  B) P pulmonale</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The ECG presented shows tall P waves in lead II, which are characteristic of P pulmonale. P pulmonale refers to the presence of abnormally tall P waves in the ECG, usually greater than 2.5 mm in height in lead II. This finding indicates right atrial enlargement, which is commonly associated with pulmonary conditions such as pulmonary hypertension. Right atrial enlargement occurs due to increased pressure or volume overload in the right atrium, often secondary to lung diseases that lead to increased pulmonary artery pressures.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Electrical alternans:</span></strong><span style=\"font-size:12.0pt\"> Electrical alternans is characterized by alternating amplitude or direction of the QRS complexes in the ECG. It is often associated with large pericardial effusions and is not indicated by the tall P waves seen in this ECG.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Ventricular bigeminy:</span></strong><span style=\"font-size:12.0pt\"> Ventricular bigeminy refers to a rhythm where every normal beat is followed by a premature ventricular contraction (PVC). The ECG would show alternating normal QRS complexes with PVCs, which is not seen here.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Improper calibration:</span></strong><span style=\"font-size:12.0pt\"> Improper calibration of an ECG machine would result in uniformly abnormal waves across all leads, which does not match the specific tall P waves observed in lead II in this case.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">P pulmonale, indicated by tall P waves greater than 2.5 mm in lead II, signifies right atrial enlargement commonly due to pulmonary hypertension or other pulmonary conditions leading to increased right atrial pressure.</span></span></span></p>",
      "correct_choice_id": 200737,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50185,
      "choices": [
        {
          "id": 200740,
          "text": "<p><span style=\"font-size:12.0pt;\">IV antibiotics, IV fluids, culture, assisted drainage, and MRI</span></p>"
        },
        {
          "id": 200741,
          "text": "<p><span style=\"font-size:12.0pt;\">IV fluids, MRI, assisted drainage, and laparotomy</span></p>"
        },
        {
          "id": 200742,
          "text": "<p><span style=\"font-size:12.0pt;\">IV antibiotics, IV fluids, culture, and assisted drainage</span></p>"
        },
        {
          "id": 200743,
          "text": "<p><span style=\"font-size:12.0pt;\">IV antibiotics, IV fluids, culture, assisted drainage, MRI, and laparotomy</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Which of the following steps are included in the management of acute necrotizing pancreatitis in a patient with large intra-abdominal fluid accumulation and pancreatic necrosis?  (INICET NOV 2022)</span></p>",
      "unique_key": "Q6605021",
      "question_audio": null,
      "question_video": null,
      "map_id": 34084944,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) IV antibiotics, IV fluids, culture, and assisted drainage</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">MRI is not indicated in patients with acute necrotising pancreatitis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The correct steps in the management of acute necrotizing pancreatitis include IV antibiotics, IV fluids, culture, and assisted drainage. Large intra-abdominal fluid accumulation and pancreatic necrosis are complications of acute pancreatitis that require immediate management.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Aggressive fluid resuscitation, pain control, and early nutrition are initiated, followed by contrast-enhanced computed tomography to diagnose necrosis. If infected necrosis is suspected, fine-needle aspiration is done, and the aspirate is subjected to Gram staining and culture sensitivity. IV antibiotics are started with carbapenem as the first-choice drug.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The step-up approach, which includes percutaneous drainage followed by minimally invasive video-assisted retroperitoneal debridement, is adopted for definitive management. Hence, the correct option is C) IV antibiotics, IV fluids, culture, and assisted drainage.</span></p>",
      "correct_choice_id": 200742,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50186,
      "choices": [
        {
          "id": 200744,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 and 2</span></span></span></p>"
        },
        {
          "id": 200745,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1 and 4</span></span></span></p>"
        },
        {
          "id": 200746,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2 and 3</span></span></span></p>"
        },
        {
          "id": 200747,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3 and 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">All of the following statements are false about IL-12 except? (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Increases production of interferon- γ</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inhibits T cells</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Inhibits B cells</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Produced by macrophages</span></span></span></li>\r\n</ol>",
      "unique_key": "Q1502606",
      "question_audio": null,
      "question_video": null,
      "map_id": 34547441,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. B) 1 and 4</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Interleukin-12 (IL-12)</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is a cytokine produced primarily by antigen-presenting cells such as macrophages and dendritic cells. It plays a critical role in the immune response by promoting the differentiation of naive T cells into Th1 cells, which are essential for cell-mediated immunity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. Increases production of interferon-γ (IFN-γ)</span></strong><span style=\"font-size:12.0pt\">: IL-12 stimulates T cells and natural killer (NK) cells to produce IFN-γ, a cytokine crucial for the immune response against intracellular pathogens.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4. Produced by macrophages</span></strong><span style=\"font-size:12.0pt\">: IL-12 is indeed produced by macrophages, along with other antigen-presenting cells, in response to pathogens.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Other options:</span></span></span></strong></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2. Inhibits T cells</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is incorrect. IL-12 actually activates T cells, particularly promoting the differentiation into Th1 cells, rather than inhibiting them.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3. Inhibits B cells</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: This is also incorrect. IL-12 does not inhibit B cells; instead, it indirectly influences B cell function by promoting a Th1 response, which supports cellular immunity over humoral (B cell) immunity.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><strong><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Educational Objective:</span></span></span></strong></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Interleukin-12 (IL-12) is produced by macrophages and increases the production of interferon- γ (IFN- γ).</span></span></span></p>",
      "correct_choice_id": 200745,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50187,
      "choices": [
        {
          "id": 200748,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase 1</span></span></span></p>"
        },
        {
          "id": 200749,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase 3</span></span></span></p>"
        },
        {
          "id": 200750,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase 2</span></span></span></p>"
        },
        {
          "id": 200751,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase 4</span></span></span></p>"
        }
      ],
      "text": "<p style=\"text-align:justify\"><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">A hospital is investigating the effectiveness of statins in a multiple-centric clinical trial. The study involves 4000-5000 patients and half of them have received the drug while the other half was given a placebo. Both the subjects and the investigators are unaware of which group is getting the drug and which group is being administered the placebo. Which of the following phases of clinical trial corresponds to this scenario? (INICET NOV 2022)</span></span></p>",
      "unique_key": "Q3711434",
      "question_audio": null,
      "question_video": null,
      "map_id": 34264736,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Ans. B. Phase 3 </span></strong><span style=\"font-family:\"Calibri\",sans-serif\"> </span></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">As the study is being conducted in multiple centers in a double blinded manner, where neither the physician nor the patients know what they are receiving, therefore this trial is in Phase 3.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The phases of clinical trials are as follows: -</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-103816.png\" style=\"height:426px; width:1000px\" /></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Phase Zero trials are called micro-dosing studies. It is an optional trial done by some companies on small number of healthy volunteers to know the pharmacokinetics of the drug. Dose used is one-hundredth of the final human dose or 100 microgram (whichever is lower).</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Pre-clinical trials are animal studies. The drugs are first tested on the small animals like rats, guinea pig etc. to know the complete pharmacokinetics.</span></span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><strong><span style=\"font-family:\"Calibri\",sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">The described clinical trial, with its large sample size, multiple centers, double-blind design, and focus on confirming the efficacy of statins, corresponds to a <strong><span style=\"font-family:\"Calibri\",sans-serif\">Phase 3</span></strong> clinical trial. This phase is crucial for determining whether the drug is effective and safe for widespread use.</span></span></span></p>\r\n\r\n<p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/22/screenshot-2024-07-22-103816.png\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200749,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50188,
      "choices": [
        {
          "id": 200752,
          "text": "<p><span style=\"font-size:12pt;\">Turner syndrome</span></p>"
        },
        {
          "id": 200753,
          "text": "<p><span style=\"font-size:12pt;\">Kallmann syndrome</span></p>"
        },
        {
          "id": 200754,
          "text": "<p><span style=\"font-size:12pt;\">Androgen insensitivity syndrome</span></p>"
        },
        {
          "id": 200755,
          "text": "<p><span style=\"font-size:12pt;\">Mayer-Rokitansky-Küster-Hauser (MRKH) syndrome</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 16-year-old presents with absent menses. Examination shows widely spaced nipples, webbed neck, and Tanner grade 1 breast development. USG shows streak ovaries. Investigation shows raised FSH, raised LH, and reduced estradiol. What is the diagnosis? </span>(INICET NOV 2022)</p>",
      "unique_key": "Q4148153",
      "question_audio": null,
      "question_video": null,
      "map_id": 34411110,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. A) Turner syndrome</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">The patient's clinical features are strongly suggestive of Turner syndrome (45XO), a condition characterized by:</span></p><p> </p><ul><li><span style=\"font-size:12pt;\"><strong>Widely spaced nipples</strong>: Shield chest appearance.</span></li><li><span style=\"font-size:12pt;\"><strong>Webbed neck</strong>: Due to congenital lymphedema.</span></li><li><span style=\"font-size:12pt;\"><strong>Tanner grade 1 breast development</strong>: Indicates no breast development.</span></li><li><span style=\"font-size:12pt;\"><strong>Streak ovaries</strong> on ultrasound: Ovaries that are underdeveloped and nonfunctional.</span></li><li><span style=\"font-size:12pt;\"><strong>Hormonal profile</strong>: Raised FSH and LH due to lack of negative feedback from the ovaries, and reduced estradiol indicating ovarian failure.</span></li></ul><p> </p><p><span style=\"font-size:12pt;\">Other clinical features of Turner syndrome include short stature, primary amenorrhea, congenital heart defects, and renal anomalies. The syndrome results in hypergonadotropic hypogonadism.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option B. Kallmann syndrome</strong>: It is characterized by hypogonadotropic hypogonadism and anosmia (lack of sense of smell), not hypergonadotropic hypogonadism.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C. Androgen insensitivity syndrome</strong>: 46XY karyotype with female external genitalia, well-developed breasts, absent axillary and pubic hair, and gonads are testes, not streak ovaries.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D. Mayer-Rokitansky-Küster-Hauser syndrome</strong>: Mullerian agenesis, where secondary sexual characters are present but the uterus, fallopian tubes, and upper vagina are absent. This syndrome does not present with webbed neck or widely spaced nipples.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12pt;\">Turner syndrome is characterized by primary amenorrhea, streak ovaries, hypergonadotropic hypogonadism, widely spaced nipples, and a webbed neck.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Ref: William’s textbook of Gynecology 3<sup>rd</sup> edition pg411, Dutta’s textbook of gynecology 6<sup>th</sup> edition pg 441</strong></span></p>",
      "correct_choice_id": 200752,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50189,
      "choices": [
        {
          "id": 200756,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">B and D</span></span></p>"
        },
        {
          "id": 200757,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">B, C and D</span></span></p>"
        },
        {
          "id": 200758,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A, B and C</span></span></p>"
        },
        {
          "id": 200759,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">A and B</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">A patient presented with ipsilateral Horner's syndrome, ipsilateral loss of pain and temperature sensations in the face, vertigo with numbness and loss of sweating, and dysarthria on the contralateral side. All these symptoms are caused due to a lesion in:</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol style=\"list-style-type:upper-alpha\">\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Medial medulla</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Lateral medulla</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Ventromedial medulla</span></span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:\"Times New Roman\",serif\"><span style=\"font-family:\"Calibri\",sans-serif\">Lateral medulla including nucleus ambiguus and spinothalamic tract</span></span></span></li>\r\n</ol>",
      "unique_key": "Q6376529",
      "question_audio": null,
      "question_video": null,
      "map_id": 34331147,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) B and D</strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The clinical scenario describes <strong>lateral medullary syndrome</strong> or <strong>Wallenberg syndrome</strong>, which occurs due to an infarction in the lateral portion of the medulla, typically caused by occlusion of the <strong>posterior inferior cerebellar artery</strong> or <strong>vertebral artery</strong>. The neurological deficits described are consistent with damage to multiple structures in the lateral medulla.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Key features of lateral medullary syndrome include:</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ipsilateral Horner’s syndrome</strong> (miosis, ptosis, anhidrosis) due to damage to descending sympathetic fibers.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ipsilateral loss of pain and temperature sensation on the face</strong> due to involvement of the <strong>spinal trigeminal nucleus</strong>.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Contralateral loss of pain and temperature sensation</strong> on the body due to involvement of the <strong>spinothalamic tract</strong>.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Vertigo and ataxia</strong> due to involvement of the <strong>vestibular nuclei</strong> and <strong>inferior cerebellar peduncle</strong>.</span></span></li>\r\n\t<li><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Dysarthria and dysphagia</strong> due to involvement of the <strong>nucleus ambiguus</strong>, affecting cranial nerves IX and X.</span></span></li>\r\n</ul>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">This pattern of neurological deficits is specific to damage in the <strong>lateral medulla</strong>, including the <strong>nucleus ambiguus</strong> and <strong>spinothalamic tract</strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Lateral medulla</strong>: While this is partly correct, it doesn’t fully describe the involvement of the specific structures (like nucleus ambiguus) responsible for the dysphagia and dysarthria.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Ventromedial medulla</strong>: A lesion in this area would affect motor pathways, such as the corticospinal tract, leading to weakness or paralysis on the contralateral side, which is not described in this patient.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Medial medulla</strong>: Medial medullary syndrome would involve the hypoglossal nerve (cranial nerve XII), causing tongue deviation and contralateral hemiparesis, which is not seen in this case.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Lateral medullary syndrome (Wallenberg syndrome) is caused by an infarction in the <strong>lateral medulla</strong>, affecting structures such as the <strong>spinothalamic tract</strong>, <strong>nucleus ambiguus</strong>, <strong>trigeminal nucleus</strong>, and <strong>sympathetic fibers</strong>, leading to a distinct pattern of ipsilateral and contralateral deficits.</span></span></p>",
      "correct_choice_id": 200756,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50190,
      "choices": [
        {
          "id": 200760,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Junction of thick descending limb and DCT</span></span></p>"
        },
        {
          "id": 200761,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Junction of thick descending limb and PCT</span></span></p>"
        },
        {
          "id": 200762,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Junction of thick ascending limb and DCT</span></span></p>"
        },
        {
          "id": 200763,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Junction of DCT and collecting duct</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Macula densa is made of specialized cells located at: </span></span></p>",
      "unique_key": "Q9250986",
      "question_audio": null,
      "question_video": null,
      "map_id": 34628582,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. C) Junction of thick ascending limb and DCT</strong> </span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>macula densa</strong> consists of specialized cells located at the distal end of the <strong>thick ascending limb of the loop of Henle</strong>, where it meets the <strong>distal convoluted tubule (DCT)</strong>. These cells are part of the <strong>juxtaglomerular apparatus</strong>, which helps regulate blood pressure and filtration rate within the kidneys by monitoring sodium concentration in the filtrate. The macula densa responds to changes in sodium chloride concentration by signaling the juxtaglomerular cells to either increase or decrease renin release, thus impacting the glomerular filtration rate.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options</strong>:</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. Junction of thick descending limb and DCT: </strong>Incorrect. The macula densa is not located at the junction of the <strong>thick descending limb</strong> of the loop of Henle and the DCT. The descending limb is involved in water reabsorption, and its function differs from that of the thick ascending limb.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Junction of thick descending limb and PCT: </strong>Incorrect. The proximal convoluted tubule (PCT) is located at the start of the nephron, near the glomerulus, and does not meet the thick descending limb of the loop of Henle where the macula densa is located.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Junction of DCT and collecting duct: </strong>Incorrect. The <strong>distal convoluted tubule (DCT)</strong> connects to the collecting duct further downstream from the location of the macula densa. The macula densa is specifically positioned near the end of the <strong>thick ascending limb</strong> of the loop of Henle.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective</strong>:</span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>macula densa</strong> is located at the junction of the <strong>thick ascending limb</strong> of the loop of Henle and the <strong>distal convoluted tubule (DCT)</strong>, and is an integral part of the <strong>juxtaglomerular apparatus</strong> responsible for regulating kidney function and blood pressure through the renin-angiotensin-aldosterone system (RAAS).</span></span></p>",
      "correct_choice_id": 200762,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50191,
      "choices": [
        {
          "id": 200764,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Timolol</span></span></p>"
        },
        {
          "id": 200765,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Netarsudil </span></span></p>"
        },
        {
          "id": 200766,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Brimonidine</span></span></p>"
        },
        {
          "id": 200767,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Acetazolamide</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">Which of the following drugs increases trabecular outflow? </span></span></p>",
      "unique_key": "Q4096036",
      "question_audio": null,
      "question_video": null,
      "map_id": 34213564,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. B) Netarsudil </strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The drug that increases trabecular outflow is <strong>Netarsudil</strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Netarsudil is a <strong>rho-kinase inhibitor</strong> used in the treatment and management of <strong>glaucoma</strong> and ocular hypertension. It lowers intraocular pressure (IOP) by directly relaxing the <strong>trabecular meshwork</strong>, thus increasing <strong>aqueous outflow</strong>. It also reduces aqueous humor production. Netarsudil is administered as an ophthalmic solution, typically <strong>one drop</strong> into the affected eye once daily in the evening. Adverse effects may include conjunctival hyperemia and <strong>corneal verticillata</strong>.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option A. </strong><strong>Timolol</strong>: Timolol is a <strong>non-selective β-blocker</strong> that reduces IOP by decreasing aqueous humor production through β-receptor blockade on the ciliary epithelium. Ocular side effects may include allergy, decreased corneal sensation, and punctate keratitis.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. </strong><strong>Brimonidine</strong>: Brimonidine is a <strong>selective alpha-2 agonist</strong>. It reduces aqueous synthesis and increases <strong>uveoscleral outflow</strong>. As it crosses the blood-brain barrier, it may cause <strong>drowsiness</strong> and <strong>CNS depression</strong>. It is contraindicated in infants and young children.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. </strong><strong>Acetazolamide</strong>: Acetazolamide is a <strong>carbonic anhydrase inhibitor</strong> that decreases IOP by reducing aqueous humor formation. It has a <strong>bitter taste</strong> upon administration and is contraindicated in individuals with sulfonamide allergies.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Netarsudil is a <strong>rho-kinase inhibitor</strong> that increases <strong>trabecular outflow</strong> in the treatment of glaucoma and ocular hypertension by relaxing the trabecular meshwork.</span></span></p>",
      "correct_choice_id": 200765,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50192,
      "choices": [
        {
          "id": 200768,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 3, 4</span></span></span></p>"
        },
        {
          "id": 200769,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">3, 4</span></span></span></p>"
        },
        {
          "id": 200770,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">1, 2, 3, 4</span></span></span></p>"
        },
        {
          "id": 200771,
          "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">2, 3, 4</span></span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">A baby is diagnosed with B cell leukemia. All of the following are good prognostic factors except: (INICET NOV 2022)</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Hyperdiploidy</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Age < 1 year</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">t(9;22)</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">t(4;11)</span></span></span></li>\r\n</ol>",
      "unique_key": "Q4723475",
      "question_audio": null,
      "question_video": null,
      "map_id": 34818560,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans. D) 2, 3, 4</span></strong> </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">B-cell acute lymphoblastic leukemia (B-ALL) is a common type of leukemia in children. Prognostic factors play a crucial role in determining the treatment plan and overall outcomes for patients.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">2. Age < 1 year:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Age less than 1 year is considered a poor prognostic factor in B-ALL. Infants with B-ALL typically have a higher risk of relapse and a poorer response to therapy.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3. t(9;22):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This translocation involves the Philadelphia chromosome, which is generally associated with poor prognosis in B-ALL. It leads to the formation of the BCR-ABL fusion protein, which is a marker of poor prognosis.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">4. t(4;11):</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> This translocation is associated with rearrangements of the MLL (Mixed-Lineage Leukemia) gene, which is a poor prognostic factor in B-ALL. It is commonly seen in infants and is associated with a poor outcome.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1. Hyperdiploidy:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> Hyperdiploidy (>50 chromosomes) is actually a good prognostic factor in B-ALL. Children with hyperdiploid B-ALL generally have a better response to therapy and a higher overall survival rate.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Thus, the factors <strong>B (Age < 1 year), C (t(9;22)), and D (t(4;11))</strong> are all poor prognostic indicators, and only <strong>A (Hyperdiploidy)</strong> is a good prognostic factor.</span></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-134221.jpg\" style=\"height:481px; width:1000px\" /></span></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-134221.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200771,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50193,
      "choices": [
        {
          "id": 200772,
          "text": "<p><span style=\"font-size:12.0pt;\">Anemia of chronic disorder</span></p>"
        },
        {
          "id": 200773,
          "text": "<p><span style=\"font-size:12.0pt;\">Thalassemia</span></p>"
        },
        {
          "id": 200774,
          "text": "<p><span style=\"font-size:12.0pt;\">Iron-deficiency anemia</span></p>"
        },
        {
          "id": 200775,
          "text": "<p><span style=\"font-size:12.0pt;\">Sickle cell anemia</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 12-year-old boy was brought to OPD with complaint of fatigue. Serum investigations revealed findings as given below. What is the likely diagnosis? (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Hemoglobin – 9 g/dl</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Mean cell volume (MCV) – 60 fL</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Mean cell Hb (MCH) – 20 pg</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Serum Ferritin – 185 mcg/L</span></p><p> </p><p><span style=\"font-size:12.0pt;\">Total leukocyte count – Elevated lymphocyte and Neutrophils</span></p><p> </p><p><span style=\"font-size:12.0pt;\">[Reference normal values for this question: Serum Ferritin: 50-200 mcg/L; Mean cell volume (MCV) - 80-100 fL; Mean cell Hb (MCH) - 27-31 pg]</span></p>",
      "unique_key": "Q2471819",
      "question_audio": null,
      "question_video": null,
      "map_id": 34848706,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Thalassemia</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The clinical presentation of fatigue, along with laboratory findings, strongly suggests <strong>thalassemia</strong>.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>MCV of 60 fL </strong>and <strong>MCH of 20 pg</strong> are both very low, indicating microcytic hypochromic anemia, which is typical in thalassemia.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Serum ferritin</strong> is within the normal range (185 mcg/L), which rules out iron-deficiency anemia, as that condition would typically present with low ferritin levels.</span></li><li><span style=\"font-size:12.0pt;\">The elevated lymphocyte and neutrophil counts could be a secondary response but are not specific to thalassemia.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\">Thalassemia is characterized by a reduction in the synthesis of globin chains (alpha or beta), leading to ineffective erythropoiesis and anemia. The microcytosis and hypochromia (low MCV and MCH) are hallmarks of this condition.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Anemia of chronic disorder</strong>: Typically presents with normal to reduced MCV and low serum iron, but ferritin is usually raised, not within the normal range.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Iron-deficiency anemia</strong>: Would show low serum ferritin, low MCV, and low MCH, but the serum ferritin here is normal.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Sickle cell anemia</strong>: Would not typically present with low MCV and MCH, as sickle cells tend to be normocytic or macrocytic.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-125253.jpg\" alt=\"\" width=\"1000\" height=\"410\"></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/11/16/screenshot-2023-11-16-125253.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200773,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50194,
      "choices": [
        {
          "id": 200776,
          "text": "<p><span style=\"font-size:12.0pt;\">Ileocolic, right colic and branch of middle colic</span></p>"
        },
        {
          "id": 200777,
          "text": "<p><span style=\"font-size:12.0pt;\">Ileocolic, right colic, stem of middle colic, left colic</span></p>"
        },
        {
          "id": 200778,
          "text": "<p><span style=\"font-size:12.0pt;\">Ileocolic, right colic and trunk of middle colic</span></p>"
        },
        {
          "id": 200779,
          "text": "<p><span style=\"font-size:12.0pt;\">Middle colic only</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A 60-year-old patient has been diagnosed with proximal transverse colon carcinoma. The physician recommends an extended right colectomy as a treatment option. Which arteries should be resected during an extended right colectomy to prevent the spread of cancer in proximal transverse colon carcinoma? (INICET NOV 2022)</span></p>",
      "unique_key": "Q5271774",
      "question_audio": null,
      "question_video": null,
      "map_id": 34132894,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Ileocolic, right colic and trunk of middle colic.</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">During an extended right colectomy, the ileocolic, right colic, and trunk of the middle colic vessels are typically resected to prevent the spread of cancer in proximal transverse colon carcinoma.</span></p><p> </p><p><span style=\"font-size:12.0pt;\">The stem of the middle colic and the left colic artery are not resected during an extended right colectomy as they are not directly involved with the blood supply to the proximal transverse colon. It is important to note that the surgical management of colon cancer depends on the stage and location of the tumor and may involve various surgical techniques, including colectomy and lymphadenectomy.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Types of radical colectomies and vessels ligated:</strong></span></p><p> </p><ol><li><span style=\"font-size:12.0pt;\">Right hemicolectomy: Ileocolic, right colic and right branch of middle colic artery</span></li><li><span style=\"font-size:12.0pt;\">Extended right hemicolectomy: Ileocolic, right colic and stem/origin of middle colic artery</span></li><li><span style=\"font-size:12.0pt;\">Left hemicolectomy: Left colic and sigmoid artery</span></li></ol>",
      "correct_choice_id": 200778,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50195,
      "choices": [
        {
          "id": 200780,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute congestive glaucoma</span></p>"
        },
        {
          "id": 200781,
          "text": "<p><span style=\"font-size:12.0pt;\">Acute anterior uveitis</span></p>"
        },
        {
          "id": 200782,
          "text": "<p><span style=\"font-size:12.0pt;\">Malignant glaucoma</span></p>"
        },
        {
          "id": 200783,
          "text": "<p><span style=\"font-size:12.0pt;\">Corneal ulcer</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">In which of the following is atropine contraindicated? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q1191161",
      "question_audio": null,
      "question_video": null,
      "map_id": 34688724,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Acute congestive glaucoma</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The use of atropine is not recommended in cases of acute congestive or angle closure glaucoma due to the risk of increasing intraocular pressure.</span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Since atropine is a mydriatic, it may lead to the obstruction of the trabecular meshwork by the peripheral iris, causing a sudden increase in intraocular pressure.</span></li><li><span style=\"font-size:12.0pt;\">Dim light can also precipitate an attack.</span><ul><li><span style=\"font-size:12.0pt;\">Atropine may be indicated as a cycloplegic agent to alleviate pain and prevent synechiae formation in corneal ulcers and acute anterior uveitis.</span></li><li><span style=\"font-size:12.0pt;\">In malignant glaucoma, atropine can be the initial management option.</span></li><li><span style=\"font-size:12.0pt;\">In corneal ulcers, atropine is used as an adjuvant therapy, to reduce pain induced by ciliary muscle spasm via its cycloplegic effect.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Acute anterior uveitis</strong>: Atropine is actually beneficial in cases of acute anterior uveitis. It helps to relieve pain by paralyzing the ciliary muscle and preventing the formation of posterior synechiae (adhesions between the iris and the lens), which can complicate uveitis.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Malignant glaucoma</strong>: In malignant glaucoma, atropine might be used as part of the management strategy to try to break the attack by deepening the anterior chamber and pulling the lens-iris diaphragm backward.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Corneal ulcer</strong>: Atropine is used in the treatment of corneal ulcers to provide comfort by relieving the painful ciliary spasm and to prevent synechiae.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Atropine should be used cautiously, and is contraindicated in acute congestive glaucoma due to its potential to exacerbate the condition by further increasing intraocular pressure.</span></p>",
      "correct_choice_id": 200780,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50196,
      "choices": [
        {
          "id": 200784,
          "text": "<p><span style=\"font-size:12.0pt;\">Phenylalanine hydroxylase</span></p>"
        },
        {
          "id": 200785,
          "text": "<p><span style=\"font-size:12.0pt;\">Isovaleryl CoA dehydrogenase</span></p>"
        },
        {
          "id": 200786,
          "text": "<p><span style=\"font-size:12.0pt;\">Fumarylacetoacetate hydrolase</span></p>"
        },
        {
          "id": 200787,
          "text": "<p><span style=\"font-size:12.0pt;\">Branched chain keto acid dehydrogenase</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">Brunt sugar smell of urine is due to the defect of? (</span>INICET Nov 2022)</p>",
      "unique_key": "Q5271346",
      "question_audio": null,
      "question_video": null,
      "map_id": 34006843,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Branched chain keto acid dehydrogenase</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Explanation:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Burnt sugar-like odour is a characteristic feature of Maple Syrup Urine Disease (MSUD) which occurs due to the inherited deficiency of branched chain Keto-acid dehydrogenase/decarboxylase.</span></li><li><span style=\"font-size:12.0pt;\">It results in a defect in oxidative phosphorylation and catabolism of branched-chain amino acids (BCAA) Valine/Isoleucine/leucine. As a result, these amino acids are excreted in urine. There is also mental retardation.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Phenylalanine hydroxylase: </strong>Deficiency of phenylalanine hydroxylase leads to phenylketonuria (PKU), which is characterized by a mousy or musty odor due to the accumulation of phenylalanine and its metabolites.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Isovaleryl CoA dehydrogenase: </strong>Deficiency of isovaleryl CoA dehydrogenase causes isovaleric acidemia, which is associated with a rancid, cheesy, or sweaty feet odor due to the accumulation of isovaleric acid.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fumarylacetoacetate hydrolase: </strong>Deficiency of fumarylacetoacetate hydrolase leads to tyrosinemia type I, which is characterized by a boiled cabbage or rotten mushrooms odor due to the accumulation of tyrosine and its metabolites.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-115715.jpg\" alt=\"\" width=\"1000\" height=\"459\"></strong></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/06/05/screenshot-2024-06-05-115715.jpg\" alt=\"Solution Image\"></p>",
      "correct_choice_id": 200787,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50197,
      "choices": [
        {
          "id": 200788,
          "text": "<p><span style=\"font-size:12.0pt;\">Standard deviation</span></p>"
        },
        {
          "id": 200789,
          "text": "<p><span style=\"font-size:12.0pt;\">Variance</span></p>"
        },
        {
          "id": 200790,
          "text": "<p><span style=\"font-size:12.0pt;\">Mean</span></p>"
        },
        {
          "id": 200791,
          "text": "<p><span style=\"font-size:12.0pt;\">Median</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">What does the provided formula correspond to? (INICET NOV 2022)</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture8666.jpg\" alt=\"\" width=\"400\" height=\"257\"></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/27/picture8666.jpg\" alt=\"Question Image\"></p>",
      "unique_key": "Q5840382",
      "question_audio": null,
      "question_video": null,
      "map_id": 34757604,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Standard deviation</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">The formula given represents the <strong>standard deviation</strong>, which measures the amount of variation or dispersion of a set of values.</span></li><li><span style=\"font-size:12.0pt;\">It is the square root of the variance, where the variance is the average of the squared differences from the mean.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Standard deviation</strong>: This is the deviation of each value from the standard value (mean). It provides insight into the spread of the data points around the mean.</span></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option B</strong>. <strong>Variance</strong> = (Standard deviation)<sup>2</sup>. It represents the average of the squared deviations from the mean.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option C.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Mean</strong> is obtained as the sum of all values divided by the number of values. It is not affected by extreme values.</span></p><p> </p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> </span><span style=\"font-size:12.0pt;\"><strong>Median</strong> is the middle most value in a distribution arranged in an ascending or descending order of values.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\">Standard deviation is the deviation of each value from the standard value [Mean].</span></li></ul>",
      "correct_choice_id": 200788,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50198,
      "choices": [
        {
          "id": 200792,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Babinski sign</span></span></p>"
        },
        {
          "id": 200793,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Withdrawal reflex</span></span></p>"
        },
        {
          "id": 200794,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Grasp reflex</span></span></p>"
        },
        {
          "id": 200795,
          "text": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">Plantar reflex</span></span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\">What is depicted in the following image? </span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12.0pt\"><span style=\"font-family:\"Calibri\",sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/08/screenshot-2024-10-08-162622.png\" style=\"height:172px; width:300px\" /></span></span></p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/10/08/screenshot-2024-10-08-162622.png\" alt=\"Question Image\"></p>",
      "unique_key": "Q5348084",
      "question_audio": null,
      "question_video": null,
      "map_id": 34831978,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Ans. A) Babinski sign</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The image depicts the <strong>Babinski sign</strong>, also known as the plantar reflex test, where the lateral aspect of the sole is stroked. In an abnormal or positive Babinski sign (as seen in upper motor neuron lesions), the great toe dorsiflexes, and the other toes fan out. This reflex is commonly tested to assess neurological function, particularly in conditions affecting the corticospinal tract.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The Babinski sign is normal in infants up to 2 years old due to the immaturity of the corticospinal pathways but is abnormal in older children and adults.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Other Options:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option B. Withdrawal reflex</strong>: The withdrawal reflex is a protective reflex that causes an involuntary retraction of a body part from a painful stimulus. It does not involve the fanning of toes or dorsiflexion of the great toe.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option C. Grasp reflex</strong>: The grasp reflex involves an involuntary flexing of the fingers or toes when the palm of the hand or sole of the foot is stimulated. It is seen in infants but is not the reflex being tested in this image.</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D. Plantar reflex</strong>: The plantar reflex refers to the downward (plantar) flexion of the toes when the sole of the foot is stroked. This is the normal response in adults, but in this case, the image shows the abnormal response (Babinski sign).</span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Educational Objective:</strong></span></span></p>\r\n\r\n<p> </p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\">The <strong>Babinski sign</strong> involves dorsiflexion of the great toe and fanning of the other toes when the lateral aspect of the sole is stroked. This sign is abnormal in adults and older children, indicating an upper motor neuron lesion.</span></span></p>",
      "correct_choice_id": 200792,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    },
    {
      "id": 50199,
      "choices": [
        {
          "id": 200796,
          "text": "<p><span style=\"font-size:12.0pt;\">There is hypertrophy of ductus arteriosus.</span></p>"
        },
        {
          "id": 200797,
          "text": "<p><span style=\"font-size:12.0pt;\">Coarctation distal to the origin of the left subclavian artery</span></p>"
        },
        {
          "id": 200798,
          "text": "<p><span style=\"font-size:12.0pt;\">Supply is from posterior to anterior thoracic artery.</span></p>"
        },
        {
          "id": 200799,
          "text": "<p><span style=\"font-size:12.0pt;\">Collaterals develop to supply upper limb.</span></p>"
        }
      ],
      "text": "<p><span style=\"font-size:12.0pt;\">A child presents with cold feet and a history of wearing socks even in the summers. On examination, lower limb pulses are diminished as compared to the radial pulse. Prominent radio femoral delay is present. What is the underlying condition? (INICET NOV 2022)</span></p>",
      "unique_key": "Q8152167",
      "question_audio": null,
      "question_video": null,
      "map_id": 34688950,
      "difficulty_level": "intermediate",
      "subjects_id": [],
      "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Coarctation distal to the origin of the left subclavian artery</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">The clinical presentation of cold feet, wearing socks even in summer, diminished lower limb pulses compared to radial pulses, and prominent radiofemoral delay is characteristic of <strong>coarctation of the aorta</strong>. This congenital condition is characterized by a narrowing (coarctation) of the aorta, typically just distal to the origin of the left subclavian artery at the ductus arteriosus.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Key Points:</strong></span></p><p> </p><ul><li><span style=\"font-size:12.0pt;\"><strong>Coarctation of the Aorta: </strong>This condition results in the obstruction of blood flow, leading to higher blood pressure in the upper limbs and lower blood pressure in the lower limbs. The radiofemoral delay is a classic sign.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Location of Coarctation:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Postductal Coarctation (Adult Type): </strong>The constriction occurs distal to the ductus arteriosus. This type is more common and leads to the development of collateral circulation to bypass the obstruction.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Predductal Coarctation (Infantile Type): </strong>The constriction occurs proximal to the ductus arteriosus, leading to different clinical features and often presenting in infancy.</span></li></ul></li><li><span style=\"font-size:12.0pt;\"><strong>Clinical Features:</strong></span><ul style=\"list-style-type:circle;\"><li><span style=\"font-size:12.0pt;\"><strong>Cold feet </strong>and preference for wearing socks may be due to poor perfusion in the lower extremities.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Diminished lower limb pulses </strong>and <strong>radiofemoral delay</strong> are hallmark signs.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Hypertension </strong>in the upper extremities due to the coarctation.</span></li></ul></li></ul><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Hypertrophy of ductus arteriosus: </strong>This condition does not cause radiofemoral delay or the constellation of symptoms seen in coarctation of the aorta.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Supply from posterior to anterior thoracic artery: </strong>This does not explain the clinical presentation, especially the radiofemoral delay.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Collaterals develop to supply upper limb: </strong>Collateral circulation is a compensatory mechanism that develops over time in coarctation of the aorta, primarily to supply blood to the lower extremities, not just the upper limbs.</span></p><p> </p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p> </p><p><span style=\"font-size:12.0pt;\">Coarctation of the aorta typically presents with cold feet, diminished lower limb pulses, and radiofemoral delay due to a narrowing of the aorta distal to the origin of the left subclavian artery.</span></p>",
      "correct_choice_id": 200797,
      "solution_audio": null,
      "solution_video": null,
      "audio_explanation_heading": null,
      "video_explanation_heading": null,
      "solution_media_position": "bottom",
      "tags": [],
      "explanation_video": null,
      "question_images": [],
      "explanation_images": []
    }
  ]
}